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P1 The conditioning of medical gases with hot water humidifiers
D Chiumello, M Cressoni, C De Grandis, L Landi, M Racagni
Policlinico IRCCS, Milano, Italy
Critical Care 2004, 8(Suppl 1):P1 (DOI 10.1186/cc2468)
During invasive mechanical ventilation due to the dryness of
medical gases is necessary to provide an adequate level of
conditioning. The hot water humidifiers (HWH) heat the water, thus
allowing the water vapor to heat and humidify the medical gases. In
the common HWH there is a contact between the medical gases
and the sterile water, thus increasing the risk of patient’s
colonization and infection. Recently to avoid the condensation in
the inspiratory limb of the ventilator circuit, new heated ventilator
circuits have been developed. In this in vitro study we evaluated
the efficiency (absolute/relative humidity) of three HWH: (1) a
common HWH without a heated ventilator circuit (MR 730,
Fisher&Paykel, New Zeland), (2) the same HWH with a heated
ventilator circuit (Mallinckrodt Dar, Italy) and (3) a new HWH (DAR
HC 2000, Mallinkckrodt Dar, Italy) with a heated ventilator circuit in
which the water vapor reaches the medical gases through a
gorotex membrane, avoiding any direct contact between the water
and gases. At a temperature of 35°C and 37°C the HWH and
heated tube were evaluated.
The absolute humidity (AH) and relative humidity (RH) were
measured by a psychometric method. The minute ventilation, tidal
volume respiratory rate and oxygen fraction were: 5.8 ± 0.1 l/min,
740 ± 258 ml, 7.5 ± 2.6 bpm and 100%, respectively. Ventilator
settings were maintained constant for all the study period. The
measurements were taken after 60 min of continuous use.
At 35°C the output of the MR 730 with a heated tube was
insufficient to provide adequate levels of conditioning, while at
37°C all the three devices were satisfactory.
Table 1
Results as mean ± SD
MR 730
heated tube Dar HC MR 730
Set temperature, 35°C
AH (mgH2O/l) 26.7 ± 0.3* 37.4 ± 0.6 38.0 ± 0.9
RH (%) 83.7 ± 1.0* 97.7 ± 1.4 93.2 ± 1.5
Set temperature, 37°C
AH (mgH2O/l) 34.5 ± 1.6* 38.7 ± 2.2† 43.1 ± 1.1
RH (%) 91.8 ± 3.2 87.7 ± 7.4† 94.6 ± 0.9
*P < 0.05 vs DAR HC and MR 730, †P < 0.05 vs MR 730.
P2 Use of a bougie during percutaneous tracheostomy
M Read
University Hospital, Cardiff, UK
Critical Care 2004, 8(Suppl 1):P2 (DOI 10.1186/cc2469)
Airway techniques for percutaneous tracheostomy include the LMA,
the Combitube, the Microlaryngeal tube and the Perforated Airway
Exchanger. Routine bronchoscopy is deemed unnecessary by many,
including intensivists in Cardiff. Our audit database stores patient
characteristics, techniques and complications, in 700 tracheostomies.
A bougie was used during 46. This technique does not use
bronchoscopic control. A bougie is passed through the tracheal tube
(TT) into the trachea. The TT is withdrawn until the cuff is above the
vocal cords. With the cuff fully inflated, the TT is advanced (using the
bougie as a guide) until the cuff impacts on the vocal cords. A gas-
Table 1
Complications (type) Number
Visible cut in bougie 2a
TT not pulled back far enough 2b
Bougie in Murphy eye of TT 1c
Failure to advance blue rhino 1d
Bleeding 1e
Late complication 2f
aIn one case the seldinger needle also blocked by bougie material. One
patient was in a hard collar. bIn one case, the seldinger needle
perforated the TT cuff and the TT prevented tracheostomy cuff sealing.
In one case, the seldinger wire passed through Murphy eye of TT and
the dilation process caused the TT to advance into the trachea. The
second passage of the dilator was done with bronchoscopic control.
cCaused no problems. dPatient previous tracheostomy: serial dilator
technique used. eThrombocytopaenic patient. No damage seen on
bronchoscopy. fInfected stoma at 5 days, pneumopericardium at 4 days.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
seal is maintained by gentle pressure on the TT keeping the cuff
pressing on the vocal cords. During percutaneous tracheostomy the
bougie remains in the trachea. When ventilation through the
tracheostomy tube (cuff inflated) is confirmed, the TT and bougie are
withdrawn. Throughout the procedure, if ventilation difficulties occur,
the TT can be easily re-inserted using the bougie as a guide.
Results Three different bougies were used: types (number used)
were Eschmann (29), size 10 Portex disposable (four) and size
12 Portex disposable (13). Three patients were trauma cases: a
neutral cervical position was maintained. In 33 cases the Blue
Rhino dilator and in 12 cases the Ultra-Perc (White Rhino) dilator
was used. One case was a serial dilator (see later).
Conclusion The bougie for airway control for percutaneous
tracheostomy was associated with zero hypoxic episodes in
46 cases. Minor bougie damage in two cases caused no problems.
Other complications seen were either minor or unlikely to be due to
the bougie.
P3 Percutaneous dilational tracheostomy in critically ill patients: progressive vs single dilatation techniques
S Zaky, K Atya
Kasr Al-Eini Hospital, Cairo, Egypt
Critical Care 2004, 8(Suppl 1):P3 (DOI 10.1186/cc2470)
Objectives To report experience with the bedside percutaneous
dilatational tracheostomy (PDT) in critically ill patients. To compare
two different methods of PDT, namely progressive and single
dilatation techniques.
Design Prospective observational study.
Patients Eighteen surgical or medical ICU patients (10 male, mean
age 32.8 ± 17 years) in a tertiary university hospital requiring
tracheostomy for airway control or prolonged mechanical ventilation.
Interventions Patients were randomized to receive PDT by either
the multiple progressive dilatation method (group A, eight patients)
or single dilatation technique (group B, 10 patients) as described
by Ciaglia.
Results Bedside PDT was performed successfully in ICU for all
18 patients in a mean time of 17.5 ± 14 min (range 5–60 min).
Single dilatation technique had a significantly lower operative time
than the multiple dilation group (9.5 ± 6 min vs 27.5 ± 15 min,
P < 0.005). Complications were significantly higher in group A
(false passage in one, moderate bleeding in one, minor bleeding in
two, conversion of the procedure to open tracheostomy in one
patient due to isthmus bleeding). On the other hand there was only
minor bleeding in one patient of group B.
Conclusion PDT is a safe and cost-effective procedure in ICU
critically ill patients. The single dilatation method is an even more
rapidly performed bedside method than the progressive dilation
method.
P4 Percutaneous dilatational tracheostomy — a comparison of three methods: Ciaglia Blue Rhino, PercuTwist and Griggs’
Guidewire Dilation Forceps (GWDF)
J Schiefner, K Magnusson, U Zaune, E Vester
Evangelisches Krankenhaus, Duesseldorf, Germany
Critical Care 2004, 8(Suppl 1):P4 (DOI 10.1186/cc2471)
Introduction In contrast to conventional surgical tracheostomy,
percutaneous dilational tracheostomy (PDT) in different variants is
spreading rapidly in intensive care units today. On two intensive
care units — cardiological and surgical–anaesthesiological — we
performed a comparative investigation of three PDT methods in a
prospective randomized study with an emphasis on clinical utility
and safety.
Methods Thirty-one patients (age 64 ± 13 [mean ± SD]) were
enrolled, PDT were performed in three groups, 10 Ciaglia Blue
Rhino (Cook), 10 PercuTwist (Rüsch) — a device employing a
screw with a hydrophilic coating and 11 GWDF — using Griggs’
specially designed dilational forceps (Portex). Duration of
intervention, oxygenation parameters, blood loss and further
complications peri-interventionally and postinterventionally were
recorded and compared.
Results We found significant differences in the duration of
procedures: Blue Rhino 5.9 ± 3.7 min, PercuTwist 11.7 ± 9.35 min,
GWDF 3.3 ± 1.65 min (P < 0.02). Two PercuTwist procedures
proved technically difficult — insufficient penetration depth of the
Percu Twist device and formation of a pre-tracheal via falsa,
successful tracheostoma placement was achieved only after a
procedural switch to Blue Rhino. One of these cases led to
significant blood loss. Pre-interventional and postinterventional
values for Hb were 10 ± 1.8 g/dl and 9.9 ± 1.2 g/dl in the Blue
Rhino group, 10.4 ± 1.8 g/dl and 10.3 ± 1.9 g/dl in the
PercuTwist, and 9.8 ± 0.8 g/dl and 9.57 ± 1.4 g/dl in the GWDF
group (n.s.). Oxygenation remained unchanged early after
intervention with a tendency towards a better PaO2/FiO2 in the
GWDF group. Three cases of cartilage fracture were recorded.
We saw no severe lasting desaturation episodes. We found no
stomal infections and no other life-threatening events. Surgical
intervention was never required. Mortality in all groups was 42%
with no procedure-related deaths. Thirteen patients have been
permanently decanulated.
Conclusion The three methods investigated in this study show
comparable feasibility, clinical utility, lack of severe complications
and margin of patient safety under the conditions of a secondary
academic teaching hospital. However, the PercuTwist method
revealed technical limitations in particular in the presence of a wide
tracheo-cutaneous distance. Shortest intervention durations were
achieved using the GWDF. To provide evidence of relevant
differences — especially regarding long-term outcome — further
comparative studies are indispensable.Available online http://ccforum.com/supplements/8/S1
P5 Optimal approach to the tracheostomy technique in critically ill patients with a short fat neck
I Dor, M Croitoru, S Krimerman, S Nicola, E Sabo, E Altman
Bnai Zion Medical Center, Haifa, Israel
Critical Care 2004, 8(Suppl 1):P5 (DOI 10.1186/cc2472)
Background and goal of study To examine and to compare our
experience with surgical tracheostomy (ST) and percutaneous
tracheostomy (PCT) in the critically ill patients with a short fat neck.
Nowadays PCT is widely used for prolonged mechanical
ventilation in critically ill patients with normal neck anatomy instead
of ST. Indications for PCT in adverse anatomical conditions like a
short fat neck are still under discussion due to minimal positive
experience.
Materials and methods From January 1998 to August 2003, a
group of 42 critically ill patients with obesity or overweight
underwent tracheostomy for prolonged mechanical ventilation.
During the first 3 years only ST was used in 18 patients, but from
2000 to 2003 PCT by Griggs technique was performed in
24 patients. ST was done by standard technique under general
anesthesia (GA) in the operating room. PCT was performed as a
bedside procedure under GA by one trained team including a
general surgeon and anesthesiologist. Hospital records were
reviewed retrospectively for patients’ demography, weight, height,
and anatomical characteristics of the neck, duration of the
procedure, and complications.
Results There was no difference in the sizes of the neck between
the ST patients (mean=47.1cm, median=47cm, range= 45–51cm)
and the PCT patients (mean = 47.3 cm, median = 47 cm,
range = 45–53 cm) (P = 0.9). The distance between the cricoid
and sternal notch was small (ST group: mean = 1.35 cm,
median = 1.35 cm, range = 0.5–1.9 cm, and PCT group:
mean = 1.37 cm, median = 1.5 cm, range = 0.5–1.9 cm) without
significant differences between the groups (P = 0.83). In both
groups of patients tracheostomy was done without bleeding,
paratracheal insertion of the tracheostomy tube or loss of airway
control. Duration of the procedure for the ST group was
mean = 41 min, median = 41 min, range = 40–45 min, and for
the PCT group duration was mean = 10.7 min,
median = 11 min, range = 10–12 min, with P < 0.0001. In the
early postoperative period we met three hemorrhagic
complications after ST, and four after PCT, which were treated
conservatively (difference not significant P > 0.05). However,
inflammation occurred after ST in six patients and after PCT in
one patient (P < 0.03, odds ratio = 11.5). There was no
operative mortality in both groups.
Conclusions Both techniques provided good results in
experienced hands. However, our study demonstrated that PCT
was less traumatic, had a shorter procedure time and better
healing of tissues around the tracheostomy tube in comparison
with ST.
P6 Evaluation of virtual laryngo-tracheoscopy in upper airway examination after percutaneous tracheostomy
S Croitoru, I Dor, M Croitoru, S Krimerman, L Abramovski, E Altman
Bnai Zion Medical Center, Haifa, Israel
Critical Care 2004, 8(Suppl 1):P6 (DOI 10.1186/cc2473)
Introduction The aim of this study is to evaluate possibilities of the
virtual laryngo-tracheoscopy (VLT) technique for diagnosis of different
deformations in the laryngo-tracheal region after percutaneous
tracheostomy (PCT). PCT is a well-established procedure for the
treatment of critically ill patients, who need prolonged mechanical
ventilation. Fiberoptic laryngo-tracheoscopy is often required for the
follow-up of these patients. This procedure, however, involves
discomfort and cannot always be used in critically ill patients.
Materials and method We examined 26 patients (18 males and
eight females) who were recruited from intensive care unit patients
after PCT. Examinations were performed between a few days and
12 months following PCT and decannulation on a multidetector CT
scanner (General Electric Medical System Lightspeed) using the
following parameters: 120 kV, 80 mA, rotation = 0.8 s, pitch = 6,
slice thickness = 2.5 mm, overlap = 1.8 mm, acquisition time =
10–12 s. Navigation through the laryngo-tracheal lumen as well as
reformatted coronal and sagittal images were performed on a
GE AW 4 workstation. The diameters of the larynx and cervical
trachea were accurately measured.
Results The pathological changes were mural granulations,
tracheal wall flap, and a polypoid mass in the tracheal wall.
Conclusions VLT allows the dynamic assessment of the central
airway and the diagnosis of mural deformities and stenosis. Being
noninvasive and short in time, requiring no patient preparation, VLT
is ideal for studying the larynx and trachea in former critically ill
patients. This technique may offer an alternative to the fiberoptic
laryngo-tracheoscopy examination.
P7 Influence of fiberoptic bronchoscopy through the endotracheal tube on ventilation parameters during mechanical
ventilation
M Croitoru, I Dor, S Krimerman, E Sabo, E Altman, U Teitelman
Bnai Zion Medical Center, Haifa, Israel
Critical Care 2004, 8(Suppl 1):P7 (DOI 10.1186/cc2474)
Background and goal of study Fiberoptic bronchoscopy (FOB) is
widely used in intensive care unit practice for percutaneous
tracheostomy, for diagnostic evaluation and for toilet of the tracheo-
bronchial tree. The risk of hypoventilation, and even life-threatening
airway obstruction due to use of FOB is known. The aim of this study
was to estimate the influence of flow, ratio between the endotracheal
tube (ETT) and FOB diameter (RTBD), respiratory rate, tidal volume
and pulmonary compliance, on mechanical ventilation parameters.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
Materials and methods Simulation experiment tests were done
on a training/test lung (Model 5601l, adult TTL; Michigan
Instruments Inc.). In the first series standard mechanical
ventilation through the ETT (7.5, 8, 9) with stable parameters and
different lung compliance was performed. In the second series,
experiments with the same ETT and ventilation parameters were
done with addition of FOB (pediatric and adult) that was inserted
inside the ETT to simulate the process of FOB during mechanical
ventilation. The increases in mean intrapulmonary pressure
(MIPP) and in the positive end expiratory pressure (PEEP) values
were estimated during the simulated procedure. The increase in
the integrated MIPP and PEEP values after stabilization of the
system was determined by computing the area between the
desired and the measured intrapulmonary pressure and PEEP.
This area was calculated using an image analysis software
(ImagePro 4.5). A multivariate regression method was applied
and a predictive formula was computed using the regression
coefficients of the statistically significant independent predictors
of MIPP.
Results and discussion For each ETT permissible size of FOB
and optimal rate respirations were estimated. Possible deviations
in ventilation parameters due to discrepancy between the size of
the ETT and the size of FOB were studied. The MIPP was best
predicted by the respiratory rate and RTBD. The increase in the
respiratory rate and the simultaneous decrease of the RTBD
determined the rise of MIPP and PEEP values.
Conclusion Our study found the reasons for undesirable
deviations of ventilation parameters connected with the insertion of
FOB in the ETT during mechanical ventilation. Hence, it is possible
to improve the airway management by the rational choice of FOB
size and ventilation parameters in relation to patients’ respiration
rate and diameter of ETT.
P8 Neonatal and pediatric noninvasive ventilation via single nasal tube
W Lesiuk, L Lesiuk
University Pediatric Hospital, Lublin, Poland
Critical Care 2004, 8(Suppl 1):P8 (DOI 10.1186/cc2475)
Objectives In clinical practice an attempt was made to provide
adequate ventilation by the use of noninvasive intermittent
mandatory ventilation (N-IMV) in the cases of apnea of prematurity,
infant hypodynamic respiratory insufficiency and bronchopulmonary
dysplasia (BPD)-caused respiratory insufficiency. Advantages of
N-IMV oppose the risk of stomach distension and regurgitation due
to high tension of the pylorus combined with inadequate cardia
tension. The aim of the study was the evaluation of the
effectiveness of N-IMV via a single nasal tube combined with the
prone position to avoid a risk of abdominal distension.
Methods  Sixty-four newborns with extremely low birth weight
(ELBW) and very low birth weight (VLBW), and 21 infants (five
with hypodynamic respiratory insufficiency, 16 with BPD-caused
respiratory insufficiency) treated with N-IMV were examined during
3 years of studies. Patients meeting the following criteria were
qualified for the studies: ineffective nasal continuous positive
pressure (N-CPAP) combined with intravenous aminophylline
loading, recurrent apnea, hypercarbia (PaCO2 > 60 mmHg in
neonate group, PaCO2 > 70 mmHg in BPD group). N-IMV was
applied through single nasal cannula placed at 3.5–5.0 cm,
depending on the patient’s age. Ventilation was started at the rate
of 10 breaths/min (f) with positive inspiration pressures (PIP) of
12 cmH2O and inspiration time (IT) of 0.35 s (constant) until
adequate ventilation was reached, with maximum
f = 35 breaths/min, PIP = 17 cmH2O. Patients were kept in the
prone position with the head and upper body parts elevated by
30°.
Results  The mean noninvasive nasal IMV time in the group of
newborns with ELBW was 18 days and in the VLBW group was
11 days. The mean ventilation time in the infant group was 39 days.
In all but three children the use of nasal intermittent mandatory
ventilation resulted in decreased incidence of apnea, normoxemia
and normocapnia. In one case intubation was required, probably
due to pneumonia, which was correlated to the incidence of
regurgitation.
Conclusions  (1) Satisfactory levels of SaO2 and pCO2 were
achieved without endotracheal tube placement during N-IMV
applied via single nasal cannula. (2) Failure and complications risks
are low in study conditions.
P9 A new way of noninvasive ventilation in ICU patients. An innovation modification of the continuous positive airway
pressure (CPAP) face mask Boussignac–Vygon in order to use it in chronic obstructive pulmonary disease (COPD) 
(type II) patients
S Papanikolaou1, P Polakis2, S Papanikolaou2, V Niakas2, M Daveronas2, O Iordanidou2, G Tasopoulos2, Th Tsouka2, M Polaki2, L Lira2
1General Hospital Pireus, Athens, Greece; 2Athens Medical Center — ‘Iasis’ Hospital ICU, Greece
Critical Care 2004, 8(Suppl 1):P9 (DOI 10.1186/cc2476)
Introduction  Noninvasive mechanical ventilation (NIMV) is the
support of the ventilation of the patient using kinds of mechanical
means but without intubation. The advantages of NIMV are well
known (autonomous interruption and adaptation, intervals in use,
self-performed, no humidification needed, no sedation, possibility
of expectorations, coughing, talking, feeding, and so on) and the
disadvantages of IMV (during intubation [spasm, heart attack,
dilatation of stomach], during IMV obstruction, ventilator-
associated pneumonia [VAP], take-off, after intubation,
tracheostomia).
Among different types of NIMV (negative pressure [iron lung],
positive pressure [intermittent positive pressure ventilation,
spontaneous intermittent mechanical ventilation, PSV, BiPAP, PAV],
CPAP), in recent years a face CPAP mask (Boussignac–Vygon) has
been developed and used in a mode of CPAP ventilation. An O2
supply is used to create through a special valve mechanism
continuous positive pressure in the airways. Although this mask is
very effective to correct hypoxemia, it has two serious disadvantages:
(1) it uses very high flow of O2 to create an effective CPAP, resulting
in an uncontrolled FiO2 more than 60% (up to 95%) in the majorityAvailable online http://ccforum.com/supplements/8/S1
of cases; (2) it cannot be used in COPD II patients because the high
FiO2 obligatory used overtreats hypoxemia ending not in correction,
but in exacerbation of hypercapnia.
Method  We modified the face mask Boussignac–Vygon
(commercially available): we created a new income on the mask to
supply O2 in full control of the FiO2 and we use the valve mechanism
of the mask to create the CPAP needed, by supplying air (21% O2).
The flow of the air was ‘guided’ from the level of the CPAP we need
to create. The flow of O2 was guided from the FiO2 we need to
supply in order to oxygenate the patient but not to overtreat him/her.
Purpose Our purpose was to be able to fully control (1) the FiO2
of the O2 we supply and (2) the level of CPAP we want to adjust in
order to best treat the patient, avoiding the intubation and improve
the outcome of the patients.
Results We treated 58 critically ill patients in Iasis Hospital ICU
and classified them in three groups:
1. Postoperative respiratory sedation: six patients (postoperative
respiratory insufficiency due to delayed action of anesthesia
drugs who were treated with modified-CPAP avoiding re-
intubation in all but one).
2. Difficult weaning: seven patients (we succeed to extubate
them using m-CPAP although they fulfill the criteria for IMV);
no-one was re-intubated.
3. Acute respiratory failure: 45 patients in three subgroups:
(a) seven patients postoperative respiratory failure (RF) (one
intubated),
(b) seven patients cardiogenic RF (three intubated), and
(c) 31 patients RF due to pulmonary infection, eight intubated
(in this group 11 patients are COPD-II, one intubated)
Conclusions (1) NIMV using CPAP mask ventilation was
successful in 83% of cases. (2) The M-BV CPAP face-mask
allows controlled oxygenation in circumstances of CPAP-NIMV.
This modification allows it to be used in patients with COPD
(type II).
P10 Which positive end expiratory pressure (PEEP) should be used during noninvasive positive pressure ventilation (NPPV) in
acute lung injury/acute respiratory distress syndrome (ALI/ARDS) patients?
M Pincelli, M Park, C Jardim, C Carvalho, C Barbas
University of São Paulo Medical School, São Paulo, Brazil
Critical Care 2004, 8(Suppl 1):P10 (DOI 10.1186/cc2477)
Objective To establish the effects of different levels of PEEP on
blood oxygenation and intra-abdominal pressurization (IAP), in
order to select a sufficient level of PEEP during NPPV of ALI/
ARDS patients.
Methods Six early ALI/ARDS patients, four male/two female, aged
49.67 ± 16.28 years, paO2/FIO2 = 202.50 ± 79.69, with bilateral
infiltrates on thoracic roentgenogram, APACHE II = 15.67 ± 5.43,
were prospectively studied.
Patients were ventilated on a BIPAP Vision. Pressure support was
fixed at 10 cmH2O. EPAP (PEEP) was applied at 5, 8, 11, 14, 17
and 20 cmH2O. paO2/FiO2 and gradients between paCO2 and
EtCO2 were calculated after 20 min at each level of EPAP. IAP
was measured through intravesical catheters. Arterial blood
pressure (ABP) and heart rate (HR) were continuously monitored.
Results Increased levels of EPAP had positive effects on oxygenation
and little effect on IAP and on hemodynamic features, showing that
most of the applied pressure was dissipated at the respiratory system,
probably recruiting collapsed alveolar units (Table 1). Mean EPAP
was 12 ± 4.90 cmH2O (range = 8–20 cmH2O). Only one of these six
patients was invasively ventilated. All patients survived.
Conclusions These EPAP levels have improved gas exchange
without aditional abdominal distension. These preliminary results of
high survival should mean that an adequate level of EPAP has been
chosen.
Table 1
EPAP level (cmH2O)
0581 1 1 4 1 7 2 0
paO2/FIO2 202.50 ± 79.69* 234.68 ± 79.69* 217.85 ± 79.13 242.03 ± 69.54 240.12 ± 77.83 279.52 ± 94.31* 279.07 ± 83.26*
paCO2–EtCO2 4.30 ± 3.44 6.82 ± 4.10 7.18 ± 3.97 4.43 ± 3.83 6.70 ± 3.44 6.92 ± 4.94 6.40 ± 3.53
IAP 16.50 ± 6.25 16.17 ± 6.27 16.75 ± 7.0 18.50 ± 4.88 18.67 ± 4.84 19.75 ± 5.67 19.25 ± 4.58
ABP 96.50 ± 17.66 96.00 ± 14.90 93.83 ± 20.25 91.67 ± 22.0 90.33 ± 20.64 91.17 ± 21.18 94.50 ± 20.81
HR 85.67 ± 19.10 80.83 ± 20.15 78.50 ± 14.35 76.33 ± 13.63 76.67 ± 13.72 79.00 ± 13.78 79.17 ± 14.97
*P < 0.05 (ANOVA/Bonferroni correction).
P11 Noninvasive high frequency jet ventilation for patients with cardiogenic pulmonary oedema
T Lazowski, G Opolski, P Andruszkiewicz
Warsaw Medical University, Warsaw, Poland
Critical Care 2004, 8(Suppl 1):P11 (DOI 10.1186/cc2478)
Background and goal of study During past years one can
observe an increase in the use of noninvasive ventilation (NIV)
fuelled by advances in technology and clinical trials evaluating its
use [1]. Acute respiratory failure (ARF) due to cardiogenic
pulmonary oedema (CPO) is typical indication for NIV.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
Materials and methods In our preliminary study we studied eight
patients with ARF due to CPO ventilated noninvasivelly with high
frequency jet ventilation (HFJV). A Paravent PAT E jet ventilator
was used (FiO2 = 0.6,  f = 2 Hz). PaO2, PaCO2, pH, saturation
were measured and dyspnoea was estimated before and every
30 min of ventilation.
Results and discussions PaO2 values before and during HFJV
are shown in Fig. 1. Mean ventilation time was 4 hours. In
1/8 patients HFJV was ineffective; the patient (no. 8) was intubated
and ventilated conventionally.
Conclusions In patients with ARF due to CPO noninvasive HFJV
is: (1) effective in reversing life-threatening hypoxemia and
respiratory acidosis; (2) well tolerated by patients.
Reference
1. Rabatin JT: Mayo Clin Proc 1999, 74:817-820.
Figure 1
Introduction We asked whether there are differences in breathing
comfort between ventilators using blowers or valves for flow
generation. We also studied Zeus®, a new anaesthesia workstation
with a closed breathing circuit that allows augmentation of
spontaneous breathing.
Methods Eleven healthy, awake volunteers (six female, five male;
35 ± 6 years) supplied with fixed standard nose masks
(Respironics) were connected to seven different ventilators. Three
were blower based: BiPAP Vision® (Respironics), Breas LTV
1000® (Pulmonetic Systems), Zeus® (Dräger Medical); and four
were valve based: Evita 2® (Dräger Medical), PB 840® and
PB 7200® (Puritan Bennett), Veolar®  (Hamilton Medical). Four
ventilatory modes were used: continuous positive airway pressure
(CPAP) (positive end expiratory pressure [PEEP] 3 mbar), pressure
support ventilation (PSV) (pressure support [PS] 5 mbar, PEEP
3 mbar), pressure-controlled synchronized intermittent mandatory
ventilation (PC-SIMV) (10 bpm, Pinsp 10 mbar, PS 5 mbar, PEEP
3 mbar), and volume-controlled synchronized intermittent
mandatory ventilation (VC-SIMV) (10 bpm, VT 6 ml/kg, PS 5 mbar,
PEEP 3 mbar). Volunteers were instructed to breathe freely for a
few minutes. Sixteen questions concerning cycling and breathing
effort during inspiration (I) and expiration (E) had to be answered
on a scale from 1 (very good, extremely comfortable) to 5 (very
poor, extremely uncomfortable). Two final questions evaluated
breathing comfort during I and E as a whole. SPSS® 11.0,
ANOVA, P < 0.05.
Results Breathing comfort differed significantly between the
ventilatory modes (VC < PC < PSV < CPAP; P < 0.001). To
compare ventilators, PC-SIMV and VC-SIMV were excluded, as
BiPAP Vision® is not capable of delivering these modes. During E
blower-based ventilators were scored better (2.2 ± 1.0 versus
2.6 ± 0.9; Fig. 1).
Conclusions Awake volunteers experience PC and VC ventilatory
modes — although synchronized and with supported spontaneous
breaths — as extremely unpleasant. Differences between ventilators
are far less, but during expiration blower-based ventilators scored
better than valve based. Despite its totally closed breathing circuit,
Zeus® belonged to the more comfortable group of ventilators.
P12 Comfort of different types of ventilators in noninvasive ventilation
H Vogelsang, C Sirtl, M Bellgardt, S Spiekermann, H Laubenthal, A Meiser
St Josef-Hospital, Ruhr-University Bochum, Germany
Critical Care 2004, 8(Suppl 1):P12 (DOI 10.1186/cc2479)
Figure 1
P13 Dead space free flow sensor reduces the ventilation effort in very low birth weight infants: an experimental study
M Wald1, V Jeitler1, K Lawrenz2, M Manfred Weninger1
1University of Vienna, Wien, Austria; 2University Hospital, Muenster, Germany
Critical Care 2004, 8(Suppl 1):P13 (DOI 10.1186/cc2480)
Introduction Bronchopulmonary dysplasia is a serious side effect
of long-term ventilation in very low birth-weight infants, high tidal
volumes being the main cause. However, technical dead space
represents the biggest part of the necessary tidal volume.
Therefore we studied whether reducing dead space could also
reduce the ventilation effort.
Methods The time needed to eliminate CO2 by mechanical
ventilation from a ‘preterm infant test lung’ flooded with CO2 was
measured. Four different Y-pieces (three with flow sensor:
integrated [A], small dead space [B], dead-space free (our patent)
[C] and one without flow sensor [D]) either connected or not
connected to an enclosed suction device were used. MechanicalAvailable online http://ccforum.com/supplements/8/S1
ventilation was standardized using a ventilation rate of 60/min, a
PIP of 16 mbar, a PEEP of 3.5 mbar and a flow of 10 l/min. A
capnograph in the expiration-part of the ventilation tube measured
CO2 concentrations. The test series were repeated 10 times and
the mean (± SD) was used for statistical analysis.
Results CO2 elimination time was: in A, 47.7 (± 0.82) s with
enclosed suctioning device, without 45.5 (± 1.18) s; in B, 42.5
(± 1.27) and 41.1 (± 0.99) s; in C, 37.5 (± 1.18) and 37.4
(± 0.97) s; and in D, 38.3 (± 1.16) s and 36.8 (± 0.79) s,
respectively.
Conclusion The use of the Y-piece with the patented dead space
free flow sensor shows the same CO2 elimination time as the
Y-piece without flow sensor. This reduced the ventilation effort by
20% compared with the Y-pieces with integrated flow sensor and
by 10% with the flow sensor with small dead space. This might
also reduce the incidence of bronchopulmonary dysplasia.
P14 Elimination of ventilator dead space in premature infants by flow partition: a new method
M Wald
University of Vienna, Austria
Critical Care 2004, 8(Suppl 1):P14 (DOI 10.1186/cc2481)
Chronic pulmonary damage, induced by mechanical ventilation,
represents a major morbidity risk for low birth weight infants. Lung
overexpansion by high tidal volumes has been recognized as a
contributory factor. In currently used ventilation modes, the inbuilt
flow sensor and the gadget for closed endotracheal suction
increase the dead space significantly. This apparative dead space
is commonly combated by high tidal volumes. A recently
inaugurated alternative consists in flushing the anatomical dead
space with fresh gas — which is split off the regular ventilation
circuit — bypassing the apparative dead space. Such a flow
partition system was compared with conventional ventilation in
17 preterm infants weighing <2000 g. Ventilation requirements
were significantly lowered in all patients. Mean minute volumes
could be reduced by 40.6% (P < 0.001), while mean arterial partial
pressures of carbon dioxide fell from 54.3 (± 10.74) mmHg to 47.4
(± 3.80) mmHg (P = 0.009) on average. We conclude that the
dead space decrease by split flow signs responsible for the
reduced ventilation requirements, and would expect
correspondingly less pulmonary injury. Specialized flow sensor
calibration will be required for routine usage.
P15 Prospective randomised controlled study of use of intrapulmonary percussive ventilation with chest physiotherapy after
cardiac surgery
V Fraipont, I Kellens, T Weber, E Swenen, F Damas
CHR-Citadelle-Soins Intensifs, Liège, Belgium
Critical Care 2004, 8(Suppl 1):P15 (DOI 10.1186/cc2482)
Introduction Intrapulmonary Percussive Ventilation® (IPV) is a
complementary chest physiotherapy technique for restrictive and
obstructive disease treatment. We tested its tolerance and efficacy
after cardiac surgery in a prospective randomised controlled study.
Patients and methods  Forty patients receiving chest
physiotherapy during their first 3 days after cardiac surgery were
randomised in two groups: the control group benefited from one
conventional chest physiotherapy per day, and the IPV group
received same treatment alternated with IPV1® application each
day. Treatment duration was the same. Blood gas, flow-volume
curve, subjective sensation of dyspnoea (using visual scale), thorax
radiograph, postoperative complications and hospital length of stay
were analysed.
Results (Table 1) Both groups were comparable regardless of
type of intervention, comorbidities and demography. Blood gas
analysis (days 1 and 3) and frequency of postoperative clinical
complications were not statistically different. However, fewer
atelectasis were seen in the IPV group on thorax radiograph.
Subjective dyspnoea sensation is less in the patients of the IPV
group. Hospital length of stay (LOS) was longer in the control
group. No IPV treatment was stopped for intolerance.
Conclusion Tolerance to IPV treatment was good early after
cardiac surgery. In this study, use of IPV during the first three
postoperative days reduces hospital LOS after cardiac surgery.
However, a larger study is necessary to confirm these results.
Table 1
IPV group Control group
(n = 20) (n = 20) P value
Atelectasis 0 5 0.048
ICU LOS (days) 3.5 ± 0.82 4.6 ± 4.28 0.98
Hospital LOS (days) 10.4 ± 0.99 13 ± 4.93 0.009
P16 Isoflurane anesthesia for status asthmaticus: 10 years’ experience
M Sharpe, C Harris
London Health Sciences Centre — University Campus, London, Canada
Critical Care 2004, 8(Suppl 1):P16 (DOI 10.1186/cc2483)
Mechanical ventilation (MV) for status asthmaticus (SA) is
associated with high mortality [1]. Prolonged isoflurane (ISO)
administration has been shown to be a safe and well-tolerated
therapy in ICU patients and is a predictedable bronchodilator [2,3].
We report our 10 years’ experience with MV and use of isoflurance
(ISO) as a therapy for refractory SA.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
Results Twenty-six of 47 patients (age 40 ± 20 years; 40 females)
admitted to our ICU required MV. Cause for asthma exacerbation
was infection in 57% of patients. Admission respiratory and heart
rate, mean blood pressure, PO2, PCO2 and pH was 37 ± 14,
127 ± 22 bpm 100 ± 23 mmHg, 133 ± 101 torr, 48 ± 29 torr, and
7.30 ± 0.18, respectively. Six of 26 patients received ISO (dose,
84 ± 106 MAC hours) for 87 ± 109 hours (range 8–227 hours).
Hypotension occurred in all ISO patients and in one non-ISO
patient, who was adequately treated with fluid (100%), and one
inotrope in 3/6 ISO patients. Continuous paralysis was required in
five patients. Patients who received ISO required a longer duration
of MV and ICU length of stay (LOS) (Table 1). There were no
pneuomothoraces, air embolism or significant hypoxia in any
patient. Five patients received sodium bicarbonate infusions for
acidosis. Three patients in the ISO group died: one anoxic
encephalopathy (VSA arrest prior to admission), one withdrawal of
life support due to comorbid diseases, and one cardiac arrest
(cause unknown). Two patients died in the non-ISO group; one
anoxic encephalopathy (VSA arrest prior to admission) and one
withdrawal of life support (comorbid diseases). None died due to
failure to oxygenate/ventilate.
Conclusions Inhalational isoflurane anesthesia is a useful
bronchodilator therapy in patients with severe exacerbations of
asthma and should be considered in patients who do not respond
adequately to conventional bronchodilator therapy.
References
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Table 1
Non-ISO ISO
Total hours ventilated 74 ± 86 158 ± 180
ICU LOS 4 ± 4 8 ± 8
Continuous paralysis 3 2
Mortality 3 2
P17 Modes of mechanical ventilation in ICUs of Brazil
M Damasceno1, C David2, P Souza3, C Leite4, M Godoy5, M Rahc6, F Dias7, Study Group of Mechanical Ventilation
1UFRJ, Rio de Janeiro, Brazil; 2Hospital de Clínicas Niterói, Brazil; 3Hospital Cardio-Trauma, Rio de Janeiro, Brazil; 4Hopital Servidores do
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Introduction The use of mechanical ventilation is one of the most
important stages in treating patients in the ICU, and knowing how
this procedure is being managed makes us better intensivists
physicians. Our purpose in this study was to know how some
Brazilian intensivists ventilate their patients.
Methods Two studies of 1 day prevalence were done in 2001 and
2002 in 42 ICUs of Brazil. From the questionaire answered by the
ICUs, we present here the modes of ventilation used, including the
weaning stage, and the diseases that were the reason of the
indication of mechanical ventilation.
Results The study evaluated 482 patients in 589 beds, with
263 patients being in some kind of ventilatory support. Thirteen
patients (13/263) were in noninvasive ventilation. The patients
that were in invasive mechanical ventilation (250/263) were
distributed as: volume controlled ventilation 76/250, pressure
support ventilation (PSV) 61/250, pressure-controlled ventilation
(PCV) 51/250, synchronous intermittent mandatory ventilation
(SIMV) + PSV 34/250, SIMV 15/250, and others 13/250. Eighty-
five patients (85/263) were in weaning of mechanical ventilation,
with PSV being the most used mode (42/85). The causes of
admission in mechanical ventilation were neuromuscular disease
(5/263), chronic obstructive pulmonary disease (26/263), coma
(26/263), and acute respiratory failure (206/263).
Conclusion More than one-half of patients admitted in ICUs were
in some kind of ventilatory support. While VCV was the most used
mode during the mechanical ventilation, PSV was the principal in
weaning stage. Acute respiratory failure was the main cause of
mechanical ventilation use.
P18 Breathing pattern and work of breathing in spontaneously breathing patients during continuous positive airway pressure
(CPAP) and pressure support ventilation (PSV) with and without automatic tube compensation (ATC)
G Ferreyra, C Melzer-Gartzke, F Hokema, K Falke, M Deja, S Weber-Carstens
Charité Universitary Medicine Berlin, Germany
Critical Care 2004, 8(Suppl 1):P18 (DOI 10.1186/cc2485)
Background and objective ATC is a new ventilatory mode
compensating for the nonlinear resistance of the endotracheal tube
and the added work of breathing related to the tube.
This study investigates the influence of ATC on breathing pattern
and work of breathing comparing CPAP and PSV with and without
ATC in a spontaneously breathing patient failing a weaning trial.
Methods Six critically ill patients still requiring ventilatory support
via endotracheal tube or a tracheal tube were studied in a
randomised order during 30 min periods of pressure support
ventilation 5 mbar, positive end expiratory pressure 5 mbar with
ATC (PSV5-ATC) and without ATC (PSV5-noATC) and CPAP
5 mbar with ATC (CPAP5-ATC)and without ATC (CPAP5-noATC).
The flow signal and airway pressure were measured with a
pneumotachograph (Fleisch) and an analogue pressure
transducer, respectively. Pressure time products per breath
(PTP/b) and per minute (PTP/m) were calculated measuring
esophageal pressure swings in the last minutes of each period.
Results  There were no significant differences in the breathing
pattern (respiratory rate [RF], inspiratory time vs total respiratory
time [Ti/Ttot], tidal volume [Vt], and peak flow [PF]) in any mode.
Peak inspiratory pressure (PIP) was significantly higher in PSV5-Available online http://ccforum.com/supplements/8/S1
ATC (12.8 mbar ± 1.5*$#) compared with PSV5-noATC
(10.3 mbar ± 0.5$#). PIP during PSV5-noATC was significantly
higher than CPAP5-ATC (8.3 mbar ± 1.5#).
There was a significant reduction in PTP/min (mbar/s/min)
during PSV5-ATC (71.6 ± 38.4*$#) compared with all other
modes. During PSV5-no ATC the PTP/min was significantly
lower than in CPAP5-ATC (115.2 ± 58.2$# vs 170.5 ± 97.7).
There was no significant difference in PTP/min in CPAP5 with or
without ATC.
Statistics Values given as mean ± SD: *P < 0.05 vs PSV-no ATC;
$P < 0.05 vs CPAP-ATC; #P < 0.05 vs CPAP-noATC.
Conclusions In intubated spontaneously breathing patients, work
of breathing was clearly reduced using ATC in addition to PSV.
CPAP5-ATC was less effective than PSV5 without ATC.
ATC without PSV did not compensate for nonlinear resistance of
the tube as there was no difference in PTP during CPAP with or
without ATC.
P19 Mechanical ventilation in hypobaric environment: aeromedical transport of critically ill patients
A Hernandez Abadia de Barbara, JA López López
Hospital Central de la Defensa, Madrid, Spain
Critical Care 2004, 8(Suppl 1):P19 (DOI 10.1186/cc2486)
Introduction Mechanical ventilation is used in the most of the
aeroevacuations of critically ill patients. Patients and mechanical
ventilators suffer from variations in pressure, partial pressure
oxygen, acceleration and vibration
Study objective We tested the changes that decreased environ-
mental pressure produced in a mechanical ventilator and also in
the individuals that were connected to this device receiving
mechanical ventilation, with the main task being to evaluate the
changes in tidal volume.
Material and methods We applied invasive mechanical ventilation
(endotracheal tube) in assisted/controlled modality with two
transport mechanical ventilators (Dräger Oxylog 2000), with a
fraction inspiration of oxygen (FiO2) of 100%, respiratory frequency
of 12–16 breaths/min and positive end expiratory pressure (PEEP)
of 5–6 cmH2O to four and10 beagle dogs with weights from 8 to
17 kg under intravenous sedation. The animals with the mechanical
ventilator and the oxygen tank were introduced into the Hypobaric
Chamber for Physiological Studies of the Spanish Unit of Aviation
and Space Medicine of the Air Force. The pressure conditions of a
profile of high altitude flight (from 2000 to 35,000 feet) were
applied inside the chamber.
The dogs were ventilated for 45 min before the experimental flight
and along the whole test. Parameters from the mechanical
ventilator were measured and also vital signs (monitoring) from the
animals. The controls of the tidal volume were measured at
14 altitudes in the climbing phase and six in the descent phase. All
the measure were taken 1 min after to arise the altitudes and to
stabilize the pressures.
Results The tidal volume was always bigger with the decrease in
the environmental pressure and even in the descenct phase we
found bigger tidal volumes that in the same altitudes in the
climbing phase. The increase in the tidal volume with the
decreasing atmospheric pressure was checked statistically with a
bilateral significance of P < 0.01 applying one Pearson test. Other
variables such as minute volume, respiratory frequency, cardiac
frequency, SpO2, Paw peak, atmospheric pressure, tidal volume
measured, PEEP, Paw medium, inspiratory time, perimeter and
theoric tidal volume were studied also.
Conclusions The tidal volume increases or decreases with
changes in the environmental pressure when mechanical
ventilation is used. This is very important in the transport of critically
ill patients. These changes can produce damage to the patients
that are under mechanical ventilation in the aeromedical
evacuations.
Correction rules can be calculated for this phenomenon using the
compliance, the saturation of oxygen, the different airway
pressures and the expiratory tension of CO2. This is a new
investigation area in which the monitoring of different parameters
(especially the compliance) plays the main role to control the
mechanical ventilation.
Table 1
Pearson Inspiration  Tidal  Respiratory  Cardiac  Paw  Pressure  Tidal  Paw 
coefficient time Perimeter Vt frequency frequency SpO2 Peak atmospheric VM PEEP media
Pressure 0.084 –0.212 –0.583 –0.019 –0.013 0.255 –0.815 1 –0.777 –0.607 –0.222
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P20 Vd/Vt test in the detection of pulmonary dysfunction in sepsis
K Cala, V Pilas, N Vucic
CH Sveti Duh, Zagreb, Croatia
Critical Care 2004, 8(Suppl 1):P20 (DOI 10.1186/cc2487)
Dyspnea and tachypnea are the leading sings of pulmonary
dysfunction in sepsis. With regards to present knowledge of
pathophysiology and pathogenesis of the pulmonary dysfunction,
the real reasons for this phenomena are still not researched
enough. It is our assumption that one of the underlying causes is in
the increased ventilation of the physiological dead space due to
the mismatch of the pulmonary ventilation and perfusion. In sepsis,
equal to change in systemic, there are changes in pulmonary
circulation, often with pulmonary hypotension and decreased
pulmonary vascular resistance. To investigate this we used a
simple test to measure the ventilation of the dead space using the
Vd/Vt test.
Patients and methods In 20 patients having conventional criteria
for sepsis and tachypnea > 20/min we measured dead space
ventilation using Bohr’s Principle. The patients with chronic
pulmonary disease (asthma, COPD) were not eligible for the study.
According to Bohr the ratio of the dead space (Vd) ventilation to
tidal volume (Vt) is a measurable variable denoted as
Vd/Vt = (PaCO2 – PECO2)/PaCO2. Normal values are 0.20–0.40.
To measure it we used a direct method with certain technical
innovations. The subjects breathed through an oronasal mask and
one-way valve. Expired air was collected in a 5-l balloon in order to
provide adequate mixture of dead space and alveolar air. The
concentration of CO2 on the end of the balloon (PECO2) was
measured with an RGM ‘Ohmeda’ capnograph (infrared technique)
together with minute ventilation. Arterial oxygen partial pressure
(PaO2) was measured simultaneously from arterial blood using a
conventional method.
Results In all subjects an increased (> 0.40) Vd/Vt index was
found (0.50 ± 0.05). Minute ventilation was also increased
(13 ± 1.4 l). We compared these results with arterial oxygen
(PaO2) partial pressure and found a high degree of negative linear
correlation for the Vd/Vt index and PaO2 (r = –0.7512, P < 0.01).
A positive linear correlation for the Vd/Vt index and MV
(r = 0.5862, P < 0.01) was also found.
Discussion and conclusion We believe that our results indicate
that dyspnea and tachypnea in sepsis are mostly a result of the
increased physiological dead space ventilation and that this test is
useful for early detection and objectification of the pulmonary
dysfunction in sepsis. The simplicity of this method makes it
suitable for large-scale clinical use.
P21 High-frequency oscillatory ventilation: a better tool for lung protection?
H Gönençer, N Ünal, M Oral, M Tulunay
AÜTF, Ankara, Turkey
Critical Care 2004, 8(Suppl 1):P21 (DOI 10.1186/cc2488)
Objective This study was performed to compare the efficacy of
high-frequency oscillatory ventilation (HFOV) with conventional
mechanical ventilation (CV) in patients with acute respiratory
distress syndrome (ARDS).
Method Ten patients with ARDS were enrolled to the study. Gas
exchange and hemodynamic parameters were measured during
initial phase of the mechanical ventilation (tidal volume [TV]
≤ 6–8 ml/kg, positive end expiratory pressure [PEEP] = 10 cmH2O,
f = 12/min, I/E = 0.5, FIO2 = 1). Then patients were randomized
into CV or HFOV groups. The upper inflection point (UIP) and
closing pressures (CP) were approximated according to blood
gases response to PEEP/continuous distending pressure (CDP)
titration. The lung protective ventilation strategy was followed for
both groups. Ventilatory settings were CDP = CP + 5 cmH2O,
f = 5 Hz, bias flow = 20 l/min for HFOV and
P E E P=C P+2c m H 2O, f = 12/min, TV ≤ 6–8 ml/kg for CV. FIO2
was set to keep on the SaO2 over 90%. After 3 hours ventilation
with each setting, groups were switched from HFOV to CMV or
vice versa. For each group, the recruitment maneuver was applied
with a pressure of 2 cmH2O below the UIP for 40–60 s at the
beginning and after all disconnections. Gas exchange and
hemodynamic parameters in addition to ventilatory settings were
recorded at 10, 60 and 120 min of each setting. Results were
mentioned as the median. The Mann–Whitney U test was used for
the comparisons.
Results The lung injury (LIS), APACHE II and multiple organ
dysfunction scores of the patients were 2.6, 23.5 and 9,
respectively. The median recruitment pressure was 41.5 cmH2O.
Peak, mean, end-expiratory pressures and tidal volumes in CV
were 28, 20, 16 cmH2O, and 6.4 ml/kg, respectively. CDP of
HFOV was 25.5 cmH2O. There was no significant difference in
gas exchange and hemodynamic parameters between the two
groups except PaCO2 values. PaCO2 values were significantly
lower in HFOV (P < 0.05) (Fig. 1). In spite of statistically
insignificant differences in the PaO2/FIO2 ratio between groups,
this ratio improved during successive measurements in HFOV
while deteriorating in CV (Fig. 1). No complication occurred in both
groups during study.
Conclusion CO2 removal capacity of HFOV may not only be
related with its active expiration feature, but also related with its
Figure 1
Values are expressed as median and interquartile range.Available online http://ccforum.com/supplements/8/S1
capability to prevent derecruitment better than CV ventilation, as
shown with an improvement in PaO2/FIO2 ratios. Therefore, HFOV
may be a better tool to follow lung protective ventilation.
Reference
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2003, 31(Suppl):S317-S323.
P22 Protective lung strategy using independent pulmonary ventilation
F Saddy, J Verdeal, G Martins, V Resende, A Chindamo, R Pinheiro
Barra D’Or, Rio de Janeiro, Brazil
Critical Care 2004, 8(Suppl 1):P22 (DOI 10.1186/cc2489)
Background Independent pulmonary ventilation was introduced in
the 1930s and allows the utilization of different ventilatory
strategies for each lung to improve gas exchange, respiratory
mechanics or both in patients with heterogeneous lung diseases.
Objectives To evaluate the utilization of independent pulmonary
ventilation with protective lung strategies and recruitment
maneuvers in patients with acute unilateral lung diseases caused
by pneumonia and chest trauma.
Patients and methods Five critically ill patients, four men and a
woman, with a medium age of 47 years (18–81 years) and
diagnosis of pneumonia with unilateral lung injury (etiologic agents,
Streptococcus pneumoniae and Staphylococccus aureus) and one
chest trauma patient with contusion and contralateral
bronchopleural fistulae. The mean APACHE II score was 21. They
were ventilated in the Siemens Servo 300 Ventilator initially in
volume controlled ventilation (VCV) with: tidal volume (Vt)
7.5 ml/kg, respiratory frequency (RF) 22 bpm, positive end
expiratory pressure (PEEP) 5 cmH2O, FiO2 100%. The mean static
compliance (Cst) and PaO2/FiO2 ratio were 32.2 and 162.8,
respectively. Augmenting PEEP to 10 cmH2O, both the mean Cst
and mean PaO2/FiO2 ratio reduced to 19.4 (40.8% reduction) and
116 (29.2% reduction), respectively.
A thoracic computed tomography (CT) scan confirmed unilateral
lung affection: three patients with left lung disease and two with
right lung disease. After that, a left Robertshaw tube was inserted
by laryngoscopy and finally positioned by bronchoscopy in all
patients. They were submitted to recruitment maneuver on the side
of disease with a continuous positive airway pressure of
40 cmH2O and then 50 cmH2O for 40 s. Four patients had
recruitment maneuvers guided by CT scan with each step guided
by serial 5 mm CT scan slices at the level of the carina. To evaluate
the best PEEP (defined as the less visually collapsed area
measured by Hounsfield Units on CT scan), a 2 cmH2O
descending PEEP curve was built from 25 cmH2O until collapsed
lung appeared . Then a new recruitment maneuver was performed
and the best PEEP was set at 2 cmH2O above the level of
collapse.
The contralateral lung was ventilated with VCV, half of the ideal Vt
calculated to the ideal body weight of each patient (3.5 ml/kg),
mean PEEP of 8 cmH2O, plateau pressure lower than 30 cmH2O
and RF of 22 bpm.
Oxygenation, individual lung mechanics and hemodynamic
parameters were measured pre and post recruitment maneuvers,
as well as at final outcome.
Results Three 41 Fr and two 39 Fr Robertshaw tubes were
inserted, one of the patients presenting a difficult airway. The mean
Cst of the diseased lungs were lower than their contralaterals:
12.4 versus 37.4. The mean Cst and PaO2/FiO2 ratio increased
after the recruitment maneuver increased from 116 to 287 and
12.4 to 23.6, respectively. Sodium bicarbonate was administered
as a buffer to three patients who presented severe respiratory
acidosis (mean pH 7.05). There was no hemodynamic instability
related to the recruitment maneuver. Two patients died, one
presented a refractory septic schock and another with gas emboli
already on conventional orotracheal tube during the weaning
process. Three patients were discharged from hospital.
P23 Effect of sustained inflation recruitment maneuvers on lung endothelial and alveolar epithelial injury in experimental acute
lung injury
J Frank, D McAuley, J Gutierrez, B Daniel, L Dobbs, M Matthay
Cardiovascular Research Institute, San Francisco, California, USA
Critical Care 2004, 8(Suppl 1):P23 (DOI 10.1186/cc2490)
Lung volume recruitment maneuvers (RMs) are a potential adjunct
to protective ventilation for acure respiratory distress syndrome
patients. However, data demonstrating improvement in important
outcomes such as lung injury severity and mortality are lacking. We
hypothesized that RMs reduce lung endothelial and alveolar
epithelial injury in a clinically relevant rat model of acid-induced lung
injury. Compared with a protective ventilation strategy without RMs,
sustained inflation RMs (30 cmH2O) every 30 min significantly
improved oxygenation, lung volume, dead space fraction, and
compliance. RMs reduced extravascular lung water (P < 0.05). RMs
also reduced lung endothelial protein permeability (217 ± 28 vs
314 ± 70 extravascular plasma equivalents, P < 0.05). However,
RMs did not prevent alveolar epithelial injury. Epithelial permeability
and BAL RTI40 levels, a previously validated and specific marker of
type I cell injury, were similar with or without RMs. RMs also
decreased epithelial fluid transport, a functional marker of epithelial
injury (Fig. 1; *P < 0.05 vs no injury, †P < 0.05 vs no RM). There was
a trend toward lower systemic blood pressure and cardiac output in
the group receiving RMs. RMs did not reduce markers of airspace
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inflammation. In conclusion, frequent RMs improved gas exchange,
and reduced lung water in part through effects on hemodynamics.
RMs may protect the lung endothelium, but do not reduce alveolar
epithelial injury. Because alveolar epithelial injury is associated with
lung injury severity and mortality, these data suggest that RMs may
not improve these patient outcomes.
P24 Altered proteomic patterns in rat alveolar epithelial type II cells after ventilation with high and low tidal volumes
J Hirsch1, K Hansen2, J Frank1, R Chalkley2, X Fang1, A Burlingame2, M Matthay1
1University of California, San Francisco, California, USA; 2Mass Spectrometry Facility, San Francisco, California, USA
Critical Care 2004, 8(Suppl 1):P24 (DOI 10.1186/cc2491)
A proteomics approach to ventilator-induced lung injury might
identify protein patterns that contribute to epithelial injury. To
identify changes in alveolar type II cells (ATII), rats were
mechanically ventilated for 5 hours with a high tidal volume (HTV;
20 ml/kg, no positive end expiratory pressure) or a low tidal volume
(LTV; 6 ml/kg, positive end expiratory pressure 4 cmH2O) and
compared with pooled controls without mechanical ventilation
(SV). ATII were isolated and lysed. Protein expression was
compared using the recently introduced cleavable isotope coded
affinity tag (ICAT) methodology. After tryptic digestion, cysteine
containing peptides were tagged with biotin, extracted using an
avidin-coated column and identified by HPLC and mass
spectrometry with collision-induced dissociation. Spectra were
interrogated against the Swissprot database and quantified using
the ProteinProspector software. HTV ventilation resulted in
morphologic changes, pulmonary edema and neutrophil influx in
the lung. Quantization showed differential expression of several
hundred proteins following both HTV and LTV ventilation. Most
proteins were upregulated by LTV ventilation compared with SV.
For some proteins, upregulation was markedly attenuated after
HTV compared with LTV. This was not true for ICAM-1, which
correlated with the increased number of neutrophils in these
samples. After HTV, surfactant proteins B and D followed different
patterns. Since the differentially expressed proteins play important
roles in innate immunity and in pulmonary edema fluid clearance,
the attenuated response of ATII after HTV ventilation might indicate
a clinically relevant impediment.
Table 1
Protein  ICAT LTV/SV ICAT HTV/LTV
Beta-Defensin 5.2 0.6
Lysozyme 4.7 0.75
ICAM-1 2.1 1.3
Na+-ATPase, K+-ATPase 4.0 0.6
Ribosomal protein L28 4.3 0.6
Surfactant protein D 3.6 1.7
Surfactant protein B 4.5 0.4
Figure 1
P25 Inspiratory vs expiratory limb of the pressure–volume curve for the positive end-expiratory pressure setting in acute lung
injury
G Albaiceta, L Luyando, D Parra, R Menendez, J Calvo, F Taboada
Hospital Central de Asturias, Oviedo, Spain
Critical Care 2004, 8(Suppl 1):P25 (DOI 10.1186/cc2492)
Background It is not clear whether the lower inflection point (LIP)
on the inspiratory limb or the point of maximum curvature (PMC) on
the deflation limb of the pressure–volume (PV) curve should be
used for the positive end-expiratory pressure (PEEP) setting in
acute lung injury (ALI).
Objective To compare two ventilatory strategies using LIP or PMC
as the PEEP level.
Methods Patients with early ALI were prospectively studied. PV
curves were traced using the continuous positive airway pressure
method. LIP and PMC were calculated using a sigmoid fitting.
Patients were ventilated at the computed tomography (CT) scan
ward with FiO2 1, tidal volume 6 ml/kg and rate according to PaCO2
and absence of autoPEEP. Two PEEP levels (LIP + 2 cmH2O and
PMC) were tested consecutively. For each PEEP level, three CT
scan slices were acquired in end-inspiration and end-expiration.
Lung mechanics and volume of hyperinflated, normal, poorly-aerated
and nonaerated lung at each slice were compared using a repeated-
measures analysis of variance. P < 0.05 was considered significant.
Results Five patients were studied (age 64.6 ± 13 years,
APACHE-II 24.4 ± 5.3, lung injury score 3.2 ± 0.4, PaO2/FiO2
Table 1
Inspiration Expiration
LIP PMC LIP PMC
Hyperinflated 2.4 ± 3 3.6 ± 3.7 1.8 ± 2.2 3.3 ± 3.7
Normal 12.6 ± 4.8 15.5 ± 3.5* 10.8 ± 5.7 14.4 ± 3.9*
Poorly-aerated 5.1 ± 2.7 5.1 ± 2.7 5.1 ± 2.9 5.6 ± 3.4
Nonaerated 5.1 ± 2.4 3.6 ± 2* 5.4 ± 2.5 4 ± 2.3*
*P < 0.05 between LIP and PMC.Available online http://ccforum.com/supplements/8/S1
154 ± 30). When compared with LIP, pressures at PMC were
always higher (22.4 ± 4.5 vs 14.6 ± 3 cmH2O, P < 0.05), and so as
plateau pressures (34.5 ± 4.3 vs 25.6 ± 3.5 cmH2O, P < 0.05), with
no changes in compliance (39.6 + 12.4 vs 34 + 6.3 ml/cmH2O,
P = 0.26). Lung volumes (ml per slice) are presented in Table 1.
Conclusions Ventilation above the PMC improves recruitment
without increasing hyperinflation. The long-term benefits of this
approach remain to be determined.
P26 Dutch intensivists do not use small tidal volumes (Vt) in mechanical ventilation (MV)
E Wolthuis1, P Spronk2, M Kuiper3, M Vroom1, M Schultz1
1Academic Medical Centre, Amsterdam, The Netherlands; 2Gelre Hospital, Apeldoorn, The Netherlands; 3Medical Centre Leeuwarden, 
The Netherlands
Critical Care 2004, 8(Suppl 1):P26 (DOI 10.1186/cc2493)
Background Use of ‘lung-protective’ MV (by applying small Vt) is
recommended in acute lung injury/acute respiratory distress
syndrome (ALI/ARDS) patients. Animal studies suggest that such
strategies may also prevent ventilator-associated lung injury in
patients with healthy lungs.
Methods To evaluate how MV is applied in ICU patients in The
Netherlands, we performed a prospective observational study in an
academic ICU and two non-academic ICUs. MV settings (mode,
actually applied Vt and total PEEP) were collected three times per
day. A total of 43 consecutive admitted ICU patients (24 with
ALI/ARDS) were studied. To determine the ideal Vt, the ideal body
weight was calculated from patients’ length. Data are means (± SD).
Statistical analysis Mann–Whitney U test. P < 0.05 was
considered statistically significant.
Results Pressure-controlled or pressure support MV modes were
most often used (97.7%). No differences were seen between the
four MV modes (ASV, IPPV, ASB and PC) with respect to applied
Vt and PEEP. Higher levels of PEEP were used in ARDS patients
(P = 0.002). Importantly, in the majority of patients Vt was
> 8 ml/kg. Moreover, Vt was significantly higher in ARDS patients
than in non-ARDS patients (P = 0.002).
Conclusion There is a large discrepancy between ideal Vt and
actually applied Vt. A possible explanation is the use of absolute
bodyweight instead of ideal bodyweight for calculation of Vt.
Implementation of small Vt–MV needs an educational program and
evaluation, which is currently in progress in all three ICUs.
Table 1
ALI/ARDS Non-ALI/ARDS
Hospital Vt % >8ml/kg PEEP Vt % >8 ml/kg PEEP
I (n = 91) 9.3 (2.0) 75.9 8.6 (4.3) 10.3 (2.7) 77.7 6.8 (3.4)
II (n = 81) 11.6 (1.8) 98.2 11.1 (3.9) 9.9 (1.4) 91.7 9.3 (2.9)
III (n = 84) 10.6 (3.4) 76.7 13.7 (4.3) 9.2 (2.0) 68.3 11.0 (3.6)
All (n = 256) 10.5 (2.6) 84.4 11.0 (4.6) 9.7 (2.3) 77.5 9.1 (3.8)
P27 Effects of recruitment maneuver and positive end-expiratory pressure on hypoxemia after pulmonary
thromboendarterectomy for chronic pulmonary thromboembolism
M Takeuchi1, H Imanaka1, K Tachibana1, M Nishimura2
1National Cardiovascular Center, Osaka, Japan; 2Tokushima University, Tokushima, Japan
Critical Care 2004, 8(Suppl 1):P27 (DOI 10.1186/cc2494)
Background Effects of recruitment maneuver (RM) and high
positive end-expiratory pressure (PEEP) are still controversial in
patients with hypoxemia. In this prospective study, we tested the
hypotheses that RM improved oxygenation in patients with
hypoxemia after pulmonary thromboendarterectomy (PTE) for
chronic pulmonary thromboembolism (CPTE) and that the
response to RM and PEEP changed with time.
Methods We enrolled 14 patients (58 ± 10 years) who underwent
elective PTE for CPTE and developed hypoxemia (PaO2 <300 torr
at FIO2 of 1.0). We performed RM and PEEP trial twice at FIO2 of
1.0; 1–2 hours after the surgery (first) and 12 hours later (second
trial). As a RM, we increased the PEEP to 30 cmH2O for 1 min
during pressure control ventilation. Then we decreased PEEP
stepwise (15, 10, 5, and 0 cmH2O) at 15–20 min intervals.
Ventilatory settings were unchanged throughout the measure-
ments. Data were obtained before RM, during RM, and at each
PEEP level.
Results At the first trial, RM followed by PEEP of 15 cmH2O
improved PaO2 in all patients (Fig. 1). On decreasing the PEEP
from 15 to 0 cmH2O, PaO2 decreased from 470 ± 83 to
225 ± 101 torr (P < 0.01). Although the mean blood pressure
decreased and the mean pulmonary artery pressure increased
(86 ± 8 to 57 ± 11 and 32 ± 9 to 36 ± 9 mmHg, respectively;
P < 0.01) during RM, these returned to the baseline level when the
PEEP was decreased to the baseline level. At the second trial,
baseline PaO2 improved to 472 ± 84 torr and decreasing theCritical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
PEEP resulted in a smaller decrease in PaO2 (to 360 ± 143 torr)
than that at the first trial (P < 0.01).
Conclusion RM improved oxygenation in all patients with
hypoxemia after PTE for CPTE. In the early postoperative period
oxygenation was highly dependent on PEEP, but this PEEP
dependency became less apparent in the later period. RM
suppressed circulation temporarily, but no adverse events
sustained.
Figure 1
Oxygenation before and after RM in each patient.
P28 The static pressure–volume curve does not predict the mechanical properties of the respiratory system during mechanical
ventilation in acute respiratory distress syndrome (ARDS) and acute lung injury (ALI)
CA Stahl1, R Kuhlen2, C Putensen2, M Sydow2, K Geiger1, J Guttmann1
1Anaesthesiologische Universitätsklinik, Heuweiler, Germany; 2Scientific Board, McREM Study Group, Germany
Critical Care 2004, 8(Suppl 1):P28 (DOI 10.1186/cc2495)
Introduction The pathophysiology of ALI and ARDS induces
distinct changes in respiratory mechanics. For more than 30 years
respiratory mechanics have been assessed by analysis of the static
pressure–volume (P–V) curve. Ventilation, however, is a dynamic
process and the mechanical properties of the respiratory system
can be assessed under dynamic conditions [1]. If the respiratory
system shows a specific dynamic behaviour that is not present
during static conditions, differing results are to be expected if
mechanics are analysed during dynamic conditions. The aim of the
present study was to test whether such differences can be
observed in ARDS and ALI.
Methods Twenty-eight patients with ARDS and ALI were included
in the study. Patients were ventilated with the Evita4Lab
measurement system (Dräger, Germany). Static respiratory
mechanics were obtained using a low-flow inflation. Dynamic P–V
curves covering the whole vital capacity range were obtained by
increasing the p[ositive end expiratory pressure (PEEP) by 2 mbar
every eight breaths during ongoing mechanical ventilation until a
plateau pressure of 45 mbar was attained. For statistical analysis,
the Wilcoxon test was used.
Results At any PEEP level the end expiratory volume during
mechanical ventilation was considerably increased as compared
with the static P–V curve. Furthermore, the difference in volume
increased with higher PEEP. In contrast, the end inspiratory volume
did not differ (Fig. 1; *P < 0.05). The intrinsic PEEP did not differ
between static and dynamic measurements. The respiratory
compliance during mechanical ventilation was lower than during
static conditions at all pressures above 5 mbar (Fig. 2).
Conclusion In patients with ARDS/ALI, the static P–V curve does
not predict the mechanical behaviour of the respiratory system
during mechanical ventilation. Under the dynamic conditions of
Figure 1 Figure 2Available online http://ccforum.com/supplements/8/S1
mechanical ventilation, the end expiratory pulmonary volume is
higher and respiratory compliance lower than expected from the
static measurement. This effect cannot be assigned to dynamic
hyperinflation. It represents an actual shift in functional residual
capacity because the differences increase with PEEP and are
similar in patients with and without intrinsic PEEP. The differences
can be explained by a slow time-dependent and pressure-
dependent phenomenon such as alveolar recruitment.
Reference
1. Guttmann J, Eberhard L, Fabry B, et al.:  Technol Health Care
1994, 2:175-191.
P29 Effect of lung protective ventilation strategy on pulmonary inflammatory response in acute respiratory distress syndrome
(ARDS) rabbit model
Q Haibo
Zhong-Da Hospital, Nanjing, China
Critical Care 2004, 8(Suppl 1):P29 (DOI 10.1186/cc2496)
Objective To evaluate the effect of lung protective ventilation
strategy on pulmonary inflammatory response in ARDS.
Methods The ARDS rabbits model were duplicated by saline
alveoli-lavaged. The rabbit were divided into six groups: (1) normal;
(2) ARDS; (3) low-volume with best positive end expiratory pressure
(PEEP) (A) (tidal volume [VT] 6 ml/kg, PEEP 2 cmH2O greater than
the pressure of lower inflection point in pressure–volume curve
[PLIP]); (4) normal volume with best PEEP (B) (VT 6 ml/kg, PEEP
PLIP + 2 cm2HO); (5) low volume with high PEEP (C) (VT 6 ml/kg,
PEEP 15 cmH2O); (6) high volume with zero PEEP (D) (VT
20 ml/kg). Lung wet/dry weight ratios (W/D) were recorded to
assess lung injury. After 4 hours of ventilation, lung homogenates
were prepared to detect NF-κB activity by EMSA, TNFα and IL-10
levels by ELISA and their mRNA expression by RT-PCR. Meanwhile
MPO and MDA in lung homogenates were assessed.
Results After 4 hours ventilation, W/D in group A (5.58 ± 1.05)
were lower than groups B, C and D, significantly (6.56 ± 0.82,
6.58 ± 0.96, 6.94 ± 0.98, P < 0.05), but there was no difference
between group A and the ARDS group. NF-κB activity was the
highest in group D. NF-κB activity in group A was 331 ± 113,
which was decreased significantly as compared with groups B, C
and D (455 ± 63, 478 ± 74, 645 ± 162, P < 0.05). The mRNA
expression of TNFα and IL-10 and their concentration in lung
homogenates in group A was lower than groups B, C and D. In
group A, the concentrations of MPO and MDA in lung
homogenates were lower significantly than in groups B, C and D.
Conclusions Lung protective ventilation strategy can inhibit the
pulmonary inflammation and may improve lung injury in ARDS, but
low low tidal volume with high PEEP may increase the lung
inflammation.
P30 Extravascular lung water (EVLW) does not change during alveolar recruitment in acute respiratory distress syndrome
(ARDS)
I Toth, T Szakmany, A Mikor, Z Molnar
University of Pecs, Hungary
Critical Care 2004, 8(Suppl 1):P30 (DOI 10.1186/cc2497)
Objectives To evaluate the relationship between the PaO2/FiO2 ratio
and EVLW during alveolar recruitment at different positive end expira-
tory pressure (PEEP) levels in ARDS in a prospective clinical trial.
Materials and methods Ten patients suffering from ARDS were
recruited. All patients were ventilated in pressure control mode
(FiO2 = 1.0, respiratory rate = 20, I:E = 1:1). Following basic
haemodynamic measurements and blood gas analysis, alveolar
recruitment was done: PEEP was set at 26 cmH2O then
40 cmH2O pressure amplitude was applied for 40 s. Optimal
PEEP was determined as follows: tidal volume was reduced to
4 ml/kg, then the PEEP was reduced from 26 cmH2O by 2 cmH2O
in every 4 min and the optimal PEEP was defined as 2 cmH2O
above the level of PEEP, where the PaO2 suddenly dropped by
> 10%. After setting the PEEP at the optimal level, the 40/40
manoeuvre was applied again and the tidal volume was set as
6 ml/kg. The FiO2 was left at 100% until the end of the trial period
of 1 hour. Haemodynamic parameters were determined by arterial
thermodilution (PiCCO) on entering the study, then during the
optimal PEEP defining process every 8 min, and 30 and 60 min
after. Data are presented as mean ± SD. For statistical analysis
multiple regression analysis, and analysis of variance (ANOVA)
was used, respectively.
Results The initially applied PEEP and the determined optimal
PEEP did not differ significantly. Compared with baseline (T0) the
PaO2 was significantly higher following alveolar recruitment (Tep)
and also after 60 min. The EVLW did not change significantly
during the study period (Table 1). Regression analysis could not
reveal any significant relationship between PaO2 and EVLW at
different PEEP.
Discussion Recently we found significant correlation between
EVLW and PaO2/FiO2 and PEEP levels. To date no clinical trials
reported the relationship between oxygenation and EVLW during
alveolar recruitment and PEEP optimisation. Based on the current
results of this pilot study it seems that the EVLW does not directly
affect oxygenation during recruitment. Completion of the study is
required to evaluate the effect of EVLW on the optimal PEEP in
ARDS.
Reference
1. Szakmany T, Heigl P, Molnar Zs: Anaesth Int Care 2004 (in press).
Table 1
T0 Tep P
PaO2/FiO2 (mmHg) 170 ± 112 330 ± 110 0.004
PEEP (cmH2O) 17 ± 4 15 ± 5 0.296
EVLW index (ml/kg) 16 ± 11 15 ± 10 0.825Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P31 Pleurodesis by autologous blood: a new concept in the management of persistent air leak in acute respiratory distress
syndrome
S Martínez-Escobar1, J Vicente Rull2, J Martínez Coronel2
1Andalucian Health Service, Almeria, Spain; 2SAS, Almeria, Spain
Critical Care 2004, 8(Suppl 1):P31 (DOI 10.1186/cc2498)
Introduction Pneumothorax is present in 48.8% of cases of acute
respiratory distress syndrome (ARDS), its development becomes
more likely as the duration of the process increases and its
presence affects the patient’s chances of survival. Bronchopleural
fistulas prolong pneumothorax in 2% of cases of ARDS, increasing
the rate of mortality by 26%. No prospective controlled studies
have been carried out into the management of persistent air leak
(PAL) in ARDS, nor has any therapeutic option for its treatment
been proved superior to another. Pleurodesis by autologous blood
(PAB) is an effective, simple and inexpensive method in a select
number of cases of oncological pulmonary surgery; also, there are
anecdotal descriptions of its use with nonsurgical patients.
Objective The goal of this study is to compare the efficacy of PAB
with the conventional continuous aspiration in the management of
PAL in ARDS patients with pneumothorax.
Design A nonrandomized study comparing two groups undergoing
artificial pairing 1:1.
Patients Two groups of 17 patients all with ARDS, pneumothorax
and PAL.
Interventions One group had undergone conventional treatment
while the other received PAB.
Results The average difference between the groups is 8 days
less seal time (P < 0.001), 11 days less weaning time
(P < 0.001), and 9 days less, on average, time spent in ICU
(P < 0.001).
Conclusions The use of PAB in comparison with the exclusive use
of a thoracic drain with a water seal for the treatment of PAL in
ARDS is an effective, inexpensive and simple method that
decreases the ventilator weaning time and makes for a shorter stay
in the ICU.
Table 1
The increase between day 1 and day 7 of respiratory values of
studies
Control group PAB group P
ICU time 31.64 ± 8.15 23 ± 13.02 0.001
D(A–a)O2 (mmHg) 223.52 ± 40.91 71.17 ± 24.46 0.001
Compliance 7.29 ± 4.11 24.11 ± 6.15 0.001
PEEP (cmH2O) 0.17 ± 2.15 –3.11 ± 0.99 0.001
RR (/min) 2.47 ± 2.18 –5.82 ± 2.29 0.001
Plateau (cmH2O) –1 ± 9.98 –15.70 ± 3.98 0.001
Tidal volume (ml) 40 ± 39.68 173.83 ± 65.18 0.001
Seal time (days) 9.35 ± 3.06 1.76 ± 0.66 0.001
Weaning time 15.58 ± 5.02 4.70 ± 2.46 0.001
P32 The utility of open lung biopsy in critically ill adult patients
C Weaver, A Saayman, P Morgan, J Mecklenburgh, G Findlay
University Hospital of Wales, Cardiff, UK
Critical Care 2004, 8(Suppl 1):P32 (DOI 10.1186/cc2499)
Introduction Open lung biopsy (OLB) is regarded as the gold
standard for the diagnosis of pulmonary infiltrates. This
procedure is associated with significant risk of morbidity and
mortality in the intensive care unit (ICU) setting. We wished to
study the efficacy of open lung biopsies in ICU patients requiring
advanced respiratory support associated with bilateral pulmonary
infiltrates.
Methods We reviewed medical case records of all patients who
underwent open lung biopsy on the ICU between August 1996
and June 2003. We included patients requiring advanced
ventilatory support, with persistent bilateral infiltrates on chest
X-ray failing to respond to first-line treatment.
The biopsies were performed in the ICU at the University Hospital
of Wales under general anaesthesia. Access to the lung was via
anterior mini thoracotomy. All operative lung samples were sent for
bacteriology Gram staining and culture, virology and histology
assessment.
Results We performed 13 OLBs in the study period. The patient
demographics (survivors versus nonsurvivors) are presented in
Table 1. Open lung biopsy provided a diagnosis in 12 out of
13 patients (92%). In all 12 of these patients specific treatment
changes were implemented. Overall mortality was 53.8%
Conclusion OLB in critically ill patients is an accurate diagnostic
tool.
Reference
1. Flabouris,  et al.:  The utility of open lung biopsy in patients
requiring mechanical ventilation. Chest 1999, 115:811-817.
Table 1
Survivors (n = 6) Nonsurvivors (n =7 )
Age 42 54
Female 6 3
Male 0 4
APACHE II 15 22
SAPS 31.2 41
Days ventilated 14 15Available online http://ccforum.com/supplements/8/S1
P33 Clinically relevant concentrations of beta agonists may stimulate alveolar fluid clearance in acute respiratory distress
syndrome
G Perkins1, D McAuley2, J Frank2, D Thickett1, X Fang2, M Matthay2
1Birmingham Heartlands Hospital, Birmingham, UK; 2University of California, San Francisco, California, USA
Critical Care 2004, 8(Suppl 1):P33 (DOI 10.1186/cc2500)
Background Acute respiratory distress syndrome (ARDS) is
characterised by the development of noncardiogenic pulmonary
oedema leading to refractory hypoxaemia. The early clearance of
alveolar oedema is an important determinant of outcome in ARDS.
β-agonists have been shown to upregulate alveolar fluid clearance
(AFC). The primary aim of this study was to determine the
concentration of salbutamol achieved in plasma after treatment
with intravenous (IV) salbutamol. A second aim was to determine
the concentration of airspace salbutamol required to stimulate AFC
in the normal rat lung.
Methods Patients with acute lung injury/ARDS were randomised
to an infusion of IV salbutamol (15 µg/kg/hour) or placebo. Plasma
salbutamol levels were measured by a commercially available
ELISA before and 24 hours after starting the infusion. In a second
series of experiments AFC was measured in rats in response to
10–4 M to 10–8 M salbutamol as previously described [1].
Results Twelve patients were recruited (six received placebo).
Median plasma salbutamol levels were 408 ng/ml in the
salbutamol-treated group (equivalent to 10–6 M) compared with
undetectable in the placebo group (P = 0.001). Basal AFC in rats
was 7.6 ± 2.2% hour. Salbutamol (10–6 to 10–5 M) increased AFC
by 100% and 400%, respectively, above baseline (P < 0.05).
Discussion The plasma concentration (10–6 M) following IV
administration in patients with ARDS may be sufficient to stimulate
AFC if a similar concentration reaches the airspaces. Aerosolised
delivery of a beta-2 agonist can achieve higher concentrations in
the distal airspaces and maximal AFC. Although both IV and
aerosolised delivery of a β2-agonist can achieve an effective
concentration, the optimal route of delivery for treating ARDS
patients remains uncertain.
Reference
1. J Clin Invest 1997, 99:325-335.
P34 A more homogeneous distribution of strain within lung parenchyma attenuates ventilator-induced lung injury in the prone
position
F Valenza, M Guglielmi, M Maffioletti, C Tedesco, GA Porro, P Maccagni, M Irace, T Fossali, G Aletti, E Carlesso, M Lazzerini, 
P Biondetti, L Gattinoni
Ospedale Maggiore di Milano, Italy
Critical Care 2004, 8(Suppl 1):P34 (DOI 10.1186/cc2501)
Introduction  The prone position has been shown to attenuate
ventilator-induced lung injury in experimental models [1,2].
Recently, it has been suggested that the mechanism may be due
to a more homogeneous distribution of strain within the lung
parenchyma [3]. This study was performed to explore this
hypothesis.
Methods A total of 30 animals were ventilated in supine (n = 15)
or prone (n = 15) positions until a similar ventilator-induced lung
injury (VILI) was reached. To do so, experiment was interrupted
when respiratory system elastance (Ers) was 150% of baseline [4].
Thereafter VILI was assessed as the lung wet-to-dry (W/D) ratio
and histology (H&H stain). In five more animals CT scans (GE
Medical System Light Speed QX/I, 0.6 mm thickness, 100 mA,
100 Kv) were taken at end-expiration and end-inspiration (90% of
inspiratory capacity) in both supine and prone positions.
Quantitative analysis (Maluna, 2.02 Mannheim, Germany) was
performed on the entire lung and dividing the lung into four zones
along the vertical axis, from ventral to dorsal. We also considered
the area of the lung as seen from a lateral view considering the
height at each scan, dividing it into upper and lower regions
according to maximal height of the lung at end-expiration (Osiris,
Medical imaging software 3.6, Geneva, Switzerland). The tidal
volume distribution was then calculated as the ratio between the
area at end-inspiration and end-expiration. This was calculated for
upper and lower regions in both the supine and prone positions.
Data are shown as mean ± SD.
Results Rats were ventilated with comparable ventilator settings
(tidal volume of 88.7 ± 8% of inspiratory capacity vs 88.6 ± 4.9,
supine vs prone, P = not significant [NS]). Similar VILI was
reached, as assessed by Ers, W/D and histology. The time taken to
achieve the target VILI was longer with prone position
(73 ± 37 min vs 112 ± 42, supine vs prone, P < 0.05).
When considering CT scan analysis, lung volumes were similar
between groups, both at end-expiration (1.84 ± 0.25 ml vs
1.97 ± 0.16, supine vs prone, P = NS) and end-inspiration
(10.07 ± 2.79 mL vs 9.52 ± 2.49, supine vs prone, P = NS).
However, at end-expiration, lung density along the vertebral axis
was similar in the prone position, while it was significantly
decreased in the supine position (ANOVA, P < 0.05). The ratio
between end-inspiratory and end-expiratory areas was greater in
the upper region as opposed to the lower region in the supine
position (1.64 ± 0.12 vs 0.74 ± 0.07, upper vs lower region,
P < 0.05), while in the prone position it was similar (1.21 ± 0.12 vs
1.13 ± 0.07, upper vs lower, P = NS).
Conclusion The prone position attenuates VILI, allowing one to
buy time on its progression. Both lung volume at end-expiration
and tidal volume are more homogeneously distributed in the prone
position, suggesting a more homogeneous distribution of strain
within lung parenchima. This may explain the protective role of the
prone position on the progression of VILI.
References
1. Broccard: Crit Care Med 2000, 28:295-303.
2. Nishimura: Intensive Care Med 2000, 26:1664-1669.
3. Gattinoni: Eur Respir J 2003, 22(Suppl 47):1s-11s.
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P35 Physiological effects of lateral steep positioning in critically ill patients suffering from acute respiratory distress syndrome
(ARDS)
T Staudinger, H Losert, P Schellongowski, G Locker, K Laczika
University of Vienna, Austria
Critical Care 2004, 8(Suppl 1):P35 (DOI 10.1186/cc2502)
Introduction Continuous rotation therapy (CRT) using specially
designed beds is known to prevent respiratory complications in
ventilated patients and to exert beneficial effects in patients
suffering from respiratory failure due to acute lung injury (ALI)
and/or ARDS. Little is known about the physiologic effects and
potentially beneficial mechanisms of CRT. Moreover, data on the
optimal setting of the turning angle and the duration of the pause in
maximal lateral steep position are rare.
Methods Twelve patients suffering from ALI and or ARDS were
investigated. Patients were included if a pulmonary artery catheter
had been placed and the decision to perform CRT had been taken.
Patients were placed into a CRT positioning system (Rotorest,
KCI, San Antonio, TX, USA) and the study was performed after
1–3 days of turning. In a first phase, oxygenation and
hemodynamics were assessed during continuous turning in the
supine and both maximal steep positions at an angle of 62°. In a
second phase, the patients were positioned in both maximal steep
positions for half an hour. Oxygenation and hemodynamics were
assessed in the supine position and every 10 min during steep
positioning. All patients were sedated and mechanically ventilated
using a pressure-controlled mode. Ventilation parameters were not
changed throughout the study period.
Results Ten male and two female patients fulfilling the diagnostic
criteria of ARDS were evaluated. The median age was 54 years
(range 22–81 years). Ten patients tolerated prolonged lateral
steep positioning well; in two patients the study had to be broken
off prematurely in the left lateral position due to a decrease in
blood pressure in one, and a decrease in arterial oxygen
saturation in the other case. The results were comparable in both
phases of the study. Overall, oxygenation did not change
significantly with position but tended to deteriorate in lateral
steep compared with in the supine position. Interindividual
changes of oxygenation with different positions showed a high
variability. Tidal volumes and lung compliance declined
significantly in the lateral steep position compared with the
supine position. The cardiac index and arterial blood pressure did
not change significantly.
Conclusion The beneficial effects of CRT are not due to
recruitment of nonventilated lung areas. Steep positioning itself
does not improve oxygenation. Continuous turning seems to exert
beneficial effects due to other mechanisms. CRT should be
performed without prolonged pauses in the maximal steep
position.
P36 Different concomitant diseases are accompanied by different effects of the prone position in acute respiratory failure
J Lewejohann
University Hospital, Lübeck, Germany
Critical Care 2004, 8(Suppl 1):P36 (DOI 10.1186/cc2503)
Introduction In acute respiratory failure (ARF), in particular acute
lung injury (ALI) and acute respiratory distress syndrome (ARDS),
change from the supine position (SP) to the prone position (PP)
can improve oxygenation by recruiting alveoli situated in dorsal-
dependent regions and by alteration of the ventilation/perfusion
ratio. The efficacy of this intervention is shown by the course of
oxygenation index. The aim of our study is to demonstrate different
effects of prone position ventilation (PPV) in ARF in patients with
different concomitant diseases.
Methods We studied 110 consecutive patients with ALI (n = 18)
and ARDS (n = 92) at mean (± SE) age 66 ± 13 years in a clinical
follow-up design at a surgical ICU in a university hospital using the
American European consensus definition. Respiratory failure was
accompanied solely or in combination by sepsis (n = 52),
pneumonia (n = 66), malignant disease (n = 25), vascular disease
(n = 60) or multiple trauma (n = 10) as concomitant disease.
All patients were ventilated intermittently in SP and PP (135° left-
side/right-side position) for at least 6 hours/day for supportive
treatment of respiratory failure. Data collection included, apart from
baseline characteristics, individual oxygenation index and
concomitant diseases of the patients.
Results Patients with ARF and sepsis showed an early (SP
165 ± 51 mmHg vs after 8 hours PP 198 ± 60 mmHg) and lasting
significant increase in oxygenation (SP 165 ± 51 mmHg vs fourth
day PP 243.23 ± 94 mmHg) after starting PPV. Patients with
pneumonia (SP 159.0 ± 56.1 mmHg vs after 8 hours PP
192.1 ± 67.8 mmHg), vascular diseases (SP 157.1 ± 52.21 mmHg
vs after 8 hours PP 193.0 ± 63.1 mmHg) or malignant diseases
(SP 146.8 ± 53.8 mmHg vs after 8 hours PP 199.6 ± 74.3 mmHg)
showed a visible increase in oxygenation on the first day after
starting PPV but only a more or less clear improvement in the
following days. Data 72–96 hours after starting PPV: pneumonia
215 ± 76.1 mmHg, vascular disease 212.7 ± 60.4 mmHg, and
malignant disease 231.7 ± 61.4 mmHg. Multiple trauma patients
showed a trend for better oxygenation but not a significant
increase of the oxygenation index after starting PPV.
Discussion Especially, patients with ARF and sepsis showed an
early and lasting increase in oxygenation after starting PPV, while
those with pneumonia, vascular disease or malignant diseases
showed a visible increase in oxygenation on the first day after
starting PPV, and a more or less clear improvement in the following
days. Multiple trauma patients showed only a trend for a better
oxygenation but not a significant increase.
Conclusion Concomitant diseases seem to have a remarkable
influence on the effect of PPV in ARF.Available online http://ccforum.com/supplements/8/S1
P37 Computerised tomography (CT) in severe acute respiratory syndrome (SARS): late-stage acute respiratory disease
syndrome (ARDS) and follow-up findings
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Introduction SARS is caused by a newly described coronavirus
[1]. About 20% of SARS patients require oxygen supplementation
and mechanical ventilation in an ICU for respiratory failure and
ARDS [2]. We aim to describe the CT findings of patients in the
late stage of ARDS caused by SARS, and report changes on long-
term follow-up.
Methods A retrospective review of CT findings in eight patients
who met CDC criteria for SARS. All patients met criteria for ARDS
[3]. CT was performed in late-stage ARDS (more than 2 weeks
after onset of ARDS) [4], and after discharge from hospital in
survivors. Relevant respiratory and ventilatory parameters, total
steroid dose and outcome were recorded.
Results All mechanically ventilated patients received low pressure
(peak pressure <30–35 mmHg), low volume (tidal volume
<8 ml/kg estimated lean body mass) ventilation [5]. Five patients
received prolonged mechanical ventilation (over 14 days), one was
only ventilated for 72 hours, and two patients were not ventilated at
all. All patients received high-dose pulse methylprednisolone
(2.5–7 g total dose). Three patients died and five survived to
hospital discharge.
ARDS chronic stage CT findings Consolidation was present in
five patients. Ground glass opacification and interstitial thickening
were present in all patients. Three had evidence of fibrosis. Small
pulmonary cysts were present in five patients and extrapulmonary
gas (pneumothorax) in two. Findings in patients after long-term
mechanical ventilation (more than 14 days) and short-term or no
ventilation were similar. At follow-up CT (mean 3 months, n =4 ) ,
consolidation and extrapulmonary gas had resolved, ground glass
opacification improved, but signs of fibrosis had generally
progressed.
Conclusion The CT features of late-stage ARDS caused by SARS
are similar to those seen in late-stage ARDS from other causes [4],
with no apparent differences between patients who received
prolonged mechanical ventilation and those who did not. Fibrotic
changes seen in the chronic phase of ARDS do not seem to
resolve significantly after discharge.
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P38 Critically ill patients with severe acute respiratory syndrome (SARS) in a designated national SARS ICU: clinical features
and predictors for mortality
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Aim An outbreak of SARS occurred in Singapore following the
hospitalisation of the first index case on 1 March 2003. We report
the clinical features and outcomes of critically ill probable SARS
patients in a designated national SARS hospital.
Methods We retrospectively reviewed the case records of all
probable SARS patients admitted to a designated national SARS
ICU from 1 March to 13 July 2003 when the last SARS patient was
discharged.
Results One hundred and ninety-nine probable SARS patients
were admitted to this national SARS hospital. Forty-six (23.1%)
required ICU admission. The mean age of these ICU patients was
49.8 ± 16.4 years with equal sex distribution and similar racial
distribution as the national population. The mean APACHE II score
was 19.2 ± 9.6. The median (interquartile range [IQR]) PaO2/FiO2
ratio on ICU admission was 88 (60–128). Eighty-five per cent
required mechanical ventilation. Complications observed included:
septicaemia 16 (34.8%), secondary pneumonia 24 (52.2%), deep
vein thrombosis 11 (23.9%), acute renal failure 9 (19.6%), acute
myocardial infraction 8 (17.4%), stress hyperglycaemia 8 (17.4%),
pneumothorax 8 (17.4%), pulmonary embolism 7 (15.2%),
cerebrovascular accidents 4 (8.7%) and pneumomediastinum 1
(2.2%), The in-ICU mortality was 54.3% (25/46). The median
(IQR) length of mechanical ventilation was 12 (9–22) days. The
median (IQR) lengths of stay in the hospital and ICU were 23.5
(15–36) days and 14.5 (7–22) days, respectively. Cox regression
analysis showed that the male sex (P = 0.03), an APACHE II score
>15 (P = 0.003) and a history of congestive cardiac failure
(0.017) were independent predictors for mortality among SARS
ICU patients.
Conclusion About one in five probable SARS patients required ICU
care. This group of critically ill SARS patients has high mortality and
morbidity. The predictors for ICU mortality were male sex,
APACHE II score >15 and history of congestive cardiac failure.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P39 Retrospective analysis of critically ill patients with severe acute respiratory syndrome admitted to an intensive care unit
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Introduction Severe acute respiratory syndrome (SARS) is a new
infectious disease that presented in Southern China in late 2002.
On 26 March 2003, Princess Margaret Hospital (PMH) was
designated as the receiving hospital for all SARS cases in Hong
Kong. Shortly after, there was a massive upsurge in the number of
cases as a result of the rapid spread of SARS through a residential
block. Over 600 cases of suspected SARS were admitted to PMH
in the first week of April, 409 of whom were confirmed with SARS.
Within 2 weeks the hospital was unable to cope. Great difficulty
was encountered in mobilizing sufficient trained ICU staff in
addition to the extra ICU beds required.
SARS is a syndrome that can progress to respiratory failure and
death. Chest radiographs are abnormal in the majority of patients
and demonstrate variable infiltrative patterns. Clinical deterioration
is accompanied by progression of pulmonary infiltrate. Early
experience suggested that approximately 20% of cases require
admission to an intensive care unit (ICU) as a result of respiratory
failure.
Objective This study aimed to describe patients with SARS who
developed respiratory failure requiring ICU admission.
Methods  Retrospective analysis of prospectively collected
demographic, clinical, biochemical, microbiological and radio-
logical data on SARS cases admitted to an ICU.
Results A total of 116 patients, including 10 health care workers,
were admitted to the ICU with a clinical diagnosis of SARS. In 62% of
cases, SARS Co-V was positive. The mean time interval between
symptom onset and hospital admission was 4.8 ± 3.7 days and the
mean time between symptom onset and ICU admission was
10.5 ± 4.7 days. The 116 patients had a mean ± SD age of
48.2 ± 14.6 (range 24 to 96) years. Sixty-eight percent had known
contact or exposure to another SARS person. Significant comorbidity
was present in 36%. Treatment consisted of broad-spectrum
antibiotics, ribavarin, corticosteroids (maintenance and pulse), and in
selected cases kaletra, immunoglobulin, convalescent serum and
Chinese herbal medicine. The median Acute Physiology and Chronic
Health Evaluation II score was 19 (range 6–49). The admission mean
ratio of the partial pressure of oxygen to the fraction of inspired
oxygen was 146 ± 80 (range 60–421). Seventy-six patients required
mechanical ventilation and the mortality in this group was 53%. No
spontaneously breathing patients died while in the ICU. Of the
ventilated patients, 28% developed barotauma. In the nonventilated
patients, 10% developed barotrauma spontaneously. Renal failure
occurred in 78% of nonsurvivors and 8% of survivors. Positive blood
cultures occurred in 37% of nonsurvivors and 8% of survivors. The
median duration of stay in the ICU was 13 days (range <1 to
111 days). The overall mortality was 34.5%.
Conclusion SARS carries a high mortality especially in mechanically
ventilated patients. Barotrauma, renal failure and sepsis were prevalent.
P40 Incidence of lung injury in acute liver failure: diagnostic role of extravascular lung water index
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Introduction Acute lung injury (ALI) was found to be a frequent
complication of acute liver failure (ALF) in a previous study [1]. The
associated mortality was high (89%) and severe hypoxia is a
contraindication for liver transplantation (LT) in many transplant
centers. We tried to study the incidence and outcome of ALI in a
heterogeneous group of patients with ALF. In addition, we aimed to
investigate the role of extravascular lung water index (EVLWI)
measurements in diagnosis and management of ALI in liver failure.
Methods A retrospective chart review of 40 patients with ALF
fulfilling poor prognostic criteria admitted to a liver ITU over an
18-month period. ALI findings on chest X-ray (CXR) around the
period of listing and perioperatively were correlated with
oxygenation and ventilator parameters as well as measurements of
EVLWI and the permeability index (EVLWI/intrathoracic blood
volume index measured via transpulmonary thermodilution; PiCCO
Pulsion, Munich, Germany).
Results The cause of ALF was paracetamol overdose in
19 patients, NANB hepatitis in eight patients, and acute
Budd–Chiari syndrome in five patients. The remaining eight patients
suffered from acute hepatitis B virus infection, Wilsons disease,
drug-induced liver failure and autoimmune hepatitis. Twenty-eight
patients (70%) were transplanted and 24 survived to hospital
discharge. Of the 12 nontransplant patients only one survived. A
diagnosis compatible with ALI was found in 23%, with no difference
between transplant and nontransplant patients. The median
PaO2/FiO2 ratio (P/F) was 167 in ALI patients against 283 in
nonlung injury patients (Mann–Whitney U test, not significant). Only
two patients (5%) were taken off the transplant list due to a
combination of refractory hypoxia and multiple organ failure.
Transplant and nontransplant patients did not differ in terms of P/F,
positive end expiratory pressure (PEEP), EVLWI or permeability
index. Poor outcome was not associated with low P/F, CXR signs
of ALI, high EVLWI or permeability index. Bilateral infiltrates on CXR
correlated with PEEP (P = 0.004), EVLWI (P = 0.001) and
permeability index (P < 0.001) but not with P/F. Focal lung infiltrates
did not correlate with the above parameters. Twelve patients
without CXR findings of ALI had significant impaired gas exchange
P/F < 200, suggesting an extrapulmonary reason for hypoxia.
Conclusion One-quarter of the patients with ALF in our series
showed signs of ALI. Severe lung injury in the peri-transplant
period was not associated with a high mortality. Hypoxia is
nonspecific for the diagnosis of ALI and should not be used as a
sole determinant to remove patients from the transplant list. The
EVLWI and the permeability index are readily available bedside
parameters for the diagnosis of ALI; however, they did not correlate
with patient outcome.
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Objectives To determine the incidence of pulmonary dysfunction
in comatose patients with severe traumatic brain injury and to
evaluate the effect of respiratory failure on neurological outcome.
Methods A retrospective study of 68 trauma patients, 18 females
(26.47%) and 50 males (73.53%), admitted to the ICU from July
1998 to July 2003 with isolated brain injury and a Glasgow Coma
Score (GCS) of 9 or less, all under sedation and mechanical
ventilation on admission. Patients enrolled in the study were aged
from 16 to 83 years, with a mean age of 40.28 ± 20.73 years.
Pulmonary function was evaluated at the latest by the fourth day of
hospitalization, using the Lung Injury Score (LIS) with the following
components: chest radiographic findings, PaO2/FiO2 and positive
end expiratory pressure. A LIS of zero was defined as normal
pulmonary function, a LIS of 0.1–2.5 as mild to moderate
dysfunction, while a LIS of more than 2.5 as severe pulmonary
dysfunction. The maximum LIS was taken in consideration for
statistical analysis. The patients’ brain computerised tomography
(CT) scan on admission was graded using the Marshall CT scoring
system. The Glasgow Outcome Scale (GOS) was used after a
30-day follow-up of the population, as good recovery (1), moderate
disability (2), severe disability (3), vegetative state (4), death (5) —
considering good outcome as (1) and (2) and bad outcome as (3),
(4) and (5). The mean value ± SD was calculated for all data. The
correlation of all variables was assessed and the outcome was
evaluated.
Results The GCS on admission was 6.47 ± 1.89. The maximum
LIS was recorded before the fourth day of hospitalization (3 ± 1)
with a mean value of 3.34 ± 0.86. Six patients (8.8%) had normal
pulmonary function, while 59 (89.7%) had mild to moderate
dysfunction and one patient (1.47%) had severe pulmonary
dysfunction. Based on the GOS 47.1% (32/68) had good
outcome and mortality reached 25% (17/68). Moderate statistical
correlation was found between the LIS and GCS (correlation
coefficient  r = –0.51), and also between the LIS and GOS
(r = 0.52), while the GCS and GOS were inversely related
(r = –0.78). Sixty-one patients (89.7%) presented a relation
between LIS and CT score (r = 0.64). The remaining nine patients
(13.23%) did not show a relation between LIS and CT score, as
aspiration prior to intubation, atelectasies and mechanical
ventilation with overdistension of the lung aggravated pulmonary
function directly and independently from the neurological status.
Conclusions Although in clinical practice we experience a strong
relation between LIS and CT scan findings for patients with severe
traumatic brain injury, this was evident in 89.7% of the population
studied. Pulmonary dysfunction was not an isolated complication in
patients with brain injury showing poor prognosis, but rather
represented the first manifestation of a systemic disease. A broader
study should be performed in order to assert these findings.
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P42 Smoke inhalation injury and tissue dysoxia: what is the link?
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Background Smoke inhalation injury is a frequent health threat
contributing to significant pulmonary derangements. The objective
of this study was to determine potential interdependencies
between pulmonary shunt fraction (Qs/Qt), tissue oxygenation and
cardiac performance in the acute phase of combined burn and
smoke inhalation injury.
Methods Following a 20%, third-degree burn, sheep (n = 10) were
subjected to cotton smoke according to an established protocol
(4 × 12 breaths, <40°C). Before (BL) and after each set of cotton
smoke inhalation, the Qs/Qt, mean pulmonary arterial pressure,
cardiac index (CI), left ventricular stroke work index (LVSWI), O2
delivery index (DO2I), O2 consumption index (VO2I) and
O2-extraction rate (O2-ER) were assessed. At the same time
points, the arterio-venous SO2 difference and veno-arterial pCO2
gradient were determined.
Statistics One-way ANOVA with Student–Newman–Keuls post-
hoc test, or linear regression when appropriate. Data are expressed
as mean ± SEM, or Pearson correlation coefficient, respectively.
Results The burn injury led to an immediate and sustained
decrease in CI (6.1 ± 0.2 vs 3.8 ± 0.6 l/min/m2), accompanied by a
depression in LVSWI (75 ± 2 vs 28 ± 1 g/m/m2; P < 0.001 each).
Smoke inhalation did not further impair these hemodynamic
changes but led to a progressive increase in the Qs/Qt, up to a
maximum of 85 ± 2% (P < 0.001 vs BL). Interestingly, the degree
in Qs/Qt was inversely correlated with both the arterio-venous SO2
difference (r = –0.90) and the veno-arterial pCO2 gradient
(r = –0.57). While the O2-ER remained unchanged, a more than
50% reduction in both DO2I (724 ± 41 vs 345 ± 43 ml/min2/m2)
and VO2I (295 ± 16 vs 123 ± 9 ml/min2/m2) occurred (each
P < 0.001 vs BL).
Conclusion This study demonstrated that in the acute phase of
combined burn and smoke inhalation injury (1) the deterioration in
tissue oxygenation is linked with depressions in myocardial
contractility and global oxygen transport as well as an increase in
the Qs/Qt, and (2) the arterio-venous SO2 difference is more
appropriate to mirror ventilation/perfusion mismatch compared with
the veno-arterial pCO2 gradient.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P43 Role of oxidative stress and FAS-induced apoptosis in acute lung injury
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The purpose of our research was to study the FAS/FASL system in
acute lung injury (ALI) (acute respiratory distress syndrome [ARDS])
and to compare these processes with dynamics of oxidative stress
markers (nitric oxide [NO], hydrogen peroxide [H2O2]).
We examined expired air condensates (EAC) of patients with
various stages of ARDS using spectrophotometry to study NO
metabolites and fluorescence to study H2O2. Identification of CD95
(FAS) in blood cells was detected using monoclonal antibodies.
Our investigation showed the increase of NO metabolite level in
EAC patients with the first and second stages of ARDS and its
significant decrease in EAC patients with the third and fourth
stages. The level of H2O2 in EAC elevated with the progress of
ARDS. All these patients have increased FASL production, but we
noted a reduction of the CD95 level in patients with the final
ARDS stage.
These data show that alveolar epithelial injury in ALI or ARDS is in
part associated with upregulation of the FAS/FASL system and
activation of oxidative stress markers. Our findings suggest that
oxygen-independent pathways may mainly operate in the process
of FAS-induced apoptosis.
P44 Effects of positive end expiratory pressure (PEEP) in right ventricular function
M de Oliveira, A Rea-Neto
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Critical Care 2004, 8(Suppl 1):P44 (DOI 10.1186/cc2511)
Introduction The addition of high levels of PEEP in patients under
mechanical ventilation can be part of recruitment maneuvers and
alveolar protection. However, it can also cause deleterious effects
in the right ventricular function.
Methods We studied 16 patients admitted in a trauma ICU during
the period January–August 2003. All patients were under
mechanical ventilation and without significant pulmonary disease.
They were submitted to the systematic increase of PEEP from
ZEEP to 5, 10, 15, 20 and 25 cmH2O every 10 min. At the same
time, we measured the haemodynamic effects and alterations in
the oxygen transportation.
Results All were traumatic patients, without significant pulmonary
disease. The mean age was 34.3 ± 11.9 years, 87.5% were male,
the mean APACHE II score was 26.4 ± 4.5, the mean SAPS II
score was 44.9 ± 11.9 and the initial mean SOFA score was
5.8 ± 1.4. The addition of PEEP caused progressive increase of
the pulmonary artery pressure, of the central venous pressure
(CVP) and of the oxygen extraction rate. At the same time, it
caused progressive decrease of the cardiac index (CI) and the
right ventricular systolic work index (RVSWI). The CVP increased
from 13.3 ± 5.5 to 21.8 ± 4.4, the CI decreased from 5.0 ± 1.6 to
4.1 ± 2.1 and the RVSWI decreased from 10.6 ± 6.2 to 7.0 ± 5.9.
All these alterations were statistically significant (P < 0.05).
Conclusions The addition of PEEP in patients under mechanical
ventilation and without significant pulmonary disease can cause
progressive right ventricular dysfunction. Haemodynamic care and
support should be taken during PEEP increases for recruitment
maneuvers and alveolar protection, even if this is done for short
periods of time.
P45 Haemodynamic and volumetric response to tidal volume and positive end expiratory pressure variation in acute lung
injury/acute respiratory distress syndrome patients
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Introduction Tidal volume limitation and incremental positive end
expiratory pressure (PEEP) correlates with improved survival in
acute respiratory distress syndrome (ARDS) [1], but the impact on
haemodynamic response is not well established [2,3].
Aim of study To evaluate (1) the haemodynamic and volumetric
response to incremental changes of tidal volume and (2) the
haemodynamic and volumetric response to incremental changes of
PEEP.
Materials and methods Twenty acute lung injury (ALI)/ARDS
patients were mechanically ventilated and connected to an
integrated monitoring system (PICCO system; Agilent) by a
fiberoptic arterial catheter (pv 2014L16) and a central venous
catheter. All patients were randomised to receive mechanical
ventilation with an incremental tidal volume (TV) (6, 8, 10 and
12 ml/kg at ZEEP) (group A) or TV = 6 ml/kg and incremental PEEP
(5, 10 and 15 cmH2O) (group B). At every change of respiratory
parameters the main haemodynamic and volumetric data were
evaluated. Cardiac output (CO) was evaluated continuously online.
All data are expressed as the mean ± SD. The ANOVA test was
used to compare changes at different TV and at incremental levels
of PEEP. P < 0.05 was considered statistically significant.
Results Tables 1 and 2 report the main hemodynamic changes
during different ventilation patterns. Volumetric parameters did not
change during the study, but the intrathoracic blood volume index
(ITBVI) correlated with CO at every step (r = 0.73,  P < 0.001,
Spearman correlation).
Conclusion (1) TV ≥10 ml/kg decreases either the CO or the
mean arterial pressure (MAP). (2) PEEP ≥ 15 cmH2O decreasesCO. (3) Mechanical ventilation with TV ≤6 ml/kg and PEEP
≤10 cmH2O has minimal impact on the cardiovascular system. (4)
Optimisation of ITBVI may improve the cardiovascular response to
mechanical ventilation adjustment.
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Table 1
Group A P value
CO (l/min/m2) TV 6 vs TV 10–12 ml/kg <0.01
MAP (mmHg) TV 6 vs TV 10–12 ml/kg <0.001
Table 2
Group B P value
CO (l/min/m2) PEEP 5 vs 15 cmH2O <0.01
MAP (mmHg) PEEP 5 vs 15 cmH2O 0.35
P46 Confounding hemodynamic effects of assisted ventilation in hemorrhagic states
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Background The detrimental hemodynamic effects of positive
pressure ventilation in hypovolemic states have been well
described for more than 60 years. Nevertheless, typical paramedic
training programs and applicable prehospital resuscitative trauma
protocols in the United States and elsewhere often call for
‘hyperventilation’ therapy (e.g. rates >15/min), particularly in
moribund trauma patients. Typically, paramedics are trained to do
so with the anecdotal rationale that they will ‘pump in more oxygen’
and better ‘compensate for metabolic acidosis’. Therefore,
considering that many of the patients receiving assisted ventilation
are those with the most severe hemorrhage, there exists concern
that such practices may be an under-recognized contributor to
worse outcomes and that they may even over-ride or mask the
potential positive effects of any resuscitative study interventions.
To begin to address this issue, a study was performed to
demonstrate that very slow respiratory rates (RRs) not only
preserve adequate oxygenation and acid–base status in
hemorrhagic states, but also that ‘normal’ or higher RRs worsen
hemodynamics, even in cases of mild to moderate hemorrhage.
Methods Eight pigs were ventilated with 12 ml/kg tidal volume
(intubated, no positive end expiratory pressure, no lung disease);
28% FiO2; and RR = 12/min. The pigs were then hemorrhaged to
< 65 mmHg systolic arterial blood pressure (SABP). After reaching
steady state, RRs were then sequentially changed every 10 min to
6, 20, 30, and 6/min, respectively.
Results With RRs at 6/min, the animals maintained
pH > 7.25/SaO2 > 99%, but increased mean SABP
(65–84 mmHg;  P < 0.05), time-averaged coronary perfusion
pressure (CPP) (50 ± 2 to 60 ± 4 mmHg; P < 0.05) and cardiac
output (Qt) (2.4–2.8 l/min; P < 0.05). With RRs = 20 and =30, the
SABP (73 and 66 mmHg), CPP (47 ± 3 and 42 ± 4 mmHg) and
Qt (2.5 and 2.4 l/min) decreased, as did PaO2 and PaCO2
(<30 mmHg) with P < 0.05 for each comparison, respectively.
When RR returned to 6/min, SBP (95 mmHg), CPP
(71 ± 6 mmHg), Qt (3.0 l/min) improved significantly (P < 0.05).
Conclusions Following moderate hemorrhage, animals can
maintain adequate oxygenation and ventilation with very slow
RRs, while increasingly higher RRs progressively impair
hemodynamics, directly resulting in diminished coronary
perfusion and Qt. It is probable that these effects will be more
pronounced in severe hemorrhagic states and may even
contribute to worse outcomes and under-appreciated
compromised study results. Current resuscitative protocols for
trauma involving provision of positive pressure ventilation should
be re-examined.
P47 Ejection fraction (EF) corrected volumetric parameters better reflect preload and fluid responsiveness
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Introduction Volumetric monitoring with right ventricular end-
diastolic volume indexed (RVEDVi) and global end-diastolic volume
indexed (GEDVi) is increasingly being suggested as a better
preload indicator than traditional intracardiac filling pressures
(central venous pressure [CVP] and pulmonary artery occlusion
pressure [PAOP]). Static volumetric monitoring, however, has not
consistently been shown to correlate with the cardiac index (CI).
This study aims (1) to evaluate the influence of ejection fraction
(EF) on RVEDVi and GEDVi, (2) to study the effect of RVEDVi and
GEDVi changes (∆) corrected for right ventricle ejection fraction
(RVEF) and global ejection fraction (GEF), respectively, on ∆CI,
and (3) to identify optimal resuscitation target volumes.
Materials and methods Complete hemodynamic profiles with the
VoLEF and PiCCO catheter (Pulsion, Germany) were obtained in
five mechanically ventilated medical ICU patients: age
62.6 ± 11.2 years, SAPS-II 41 ± 15.4, APACHE II 18.8 ± 5.4, and
SOFA 4.8 ± 2.1. In total 125 paired measurements of CVP, PAOP,
RVEDVi, RVEF, GEDVi, GEF and CI were performed.
Results Figure 1 shows the correlation of ∆RVEDVi corrected for
RVEF (∆RVEDVi-C) with ∆CI (R2 = 0.69,  P < 0.0001). Figure 2
shows a similar correlation between ∆GEDVi corrected for GEF
(∆GEDVi-C) with ∆CI (R2 = 0.62,  P < 0.0001). Adjustment of
volumes was achieved by exponential correction for the EFCritical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
deviation from normal (Fig. 3). The RVEDVi-C and GEDVi-C
volumetric targets corrected for EF are presented in Table 1. We
did not found any correlation between (∆) filling pressures or (∆)
static volumes and (∆) CI.
Conclusion Filling pressures and static volumes are unreliable
preload indices. The EF corrected target volumes better predict
fluid responsiveness. We suggest using RVEDVi-C and GEDVi-C
as target resuscitation or restoration of organ perfusion endpoints.
Unneccessary over-resuscitation past these values will not benefit
the patient.
Table 1
Ejection
fraction 10% 20% 30% 40% 50%
RVEDVi-C 265–350 200–250 150–170 110–115 80
GEDVi-C 950–1150 750–900 600–675 475–525 400
Figure 1                                                                   Figure 2                                                                Figure 3
P48 Assessment of blood flow during extra-corporeal circulation from arterial waveform analysis
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Background The pressure recording analytical method (PRAM) is
a recently developed method for beat-to-beat quantification of
cardiac output (CO) based on the analysis of the arterial waveform.
Since PRAM can be implemented in various conditions of flow, we
assessed its accuracy in cardiac surgery during extra-corporeal
circulation (ECC), using the roller pump device (RP) as the
reference gold standard.
Methods In 25 patients undergoing cardiac surgery, CO values
obtained by the PRAM from the radial artery were compared with
bolus thermodilution (TD) before and after ECC, and with the RP
readings during ECC before and after aortic clamp. PRAM flow
measurements during ECC were based on the analysis of each
sinusoidal arterial waveform (the continuous component of flow)
produced by the RP.
Results The estimates of blood flow measured by the PRAM
closely agreed with TD (r2 = 0.75; P < 0.0001; bias = 0.07 ± 0.40;
coefficient of variation <2%) and simultaneous RP readings
(r2 = 0.71; P < 0.0001; bias = 0.11 ± 0.33; coefficient of variation
2.5%). During weaning from ECC, two patterns of hemodynamic
adaptation were documented by PRAM following resumption of
cardiac contraction. (1) Most patients (Fig. 1A, upper line) had a
rapid and stable recovery of CO (a reduction <10% as compared
with ECC flow) at the decreasing of RP-infused volumes (lower
line). (2) Five patients showed a marked fall in CO >10% up to
38% (Fig. 1B, upper line) and required longer ECC assistance and
weaning time (lower line), and inotropic support. In Figs 1A,B,
shaded areas represent the cardiac contribution to CO.
Conclusions The PRAM provided accurate and continuous
quantification of flow during each phase of cardiac surgery. This
new method may allow early recognition of low CO during weaning
from ECC.
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Figure 1Available online http://ccforum.com/supplements/8/S1
Background The N-terminal prohormones of the natriuretic
peptides ANP and BNP (NTproANP and NTproBNP) are accepted
markers of myocardial dysfunction [1] and are increasingly used in
critically ill patients. While it is well recognized that plasma levels of
ANP are altered by variations in thoracic blood volume and during
intravenous sodium loading [2], only incomplete data are available
on the course of BNP during these interventions [3].
Materials and methods Two groups of eight healthy subjects
were randomly tilted into a 15°-feet-down (FD) or a 15°-head-down
(HD) position. Ten volunteers were crossover subjected to an
infusion of 15 ml/kg NaCl 0.9% (over 60 min) or control during an
observation period of 10 hours. Blood was sampled at timed
intervals. NTproANP and NTproBNP were determined by
radiochemiluminescence and electrochemoluminiscence
immunoassays, respectively.
Results NTproANP levels (in % of baseline levels) were higher
(P < 0.05) during HD (124 ± 13%) than during FD (82 ± 6%),
while NTproBNP levels were not affected by tilting. Following
sodium loading (Fig. 1), plasma NTproANP levels increased
immediately and returned back to baseline after 8 hours. In
contrast, NTproBNP levels increased 3 hours after infusion and
had doubled at the end of the observation period.
Conclusions Besides relevant physiological implications — a
sequential increase of NTproANP and NTproBNP after sodium
loading has not been shown previously in humans — our data show
that NTproBNP levels are influenced by sodium infusion. This may
be relevant for the interpretation of NTproBNP levels in critically ill
patients.
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Figure 1
The course of plasma levels of NTproANP and NTproBNP in 10 healthy volunteers during the control protocol () and the sodium loading protocol
(). Data are mean ± SEM. *P < 0.05, between-group difference. §P < 0.05, versus baseline value. Friedman’s test and Wilcoxon’s matched pairs
test as appropriate.
P50 Flow guided peripoperative resuscitation shortens hospital stay
S Lowson
University of Virginia Health System, Charlottesville, Virginia, USA
Critical Care 2004, 8(Suppl 1):P50 (DOI 10.1186/cc2517)
Studies in surgical patients [1,2] have suggested that using
noninvasive measurements of cardiac output to guide intraoperative
fluid resuscitation results in improved patient outcome. We tested
this hypothesis in patients for major elective surgery.
Methods Fifty patients scheduled for major urological surgery were
sequentially randomized to a control (C) group or a flow guided (FG)
group. In the C group, intraoperative fluids were given according to
blood pressure, heart rate and blood loss. In the FG group, in
addition to the above, a volume was given to maximize the cardiac
output or until a cardiac index of >3.0 l/min/m2 was achieved. We
used a NICO (Novametrix) noninvasive cardiac output to record
continuous measurements of cardiac index. Patients were followed
postoperatively by the investigator team, who recorded the return of
bowel function and the time to hospital discharge. The decision to
discharge patients were made by the surgical team per protocol.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
Results Patient demographics are presented in Table 1. Patients
in the FG group were older than in the C group. Patients in the FG
group were given significantly more volume/hour of surgery than
those in the C group. The time to passage of flatus, the ability to
tolerate a soft diet and hospital discharge were all decreased in the
FG group (Table 2). There was no difference in morbidity or
mortality between the two groups.
Conclusion  This study sugests that the use of continuous
noninvasive measurements of cardiac output to guide
intraoperative volume replacement results in more volume being
given but in a faster postoperative recovery of bowel function and
faster hospital discharge.
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Table 1
Control (n = 25) Flow Rx (n = 25)
Age (years) 69 ± 11 61 ± 14*
Male:female 20:5 18:7
Cystect:neph 14:9 14:9
Table 2
Control (n = 25) Flow Rx (n = 25)
Volume (ml)/hour 1321 ± 314 1941 ± 701*
Time flatus (hours) 96 ± 45 75 ± 39 *
Time soft diet (hours) 124 ± 57 101 ± 49*
Hospital stay (days) 7.7 ± 3.9 6.1 ± 2.1*
P51 The relationship between central venous saturation and outcome following high-risk surgery
R Pearse, D Dawson, J Fawcett, S Wort, A Rhodes, R Grounds
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Introduction Central venous oxygen saturation (ScvO2) reflects
both tissue oxygen delivery and consumption and has been shown
experimentally to closely reflect a range of circulatory disturbances.
This and related parameters have been used successfully to
improve outcome in various patient groups. Despite this fact, there
is little or no observational data to link derangements of these
parameters to outcome in the high-risk surgical patient.
Methods Data was collected on high-risk surgical patients for the
first eight post-operative hours. Routine monitoring included
cardiac output and central venous saturation. Patients were
divided into high and low ScvO2 groups according to whether the
ScvO2 fell below 65% for two consecutive hourly readings and
were followed up for 28 days.
Results Seventy-nine patients were enrolled. There were eight
deaths (10.1%) and 93 morbidity episodes (1.2 episodes per
patient). The median age was 67 years (31–86 years). The median
APACHE II score was 9 (2–23). Trends in ScvO2 and cardiac
index indicated circulatory failure when many routine parameters
were normal (e.g. blood pressure, heart rate and serum lactate). A
higher incidence of complications in particular septic and cardiac
complications, a longer hospital stay and a trend towards
increased mortality were found in patients with low ScvO2 (see
Table 1).
Conclusion Low ScvO2 appears to indicate patients at high risk of
complications after surgery. ScvO2 may indicate hypovolaemia at
an earlier stage than traditional parameters. ScvO2 may be a
suitable haemodynamic goal in surgical patients, as has been
shown in severe sepsis.
Table 1
High ScvO2 Low ScvO2 P
n 57 22 –
Morbidity/patient 0.84 (0-5) 2.05(0-5) 0.023
Ventilator (hours) 3 (0-260) 6.5 (0-44) 0.47
ITU LOS (hours) 48 (10-1584) 45 (19-336) 0.76
Hospital LOS (days) 12 (4-104) 20.5 (3-60) 0.03
Mortality 5 (8.8%) 3 (13.6%) 0.68
LOS, length of stay.
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Introduction There is strong evidence that early goal directed
therapy (EGDT) for patients with severe sepsis and septic shock
leads to a survival benefit, as well as a reduction in morbidity and
mortality, hospital stay, and costs. Despite the accepted evidence
behind this practice, few centers have successfully implemented
EGDT. No data currently exist regarding various models for
instituting EGDT.
Objective This pilot investigation describes two EGDT implementa-
tion models: (1) the medical intensive care unit (MICU)-initiated
model; and (2) the emergency department (ED)-initiated model.
Methods This is a prospective, descriptive study reporting a
qualitative assessment of the advantages of, and relative barriers
for, two models of EGDT implementation. The models wereAvailable online http://ccforum.com/supplements/8/S1
developed by two tertiary care hospitals. Patients eligible for the
EGDT protocol were those with suspected infection criteria and
either septic shock (systolic blood pressure <90 despite
30 cm3/kg fluid resuscitation) or lactate (>4 mmol/l).
Implementation at each center included a 1-month initial phase
comprised of MICU and ED physician and nursing staff education.
The MICU-driven protocol conducted a 2-month baseline data
collection period.
Results Both models are collaborative, but vary in terms of
initiation of the protocol. The MICU-driven model developed and
introduced a protocol with ensuing support from the ED. The ED-
driven model developed and introduced a protocol with ensuing
support derived from the MICU. Timing of patient identification,
protocol compliance and ED transfer time to the MICU are
continuously evaluated in both models. Insertion of an ScvO2
central venous oximetry catheter (PreSep) is shared between the
MICU and ED teams based on ED acuity, operator skill, and
physiologic urgency. The MICU-driven protocol is strongly
supported by the intensive care staff; early transfer from the ED to
the MICU is a priority. During the course of this study, timing of
patient identification and MICU/ED collaboration continues to
improve. The ED-driven protocol team has found that early
identification and initiation of the protocol, in combination with
strong support from the ICU, results in collaborative streamlining
based on ED and MICU workloads. Both institutions have found
that challenges in patient identification and line insertion present
the most time-consuming obstacles to protocol initiation.
Conclusion Implementation of EGDT protocols is possible through
a collaborative process, whether driven by intensive care unit or
emergency department teams. Frequent education and
collaborative communication appear to be key elements for
success.
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Introduction and objective The peripheral perfusion index (PFI),
derived from the pulse oximetry signal, permits a quantitative
analysis of the peripheral perfusion in patients. However, the
relationship between variations of this index and variations in
peripheral blood flow in critically ill patients has not been studied.
We therefore studied the ability of the PFI to detect the vascular
response produced by induced reactive hyperemia in critically ill
patients.
Materials and methods PFI was obtained using a conventional
pulse oximetry. The peripheral temperature was measured using a
proximal temperature probe (Phillips 21078A) placed on the
forearm and a distal probe placed on the middle fingertip of the
same arm used for PFI measurements. The skin-surface
temperature gradient between the proximal and distal probe (dT)
was calculated as a measure of changes in forearm bloodflow.
Reactive hyperemia was produced by arrest of forearm blood flow
with a sphygmomanometer pneumatic cuff placed around the
upper arm not used for arterial cannulation. The cuff was inflated to
a pressure approximately 30 mmHg greater than systolic pressure
for 3 min, after which the cuff was rapidly deflated to 0 mmHg. The
hyperemic response was analysed by measuring the maximum
increase in PFI relative to baseline PFI. A student’s t test was used
to assess the differences at baseline and maximum PFI. P < 0.05
was considered statistically significant.
Results Fifty-six measurements were carried out in 14 patients. In
all patients the PFI increased after release of the pneumatic cuff.
The changes in hemodynamics, PFI and dT are presented in
Table 1.
Conclusions PFI can be used to assess vascular reactivity in
critically ill patients.
Table 1
Parameter At baseline PFI At maximum PFI
Heart rate (bpm) 88.7 ± 13.4 88.7 ± 13.1
MAP (mmHg) 79.7 ± 13.6 78.2 ± 13.5
dT (ºC) 3.1 ± 3.3 2.4 ± 3.7*
PFI 2.8 ± 1.8 3.9 ± 2.1*
*P < 0.01.
P54 Simultaneous measurements of subcutaneous and intramuscular tissue pO2 in critically ill patients
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The primary goal in the treatment of patients with shock is to restore
the tissue perfusion and oxygenation. Clinical endpoints of
resuscitation (i.e. bloodpressure, heart rate, urine output and oxygen
saturation) give an incomplete or even misleading picture. Tissue
oxygen tension (ptO2) reflecting tissue oxygenation may be a useful
endpoint; however, in the clinical setting ptO2 measurements
subcutaneously (ptO2sc) and in muscle (ptO2im) are both used,
although a comparative study has never been performed.
In 18 critically ill patients ptO2sc and ptO2im were
simultaneously and continuously measured using polarographic
Clark-type electrodes (LICOX Catheter Measurement System,
GMS), placed subcutaneously and in the m. biceps brachii of the
upper arm.
Eighteen men and two women with septic shock (n = 8), severe
sepsis (n = 5), sepsis (n = 1), polytrauma (n = 3) and nonseptic
acute respiratory distress syndrome (ARDS) (n = 1) were included.
The median age was 60 years (range 22–80 years), and the
median APACHE score on admission was 18 (range 10–31). The
median duration of tissue oxygen measurements was 5 days (range
2–8 days). Median ptO2 values of different groups are presented in
Table 1. Wilcoxon’s signed rank test was used to compare
changes within the group and a one-way analysis of varianceCritical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
(ANOVA) was used for comparison between the variation of ptO2
values within groups. Although differences between ptO2sc and
ptO2im were found in individual patients and between goups, a
clear pattern could not be established. Measurement of tissue
oxygenation can be performed in subcutaneous tissue as well as in
muscle tissue.
Table 1
Wilcoxon’s
ptO2sc ± SE ptO2im ± SE signed ANOVA
(mmHg) (mmHg) rank test PP
Septic shock 39.2 ± 1.6 32.1 ± 1.3 0.02* 0.06
Severe sepsis 30.8 ± 1.5 35.4 ± 2.1 0.38 0.05
Sepsis 43.4 ± 3.7 37.4 ± 2.5 0.25 0.19
polytrauma 30.1 ± 1.9 29.2 ± 1.3 0.05 0.05
ARDS 27.5 ± 5.3 37.7 ± 7.4 0.50 0.38
P55 Transcutaneous (tcCO2) measurement versus arterial blood gas CO2 measurement in critically ill adult patients
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PaCO2 reflects the adequacy of alveolar ventilation in the intensive
care unit patient. Arterial blood-gas sampling is considered the
‘gold standard’. There is, however, a significant morbidity
associated with arterial line placement.
We compared the efficacy of transcutaneous monitoring of CO2
(tcCO2) with traditional PaCO2 from arterial blood-gas samples.
Method We studied consecutive ICU admissions during an 8-day
period. We included all new patients aged 18 and over who were
expected to survive for 24hours. A TOSCA transcutaneous
monitor (tcCO2) was attached to the earlobe. The probe was
moved every 4hours and 4-hourly routine arterial blood-gas
samples were taken and PaCO2 values recorded.
Results We studied eight patients (four males and four females).
The mean age was 56years. The mean admission APACHEII and
SAPS scores were 19.5 and 31.3, respectively. The mean hospital
stay was 31days. ICU survival was 75%. Two patients were
ventilated using a high-frequency oscillator. A total of
64 comparisons were made.
We detected a significant difference between blood-gas PaCO2
and TOSCA tcCO2 of 0.43 kPa (paired t test P=0.0012). Figure1
shows the bias and limits of agreements. A regression line was
fitted and the slope and intercept were highly significant. It is
possible to predict PaCO2 from tcCO2 using the following
regression equation: PaCO2 = 2.7 + 0.5 × tcCO2.
Conclusion Although there is a difference between PaCO2 and
tcCO2, it is possible to accurately predict the PaCO2 level using
tcCO2 with moderate precision. tcCO2 may be an adequate
alternative to arterial blood gas sampling.
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Figure 1
Bland Altman plot of TOSCA data.
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Objective To demonstrate the relations of the plasma N-terminal
pro-brain natriuretic peptide (NT-proBNP) concentration with the
severity of heart failure, the underling heart disease and New York
Heart Association (NYHA) functional classifications in patients with
cardiovascular disease.
Method Plasma NT-ProBNP concentrations of patients with
cardiovascular disease (n = 65) and of normal controls (n = 16)
were measured by nonextracted, enzyme-linked, sandwich
immunoassay (Elecsys®) after admission. Constructive and
functional parameters of heart were measured with echocardio-
graphy in 65 patients at the same time.
Result The plasma NT-ProBNP concentrations of patients were
significantly higher than those of normal controls. They also
increased according to the severity of heart failure classified by
NYHA functional classifications (P < 0.001). The plasma
NT-ProBNP concentrations and left ventricular end diastolicAvailable online http://ccforum.com/supplements/8/S1
volume (LVEDV) also had significant positive correlations with
NYHA functional classifications (r = 0.769,  P < 0.001 and
r = 0.376, P = 0.02, respectively). For NT-proBNP in the diagnosis
of heart failure, a level >200 pg/ml had a sensitivity of 100%, a
specificity of 97%, a positive predictive value of 98% and a
negative predictive value of 100%.
Conclusion The plasma levels of NT-ProBNP increase
significantly according to the severity of heart failure classified by
NYHA functional classifications. The plasma NT-ProBNP
concentration is a sensitive biochemical parameter for evaluating
the heart function.
P57 The repeatability of transpulmonary thermodilution measurements
S Wolf, D Plev, L Schürer, C Lumenta
Academic Hospital Munich-Bogenhausen, Munich, Germany
Critical Care 2004, 8(Suppl 1):P57 (DOI 10.1186/cc2524)
Introduction Recently, less invasive cardiovascular monitoring with
transpulmonary thermodilution with the PiCCO system using a
central venous line and an arterial thermodilution catheter got
increasingly popular. In the last issue of the Yearbook of Intensive
Care and Emergency Medicine, the opinion was stated that a
single cold saline injection is sufficient to adequately measure
cardiac output and derived thermodilution parameters [1]. Since
there are no reported investigations in the literature on the subject,
we wanted to examine this hypothesis.
Methods We retrospectively examined the data of the PiCCO
system (Pulsion, Munich, Germany) from 18 patients treated in our
neurosurgical intensive care unit. Neurosurgical diagnosis was
mainly severe subarachnoid hemorrhage; 10 patients were
additionally diagnosed with systemic inflammatory response
syndrome, acute respiratory distress syndrome or cardiac failure.
Thermodilution measurements consisted of up to five single
injections with a bolus of 20 cm3 iced saline. Data was
automatically stored on a laptop connected to the PiCCO system.
From a raw data volume of 200 MB, the thermodilution
measurements were extracted and analysed for repeatability. An
analysis of variance (ANOVA) was performed to quantify the
disagreement between single measurements.
Results A total of 417 thermodilution procedures consisting of
1465 single bolus injections were analyzed for indexed cardiac
output (CI), intrathoracic blood volume (ITBI) and extrapulmonary
lung water (ELWI). The median difference between the lowest and
highest value in a single series was 0.3 l/min/m2 (CI), 80 ml/m2
(ITBI) and 1 ml/kg (ELWI), respectively. Calculated from the within-
subject variance of the ANOVA, the 95% repeatability coefficient
for two measurements of the same thermodilution sequence was
0,72 l/min/m2 (CI), 270 ml/m2 (ITBI) and 3.5 ml/kg (ELWI). This
translates to 48% (CI), 180% (ITBI) and 87% (ELWI) of the
measured parameters’ normal ranges.
Discussion According to our data, we disadvise the use of a
single injection for the measurement of transpulmonary
thermodilution. Especially for preload parameters, the mean of at
least three repeated measurements reflects the patients status
more appropriately. It remains a clinical judgement how much
imprecision of measured data a clinician is willing to accept. This
may vary in different situations and is, as a matter of principle, not
solvable by statistics [2].
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Introduction Cardiac output can be measured continuously by an
invasive pulmonary artery catheter (PAC) or by noninvasive
impedance cardiography. The purpose of this study is to
determine how well the two methods correlate in ventilated
patients.
Method Patients requiring mechanical ventilation and a PAC were
studied in a combined surgical and medical intensive care unit
from October 2002 to October 2003. Simultaneous
measurements of cardiac output were obtained, utilizing a
Swan–Ganz CCOmbo V catheter (Edwards Lifesciences, Irvine,
CA, USA) and impedance cardiography utilizing a BioZ
(Cardiodynamics, San Diego, CA, USA). Measurements were
recorded at initial placement and at 12, 24 36, and 48 hours.
Results Twenty-two patients were studied. The average
PaO2/FiO2 was 184 ± 85. Sixteen (73%) of the patients required
dopamine, norepinephrine and/or dobutamine. Overall the
correlation coefficient was r = 0.48 and r2 = 0.23. There was a
decrease in correlation with time, as shown in Table 1. Six (27%)
of the patients had a cardiac output greater than 9 l/min measured
Table 1
Time Correlation coefficient r
Initial placement 0.64
12 hours 0.52
24 hours 0.51
36 hours 0.34
48 hours 0.36Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
by the PAC. The correlation coefficient was r = 0.52 and r2 = 0.27.
In the 18 patients with a cardiac output less than 9 l/min, the
correlation coefficient was r = 0.89 and r2 = 0.80.
Conclusion The cardiac output measured by impedance
cardiography has good correlation with the PAC in patients with a
cardiac output less than 9 l/min. With time, the correlation between
the two methods decreases. Further studies are indicated to
determine which method is best suited for ventilated patients.
P59 Evaluation of cardiac function in septics patients by the PiCCO system
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Background and goal of study Myocardial dysfunction is a
fundamental aspect of sepsis, but goal-directed therapy and
accurate diagnosis at the bedside is a difficult challenge. We have
evaluated myocardial function in the initial phase of sepsis by
PiCCO device (pulse contour analysis and transpulmonary
technique).
Materials and methods Fifteen septic patients (Group A) and
15 nonseptic patients (Group B) were enrolled in this randomised,
double-blind study and monitored by optical femoral artery catether
and central vein catether for hemodynamic measurement. Cardiac
output (CO), extravascular lung water index (EVLWI), intrathoracic
blood volume index (ITBVI), DpDt max and stroke volume variation
(SVV%) were measured. The hemodynamic and volumetric data
were studied at T0 (basal), T1 (after colloid infusion 8 ± 4 ml/kg
hydroxyethyl starch 130/0.4 for intravascular volume replacement)
and T2 (inotropic support as dobutamine 4.5–7 µg/kg/min infusion
for 45 min). Statistical analysis was performed by ANOVA test for
repeated measurement. Data are shown as mean ± SD. A linear
regression analysis was performed to evaluate correlation between
indexes of cardiac function and preload indexes.
Results Table 1 reports the main results at T0.
At T1, the DpDt max–ITBVI correlation was depressed in septic
but not in nonseptic patients (P < 0.02), ITBVI improves in the
nonseptic group (P < 0.05), and the ITBVI stroke volume index
(SVI) was r = 0.49 in septic and r = 0.79 in nonseptic patients. At
T2, DpDt max increased only in Group B (P < 0.05).
Conclusions In early sepsis myocardial function is depressed as:
DpDt max and SVI lay down at basal time and they do not increase
during the study, SVV% improves, the DpDt max–ITBVI correlation
is depressed during the fluid challenge and the cardiac response
to dobutamine test is impaired.
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Table 1
Group A Group B P
DpDt max (mmHg/s) 1069 ± 127 1327 ± 566 <0.01
SVV% 24 ± 6 11 ± 9 <0.01
SVI (ml/m2) 34 ± 9 46 ± 9 <0.01
ITBVI (ml/m2) 749 ± 136 831 ± 182 Not significant
P < 0.05, statistically significant.
P60 Intrathoracic blood volume (ITBV)-guided volume therapy maintains intestinal perfusion and oxygenation despite positive
end expiratory pressure (PEEP) ventilation
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Introduction Reduced intestinal perfusion is one major cause in
the development of multiple organ failure. Furthermore, the harmful
effects of PEEP on intestinal perfusion and oxygenation are well
described and it has been demonstrated that volume therapy
reduces these effects. But there is no evidence on how to guide
volume therapy, or whether volume therapy alone restitutes
Table 1
PEEP 20 ZEEP PEEP5 PEEP10 PEEP15
Control ITBV Control ITBV Control ITBV Control ITBV Control ITBV
CI (ml/kg/min) 102* 142† 167 168 158 162 135 163 120* 154†
ITBV (ml/kg) 24* 32† 31 33 33 33 30 31 26* 31†
SMABF (ml/kg/min) 12* 20† 19 19 17 18 18 20 15* 20†
DO2 (ml/min) 44* 55† 61 65 54 61 55 57 48 62
CO2 gap (kPa) 2.2 1.5 0.9 1.9 1.1 2.1 1.7 1.9 2.0 2.2
SMABF, superior mesenteric artery blood flow. *P< 0.05 versus ZEEP in the same group, †P < 0.05 between both groups at corresponding PEEP levels.Available online http://ccforum.com/supplements/8/S1
intestinal perfusion and oxygenation at PEEP levels above
10 cmH2O. Therefore we explored the effects of PEEP in an animal
model of ITBV-guided volume loading.
Methods Twenty anesthetized and ventilated pigs were studied.
An ultrasonic flow probe was placed around the superior
mesenteric artery, catheters were inserted into the femoral artery
and mesenteric vein. Animals were randomly assigned to:
group 1 = controls (n = 9), received crystalloids; and group 2 =
ITBV (n = 11), received crystalloids and continuous colloid
substitution to maintain ITBV at the baseline level. Measurements
were made at ZEEP and PEEP of 5, 10, 15 and 20 cmH2O. ITBV
was measured by the COLD® System. Oxygen metabolism was
calculated according to Fick’s Law. Intestinal CO2 was determined
by tonometry.
Results See Table 1. All data are presented as the median.
Conclusion ITBV-guided volume loading maintains intestinal blood
flow and O2 delivery up to a PEEP level of 20 cmH2O. The
intestinal–arterial CO2 gap remained unchanged. In conclusion,
ITBV-guided volume therapy is a helpful concept to reduce the
harmful intestinal effects of PEEP.
P61 Intrathoracic blood volume index and extravascular lung water index in septic shock patients
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Introduction We analyzed the intrathoracic blood volume index
(ITBVI) and the pulmonary artery occlusion pressure (PAOP) with
respect to the stroke volume index (SVI) as the preload index. The
extravascular lung water index with respect to the PaO2/FiO2 ratio
was also analyzed.
Methods We prospectively studied 10 patients with septic shock
monitored with a pulmonary artery catheter and the COLD System
(COLD-Z021 Pulsion Medical System, Munich, Germany).
Measurements were performed every 8 hours from the study
admission until 48 hours. The relationships between variables were
analyzed by linear regression.
Results Linear regression between ITBVI/SVI was r2 = 0.30
(P < 0.0001) while the PAOP failed to correlate (r2 = 0.03) (Fig. 1).
The EVLWI showed a significant correlation with PaO2/FiO2
(r2 = –0.23, P < 0.0001) (Fig. 2).
Conclusions Our results showed that ITBVI is a more reliable
indicator than PAOP for preload assessment in septic shock
patients. EVLWI confirmed to be a very interesting bedside lung
edema index in this selected population.
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Objective To analyse the value of extravascular lung water (EVLW)
as a prognostic clinical tool in surgical critically ill patients.
Method  A retrospective study on a surgical intensive care unit.
Forty-six patients were analysed. All patients were mechanicallyCritical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
ventilated. In all patients a PiCCO (Pulse Contour Cardiac Output)
catheter was inserted. Variables suxh as length of ICU admission,
length of pressure controlled ventilation and ventilation settings,
APACHE II score (acute physiology and chronic health evaluation)
and EVLW were collected. The correlation between variables was
evaluated with a linear regression model.
Results The median APACHE II score of the included patients was
13, ranging from 7 to 33. All patients were mechanically ventilated
in a pressure control mode with positive end expiratory pressure
ranging from 5 to 15 and an inspiration pressure ranging from 15
to 40 cmH2O. We divided patients into two groups: one included
patients with EVLW <10 and one included patients with EVLW of
10 or more. In the group with EVLW ≥10, we saw a higher
mortality rate compared with the group with EVLW <10 (35.5% vs
23.8%). In both groups we found no correlation in length of ICU
admission, length of mechanical ventilation or the APACHE II score
with EVLW.
Conclusion  Although we found an association between EVLW
and mortality in surgical critically ill patients, we could not confirm a
relation between EVLW and length of ICU admission and length of
mechanical ventilation in the patient population we studied.
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Introduction Use of hemodynamic monitoring allows one to
evaluate and follow-up patients with acute myocardial infarction
(AMI), monitor the effect of treatment, and compare different
treatment options. On the other hand this creates additional
problems, such as how to choose the method for monitoring that
should be cheap, reliable and easy to use for the staff.
Aim To evaluate the possibility of continuous hemodynamic
monitoring application for patients with AMI and compare the
results of two noninvasive methods — impedance cardiography
(ICG) and transthoracic echocardiography (TTE) — in patients with
AMI.
Design A prospective study.
Setting Kaunas University of Medicine, Clinic of Cardiology.
Patients Patients with AMI, admitted within 12 hours after the
onset of disease.
Methods A standard eight-electrode ICG was recorded. The
average value of the stroke volume (SV) derived from the last
10 min of the ICG record (60 SV instantaneous values) was used
for the comparison of ICG and TTE results. SVTTE was calculated
as the difference of left ventricular end-diastolic and end-systolic
volumes. A four-chamber and two-chamber view was used for
SVTTE analysis. SVTTE was alternatively evaluated by measuring
the flow velocity-time integral in the left ventricular outflow tract.
Results Eighty-seven patients were investigated according to
study protocol. The results of 74 patients were used for
comparative analysis: 56 (75.7%) men and 18 (24.3%) women.
The average age was 64.2 ± 14.9 years, body mass index (BMI)
was 28.6 ± 3.9, and ejection fraction was 42.8 ± 10.6%.
Comparing the values of SV derived from ICG and TTE, the
calculated correlation coefficient (r) was 0.73. The correlation
between the methods of ICG and TTE reached r = 0.79 in men,
but only r = 0.32 in women.
Week correlation between methods was observed when SV values
were compared for patients with BMI >29 or <19 (r = 0.42), as
well as SV measured by evaluating the flow velocity–time integral
in the left ventricle outflow tract (r = 0.37).
Conclusions Significant correlation of SV was observed between
ICG and TTE. Noninvasive monitoring during AMI can be
considered a reliable method for further application.
Figure 1
P64 Prognostic value of low cardiac output early after cardiac surgery
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Introduction The benefit of routine measurement of cardiac output
after cardiac surgery is still discussed. Some studies found no
benefit of routine right heart catheterisation [1] while others found
a reduce length of stay [2]. Clinical prediction of cardiac output isAvailable online http://ccforum.com/supplements/8/S1
poor after cardiac surgery [3]. Clinicians also do not really know
what value of cardiac output is necessary after cardiac surgery. The
aim of the present study was to verify whether the commonly
accepted lower value of cardiac index of 2.2 l/min/m2 [4] at arrival in
the ICU was a good predictor of complications after cardiac surgery.
Methods Seventy-three consecutive patients with a value of
cardiac index lower than or equal to 2.2 were included in a
prospective observational study. Right heart catheterisation was
decided in the operating room if the patient had a complex surgery
or a left ventricular dysfunction. Routine hemodynamic measure-
ments were performed at arrival in the ICU, 2, 6 and 18 hours later
and included arterial and mixed venous blood gases. Postoperative
complications were defined as death, renal insufficiency, and need
for prolonged mechanical ventilation.
Results Fifty-one patients had no complication (Group 1), and
22 patients (Group 2) present a postoperative complication
(including four deaths). No difference was found between the two
groups for preoperative or intraoperative data (age, ejection
fraction, EuroSCORE, length of bypass or aortic clamp) or for the
blood lactate level, pH or base excess. At the arrival in the ICU and
18 hours later, hemodynamic parameters were similar between the
two groups. Complicated patients had lower cardiac output and
SVO2 values 2 and 6 hours after the arrival in ICU. In the logistic
regression analysis, a reduced cardiac index at 2 and 6 hours after
admission in the ICU had the strongest independent predictive
value for postoperative complication.
Discussion A low cardiac output 2 or 6 hours after arrival in the
ICU is associated with a high level of postoperative complication.
Using right heart catheterisation allows early prediction and
treatment of low cardiac output in order to prevent postoperative
complication [2].
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During microcirculatory failure in septic shock, the relationship
between modifications in macro-circulation and micro-circulation
may depend on the resuscitation. How is the microcirculation
modified during cardiac output (CO) increase by fluid?
Four septic shock patients (73 ± 12 years old) were investigated
with orthogonal polarization spectral imaging (OPS) and with a
Swan–Ganz catheter. The SAPS score was 60 ± 8, and
norepinephrine was 0.6 ± 0.3 µg/kg/min. In three sublingual areas
per patient, the number of vessels (small, medium, large) were
quoted as no flow = 0, sludge = 1, moderate = 2, normal = 3,
allowing one to compute a microcirculatory ratio for each vessel
category. Systemic hemodynamic and OPS data were taken
before and within 30 min after fluid bolus (5–7 ml/kg). OPS data
presented as median (interquartile range), demographic and
hemodynamic data presented as median ± SE.
Only the number of small vessels/field tended to increase after
fluid from 34 (15) to 55 (21) (P = 0.09). In Fig. 1, all vessel
categories increased the ratio (P < 0.01). The blood pressure did
not increase after fluid challenge, whereas the CO increased by
39 ± 18% (P < 0.05; Fig. 2).
All sizes of microvessels changed with fluid loading, with different
patterns between small and larger vessels, going from recruitment
to increased blood velocity.
Figure 1
Figure 2
SAP, systolic arterial pressure; DAP, diastolic arterial pressure; CVP,
central venous pressure.
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Objective In patients with septic shock, increased microvascular
permeability and subsequent formation of edema is frequently
encountered and a major determinant of end organ damage. As a
model to examine the pathophysiology of sepsis, endotoxin
administration to humans has facilitated the research on
inflammation, coagulation and cardiovascular effects. The presentCritical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
study was undertaken to test whether endotoxin administration to
human volunteers can be used as a model to study the sepsis-
induced increase in microvascular permeability.
In healthy, nonsmoking volunteers, microvascular permeability was
assessed before and 5 hours after the administration of endotoxin
(2 ng/kg body weight, n = 8) or placebo (n = 8), by (1)
transcapillary escape rate of I125-albumin (TER-alb); (2) venous
occlusion strain-gauge plethymography to determine the filtration
capacity (Kf); and (3) bioelectrical impedance analysis (BIA) to
determine extracellular water (ECW) and total body water (TBW).
Administration of endotoxin resulted in the expected increase of
pro-inflammatory cytokines (TNF-α from <0.015 to
856 ± 158 pg/ml,  P = 0.002), accompanied by fever (maximum
temperature 38.7 ± 0.3°C, P < 0.0001), flu-like symptoms and
cardiovascular changes (heart rate from 63 ± 3 bpm at baseline to
91 ± 3 bpm at t = 5 hours,  P < 0.0001; mean arterial pressure
from 96 ± 3 mmHg to 79 ± 4 mmHg, P < 0.0001; and forearm
blood flow from 3.7 ± 0.8 ml/min/dl to 6.8 ± 1.1 ml/min/dl forearm
volume). All changes were significantly different from the control
group. In the endotoxin-treated subjects all microvascular
permeability parameters remained unchanged: TER-alb from
7.2 ± 0.6% to 7.7 ± 0.9% (P = NS); Kf from 5.0 ± 0.4 to
4.2 ± 0.4 (P = NS); and ECW/TBW measured by BIA from
0.42 ± 0.01 to 0.40 ± 0.01 (P = NS). Also, no significant changes
appeared in the microvascular permeability parameters in the
control group.
Conclusions: Although endotoxin is frequently used as a model to
study sepsis-associated effects, an endotoxin-induced increase in
microvascular permeability in vivo could not be detected by three
different methods. Endotoxin administration to human volunteers is
not suitable as a model to study changes in microvascular
permeability.
P67 Microvascular oxygen transport abnormalities in experimental sepsis interpreted using a computational model
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Experimental studies using a peritonitis model of sepsis in rats
have reported abnormalities in microvascular perfusion including
increased stopped flow capillaries, increased fast flow capillaries
and impaired regulation of blood flow. We have used a
spectrophotometric functional microvascular imaging system to
quantify capillary geometry, red blood cell flow and red blood cell
hemoglobin oxygen saturation during sepsis. We found that while
oxygen saturation at the entrance of the capillary bed was
unaffected in sepsis, there was a significant drop in saturation at
the venous end of capillaries with normal velocities. Although the
fall in oxygen saturation correlated with the number of stopped
flow capillaries, we could not determine from this data whether
tissue oxygen consumption changed with sepsis, whether fast
flow capillaries acted as functional oxygen shunts or whether any
regions of the tissue were anoxic. To address these questions we
constructed a computational model that simulated O2 transport in
a three-dimensional volume of tissue supplied by heterogeneously
spaced capillaries with fast, normal and stopped flow. The model
was based on our experimental oxygen transport data (capillary
density, number of stopped flow capillaries, capillary red blood
cell velocity and supply rate, and entrance oxygen saturation
levels) and the model predicted oxygen consumption, tissue
oxygen levels and oxygen transport in fast flow capillaries; data
that could not be measured experimentally with current
technology. Tissue oxygen consumption in the model was
adjusted to yield the same venous end oxygen saturation values
as measured experimentally. Two cases were modeled; average
sepsis (AS) with 33% stopped, 33% normal and 33% fast flow,
and extreme sepsis (ES) with 50% stopped, 25% normal and
25% fast flow. Simulations found approximately twofold and
fourfold increases in tissue oxygen consumption for AS and ES,
respectively. Average (minimum) tissue PO2 decreased from 43
(40) mmHg in control to 34 (27) and 26 (15) mmHg in AS and
ES, respectively. Clustering fast flow capillaries to increase flow
heterogeneity resulted in only a slight decrease in minimum tissue
PO2, to 14.5 mmHg. Although fast flow capillaries did appear to
be oxygen shunts with higher venous oxygen saturations, they
were a significant factor in preventing tissue anoxia during sepsis.
Despite the contribution of fast flow capillaries, simulated tissue
PO2 values continued to fall as the degree of microvascular injury
increased. The model predicts that microvascular oxygen
transport abnormalities associated with sepsis expose the tissue
to local regions of a hypoxic environment that may lead ultimately
to significant changes in cellular function.
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P68 Venoarterial PCO2 gradient does not correlate with cardiac output, base excess and arterial lactate concentration in septic
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Introduction According to modified Fick equation, the venoarterial
PCO2 gradient (∆PCO2) is inversely correlated to cardiac output
so that an increase in the ∆PCO2 value can alert to the presence
of low-flow states or at least to a mismatch between tissue blood
flow and metabolism. In septic shock patients, however, the
relation between cardiac output and ∆PCO2 is quite complex due
to possible distributive abnormalities of macrocirculatory and
microcirculatory blood flow. The objectives of this study was to
determine whether there is a good correlation between cardiac
output and ∆PCO2 in a group of septic shock patients and
between  ∆PCO2, base excess (BE) and arterial lactate
concentration (LAC), these two latter already demonstrated as
good predictors of mortality in critically ill patients.
Methods We retrieved 21 patients from our prospective collected
data base from January to December 2000. APACHE II scores
were calculated at admission and ∆PCO2, cardiac output, BE and
LAC were recorded at the moment of pulmonary artery catheterAvailable online http://ccforum.com/supplements/8/S1
insertion and 24 hours after. All four variables had a normal
distribution in our sample. Correlation between ∆PCO2 and the
other three variables was performed, using the Pearson coefficient.
Results The patients’ age was 53.1 ± 13.9 years and the
APACHE II score was 26.0 ± 7.4. ∆PCO2 was not correlated with
any of the other three variables. The Pearson correlation coefficient
was –0.173 (P = 0.29), 0.291 (P = 0.07) and 0.08 (P = 0.66) for
cardiac output, BE and LAC, respectively.
Conclusions ∆PCO2 is not correlated with cardiac output, BE and
LAC in septic shock patients.
P69 Measurement of indocyanine green plasma disappearance rate by two different dosages
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Background and goal of study Monitoring of organ function is
often crucial for guiding therapy in critically ill patients. Most
recently, the indocyanine green plasma disappearance rate
(ICG-PDR) has been suggested for assessment of liver function
and a transcutaneous system has been clinically introduced and
validated [1]. In this study, we analyzed the agreement between
ICG-PDR measured with the recommended dosage (0.5 mg/kg)
and a reduced dosage (0.25 mg/kg).
Materials and methods We studied 16 critically ill patients (five
female, 11 male) who underwent monitoring of ICG-PDR for
clinical indication (LiMon, Pulsion Medical Systems, Germany). For
each comparative measurement, in a random fashion, either
0.5 mg/kg or 0.25 mg/kg ICG were injected and followed by the
corresponding dosage 60 min later. We analyzed 31 pairs of
ICG-PDR measurements by applying the recommended dosage
(0.5 mg/kg, ICG-PDR 0.5) and a reduced dosage (0.25 mg/kg,
ICG-PDR 0.25). Respirator settings and dosages of vasoactive
drugs remained unchanged during the study. No drugs that may
influence hepatic blood flow were administered during the study
period. There were no changes in fluid status and the central
venous pressure was unchanged at the two time points.
Results and discussions ICG-PDR0.25 was between 2.7 and
25.0%/min and ICG-PDR0.5 between 4.5 and 24.5%/min,
respectively. Linear regression analysis revealed ICG-PDR
0.25 = 1.13 and ICG-PDR 0.5 = 0.66%/min (r = 0.95, P < 0.0001)
with a mean bias of 1.0%/min (standard deviation 2.5%/min). The
15-min residual rates were also highly correlated (r = 0.92,
P < 0.0001) with a mean bias of 0.3%.
Conclusion A reduced dosage of ICG (0.25 mg/kg) is sufficiently
accurate for transcutaneous measurement of ICG-PDR in critically
ill patients.
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Introduction Indocyaninegreen (ICG) clearance can be measured
with the LiMON® device (Pulsion, Germany) and is expressed by
the plasma disappearance rate (PDR) for ICG (normal value
18–25%) and the residual ICG after 15 min (R15, normal value
0–10%). In this study we investigated the correlation between
PDR/R15 and IAP, SOFA score, and classic liver function tests in
mixed ICU patients.
Methods A total of 130 paired measurements were performed in 28
patients. The IAP was obtained using a balloon-tipped stomach
catheter connected to an IAP monitor (Spiegelberg, Germany). The
male/female ratio was 3/2, age was 58.2 ± 12.1 years, APACHE II
score was 25.8 ± 15.7, SAPS II score was 44.4 ± 13.9, MODS was
6.4 ± 3, and SOFA score was 6.9 ± 3.6. The number of
measurements in each patient was 4.6 ± 3.6. Calculation of correlation
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was performed with the Prism GraphPad™ software (version 2.00,
31 October 1995), and values are presented as mean ± SD.
Results The values for IAP were 10 ± 4 mmHg (normal value
0–5 mmHg), PDR was 13.6 ± 8.4%, and R15 was 22.3 ± 19.8%.
The correlation between IAP and PDR/R15 was poor although
significant (R = 0.4), as was the correlation between PDR/R15 and
the classic liver test (with R < 0.1): aspartate aminotransferase,
alanine aminotransferase, lactate dehydrogenase, gammaglutamyl
transferase, alkaline phosphatase, or venous NH3. From the so-
called liver synthesis function tests, albumin, bilirubin, plasma
cholinesterase levels and prothrombin time, only the latter had a
good correlation. Neither platelets nor general hemodynamic
parameters or lactate were well correlated. A significant and
reasonable correlation was observed between PDR/R15 and SOFA
score and the number of organ failures. Finally, the correlation
between PDR and R15 was good (R = 0.8). Mortality was 57%,
PDR was significantly lower (10.4 ± 5.7 vs 16.3 ± 6.6) in patients
who died, while IAP (10.6 ± 3.9 vs 8.6 ± 3.6), SOFA score
(13 ± 3.3 vs 7.7 ± 3.4) and number of organ failures (2.5 ± 1.1 vs
1.2 ± 0.9) were significantly higher. The number of measurement
failures was 14% before and 3% after the software upgrade.
Conclusions LiMON® measurements are feasible at the bedside.
There is no correlation between LiMON®-derived parameters and
the classic liver function tests except coagulation. Correlation with
IAP was significant but poor. LiMON®-derived parameters
correlated with SOFA score and number of organ failures and give
additional information. The PDR was lower in patients who died
while IAP, SOFA and organ failures were higher.
P71 A 3-year experience of ultrasound-guided catheterization of internal jugular vein in an intensive care unit (ICU)
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Introduction Ultrasound-guided catheterization of the internal
jugular vein has proved to be of benefit especially for patients with
specific problems such as those hospitalized in ICUs. Our purpose
was to evaluate the usefulness of such a method compared with
the landmarks method, when the former is performed by a senior
intensivist trained in ultrasound for 1 year and recently taught the
Doppler guidance method and the latter by experienced staff.
Patients and methods A prospective randomized study was
performed during a 3-year period, in the 12-bed multidisciplinary
ICU of ‘G. Gennimatas’ General Hospital (1 November 2000–
1 November 2003). One group was assigned to internal jugular
vein cannulation by the landmarks method (control group) and the
other with ultrasound guidance (ultrasound group).
Measurements and results Sixty-six patients (17 women and
49 men) were examined. Thirty-five patients were submitted to
catheterization with the landmarks method and 31 patients with
ultrasound guidance. Internal jugular vein cannulation was
successful in 29 cases (82.8%) in the control group and in
30 cases (96.7%) of the ultrasound group (P = 0.07). Carotid
artery puncture occurred in two cases in the first group and in one
case in the second (P = 0.80). Jugular cannulation was successful
at the first attempt in 74.2% and 86.6% of cases in the first and
second group correspondingly (P = 0.25). The average access
time was longer in the control group (9.33 s vs 6.85 s in the
ultrasound group).
Conclusion Ultrasound guidance improved the success rate of
jugular vein cannulation and reduced the number of failures and
complications as well as the number of attempts, but the difference
between the two methods was not significant. The familiarity of the
operators with the method is probably a contributing factor and
must be taken into account.
P72 Ultrasound-guided central line insertion
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Introduction In the United Kingdom the use of real-time ultrasound
(US) is recommended for the insertion of central venous catheters
(CVCs) into the internal jugular vein in adults [1]. This is associated
with decreased complications, decreased failure rates [2] and is
possibly faster than insertion by a standard landmark technique.
Concerns, however, exist regarding the training implications, cost
and usefulness of these recommendations. We evaluated the
effectiveness of US-guided central line insertion.
Methods Between 1 February 2003 and 1 August 2003 we
prospectively collected data regarding the use of US for CVC
insertion using the Sonosite180PLUS ultrasound machine at a
14-bed general intensive care unit. All junior doctors underwent
both bedside and theoretical teaching. One junior doctor
underwent formal training.
Results Eighty-two US-guided CVCs were inserted, the majority by
senior house officers (88%). Most (82%) were inexperienced with
the use of US (less than 20 previous US-guided CVCs inserted),
while most (81%) were experienced in non-US placement (greater
than 20 previous non-US-guided CVCs inserted). Eighty-five per
cent of CVCs were inserted into the internal jugular veins and 15%
inserted into the femoral veins. There was a 4% failure rate. Sixty-
three per cent of CVCs were inserted on the first attempt, and 21%
were inserted on the second attempt. The average duration of
insertion was 18 min, with 57% taking less than 15 min. There was
a 10% complication rate (excluding threading of guide wire-related
problems). All were minor.
Conclusions  US-guided CVC insertion by inexperienced junior
doctors with minimal training is not only feasible, but also appears
to decrease complication and failure rates as well as increasing
rates of first pass insertion.
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Objective We performed this study to assess the clinical spectrum
and evaluate the outcome of patients with HELLP syndrome
compared with those with severe pre-eclampsia but without
HELLP managed in the intensive care unit (ICU). Serum albumin
level was measured as a prognostic factor.
Study design A prospective clinical and laboratory study that was
conducted over an 18-month period where 67 pre-eclamptic
postpartum women admitted to the ICU were studied, and were
divided into two groups. Group I (21 patients with HELLP
syndrome) and group II (46 patients with severe pre-eclampsia
only) were compared and contrasted concerning medical and
laboratory data.
Results Patients in group I were older than those of group II
(28.7 ± 6.6 vs 24.5 ± 4.6, P < 0.05) and had higher medical
complications than patients in group II. Eclampsia 62% vs 19%
(odds ratio = 5.95% confidence interval [CI] = 1.2–20.6,
P < 0.01), adult respiratory distress syndrome with respiratory
failure 29% vs 4% (odds ratio = 12.4, 95% CI = 1.2–12.6,
P < 0.01), multiorgan failure (MOF) 43% vs4% (odds ratio = 8.4,
95% CI = 1.4–52, P < 0.005) and mortality 38% vs7% (odds
ratio = 11.6, 95%, CI = 1.9–70.2, P < 0.01). There was no
significant difference between both groups concerning
disseminated intravascular coagulation and circulatory failure.
Serum albumin on admission was significantly lower in HELLP
syndrome patients (2.2 ± 0.6 g/dl) than patients with severe pre-
eclampsia (2.8 ± 0.6 g/dl, P = 0.01). Serum albumin correlated
significantly with both MOF (t value = 2.7, DF = 40, P = 0.01) and
mortality (t value = 3.7, DF = 27, P = 0.001).
Conclusion Pre-ecalmptic patients with HELLP syndrome are
amenable for serious medical complications and higher mortality
rate than patients with severe pre-eclampsia but no HELLP
syndrome. Serum albumin is lower in patients with HELLP
syndrome and correlates well with the development of MOF and
mortality so it can be used as a useful predictor of both morbidity
and mortality in critically ill pre-ecalmptic patients.
P74 Cardiac involvement in pre-eclampsia and eclampsia syndrome
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Of the various complications of pregnancy, pregnancy-induced
hypertension, pre-eclampsia and eclampsia syndrome (PE-EC)
represent the most prevalent and potentially the most serious
events. The adverse effects on the cardiovascular system in PE-EC
syndrome comprise hypertension-induced left ventricular (LV)
hypertrophy, LV diastolic dysfunction, LV failure, cerebral oedema,
renal involvement and cardiac arrest.
The present study is intended to assess the prevalence of cardiac
involvement in PE-EC syndrome and the prognostic implications
therefrom. Out of a total 70 females (mean age 26.8 ± 7.4 years)
referred from the obstetric section to the Critical Care Center to
handle various crises, 38 had PE-EC and 32 had no PE-EC.
Following clinical evaluation, all patients were subjected to routine
laboratory tests, ECG and echocardiography with follow-up during
hospitalization. Hypertension was defined as blood pressure (BP)
>160/100 mmHg.
Out of 38 patients with PE-EC, underlying heart disease (HD) was
present in five patients (13%) (peripartum cardiomyopathy in one
and rheumatic HD in four), and 33 had no underlying HD. Of
32 patients having no PE-EC, 20 (62%) had underlying HD
(11 rheumatic HD, five peripartum cardiomyopathy, two ischemic
HD, one congenital HD, and one ventricular tachycardia).
Compared with the noneclamptic group, those with PE-EC
syndrome exhibited a higher prevalence of hypertension (mean
systolic BP 160 ± 62.4 vs 93.4 ± 23.1 and mean diastolic
BP 104 ± 29.7 vs 65.6 ± 23.4, P < 0.05). Nevertheless, LV
systolic function expressed as depressed ejection fraction (EF)
<40% was insignificantly worse in the noneclamptic group
compared with the PE-EC subset with a mean EF of 32.5 ± 4.5 vs
34.3 ± 6.08, respectively.
However, out of 38 patients with PE-EC syndrome 13 (32%) died,
vs five patients (16%) out of 32 in the noneclamptic group.
Mortality was due to cerebrovascular stroke stroke in six patients,
antepartum hemorrhage in four, systemic inflammatory syndrome in
three, acute pulmonary edema in three and renal failure in nine
patients.
Conclusion Despite the relatively few cases of underlying HD in
the PE-EC obstetric patients referred, the insignificantly lesser
prevalence of depressed LV systolic function despite the higher
BP, yet the greater incidence of mortality compared with the
noneclamptic syndrome clearly point to the malignant nature of the
PE-EC syndrome and raise the issue of early diagnosis and need
for early intervention. The cardiovascular involvement in PE-EC
syndrome is apparently related to hypertension-induced target
organ damage and at best would represent a marker, pointing to
the seriousness of pre-eclampsia syndrome in terms of mortality
and adverse cardiac events.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P75 Heart dysfunction and heart rate variability prognoses in sepsis
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Objective Sepsis is a leading cause of mortality in intensive care
units (ICUs). Septic patients have better prognoses when multiple
organ dysfunction syndrome is not present. Regarding the heart,
the variability of the R–R interval (HRV) also depends on the
coupling between the heart and other organs; sepsis may be a
readily available tool for evaluation of nonlinear dynamic
relationships among organ and multiple organ dysfunction
syndrome development. We conducted a prospective study to
analyze HRV, hemodynamic, ecocardigraphic, and serum cardiac
markers (troponin and creatin phosphate kinase), and to evaluate
its possible relation with outcome.
Design A prospective observational analysis of serum of patients
meeting the criteria for septic shock.
Setting A 28-bed medical-surgical ICU in a university hospital.
Patients Twenty-five patients were analyzed in the study.
Materials and methods We selected all consecutive patients who
met the criteria for septic shock in our ICU and we collected blood
samples for analysis on days 1, 3, 6, 9, 12 or until death. We
analyzed creatin phosphate kinase total (CPK) and MB (CK-MB),
and also analyzed troponin. We analyzed hemodynamic parameters
by pulmonary catheter, cardiac ultrasonography and Holter
recording for 24 hours on the time points days 1, 3, 6, 9, and 12.
Statistical analysis All results are presented as the mean and
standard deviation. For analysis we divided patients into survivors
and nonsurvivors up to hospital release. We performed an ANOVA
for repeated measurements in continuous variables, and correlation
coefficients were determined according to multiple-level regession
analysis. P < 0.05 was considered significant.
Results Our mortality was 60%. We had 15 patients in the
nonsurvivor group and 10 patients as survivors. The two groups
had similar APACHE II scores (nonsurvivors 26; survivors 24 ± 5;
NS). CPK, CK-MB, ecocardiography analysis, cardiac output, and
vascular resistance did not show any significant difference at any
moment during the study period. However, troponin showed a
significant difference from the first day of study, followed by the
stroke work analysis as a significant difference between survivors
and nonsurvivors. The difference in stroke work data become
higher from day 3 onwards. The HRV showed a significant
difference in maximal and minimal low frequency (LF) and in
maximal high frequency. There was correlation as an independent
variable only for maximal LF as a predictor of patient outcome.
Conclusions In our study, HRV showed the capability to prognose
patient outcome. Heart dysfunction was detected only by serum
troponin levels and the hemodynamic data: stroke work.
P76 The timing of new acute hemodynamic events in ICU patients
A Kersten, G Clermont, E Hoste, D Huang, E Milbrandt, D Martich, J Kellum, D Angus
CRISMA, University of Pittsburgh, Pennsylvania, USA
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Introduction  Whether the day and time of ICU admission or
discharge impacts patient care and outcome has been the focus of
recent inquiry. There may also be a relationship between timing
and outcome for events occurring within the ICU. As a first step to
explore this issue, we aimed to describe the timing of new acute
hemodynamic events in a large ICU population.
Hypothesis  Acute hemodynamic events are equally distributed
throughout the day and throughout the week.
Methods From 1 July 1 2000 to 1 June 2001, we prospectively
collected data for all ICU patients at the University of Pittsburgh
Medical Center, a tertiary care academic medical center with
>120 ICU beds serving medical, surgical, trauma, neurological,
and transplant patients. Because we wished to focus on new
‘within-ICU’ events, we defined an event as the first occurrence of
acute hemodynamic instability after >24 hours in the ICU (to
exclude events associated with the initial admission) and >6
immediately-preceding hours with a cardiovascular SOFA score
≤1. We defined acute instability as MAP <60 mmHg, SBP
<90 mmHg, or a decrease in SBP ≥40 mmHg when the prior SBP
was <150 mmHg. We generated event frequency by hour and by
day of the week.
Results  There were 5592 patients with an ICU length of stay
>24 hours incurring 6758 ICU admissions. In 1449 (32%) of
these patients there was at least one event. Acute hemodynamic
events after being in the ICU >24 hours happened on average on
day 3 of the ICU stay. The event frequency did not vary by day of
the week (Monday 14.6%, Tuesday 15.9%, Wednesday 13.3%,
Thursday 13.5%, Friday 14.8%, Saturday 13.9%, Sunday 14.0%).
Although there was a trend to less events in the early morning and
evening, event frequency generally varied little by hour of the day
(Fig. 1).
Figure 1
Distribution of events throughout the day.Available online http://ccforum.com/supplements/8/S1
Conclusion  New acute hemodynamic events are extremely
common in the ICU. They vary little by time of day and day of week.
This finding may have important implications for ICU staffing
patterns.
P77 Management and outcome of patients with acute coronary syndrome in different units: predictors of outcome at the
admission
I Gornik, V Gasparovic, M Strozzi, Z Pisl
University Hospital Rebro, Zagreb, Croatia
Critical Care 2004, 8(Suppl 1):P77 (DOI 10.1186/cc2544)
Introduction and methods Patients with acute coronary
syndrome (ACS) examined in Zagreb Clinical Centre Emergency
Room can be admitted either to the coronary unit (CU), the general
medical ICU (ICU) or one of cardiology wards (CW). For all the
patients there has been a unique coronary intervention unit
available on a 24-hour basis since January 2001. In the year 2002
there were 5731 emergency admissions (33.8% of 16,924
patients examined). All 681 patients with ACS, 318 with
myocardial infarction (MI) and 363 with unstable angina (UA) were
retrospectively analysed. The aim was to determine predictors of
mortality and differences in treatment and hospital mortality (as a
measure of quality of care) in the CU, the ICU and the CW.
Number of admissions and diagnoses varied due to different unit
profiles and capacities: 237 (195 MI, 41 UA) to the CU, 87 (60 MI,
27 UA) to the ICU, and 237 (60 MI, 286 UA) to the CW. Chi-
square and nonparametric tests were used in statistical analyses.
Results There were no statistically significant age (P = 0.265) or
sex (P = 0.386) differences between patients in different units. No
statistically significant difference (P = 0.659) in hospital mortality of
patients with MI in the CU (14.3%), the ICU (13,9%) or the CW
(21,4%) was found. The proportion of patients with AMI on which
coronary angiographies and subsequent percutaneous coronary
intervention (PCI) was performed did not differ significantly
(P = 0.635) in the CU, the ICU and the CW (74.7%, 65.52% and
44.44%, respectively). The proportion of patients with UA to whom
PCI was performed in the same hospital stay did not differ
significantly (P = 0.59). All patients undergoing PCI were treated
with clopidogrel 1 month following. Age, sex, hypertension,
smoking, diabetes, coronary artery disease (CAD), previous MI, high
cholesterol, localisation of MI were tested (through univariate
analysis) for association with hospital mortality. The following were
found to be associated: age (P = 0.0001), female sex (P = 0.0471),
history of CAD (P = 0.0196) or MI (P = 0.012), high cholesterol
(P = 0.0276) and smoking (P = 0.0142). Patients treated with PCI
had significantly (P = 0.0001) lower hospital mortality (6.3%) than
those not treated (32.0%). Not-treated patients were significantly
older, but lower mortality of treated patients was significant in every
10-year age range tested (highest P = 0.012).
Conclusions PCI significantly decreases hospital mortality of
patients with MI. Although patients with ACS could be admitted to
different types of units, no significant difference was found in
hospital mortality or treatment strategy. Several hospital morality
risk factors were identified: age, female sex, previous MI or CAD,
high cholesterol and smoking.
P78 Why do we ‘over diagnose’ unstable angina in the medical emergency room?
I Gornik, V Gasparovic
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Introduction and methods Work in the Medical Emergency Room
(ER) of the University Hospital Rebro is supervised by one of the
medical ICU staff (working days 8 am–2 pm) or a senior specialist
from another medical department (afternoons, nights, weekends).
In this retrospective study we have analyzed all the patients
(n = 363) with unstable angina (UA), admitted through the ER in
2002. The aim was to determine the quantity and characteristics of
‘overdiagnosed’ patients. Anthropological data, data from the ER
admission charts (hour of admission, duration of examination,
history of coronary artery disease [CAD] or myocardial infarction
[MI], arterial hypertension, diabetes, high cholesterol and smoking)
and data from the hospital stay were analyzed.
Results The majority of patients (n = 255) did prove to have an
ischemic heart pain (group A), 59 of them developed MI and 196
had angina and were treated accordingly. The rest of the patients
could be divided into two groups: patients with no heart condition
(group B,  n = 62) discharged as musculoskeletal pain (n = 54),
cholecystitis (n = 3), gastritis (n = 2), depression (n = 1), sepsis
(n = 1) or meningitis (n = 1); and patients with cardiovascular
disease but no actual ischemia (group C, n = 46) discharged as
heart failure (n = 18), hypertension (n = 16), tachycardia (n =5 ) ,
bradycardia (n = 3), dissection of aorta (n = 2) and pulmonary
embolism (n =2 ) .
There were no statistically significant differences in gender
between the groups. Patients in groups B and C were older than
those in group A (P < 0.05), the significance is even greater when
comparing only groups A and B (P < 0.005). Duration of
examination in the ER did not influence the accuracy of diagnosis,
patients in groups B and C were even longer examined (P < 0.05).
We have found that the proportion of patients with history of
angina or MI was greater in group A than group B or C (55.1%,
31.1% and 31.3%, respectively) and this was statistically
significant (P < 0.005). Smoking, high cholesterol, hypertension,
and diabetes did not significantly differ between the groups.
Interestingly, we have found that proportion of patients admitted
during the afternoons, nights or weekends was higher in groups B
and C than in group A (P < 0.05), although characteristics of these
patients did not differ from those admitted during the ‘ICU staff
shift’.
Discussion Although mistakes in diagnosing UA are inevitable,
some progress could surely be made. A smaller proportion of
‘overdiagnosing’ while ICU staff is supervising the ER could be
explained with greater experience in the field. Older patients and
patients with a history of angina or MI presenting with chest pain
could be admitted with greater certainty of UA. Other risk factors
seem to be of little help in our population.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P79 Nitric oxide in ischemic heart disease. Defective production or impaired function?
A Rizk, N Samir, A El Hadidi, A El Naggar, E Omar, H Mowafi, S Mokhtar
Cairo University, Egypt
Critical Care 2004, 8(Suppl 1):P79 (DOI 10.1186/cc2546)
Among the mediators released by coronary arterial endothelium,
namely prostacyclin, endothelin, thrombomodulin, and so on, nitric
oxide (NO) (i.e. endothelial-derived relaxing factor) has been the
subject of our intense research. A biologic link between endothelial
damage and atherosclerotic coronary arterial disease has been
presumably related to decreased arterial bioavailability of NO
through predisposing to leucocyte and platelet adhesion,
vasoconstriction and smooth muscle cell proliferation.
The present study is intended to re-evaluate the potential role of
NO in the pathophysiology of coronary heart disease through
assessing the serum NO metabolites (nitrites and nitrates) in
150 patients (patients) with ischemic heart disease (118 male,
32 female; mean age 53.4 ± 8.3 years, range 33–80 years). Of the
latter, 77 patients (51.3%) had unstable angina (AP), and 73
(48.7%) had recent myocardial infarction (MI). Twenty subjects
with normal coronary arteriography (15 male, 5 female; mean age
55.4 ± 4.5 years) served as a control group. Of the studied
patients, 89 (59%) were smokers, 68 (45%) were diabetics, 60
(40%) were hypertensives and 63 (43%) were dyslipidemic.
Following clinical evaluation including 12-lead ECG, all patients
were subjected to routine laboratory testing (including liver and
kidney functions, lipid profile, CBC, and random blood sugar).
Specific laboratory tests included serum fibrinogen and plasma
NO expressed as its metabolites, nitrites and nitrates (NOx), as
measured by the Griess reaction.
All patients and controls were subjected to diagnostic coronary
arteriography with assessment of the extent of coronary disease
(number of affected vessels) as well as the severity of stenosis
(using the Gensini scoring system).
Compared with the control group, ischemic patients had
significantly lower levels of NOx (52.8 ± 7.3 vs 15.8 ± 7.3,
P < 0.000) with a significantly lower level of NOx in the MI group
compared with the AP group (22.1 ± 3.4 vs 9 ± 2.3, P < 0.000).
No significant correlation either with the extent or the severity of
coronary artery disease was shown.
Furthermore, compared with nonsmokers, smokers with ischemic
heart disease exhibited significantly lower levels of serum NOx
(28.5 ± 14.2 vs 13.8 ± 10.3, P < 0.002). Other risk factors
(dyslipidemia, hypertension, diabetes mellitus [DM]) in the
ischemic group did not show any significant correlation with serum
NOx level (P = 0.1, P = 0.09, P = 0.1, respectively).
In conclusion, although NO plays a major role in mediating
coronary arterial dilation under healthy condition, it is substantially
defective in coronary arterial disease, yet the poor correlation with
DM and dyslipidemia (diseases primarily characterized by
endothelial dysfunction) would point to impaired NO function
rather than just defective production.
P80 Serum nitric oxide in patients with acute coronary syndromes: correlation with the extent of myocardial ischemia and role
of diabetes mellitus
A Rizk, A Abd El Fattah, A Wadie, M Ashraf, W Samy, S Mokhtar
Cairo University, Egypt
Critical Care 2004, 8(Suppl 1):P80 (DOI 10.1186/cc2547)
An intact endothelium releases nitric oxide (NO), which acts
through cyclic GMP to mediate coronary dilatation, whereas a
diseased endothelium releases less NO and more endothelin and
poorly reduces the vasomotor tone. Release of NO is indirectly
assessed by the measurement of NO synthase and the end
product metabolites of NO (i.e. nitrites and nitrates). Diabetic
patients (patients) with the potential of diabetic microangiopathy
and endothelial dysfunction are theoretically expected to be poor
secretors of NO. The aim of the present study is to correlate the
serum level of NO in patients with acute coronary syndromes
(ACS) (i.e.unstable angina, nonST segment elevation myocardial
ischemia [NSTEMI], and ST segment elevation myocardial
ischemia) in correlation with the extent of the total ischemic burden
in relation to the presence or absence of diabetes mellitus. To
achieve this aim we studied 59 patients, 20 diabetics and
39 nondiabetics (53 males, six females), with ACS (unstable
angina in 20 patients, NSTEMI in five patients and acute
myocardial ischemia in 34 patients). Before any therapeutic
intervention, arterial blood samples were withdrawn to assess the
serum NO metabolites level by the Griess reaction. Acute
myocardial perfusion imaging with gated SPECT study was carried
out by injecting 10 mci 99mTC SestaMIBI IV during chest pain with
acquisition of the first set of SPECT images to asses the area of
myocardium at risk (MAR), and to estimate of the initial ejection
fraction. The second set was acquired 72 hours later to assess the
extent of myocardial salvage achieved by different therapeutic
modalities (PTCA, SK, etc.). A twenty-segment scoring system was
applied for both sets of images to estimate the salvage index (SI):
SI = [(MAR – second score) / MAR] × 100. A control group of
20 patients matched for age and sex were also studied.
Results Compared with the control group patients with acute
ischemic syndromes had a significantly lower level of serum NO
metabolites (mean 24 ± 10 Ug/l vs 39 ± 11 Ug/l, P < 0.05). The
initial perfusion score averaged 27 ± 15. The second score
averaged 15 ± 5 and the SI averaged 40%. Compared with the
control group, diabetic patients had significantly lower level of
serum NO metabolites with no significant difference between
diabetic and nondiabetic patients.
Conclusions Significantly lower serum levels of serum NO
metabolites in patients with acute ischemic syndromes are a
marker of substantial endothelial dysfunction with consequent
impaired coronary perfusion. Despite the key role of NO in
maintaining the normal vasomotor tone and coronary flow,
therapeutic inhalation of NO would not be expected to improve
coronary flow in acute coronary syndromes as extrapolated from
our data showing poor correlation between the serum level of NOand the extent of myocardial salvage. Adverse effects of diabetes
mellitus on endothelial function in ischemic patients are not
apparently mediated solely by the NO pathway, as shown by little
difference between diabetic and nondiabetic patients.
Available online http://ccforum.com/supplements/8/S1
P81 Elevated Troponin T levels in patients with and without renal dysfunction in a general intensive care unit
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Myocardial dysfunction is common in critically ill patients. The
diagnosis of an acute coronary syndrome has been revolutionised
by the protein isomer, cardiac Troponin T (cTnT). In the
nonintensive care setting early recognition of patients with elevated
cTnT and the instigation of appropriate treatment has been shown
to reduce the risk of death and myocardial infarction. Concern has
been raised about the prognostic value of cTnT in patients with
renal dysfunction as troponin is renally excreted.
Methods A retrospective audit was carried out on
180 consecutive admissions to a general (noncardiothoracic)
intensive care unit (ICU) to establish the incidence of raised cTnT
(cTnT >0.1 ng/ml) in patients with and without renal dysfunction.
Renal dysfunction was defined as Creatinine >120 µmol/l. Results
expressed as median (minimum–maximum).
Results Of 180 admissions, 62 patients (39 males, age 69 years
[34–85 years]) had an elevated cTnT >0.1 ng/ml during their time
on the ICU. The length of stay was 5.5 days for patients with a
raised cTnT and 3 days for patients with a normal cTnT
(P < 0.003). The primary diagnosis for admission was cardiac in six
patients, respiratory in 14 patients, general medical in 18 patients,
vascular surgery in nine patients and general surgical in
15 patients. Of these 32/62 (51.6%) died while on the ICU
compared with 24/118 (20.3%) of those with a normal cTnT
(P < 0.001). In 70.9% of cases the raised cTnT occurred within
the first 72 hours of admission.
The outcome and cTnT of patients with and without renal
dysfunction are presented in Table 1. There was no correlation
between renal function and cTnT level (r = –0.06). There was no
significant difference in outcome between raised cTnT patients
with and without renal dysfunction.
Conclusion Elevated markers of cardiac myocyte damage are
common in critically ill patients and are associated with an increased
mortality rate. This effect is seen irrespective of renal function.
Table 1
Renal impairment Normal renal function
Alive Dead Alive Dead
Total number 19 20 11 8
of patients
cTnT (ng/ml) 0.4 0.31 0.35 0.35
(minimum–maximum) (0.14–2.17) (0.12–12.2) (0.12–7.1) (0.11–3.74)
P82 Systemic and regional effects of levosimendan and arginine–vaopressine in endotoxin-treated rabbits
H Kaskos, V Faivre, M Losser, D Payen, A Mebazaa
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Critical Care 2004, 8(Suppl 1):P82 (DOI 10.1186/cc2549)
Vascular and myocardial dysfunctions are often combined in septic
mammals. Septic shock treatment therefore usually associates
vasoconstricting and positive inotropic agents, mostly dopamine,
norepinephrine (NE) and/or dobutamine. An alternative can be the
use of noncatecholamine agents: arginine–vaopressine (AVP) and
levosimendan (LS).
Methods Thirty-six hours after intravenous endotoxin (LPS)
administration, 26 rabbits were anaesthetised and ventilated.
Systolic arterial pressure (sAP), diastolic arterial pressure (dAP),
and mean arterial pressure (mAP) (mmHg), systolic aortic blood
flow velocities (sAoV) and mean aortic blood flow velocities
(mAoV) (20 MHz pulsed Doppler; cm/s), and systolic renal artery
blood flow (sRen) and diastolic renal artery blood flow (dRen)
(transonic Doppler, ml/min) were measured in anaesthetised and
ventilated rabbits. Heart inotropic quality was estimated by maximal
acceleration (Gmax, cm/s2) and sAoV. After 30 min stabilisation,
rabbits received levosimendan (200 µg/kg/hour, LS+) or saline
(LS–) for 30 min. They were then separated into four groups: (1)
LS+ with NE (1 µg/kg/min, 90 min); (2) LS+ with AVP
(14 ng/kg/min, 90 min); (3) NE alone; (4) AVP alone. All
parameters were gaussian. Statistical analysis was performed
using one-way and two-way ANOVA.
Results LS consistently improved sAoV and Gmax within 30 min
(P < 0.05 for both), while sAP, dAP, and mAP decreased
(P < 0.05). Addition of AVP or NE similarly restored mean arterial
pressure. However, their effects on myocardial function diverged.
While NE did not alter sAoV and Gmax, AVP dramatically
deteriorated both contractile parameters (–25% and –45%,
respectively, after 60 min; both P < 0.01). This effect of AVP was
observed when used in combination with LS or alone. No
significant effect of treatments was observed on sRen and dRen.
Summary Our study demonstrated that LS is a good alternative to
restore cardiac contractile function when combined with NE. The
use of AVP may lead to further deteriorate sepsis-related myocardial
dysfunction even when combined with a positive inotropic agent.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P83 Efficacy of levosimendan in shock
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Critical Care 2004, 8(Suppl 1):P83 (DOI 10.1186/cc2550)
Levosimendan is used intravenously for the management of heart
failure. At the therapeutic dose, levosimendan acts predominantly
as a calcium sensitizer and ATP-sensitive K+-channel (KATP-
channel) opener. It binds directly to the calcium-dependent site
on troponin C, stabilizing the calcium-induced conformational
change and enhances the calcium sensitivity of the cardiac
myofilaments. The advantages of a calcium sensitizer over
dobutamine is the lack of intracellular calcium overload and that it
acts without increasing the energy demand for handling
intracellular calcium.
Method Fifteen patients with cardiogenic, septic or mixed
cardiogenic/septic shock were administered a loading dose of
12 µg/kg/min levosimendan, followed by a continuous infusion of
0.1 µg/kg/min for 24 hours. Five patients were diagnosed with
septic shock, six with cardiogenic shock and four with mixed septic
and cardiogenic shock.The mean APACHE II score was 21.3 ± 6.4
The arterial blood pressures of the patients were monitored closely
via arterial catheters. Intravenous noradrenaline was administered,
where necessary, to maintain mean arterial pressure >65 mmHg.
Echocardiographic left ventricular ejection fraction (LVEF)
(Simpson’s method) and plasma B-type natriuretic peptide (Biosite
Triage method) were measured before and after (within 1 hour)
levosimendan infusion.
Results The LVEF showed a significantly but relatively small
improvement in response to levosimendan infusion (pre,
25.7 ± 11.0% vs post, 29.8 ± 8.6%), representing an absolute
change of 4.1 ± 8.4% (P = 0.039). The plasma B-type natriuretic
peptide concentrations demonstrated a significant decrease, from
993 ± 389 to 644 ± 408 pg/ml, before and after levosimendan
infusion (P = 0.001).
Conclusion The use of levosimendan in shock patients proved to
be feasible, and holds promise as a potential alternative to
catecholamine inotropes.
P84 Hemodynamic and volumetric response to levosimendan in critical care patients
F Turani1, P Aurisicchio2, P D’Ercole1
1S. Eugenio Hospital, Rome, Italy; 2Tor Vergata University, Rome, Italy
Critical Care 2004, 8(Suppl 1):P84 (DOI 10.1186/cc2551)
Introduction Levosimendan (LS), a new inodilator, improves
survival in patients with congestive heart failure, but data on
critical care patients with cardiorespiratory failure are scanty [1].
The aim of this study is to evaluate the homodynamic and
volumetric response to LS in critical care patients with
cardiogenic shock.
Materials and methods Ten critical care patients with cardiogenic
shock were studied. All patients were mechanically ventilated and
connected to an integrated monitoring system (PICCO
system/Agilent) by a fiberoptic arterial catheter (pv 2014L16) and
by a Swan–Ganz catheter. At basal time (T0) and at 1 hour (T1),
6 hours (T2), 12 hours (T3), 24 hours (T4) during LS infusion and
at 12 hours post LS suspension (T5), the main haemodynamic and
volumetric data were studied. All data are expressed as
mean ± SD. The ANOVA test for RM was used to compare
changes during times study.
Results Table 1 presents the main hemodynamic changes of
cardiac output (CO), pulmonary capillary wedge pressure
(PCWP), intrathoracic blood volume (ITBVI) and extravascular lung
water (EVLWI).
Conclusions  (1) LS increases the cardiac index and improves
filling pressures in critical care patients. (2) This improvement
correlates with decreasing of ITBVI and lung edema. (3) A
haemodynamic effect is maintained after LS infusion: this may be
useful during rapid weaning from ventilatory support.
Reference
1. Kart GD: Acta Anesthesiol Scand 2003, 47:1251-1256.
Table 1
Parameter T0 T1 T2 T3 T4 T5
CO 3.7 ± 0.9 4.9 ± 1.2* 4.8 ± 1.1 4.5 ± 1.8 4.7 ± 0.7 5.5 ± 1.3**
PCWP 19.8 ± 5 12.4 ± 3** 11.4 ± 3*** 11.3 ± 2*** 12.1 ± 2*** 11.3 ± 0.9***
ITBVI 831 ± 34 782 ± 123 882 ± 146 715 ± 115* 842 ± 84 857 ± 110
EVLWI 14.1 ± 9 12 ± 7 11.8 ± 7 9.4 ± 3 9.1 ± 3 8 ± 0.9*
*P < 0.05 vs basal time. **P < 0.01 vs basal time.***P < 0.001 vs basal time.Available online http://ccforum.com/supplements/8/S1
P85 Levosimendan in cardiac surgery
V Harjola, K Siirilä, R Suojaranta-Ylinen
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Critical Care 2004, 8(Suppl 1):P85 (DOI 10.1186/cc2552)
Background Levosimendan is a new calcium sensitizer with
inodilatory properties. The aim of this case series report was to
evaluate the effects of perioperative and postoperative use of
levosimendan in cardio-surgical patients with high perioperative
risk, compromised left ventricular (LV) function or with difficulties in
weaning from the cardiopulmonary bypass (CPB).
Methods Sixteen cardio-surgical patients received levosimendan
infusion with a maximum duration of 29 hours. Eight infusions were
initiated preoperatively and eight postoperatively. Most patients
received 0.1 µg/kg/min levosimendan after a bolus of 12–24 µg/kg
for 10 min. The main operative indication was coronary artery disease.
Seventy-five per cent of the subjects were high-risk patients. Because
of cardiac pacing postoperatively, the heart rate was not analysed.
Results Continuous infusion of levosimendan increased the
cardiac index in both groups significantly. The pulmonary
capillary wedge pressure and systolic blood pressure did not
change. Crystalloids and vasopressors, most commonly
noradrenaline and adrenaline, were administered as needed.
Weaning from CPB was successful in all the patients. Two of the
infusions were discontinued due to hypotension. One high-risk
patient in the preoperative group died during the operation. In the
postoperative group, two patients with multiorgan failure died
postoperatively.
Conclusions Levosimendan can safely and effectively be used in
high-risk cardio-surgical patients. Compared with the high risk of
the patients, the mortality remained rather low. In addition to
administering levosimendan as postoperative rescue therapy for
patients with difficult weaning from CPB, an elective initiation of
levosimendan preoperatively seems to be beneficial for patients
with high perioperative risk or compromised LV function.
P86 Hemodynamic effects of the new calcium sensitiser levosimendan in cardiosurgical ICU patients
C Iasonidou, T Karakasis, G Vasiliadou, M Rizou, F Ambatzidou, N Kapravelos
Papanikolaou General Hospital, Thessaloniki, Greece
Critical Care 2004, 8(Suppl 1):P86 (DOI 10.1186/cc2553)
Introduction The aim of the study was to determine the
hemodynamics and clinical effects of levosimendan (LS) in
cardiosurgical patients. LS enhances the contractile function of
stunned myocardium without increasing concetrations of
intracellular calcium and myocardial oxygen consumption.
Methods Ten patients (age 71 ± 6 years) mechanically ventilated
and sedated were included in this study (n = 10). Diagnosis was
coronary artery bypass operation (n = 7), valve replacement (n =1 )
and pulmonary edema (n = 2). Patients were prospectively
selected to receive LS, if hemodynamic data measured by a
pulmonary artery catheter and estimation of cardiac function by
echocardiography indicated a need for positive inotropic support.
The infusion rate of LS was 0.1–0.2 µg/kg/min. A pre-existing
infusion with epinephrine or norepinephrine was titrated to maintain
a mean arterial pressure of 65–100 mmHg. Crystalloids and
colloids were administered to maintain pulmonary capillary wedge
pressure (PCWP) >14 mmHg. Measurements were obtained at
baseline, 3 hours and 24 hours after starting LS infusion. Statistical
analysis was performed with a paired t test.  P < 0.005 was
considered statistically significant.
Results LS caused a significant increase in cardiac index (CI) from
2.2 ± 0.4 l/min/m2 at baseline to 3.3 ± 0.5 l/min/m2 after 24 hour
infusion. The increase in CI was due mainly to increase in stroke
volume, as the heart rate remained nearly unchanged during the
study period. The stroke volume index increased from
22.9 ± 4 ml/m2 to 33.9 ± 9 ml/m2 (P < 0.005). The left ventricular
ejection fraction, as estimated by echocardiography, increased
from 29.5 ± 5.5% to 33.9 ± 9% (P = 0.001). The systemic
vascular resistance index significantly decreased from
2539.5 ± 551.4 dyn/s/cm–5/m2 to 1791.5 ± 276 dyn/s/cm–5/m2
(P < 0.005). LS did not cause significant changes in pulmonary
vascular resistance (PVRI at baseline 318.5 ± 104 dyn/s/cm–5/m2,
after 24 hours 293 ± 136 dyn/s/cm–5/m2). There was a fall in
PCWP, although this was not significant.
Conclusion: In this study the effects of a new calcium sensitiser were
evaluated after cardiac surgery. The study demonstrates that LS
exerts favourable hemodynamic responses in these patients, without
increasing myocardial oxygen consumption. LS has the potential to
treat low cardiac output states after cardiopulmonary bypass surgery
and its use in these situations might be of special value.
P87 Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely
decompensated heart failure
A Mebazaa1, A Cohen-Solal2, F Kleber3, M Nieminen4, M Packer5, S Pocock6, P Põder7, T Sarapohja7, M Kivikko7
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Acutely decompensated heart failure (ADHF) represents the most
severe form of heart failure with a short-term mortality approaching
30%. The SURVIVE study is the first prospective, randomised trial
utilising mortality as the primary variable in evaluating the efficacy
of intravenous drug therapy in ADHF.
Levosimendan (LS) is a new calcium sensitiser for the treatment of
ADHF. Previous studies with LS have shown decreased mortality
in comparison with placebo or dobutamine (DB). The studies have,
however, not been powered for mortality. A suspicion of
detrimental mortality effect of DB has also been raised, but it hasCritical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
not been proven in any sufficiently powered single study or meta-
analysis. Therefore, DB is still the most widely used intravenous
(IV) inotropic agent in the treatment of ADHF.
The SURVIVE study is a multicentre, parallel-group, randomised,
double-blind, double-dummy study in patients with ADHF
comparing the efficacy of LS with that of DB.
The SURVIVE study includes hospitalised patients with ADHF, left
ventricular ejection fraction ≤30% and clinical need for IV inotropic
support. The primary endpoint of the study is all-cause mortality
during 180 days following randomisation.
Patients will receive two simultaneous intravenous infusions,
‘LS/placebo’ with a maximum duration of 24 hours and
‘DB/placebo’ according to clinical judgement (but minimally for
24 hours and starting with a dose of 5 µg/kg/min). During the
180-day period, the originally randomised study drug can be re-
administered when clinically justified.
Altogether 700 patients will be recruited. The sample size is based
on assuming 30% 180-day mortality in the DB group, 33% relative
risk reduction in the LS group, with a power of 85% and an alpha-
level of 0.05.
The study is ongoing in eight countries (Finland, France, Germany,
Israel, Latvia, Poland, Russia and UK).
After 450 patients have been followed for 1 month or after
90 deaths have occurred, the Data and Safety Monitoring Board
will make a recommendation on the continuation/discontinuation of
the study following pre-specified stopping rules. Separately, the
Steering Committee follows the mortality rate without opening the
treatment code and may recommend increasing the sample size.
SURVIVE thus represents the first study with two ambitious goals
in ADHF: (1) to study a new drug against the accepted reference
treatment, DB; (2) to assess mortality. In future, other trials will
probably have to follow this new standard of design in this setting.
P88 Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study
S Johansson1, M Apajasalo1, T Sarapohja1, C Garratt2
1Orion Pharma, Espoo, Finland; 2Orion Pharma, Nottingham, UK
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Background Hospitalisation, especially length of stay in intensive
care, is the main cost driver in heart failure (HF). Levosimendan, a
novel calcium sensitiser, improves both short-term and long-term
outcome of patients with acute HF.
Objective To evaluate the length of intensive care and hospital
stay in acute decompensated HF patients treated with
levosimendan compared with placebo.
Methods The REVIVE I trial was a pilot trial comprising
100 patients with acute HF who were hospitalised for worsening
HF and had dyspnea at rest despite intravenous (IV) diuretics.
Patients were randomised (double-blind) to receive placebo (PBO)
(n = 49) or IV levosimendan (LS) (n = 51), given as a loading dose
of 12 µg/kg over 10 min and followed by a continuous infusion
(0.1 µg/kg/hour for 50 min and 0.2 µg/kg/hour for 23 hours).
Among other measures, the duration of hospitalisations and
intensive care (ICU/CCU) were prospectively recorded.
Results At baseline, 34 out of 51 (67%) patients in the LS group,
and 25 out of 49 (51%) patients in the PBO group were treated in
the ICU/CCU. One levosimendan and three placebo-treated
patients were subsequently admitted to the ICU/CCU after
randomisation. The mean treatment time at the ICU/CCU was
4.4 days in the LS group and 5.1 days in the PBO group (median
4 days vs 5 days). The mean duration of index hospitalization after
randomization was 5.7 days for the LS group and 6.8 days for the
PBO group (median 5 days in both groups). After the initial
discharge, one patient in the LS group and seven patients in the
PBO group were admitted to the ICU/CCU during a subsequent
rehospitalization up to day 31. The mean treatment time at the
ICU/CCU for these patients was 2.0 days in the LS group and 4.4
in the PBO group (median 2 days vs 5 days).
Conclusions Of the acute HF patients who were admitted to
intensive care, those treated with levosimendan spent on average
1 day less in an ICU/CCU than patients treated with usual care.
Shortening the ICU treatment time by 1 day without increasing the
total length of the initial hospitalisation could reduce total
hospitalisation costs by up to US$2000–3000 per patient. These
promising initial results await confirmation in the ongoing REVIVE II
trial.
P89 Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart
failure: results with levosimendan in the REVIVE 1 study
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1Orion Pharma, Nottingham, UK; 2Columbia University, New York, USA; 3Boston University School of Medicine, Massachusetts, USA;
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Traditionally, intravenous (IV) drugs in decompensated heart failure
(HF) have been evaluated based on their hemodynamic effects.
Thus, no endpoint to measure symptomatic improvement in
decompensated HF has yet been validated. To do so, we adapted
the clinical composite (which has been validated in trials of chronic
HF) to the evaluation of IV levosimendan in a pilot trial of acute
decompensated HF (REVIVE-1).
A total of 100 patients who were hospitalized for worsening HF
and had dyspnea at rest despite IV diuretics were randomized
(double-blind) to receive placebo (PBO) (n = 49) or IV
levosimendan (LS) (n = 51), given as a loading dose of 12 µg/kg
over 10 min and followed by a continuous infusion (0.1 µg/kg/hour
for 50 min and 0.2 µg/kg/hour for 23 hours); patients were then
followed closely for an additional 4 days. Patients were classifiedAvailable online http://ccforum.com/supplements/8/S1
as improved if they reported their HF to be moderately or markedly
improved at specific timepoints. Patients were classified as worse
if they died or received an IV medication for worsening HF during
the 5-day study period. Patients were considered unchanged if
they were neither improved nor worse. Different models using
different definitions for improvement and worsening were
prospectively and retrospectively examined.
The initial model defined improvement based on the responses at
24 hours and at 5 days and restricted the definition of worsening to
the use of IV vasodilators or inotropic agents. Using this model,
improvement was observed more frequently with LS than with PBO
(49% vs 33%), with no between-group difference in the proportion
of patients who were worse (overall P = 0.229). When the definition
of worsening was expanded to include the use of IV diuretics for
worsening HF and confined to the occurrence of clinical events, LS-
treated patients not only were more likely to show improvement
(51% vs 33%) but were less likely to exhibit worsening (20% vs
35%) (overall P = 0.043). When the definition of improvement was
expanded to include the responses at 6 hours (in addition to
24 hours and 5 days), the separation between the treatment groups
increased even further (improvement in 33% vs 14% and
worsening in 24% vs 37%) (overall P = 0.029) (LS vs PBO). The
greater level of improvement in the clinical composite on
levosimendan was supported by significant reductions in median
plasma B-type natriuretic peptide concentrations compared with
placebo at both 24 hours (–303 pg/ml vs –77.5 pg/ml, P = 0.001)
and 5 days (–376 pg/ml vs –99.5 pg/ml, P = 0.027).
These findings indicate that a clinical composite approach can be
used to develop an endpoint that distinguishes the effects of IV LS
in the setting of acute decompensated HF. The new endpoint is
now being used prospectively to evaluate the effects of LS in a
definitive second study (REVIVE-2).
P90 Levosimendan reduces pulmonary vascular resistance: clinical echocardiographic study
M Nalos, S Huang, I Ting, A McLean
Nepean Hospital, Penrith, Australia
Critical Care 2004, 8(Suppl 1):P90 (DOI 10.1186/cc2557)
Introduction The calcium sensitizer levosimendan is a novel
inotrope used for the treatment of cardiac failure. Animal data
suggest pulmonary vasodilating properties and levosimendan has
been suggested for the treatment of right ventricular (RV) failure
despite scarce data in patients [1].
Settings An ICU and echo-laboratory in a tertiary teaching hospital.
Methods  We reviewed prospectively recorded transthoracic
echocardiograms of seven cardiac failure patients and six critically
ill patients before and after 24 hours of levosimendan infusion
(bolus 12 µg/kg + 0.1 µg/kg/min) in whom continuous wave
Doppler signal (CW) of peak tricuspid regurgitant (TR) flow
velocity recordings before and after levosimendan infusion were
available. The left ventricular ejection fraction (LVEF) was
measured by the Simpson’s method. RV contractility was assessed
by the maximal tricuspid annulus displacement during the cardiac
cycle by M-mode (six patients only) and/or by a blinded observer.
The maximal RV–right atrium gradient (TRmax) calculated from the
CW recording (by the modified Bernoulli equation) of peak TR flow
velocity in parasternal short axis or apical four-chamber views is
regarded as a preload independent estimate of pulmonary artery
vascular resistance (PVR) [2].
Values are expressed as the mean ± SD. The Wilcoxon Signed-
Rank test was used to calculate the difference before and after
levosimendan infusion.
Results The patients were 10 males and three females with mean
age 66 ± 14 years. The mean TRmax was 38.0 ± 9.2 mmHg prior
to levosimendan infusion. After 24 hours of levosimendan infusion
TRmax decreased to 30.9 ± 6.7 mmHg (P = 0.0015). In patients
with markedly elevated baseline TRmax (>35 mmHg), the median
drop in TRmax was more pronounced then in patients with mild
elevation of baseline TRmax (7.8 mmHg vs 2.4 mmHg). Although
LVEF increased in all patients (from 18 ± 6% to 25 ± 7%) and RV
contractility assessed by M-mode was better (from 1.48 ± 0.2 cm
to 1.61 ± 0.2 cm), the blinded observer was not able to confirm
improvement in RV contractility.
Conclusion Levosimendan reduced te TRmax of peak TR flow
velocity in cardiac failure and critically ill patients, implying a
reduction in PVR. The degree of PVR reduction is greater in
patients with baseline pulmonary hypertension.
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P91 Acute and short-term haemodynamic effect of Sildenafil in pulmonary hypertension: Egyptian pilot study of seven patients
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Pulmonary hypertension (PH) patients usually present with heart
failure, limited exercise tolerance and limited life expectancy.
Vasodilators might cause a deterioration in gas exchange. There
have been isolated case reports where oral Sildenafil, a selective
phosphodiestrase inhibitor (PDEI), has been used as an alternative
to prostacyclin in primary PH with early success. Our aim was to
assess acute and short-term effect of Sildenafil in patients with PH
with different etiologies.
Seven patients have been studied (four female, three male; mean
age 49 ± 12 years). They included two patients with primary PH,
two patients with Eisinmenger syndrome, two patients with
thromboembolic PH and one patient with Bilharzial PH. Following
clinical evaluation, all patients were subjected to Swan–Ganz
catheterization and the mean pulmonary artery pressure (mPAP),
pulmonary vascular resistance (PVR), and mixed venous oxygen
saturation (mVO2) were invasively measured. Patients were also
subjected to echocardiographic evaluation of the right ventricular
diameter (RVD) in the short axis, of the left ventricular stroke
volume (SV) and of the cardiac output (COP). Readings were
recorded before, 3 days and 3 months after the start of Sildenafil.
We used oral Sildenafil (25 mg) every 6 hours for all patients.
Results Out of the seven patients, five showed significant clinical
(New York Heart Association [NYHA] class IV to NYHA class III),
hemodynamic and echocardiographic improvement 3 days after
therapy. The five patients included two patients with primary PH,
one patient with Eisenmenger syndrome, one with Bilharzial PH
and one thromboembolic patirnt. The latter patients showed
significant reduction of mPAP (107 to 73 mmHg, –32%, P < 0.01),
mPVR (1988 to 1177 dynes/s/cm5, –41%; P < 0.01) with
insignificant rise in mVO2 (48 to 53 Torr). All hemodynamic
changes occurred without significant reduction of arterial blood
pressure and SVR. Echocardiography showed insignificant mild
reduction in RVD (6.6 to 6.4 cm) with a significant rise in SV (35 to
42 ml), and COP (3.7 to 4.2 l/min). Follow-up 3 months later
showed improvement in four out of the latter five patients. The fifth
patient is the Bilharzial PH one who died suddenly 5 days after
discharge. The other four patients showed further subjective
improvement (NYHA class III to II), reduction of mPAP (73 to
57 mmHg, –22%; P < 0.05), mean PVR (1177 to
759 dynes/s/cm5, –36%; P < 0.05) with a further rise in mVO2 (53
to 60 Torr). Echocardiography also showed a significant reduction
of the RVD (6.4 to 5.6 cm) with a further rise in SV (42 to 48 ml)
and COP (4.2 to 4.7 l/min, P < 0.01).
Conclusions (1) Sildenafil proved to be effective in the acute and
short-term condition, subjectively and objectively, especially in
patients with primary PH. Yet, the long-term effect and 5-year
mortality are to be evaluated. (2) The effect of Sildenafil on
Bilharzial PH is guarded. A larger group of Bilharzial PH patients
should be studied, especially the milder forms. (3) Sildenafil and
other selective PDE5 inhibitors with improved selectivity and
longer half-life merit further evaluation.
P92 Incidence and risk factors of atrial fibrillation in a surgical intensive care unit
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Objective To evaluate the incidence and risk factors of atrial
fibrillation (AF).
Design A prospective, observational study.
Setting A 21-bed teaching surgical intensive care (SICU).
Patients All patients with new onset of AF admitted in the SICU
between April and October 2001.
Interventions None.
Measurement and results A total of 453 patients were included.
AF occured in 24 patients (5.3%). In univariate analysis advanced
age, pre-existing cardiovascular disease, previous treatment by
calcium-channel blockers, and Simplified Acute Physiologic Score
(SAPS II) were significant predictors of AF. Patients with AF
received significantly more fluids and catecholamines, and
experienced more sepsis, shock (especially septic shock), and
acute renal failure. The severity (SAPS II), the ICU workload
(OMEGA), the ICU and hospital length of stay, and mortality were
significantly increased in patients who developed AF. Multivariate
analysis identified five independent predictors of AF: advanced
age, blunt thoracic trauma, shock, pulmonary artery catheter, and
previous treatment by calcium-channel blockers.
Conclusions The incidence of AF in a SICU appeared more
frequent than in the general population but less than in the cardiac
surgery unit. The onset of AF reflects the severity of the disease
and is associated with an increased mortality and morbidity. Five
independent risk factors of AF were identified. AF seems to be
more frequent after blunt thoracic trauma.
Table 1
Odds ratio (95% confidence interval) P
Age 1.04 (1.01–1.07) 0.009
Thoracic trauma 16.84 (4.00–71.20) <0.0001
Shock 6.77 (2.17–21.12) 0.01
Pulmonary artery catheter 5.46 (1.84–16.21) 0.002
Calcium-blockers 3.87 (1.18–12.74) 0.026Available online http://ccforum.com/supplements/8/S1
P93 Perioperative changes in plasma brain natriuretic peptide and N-terminal probrain natriuretic peptide in patients
undergoing coronary bypass surgery under cardiopulmonary bypass
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Introduction  Brain natriuretic peptide (BNP) is secreted by the
cardiac ventricles in response to volume expansion and pressure
overload. BNP and N-terminal (NT) proBNP are biochemical
markers of left ventricular function [1]. In cardiac surgery at the
present time there are few studies devoted to the evolution of
natriuretic peptides into the perioperational period [2–5].
Objective The aim of our study was to examine the release pattern
of BNP and NT proBNP in the perioperative period of coronary
surgery in two groups of patients: ventricular ejection fraction
(VEF) >50% and VEF <50%. A secondary aim was to compare
plasmatic levels of BNP and NT proBNP with the homodynamic
parameters.
Methods  (1) Twenty-one patients undergoing coronary artery
bypass grafting (CABG) by sternotomy, cardiopulmonary bypass
(CPB) and moderate systemic hypothermia were divided into two
groups: group I = 11 patients with normal left ventricular ejection
fraction (LVEF >50%) and group II = 10 patients with deteriorated
LVEF (LVEF <50%). Intraoperative anesthetic management was
uniform for all patients. (2) Blood sampling was taken before
surgical incision, after removal of the aortic cross clamp (10 min
following cross-clamp removal) and after surgery: at the arrival in
intensive care (T0) and 3, 6, 9, 12, 24, and 48 hours and 8 days
after CPB. BNP and NT proBNP concentrations were measured
by electrochemiluminescence immunoassay. (3) Hemodynamic
parameters were measured at the same time with blood samples
taken.
Statistics  Statistical comparisons were performed by the
Mann–Whitney U test and the Wilcoxon nonparametric test.
P < 0.05 was considered to indicate statistical significance.
Results BNP and NT proBNP decreased when the aortic clamp
was applied. After removal of the aortic cross clamp, BNP and NT
proBNP increased gradually in the two groups. The peak of BNP
ranges between 12 and 24 hours and the peak of NT proBNP
ranges between 24 and 48 hours. BNP and NT proBNP increased
in the same manner, in a similar exponential fashion, until 12 hours
after surgery. The logarithmic model showed the same constant of
time in both groups.
There is a good correlation between BNP and NT proBNP with the
hemodynamic parameters of the left ventricle.
Discussion In this cohort of uncomplicated CABG patients, BNP
and NT proBNP increase in a similar exponential fashion until
12 hours after surgery. This very strong correlation between BNP
and NT proBNP at all time points with baseline values implies that
there is a similar process occurring in all our patients undergoing
cardiac surgery. NT proBNP is more sensitive than BNP to the
change of the hemodynamic parameters.
Conclusions (1) This consistent and predictable pattern of BNP
and NT proBNP release following CPB enables us to conceive a
mathematical model of evolution of BNP and NT proBNP after
uncomplicated cardiac surgery. The pattern may be different when
there is postoperative ventricular dysfunction. (2) The strong
correlation between the plasma NT proBNP concentration and the
systemic vascular resistance means that the NT proBNP
vasorelaxation action may be important for maintaining homeostasis
after cardiac surgery.
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P94 Irreversible myocardial cell injury and early postoperative function of the heart after coronary artery bypass grafting
(CABG)
I Karu1, R Loit1, A Paapstel1, J Starkopf2
1North Estonian Regional Hospital, Tallinn, Estonia; 2Tartu University, Tartu, Estonia
Critical Care 2004, 8(Suppl 1):P94 (DOI 10.1186/cc2561)
Myocardial injury can be assessed by release of Troponin I (TnI)
and creatinine kinase MB isoenzyme (CK MB). Concentrations of
TnI have prognostic value for morbidity and mortality after cardiac
surgery. The aim of the study was to evaluate whether the extent of
myocardial necrosis is predictive for contractile dysfunction of the
heart after CABG.
Methods Twenty patients underwent CABG with cardiopulmonary
bypass (CPB). The cardioplegia (CP) time was 84 (50–126) min.
Blood for TnI and CK MB mass was simultaneously sampled from
radial artery and coronary sinus (CS) cannulas before CPB and at
1, 5, 10, 20 min of reperfusion and arterio-CS differences were
calculated. The cardiac index (CI), right ventricular stroke work
index (RVSWI), and left ventricular stroke work index (LVSWI)
were measured before sternotomy, 15 min and 1, 2, 4, 6, 9,
12 hours after CPB.
Results Before CP myocardial necrosis was not detectable.
Release of TnI and CK MB to the CS appeared from the first
minute of reperfusion, and was increased in time (Fig. 1). The early
postoperative performance of the heart was not inferior to pre-CPB
values (Table 1).Conclusion CP is associated with irreversible myocardial injury.
The contractile function of the heart evaluated by pulmonary artery
catheter provides little information of the exent of myocardial
damage.
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Table 1
Before CPB 15 min  1 hour 2 hours 4 hours 6 hours 9 hours 12 hours
CI (l/min m2) 3.14 ± 0.80 3.99 ± 1.03* 3.77 ± 0.92* 4.37 ± 1.29* 3.91 ± 1.07* 3.67 ± 0.91 3.72 ± 0.80* 3.99 ± 0.84*
RVSWI (g/m2) 6.72 ± 2.55 8.09 ± 4.17 6.81 ± 3.12 7.86 ± 3.89 6.96 ± 2.96 6.30 ± 3.23 6.65 ± 3.14 5.67 ± 2.41
LVSWI (g/m2) 31.0 ± 24.9 29.8 ± 23.4 28.5 ± 21.6 32.6 ± 24.3 24.5 ± 16.2 21.2 ± 17.5 24.8 ± 17.1 23.4 ± 17.5
*P < 0.05 compared with the values before CP.
Figure 1
P95 Impact factors of short-term prognosis in very elderly patients (aged 80 years and older) with acute myocardial infarction:
multivariate logistic regression analysis
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Objective To investigate the impact factors of short-term
prognosis in very elderly patients (aged 80 years and older) with
acute myocardial infarction (AMI).
Methods One hundred and twenty-three very elderly patients with
AMI were admitted to the Chinese PLA General Hospital from
1 January 1993 to 31 August 2002. Patients were divided into two
groups. The patients in group A died and the patients in group B
were alive in hospital within 30 days. Their clinical characteristics,
risk factors, clinical presentation, treatment and complications
were analyzed.
Results Twenty-six patients died of AMI within 30 days. Univariate
analysis indicated that histories of diabetes, prior myocardial
infarction and cerebral infarction, high white blood cell count
(≥1 0×1 0 9/l), low left ventricular ejection fraction (<50%),
inhospital complications including arrhythmia, pump failure and
pneumonia, as well as the therapy without aspirin were significantly
associated with the inhospital mortality within 30 days. Multivariate
logistic regression analysis, using mortality as the dependent
variable and using the history, inhospital complications and so on
as the independent variable, showed that the major determinants
of the inhospital mortality were the histories of diabetes (odds
ratio = 3.58, 95% confidence interval [CI] = 1.08–11.90) and
cerebral infarction (odds ratio = 6.82, 95% CI = 1.55–29.98), and
inhospital complication of pump failure (odds ratio = 13.11, 95%
CI = 3.84–44.78).
Conclusions These findings demonstrate that the histories of
diabetes and cerebral infarction, as well as inhospital complication
of pump failure were the independent impact factors of short-term
prognosis in very elderly patients with AMI.
P96 Long-term outcome after angioplasty in cardiogenic shock
P Bulpa, Y Ernst, J Jamart, P Chenu, P Evrard, M Gonzalez, B Marchandise, E Installe, E Schroeder
Cliniques Université Mont-Godinne, Yvoir, Belgium
Critical Care 2004, 8(Suppl 1):P96 (DOI 10.1186/cc2563)
Background Early revascularization in the setting of acute
myocardial infarction complicated by cardiogenic shock improves
6-month survival. In the absence of available data on the long-term
outcome (more than 16 months) of this strategy, we studied the
5-year outcome in a consecutive group of patients undergoing
percutaneous transluminal coronary angioplasty (PTCA) in
cardiogenic shock due to myocardial ischemia.
Methods The study period covers 1986–2002. The survival status
on March 2003 was available for all 123 patients. The medianAvailable online http://ccforum.com/supplements/8/S1
follow-up was 4.7 years. The mean age was 64 ± 10 years. Major
comorbidities were diabetes (15%), peripheral vascular disease
(18%), cerebrovascular disease (13%), renal failure (18%), and
chronic pulmonary disease (10%). Nineteen per cent had previous
coronary artery bypass grafting (CABG), 11% previous PTCA.
Myocardial infarction occurred within less than 7 days in 80% and
less than 24 hours in 60%. One vessel was treated in 83% of the
cases. The ratio of stented segments was 0.56. The
success/segment was 84%. Full procedural success was obtained
in 80%, incomplete success in 4%. Sixteen per cent of the
attempts failed.
Results Inhospital mortality was 54%. Inhospital major adverse
events (death, CABG, myocardial infarction) occurred in 62%.
Survival at 1 year and 5 years was 41 ± 4% and 40 ± 4% (NS),
respectively. Survival at 5 years after a successful procedure was
44 ± 5% versus 17 ± 8% after incomplete success/failure
(P < 0.001). Multivariate analysis showed four independent
variables for the long-term outcome: age, left ventricular
dysfunction, extent of coronary artery disease and procedural
result.
Conclusions (1) Survivors at hospital discharge after PTCA in
cardiogenic shock have an excellent long-term outcome. (2) The
favourable impact of successful PTCA procedures and the
excellent long-term outcome of hospital survivors are strong
arguments in favour of an ‘invasive’ approach in the presence of
cardiogenic shock.
P97 Hemodynamic support with the Impella acute 100 in patients with cardiogenic chock, or high-risk coronary artery bypass
graft (CABG) or percutaneous coronary intervention (PCI)
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Background The Impella device is a 13 F microaxial blood pump
allowing femoral vascular access. It provides nonpulsatile blood
flow of up to 2.4 l/min.
Aim To assess the safety, feasibility and efficacy of the Impella
device in patients with cardiogenic shock or patients undergoing
high-risk surgery or PCI.
Study A triple-centre, prospective, nonrandomised two-arm study.
Methods The patient population was: Arm 1, cardiogenic shock
patients with low cardiac output defined as a cardiac index
<2.0 l/min/m2 and pulmonary capillary wedge pressure (PCW)
>18 mmHg, or patients with PCW >18 mmHg and a systolic
blood pressure (BP) <90 mmHg or in need of inotropes to keep
systolic BP >90 mmHg; and Arm 2: high-risk CABG or high-risk
PCI following the Euroscore criteria. Sample size: 20/45 patients
are included. Hemodynamics included the assessment of cardiac
output (CO), PCW, arteria pulmonalis (AP), arterial BP and
intracardiac pump parameters. Biochemistry included free
hemoglobin at baseline, each hour during the pump run and
6 hours after removal of the pump.
Results The results of the first 20 patients are presented in
Tables 1 and 2.
Conclusions These preliminary data indicate the feasibility of the
Impella pump for patients in cardiogenic shock, high-risk CABG
and PCI. More data will be available in March 2004.
Table 1
Demographics
% male 85
Age (years) 65.3 ± 10.3
Body mass index 27.5 ± 4.8
Table 2
Indication Arm 1 Arm 2
PCI 4 7
CABG 1 7
Congestive heart failure 1 0
Support time (hours) 19.7 2.5
CO (l/min)
Pre 4.8 ± 1.6 4.0 ± 1.0
At 1 hour 4.8 ± 2.3 5.2 ± 0.8
PCW (mmHg)
P r e 2 8±1 0 1 8±7
At 1 hour 22 ± 3 13 ± 4
P98 Prosthetic heart valve trombosis: thrombolytic therapy as first approach
J Santos Gracia1, F Cáceres Loriga1, H Perez Lopez1, K Morlans Hernandez1, J Valiente Mustelier1, M Marrero Miragaya2
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Background and goal of study Prosthetic heart valve thrombosis
(PHVT) after surgical replacement is a threatened complication.
The incidence of PHVT may be as high as 13% in the first year or
higher if concern to the tricuspid valve. Emergency surgery
(thrombectomy or another valve replacement) is the recommended
treatment. Thrombolytic therapy has been proposed as an
alternative to surgery and is considered the treatment of choice for
tricuspid PHVT. Optimal management of patients with PHVT
remains controversial.
Materials and methods Sixty-five consecutive patients (January
1997 and December 2003) met clinical and echocardiographic
evidence of prosthetic valve dysfunction (thrombotic). Intravenous
recombinant streptokinase (SKr) at a loading dose of 250,000 IUCritical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
over 30 min followed by an infusion of 100,000 IU/h was infused.
Clinical and echocardiography surveillance were conducted in an
intensive care unit.
Results and discussion Sixty (92.3%) patients were succesfully
treated. Fifty-six (86.1%) had a total recovery, four (6.1%) had a
partial response and treatment failed in five patients (7.6%).
Embolic migration occurred in five (7.6%) patients and two
patients (3%) died because of it. Three patients (4.6%) had some
hemorrhagic disorders.
Conclusions Thrombolytic therapy is feasible and safe. Surgical
treatment is not contraindicated even if thrombolitic therapy
partially failed allowing better hemodynamic status after all.
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Introduction Deep vein thrombosis (DVT) is a serious
complication that may develop in critically ill ICU patients as a
consequence of immobilization, femoral central venous catheter
(CVC) placement and activation of the thrombotic cascade.
Materials and methods We investigated the epidemiology of DVT
in critically ill ICU patients expected to be hospitalized for at least
2 weeks. We used a triplex examination of lower extremities on
admission, on days 7 and 14, and on clinical suspicion of DVT.
Results We included 50 consecutive patients of mean age
48.2 ± 3.8 years (15 females) having illness severity on admission
of SAPS II score 51.8 ± 2.9 and APACHE II score 23.3 ± 1.4. Six
of the patients did not experience a femoral CVC during
hospitalization. The mean ICU stay was 18.8 ± 0.8 days (range
13–28 days). All patients were receiving low molecular weight
heparin for DVT prevention. Seven patients (14%) developed DVT
confirmed by triplex examination: one on day 4, three on day 7,
one on day 14, one on day 16 and one on day 23. All of them had
a femoral CVC on the side of thrombosis on the confirmation of
DVT. None of them developed pulmonary embolism investigated
by a thorax spiral computerised tomography. None of them died
due to pulmonary embolism. Of the remaining 43 patients,
37 experienced a femoral CVC during hospitalization. The mean
duration of femoral CVC stay was 8.0 ± 1.5 in patients who
developed DVT and 6.5 ± 0.5 for patients that did not develop
DVT (P > 0.05). The relative risk for developing DVT in the
presence of a femoral CVC was 1.2 (confidence interval
1.04–1.3).
Conclusions DVT may develop in critically ill patients, which may
be related to the presence of a femoral CVC. Other sides for CVC
placement should be preferred if possible for the prevention of
DVT, especially in predisposed patients.
P100 Morphologic characteristics of central pulmonary thromboemboli predict thrombolytic efficacy in massive pulmonary
embolism
M Podbregar, G Voga, B Krivec
General Hospital Celje, Slovenia
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Objective On hospital admission, the morphology of the central
pulmonary artery thromboemboli is an independent predictor of
30-day mortality in patients with massive pulmonary embolism
(MPE). This may be due to different susceptibility of thromboemboli
to thrombolysis. The aim of this study was to assess the efficancy
of thrombolysis in patients with MPE and morphologically different
thromboemboli.
Design A prospective observational study.
Setting An 11-bed closed medical ICU at a 860-bed community
general hospital.
Patients Twelve consecutive patients with shock or hypotension
due to MPE and central pulmonary thromboemboli detected by
transesophageal echocardiography who were treated with
thrombolysis between January 2000 and April 2002.
Procedures Patients were divided into two groups according to
the characteristics of detected central pulmonary thromboemboli:
Group 1, thrombi with one or more long, mobile parts; and
Group 2, immobile thrombi. Urokinase infusion was terminated
when mixed venous oxygen saturation was stabilized above 60%
for 15 min.
Results At 2 hours the total pulmonary vascular resistance 
index was reduced more in Group 1 compared with Group 2
(27 ± 12 to 14 ± 6 mmHg/[l/min/m2] [–52%] vs 27 ± 8 to
23 ± 10 mmHg/[l/min/m2] [–15%], respectively; P = 0.04). In
Group 1 thrombolysis was terminated earlier compared with
Group 2 (89 ± 40 min vs 210 ± 62 min, respectively; P = 0.0024).
The cumulative dose of urokinase used in Group 1 was lower
compared with Group 2 (1.7 ± 0.3 MIU vs 2.7 ± 0.5 MIU,
respectively; P = 0.023).
Conclusion Thrombolysis is more efficient in patients with mobile
central thromboemboli detected by transesophageal echocardio-
graphy during MPE.Available online http://ccforum.com/supplements/8/S1
P101 Clinical and laboratory characteristics in the patients with pulmonary embolism
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Pulmonary embolism is a common disorder that is accompanied by
significant morbidity and mortality. This study attempts to
determine the clinical and laboratory characteristics of established
acute pulmonary embolism in the medical intensive care unit.
Between 1 January 2002 and 1 November 2003, 33 consecutive
patients admitted to the Medical ICU had a diagnosis of acute
pulmonary embolism proved by angiography. There were 21 men
(63%) and 12 women (37%), with a mean age of 63.7 ± 12.6
years (range, 23–90 years). Whereas only eight of these
33 patients had associated deep vein thrombosis, 11 patients had
heart failure, nine had diabetes mellitus, eight had associated
malignancy, and seven patients had hypertension.
Sudden onset dyspnea (69%), palpitations (21%), cough (18%),
and pleuritic chest pain (12%) were the most common comlaints.
Tachycardia (33%), tachypnea (27%), and crackles (15%) were
the most common findings on physical examination.
Fourteen of 33 patients had normal effusion, nine had pleural
effusion and five had hilar effusion, and seven had atelectasia
findings on chest X-ray. ECG findings were normal in eight patients
(24%), inverted precordial T waves in nine patients (27%), atrial
fibrillation in seven patients (21%), and nonspecific ST segment
abnormalities in four patients (12%). Echocardiografic examination of
patients revealed that 18 of 33 patients had normal findings (54%),
10 patients had pulmonary hypertension (30%) and five of them had
right atrial enlargement (16%). Biochemical analysis results were
within normal range in nine patients (27%), whereas LDH elevation
in 17 (51%) and AST elevation in 13 patients (40%) were detected.
Arterial blood gas analysis results gave that CO2 and O2 levels were
below the reference values in 27 of 33 patients (81%). Mean
APACHE II scores were 13.03 ± 4.01 points (range 5–17). The
average ICU length of stay was 11.7 ± 3.3 days, and 24 of
33 patients (72%) were discharged home after that period. Nine of
10 patients diagnosed with massive embolism and complicated
conditions (e.g. diabetes, heart failure) died before day 3 (28%).
This study’s results showed, similar to the literature, that pulmonary
embolism has challenges with a considerably high mortality rate.
Future research should be planned on more accurate and specific
diagnostic tests, which probably will improve mortality rates.
P102 Emergency angiography in acute pulmonary embolism: role in clinically suspected cases
AW Andraos, M Ashraf, A El Sherif, M El Badry, M Mostafa, A Rizk, O Metwally, AA Fattah, S Mokhtar
Kasr Al Ainy University Hospitals, Guiza, Egypt
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Massive and submassive pulmonary embolisms (PE) have been
diagnosed by clinical suspicion according to the criteria of low,
intermediate and high probability subgroups, depending on
symptoms (sudden dyspnea, chest pain, syncope), signs
(tachycardia, hypotension, elevated central venous pressure),
electrocardiogram (right ventricle strain, right bundle branch
block, S1Q3), laboratory data (hypoxia, hypocapnia, elevated
plasma D-dimer, lactate dehydrogenase, fibrin degradation
products) and echocardiography (right ventricular dilatation,
paradoxical septal motion, pulmonary hypertension) in a patient
with predisposing risk factors and diagnostic confirmation via
ventilation perfusion lung scan. The latter was not done for all
patients as it is diagnostic in only 30–50% of cases, and the
remaining 50–70% nondiagnostic scans may represent a
probability for underlying PE of between 4% and 66% depending
on clinical circumstances.
Because of its invasive nature and technical complexity, pulmonary
angiography (PA), the golden diagnostic standard, was not a
routine procedure.
We hereby report our experience with emergency PA in clinically
suspected cases of PE to highlight its merits and the limitations of
clinical examination. We studied 18 patients with clinically
suspected PE (six male, 12 female; mean age 49.5 years).
Predisposing factors included heart disease in two patients,
diabetes mellitus in five patients, polytrauma in three patients and
autoimmune disease (i.e. Behcet disease) in one patient. Four
patients were dehydrated and bedridden.
Following clinical evaluation, elctrocardiogram and chest X-ray, all
patients. were subjected to routine laboratory evaluation, arterial
blood gas measurement and specific coagulation profile (fibrin,
fibrin degradation products, D-dimer). All patients were then
subjected to first-pass radionuclide angiography. PA was done in
all patients within a mean period of 2 days (day 0–day 4). Following
acute imaging, PA revealed the presence of PE in only eight
patients in the form of distal cutoff and/or filling defects, while
10 patients had negative PA for PE. Compared with patients with
negative PA, those with positive findings were more frequently
hypotensive (50% vs 20%), more hypoxic (100% vs 90%), more
congested (100% vs 80%) with more positive echocardiographic
data (85% vs 60%). They also exhibited significant scintigraphic
evidence of impaired RV ejection fraction than patients with
negativeve PA (80% vs 20%).
Conclusion Emergency PA is a feasible, safe, highly sensitive
diagnostic tool in acute PE before starting intrapulmonary or
systemic thrombolytic therapy with its potential hazards. In view of
the ready availability of the catheter laboratory as well as its safety
and ease of performance, emergency diagnostic PA is
recommended in suspected clinical settings of PE.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P103 Burden of Illness in ThromboEmbolism in Critical Care (BITEC) study: a multicenter Canadian study
R Patel1, L Griffith2, M Mead2, S Mehta3, R Hodder4, C Martin5, D Heyland6, J Marshall3, G Rocker7, S Peters8, F Clarke2, 
E McDonald2, M Soth2, J Muscadere9, N Campbell2, G Guyatt2, D Cook2, for the Canadian Critical Care Trials Group
1Hamilton Health Sciences Corporation, Burlington, Canada; 2McMaster University, Hamilton, Canada; 3University of Toronto, Canada;
4University of Ottawa, Canada; 5University of Western Ontario, London, Canada; 6University of Kingston, Canada; 7Dalhousie University,
Halifax, Canada; 8Memorial University, St John’s, Canada; 9University of Windsor, Canada
Critical Care 2004, 8(Suppl 1):P103 (DOI 10.1186/cc2570)
Background Medical–surgical critically ill patients are at risk of
venous thromboembolism (VTE) during their stay in the intensive
care unit (ICU). The rates of deep vein thrombosis (DVT) detected
by screening ultrasonography (10%), and DVT and pulmonary
embolism (PE) identified at autopsy (20%), suggest that many VTE
events are clinically undetected. The burden of illness associated
with VTE (DVT and/or PE) diagnosed during critical illness is
unclear.
Objective The primary objective of this study was to estimate the
prevalence and incidence of diagnostically confirmed DVT and PE
in medical–surgical ICU patients. The secondary objective was to
examine VTE prophylaxis longitudinally, estimating the proportion of
VTE events associated with prophylaxis failure versus failure to
implement prophylaxis. The tertiary objective was to estimate the
morbidity and mortality outcomes of patients with VTE.
Design A 1-year retrospective observational multicenter cohort
study of patients admitted to an ICU during 2000.
Setting Twelve university-affiliated closed medical–surgical ICUs
in eight cities in three provinces.
Patients We identified medical–surgical adult ICU patients who
had either upper or lower limb DVT or PE in the 24 hours
preceding ICU admission up to 48 hours post-ICU admission
(prevalent cases), and any time during the ICU admission, or up to
8 weeks following ICU discharge (incident cases). DVT was
diagnosed by compression ultrasound of the upper or lower
extremity, or venography. PE was diagnosed by ventilation
perfusion lung scan, chest computerized tomography, pulmonary
angiogram, echocardiogram, S1Q3T3 on EKG, or autopsy. Based
on  a priori criteria, patients were categorized as definite or
indeterminant VTE.
Results Among over 10,000 patients, 252 patients had definite or
indeterminant VTE; these patients were 62.5 (16.7) years of age,
with an APACHE II score of 17.6 (7.9). The range of diagnostically
confirmed VTE events across centers was wide.
Among patients with incident VTE, either anticoagulant or
mechanical prophylaxis occurred in 72.2% (70.2–74.1%) of
eligible ICU days. The median ICU length of stay was similar for
patients with DVT and PE (DVT, 4.0 days [interquartile range 2,
13]; PE, 4.0 days [interquartile range 2, 7]). ICU mortality was
17.9% and hospital mortality was 30.4% for patients with VTE.
Intravenous anticoagulation with unfractionated heparin was the
predominant treatment, and treatment complications were
infrequent.
Conclusions The burden of illness associated with diagnostically
confirmed DVT and PE in medical–surgical critically ill patients is
low in comparison with higher event rates of 10–20% detected by
screening ultrasonography and autopsy studies. Most VTE events,
although underdiagnosed, are associated with prophylaxis failure
rather than failure to prophylax. More active implementation of VTE
prevention strategies are needed in the ICU, as well as more
rigorous evaluation of VTE prevention strategies.
Acknowledgement  This study was funded by an unrestricted
grant from Pharmacia, Inc., the Physicians’ Services Incorporated
of Ontario, and the Ontario Thoracic Society.
Table 1
Events Definite or indeterminite Definite
Prevalent DVT 0.4% (0.3–0.6) 0.4% (0.3–0.6)
Prevalent PE 0.8% (0.6–1.0) 0.5% (0.4–0.7)
Incident DVT 1.0% (0.8–1.3) 1.0% (0.8–1.2)
Incident PE 0.9% (0.7–1.1) 0.6% (0.4–0.7)
P104 Thromboelastogram as a screening tool for hypercoagulabilityin traumatic brain injury
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Background The term hypercoagulability has been randomly used
to describe the increased risk of pathologic thrombus formation.
Traumatic brain injury (TBI) is often complicated by life-threatening
thromboembolic events [1]. In the trauma patient the incidence of
deep venous thrombosis (DVT) is estimated to be from 20% to
90% and to be 4–22% for pulmonary embolism (PE) [2]. The use
of the thrombelastograph (TEG) has proven useful in determining
an adult patient’s coagulation status by measuring the
enzymatic/protein elements of coagulation, platelet function, and
fibrinolysis from a whole blood sample [3]. The purpose of this
study is to compare the TEG as a screening tool for
hypercoagulability against other known parameters.
Materials and methods A prospective study was conducted at
University of Mississippi Medical Center, Jackson, MS, using 30 TBI
patients, 22 male and eight female, ranging in age from 18 to
79 years. TEG panels were drawn using either venous or arterial
blood at 24 and 96 hours post TBI admission. Thirty replicated
measurements were made with a two-channel TEG machine. A total
of 13 subjects were considered to be hypercoagulable, eight were
emerging hypercoagulable and nine were normal. The fibrinogen
level as well as the factor 8 level were measured at the same time.
Results  Intrasample variation as to expected fibrinogen results
were estimated by the coefficient of variation for each subject. AAvailable online http://ccforum.com/supplements/8/S1
random effect analysis of variation (ANOVA) was performed and
the coefficient of variation (r) was estimated by measuring the ratio
of hypercoagulate to fibrinogen and factor 8. A level of confidence
>0.05 was considered statistically significant. Coefficient of
variation was 0.96 for the fibrinogen level and 0.62 for factor 8.
Conclusion Although the sample size is small, we suggest that teh
TEG is a useful screening tool for hybercoagulability in TBI and
hence careful monitoring for DVT and PE.
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Introduction Heparin-induced thrombocytopenia (HIT-II) is the
most significant complication of heparin therapy depending on the
type and the duration of therapy, and the patient population.
Although its incidence is known to be high after cardiac and
orthopaedic surgery [1–3], it remains unknown in patients of a
general intensive care unit (ICU patients).
Purpose To investigate the frequency and clinical significance of
positive heparin-platelet factor-4 antibodies (HPF4-Abs) in ICU
patients.
Patients and methods We prospectively investigated the
incidence of HPF4-Abs in ICU patients, which were treated with
unfractionated heparin (UFH) or low molecular weight heparin
(LMWH) as prophylaxis or treatment of venous thromboembolism
or intermittent flushing solution of UFH (5 IU/ml) for maintenance of
central venous or arterial catheter patency (FUFH). The HPF4-Abs
were performed by enzyme-linked immunosorbent assay (ELISA)
(Asserachrom HPIA; Stago) on days 1 (admission), 7 and 15 of the
treatment. The result was defined as negative if absorbance at 492
nm (A492) was <0.671 and as positive if A492 ≥0.671. HIT-II was
defined by clinical evaluation.
Results We investigated 55 patients (16 female; median age
60 years, range 12–92 years) having an illness severity score
APACHE II of 20.28 ± 6.8. Eleven patients were treated with
FUFH, 38 with FUFH and LMWH, three with LMWH and one with
UFH. Positive HPF4-Abs were detected in 17 (30.9%) patients on
day 7 and 21 (39.5%) patients on day 15 (Table 1). None of the
patients developed HIT-II.
Conclusion Despite the high prevalence of positive HPF4-Abs in
ICU patients treated with FUFH or LMWHs, its clinical significance
remains to be investigated in a larger number of patients, especially
in case of re-exposure to heparin.
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Table 1
Number Platelets
Abs of patients (×109/l) D-dimers (µg/l)*
Day 7 (+) 17 319 ± 162.87 901.72 ± 491.87
Day 7 (–) 38 257 ± 99.36 1313.81 ± 1045.05
Day 15 (+) 21 438 ± 165.48 569 ± 373.02
Day 15 (–) 34 469 ± 146.46 2374.33 ± 1042.54
*P < 0.05 ([+] versus [–] Abs). Values are expressed as mean ± SD.
P106 Circulating thrombomodulin in ischemic heart disease: correlation with the extent and severity of coronary atherosclerosis
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Introduction Abnormal endothelial physiology has been implicated
both in early atherogenesis and, later, in the control of dynamic
plaque behavior. The biologic link between endothelial damage
and atherosclerosis may be related to decreased arterial
bioavailability of nitric oxide (NO), which may predispose to
leucocyte and platelet adhesion, vasoconstriction and smooth
muscle cell proliferation. Substances released by the endothelium
include prostacyclin, NO, endothelin, von Willebrand factor and
thrombomodulin (TM), and so on.
TM is an integral membrane glycoprotein that can change the
function of thrombin, to an anticoagulant through activation of protein
C — which, in the presence of protein S, inactivates factor VIIIa and
factor Va, and thereby inhibits further formation of thrombin.
Soluble TM is thought to indicate endothelial-cell damage. A
positive relation between the concentration of soluble
thrombomodulin and the risk of atherosclerotic disease is widely
assumed.
Aim of the study To assess the diagnostic role of circulating TM
as a marker of the extent and severity of coronary arterial
atherosclerosis. We studied 150 patients with ischemic heart
disease (118 male, 32 female; mean age 53.4 ± 8.3 years, ranging
from 32 to 80 years), together with 20 nonischemic patients who
were catheterized prior to valve replacement (13 male, seven
female; mean age 58.4 ± 4.5 years) serving as controls. Of the
150 ischemic patients, 77 had anginal pain (AP) and 73 had acute
myocardial infarction (AMI).Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
Following clinical evaluation, all patients were subjected to 12-lead
ECG and routine laboratory work, and coronary arteriography to
assess the extent and severity of the stenotic lesions using the
Gensini scoring system. All patients had TM levels, measured in
arterial samples withdrawn from the coronary artery during the
catheter procedure using the enzyme immunoassay ELISA.
Compared with the control subjects, the ischemic patients
exhibited significantly higher levels of serum TM (42.5 ± 15.4 vs
2.8 ± 0.8, P < 0.0000), with progressively higher levels of serum
TM from the anginal group to the AMI group (35.7 ± 11.3 vs
49.6 ± 16.1, P < 0.000001).
Serum TM correlated significantly with the severity of coronary
artery pathology, expressed as the Gensini score with P < 0.000
for the angina group and P < 0.000 for the AMI group. Again,
both groups exhibited significant correlation between serum TM
and the number of diseased vessels, with P < 0.000 for both
groups.
Conclusion TM, an endothelial glycoprotein resulting from the
damage to the vascular endothelium by the atheromatous process,
showed significant correlation with the extent and severity of
coronary artery disease (expressed by the Gensini score system).
The higher TM level in the AMI group compared with the AP group
points to the more significant endothelial damage in the former
compared with the latter. That stresses the importance of serum
TM as a molecular marker of endothelial dysfunction in acute
ischemic syndromes.
P107 Antithrombin and free tri-iodothyronine in sepsis
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Background Plasmatic activity of antithrombin (AT), a physiological
coagulation inhibitor with anti-inflammatory properties, is a marker of
severity validated in sepsis. The nonthyroidal illness syndrome,
whose first stage is a decrease in free tri-iodothyronine (fT3)
plasmatic concentration, is frequently observed in intensive care
unit (ICU) patients. Plasmatic levels of fT3 and free thyroxine (fT4)
are respectively in correlation with severity and prognosis. The aim
of this study is to determine whether a significant correlation exists
between T3 and AT in sepsis.
Methods Eighty-two patients, with 28 of them suffering from
sepsis, admitted in the ICU of a general hospital over a 5-month
period, were included at random. The exclusion criteria were a
history of dysthyroidism or treatment intake that affects thyroid
function. The levels of AT, thyroid stimulating hormone (TSH), fT3,
fT4, C reactive protein (CRP) and leukocyte count were measured
at admission. These investigations concerning blood samples were
part of the routine biological balance. APACHE II and SAPS II
scores were calculated using data from the first 24 hours of the
ICU stay. Patients were followed until ICU discharge or death to
determine the survival rate. P < 0.05 and r < 0.05 were considered
significant.
Results A nonlinear significant correlation between AT and T3 was
shown in our nonseptic (P = 0.0043,  r = 0.393) and septic
(P = 0.00220, r = 0.449) population, whereas it was neither with
T4 (nonseptic group, P = 0.571; septic group, P = 0,265) or with
TSH (nonseptic group, P = 0.993; septic group, P = 0.421). Only
in the septic group were AT and fT3 significantly in correlation with
gravity, evaluated by APACHE II/SAPS II scores. A significant
correlation between fT4 at admission and survival (P = 0.0208)
existed only in patients with septic shock. fT3 (1.39 ± 0.56 ng/l vs
2.04 ± 0.54 ng/l,  P < 0.0001), as AT (51 ± 22.82% vs
82 ± 23.62%,  P < 0.0001), was significantly lower in the septic
group. Among other measured parameters, CRP (131 ± 75 mg/l
vs 44 ± 53 mg/l, P < 0.0001) and fT4 (9.4 ± 4.15 vs
11.37 ± 3.25 ng/ml, P = 0.0239) were discriminative between the
two groups, contrary to the leukocyte count (P = 0.1375). We
proposed an explanation of the inter-relation between AT and T3 in
sepsis, based upon nuclear properties of T3 on the AT gene and
upon effects of AT on the NF-κB path, regulating the peripheral
deiodination of T4 to T3.
Conclusions A significant correlation was underlined in the septic
group, at ICU admission, with T3 and AT, whereas it was neither
with T4 or with TSH, and with T3, AT and APACHE II/SAPS II
gravity scores. A significant correlation between fT4 at admission
and survival was found, but only in the septic shock subgroup. The
decrease in fT3 is involved in the decrease in AT, reliable to gravity
and prognosis. A physiopathological explanation in sepsis could
imply NF-κB. Measurement of AT realized in septic patients could
be usefully completed by fT3 measurement.
P108 Effects of recombinant surfactant protein C and elastase inhibitor on neutrophil apoptosis
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Acute lung injury (ALI) and acute respiratory distress syndrome
(ARDS) are associated with mortality in excess of 50%. About
5–35% of patients with sepsis develop ARDS and the condition is
characterised by infiltration and accumulation of activated
polymorphonuclear leukocytes (PMNL) within the capillary and
alveolar spaces. Increased alveolar neutrophil elastase and
decreased antiprotease activity also occurs. Elastase directly
damages surfactant-specific protein in vitro and alters surfactant
function. Recombinant surfactant protein C (r-SPC) improves
pulmonary dynamics, oxygenation and reduces hyaline membrane
formation in animal models of ALI/ARDS. Accumulated neutrophils
are removed by programmed cell death or apoptosis, resulting in
resolution and healing. We determined the effect of r-SPC with
and without elastase inhibitor (EI) on neutrophil apoptosis.
Heparinised venous blood samples were obtained from 10 healthy
adult volunteers, and PMNL were isolated by density gradient
centrifugation and suspended in minimum essential medium
supplemented with 10% autologous plasma. Cells were incubated
for 16 hours with either 2 µg/ml lipopolysaccharide (LPS)(stimulated) or phosphate-buffered saline (unstimulated) in the
presence of r-SPC or EI, or both. Cells were washed and treated
with Annexin V/propidium iodide stains and analysed by dual-laser
flow cytometry. The percentage of early apoptotic cells was
determined using four-quadrant analysis. Data were analysed using
Friedman analysis of variance with post hoc testing by Wilcoxon
signed ranks testing for paired data (Table 1).
The results of this pilot study show that r-SPC significantly
increases activated PMNL apoptosis, and this is maintained in the
presence of EI. This suggests the possible use of r-SPC and
elastase inhibitor in inducing neutrophil apoptosis and hence
clearance of neutrophils in ALI/ARDS. Further studies are needed.
Available online http://ccforum.com/supplements/8/S1
Table 1
P value
Median (range) (Wilcoxon signed ranks)
Unstimulated 58 (21–70)
LPS + r-SPC 90 (64–97) 0.0020
LPS + EI 53 (21–70) 0.1055
LPS + r-SPC + EI 85 (66–97) 0.0020
P109 Recombinant human activated protein C upregulates cyclooxygenase-2 and release of prostaglandins from cultured
human endothelial cells via the endothelial protein C receptor
M Brueckmann1, K Fukudome2, S Horn1, S Lang1, V Liebe1, U Hoffmann1, M Borggrefe1, K Haase1, G Huhle1
1University Hospital Mannheim, Germany; 1Saga Medical School, Japan
Critical Care 2004, 8(Suppl 1):P109 (DOI 10.1186/cc2576)
Background Cyclooxygenase-2 (COX-2) is the inducible COX
isoform that catalyzes the formation of prostaglandins in
response to proinflammatory cytokines. Prostacyclin, the major
prostanoid generated by endothelial cells, is a potent inhibitor of
platelet aggregation and a powerful vasodilator. Although the role
of Drotrecogin alfa (activated) (recombinant human activated
protein C [rhAPC]) in modulating microvascular coagulation
through the inhibition of thrombin generation has been well
studied in experimental and clinical settings of severe sepsis,
little is known about its effects on prostanoid release from
endothelial cells.
Methods The effect of rhAPC (1–20 µg/ml) on the expression of
COX-2-mRNA in human umbilical vein endothelial cells (HUVEC)
was measured by a colorimetric assay (Quantikine assay™). The
COX-2 protein content in endothelial cells was determined by
western blots. Cell supernantants were assayed for 6-keto-
PFG1α, the stable hydrolysis product of prostacyclin, by ELISA.
Statistical analysis was performed by unpaired Student’s t test
and ANOVA.
Results rhAPC dose-dependently upregulated COX-2 mRNA in
endothelial cells after an incubation time of 4 hours (controls,
11.7 ± 0.6 amol/ml; HUVEC treated with 20 µg/ml rhAPC,
18.4 ± 0.8 amol/ml; mean ± SEM, P < 0.001). Western blot
analysis revealed an increase of COX-2 protein content after a
10-hour treatment with rhAPC (1 µg/ml). rhAPC dose-dependently
increased 6-keto-PFG1α-levels in HUVEC supernatants (controls,
62.5 ± 8.7 pg/ml; HUVEC treated with 20 µg/ml rhAPC,
151.7 ± 16.3 pg/ml, P < 0.001). As shown by antagonists to the
thrombin receptor PAR-1 (WEDE 15 and ATAP2) and by a
monoclonal antibody (RCR-252) against the endothelial protein C
receptor (EPCR), the effect of rhAPC on COX-2 mRNA
upregulation was mediated by the EPCR receptor.
Conclusions The ability of rhAPC to upregulate COX-2 in human
endothelial cells, as well as the release of prostanoids, very
probably mediated by the EPCR receptor, may represent a new
molecular mechanism, by which oxygen delivery at the site of injury
may be improved and intravascular aggregation of platelets may be
reduced, thereby contributing to the efficacy of rhAPC in systemic
inflammation and sepsis.
P110 Drotrecogin alfa (activated) does not impair platelet receptor expression in vitro
T Schuerholz, I Kornau, L Friedrich, B Juettner, H Elsner, D Scheinichen
Hannover Medical School, Germany
Critical Care 2004, 8(Suppl 1):P110 (DOI 10.1186/cc2577)
Introduction During the past decade attempts were made to find a
drug decreasing the high mortality in severe sepsis and septic
shock. Recently, a trial showed a significant reduction in mortality
under the application of drotrecogin alfa (activated) (Xigris; Eli Lilly,
Bad Homburg, Germany) (recombinant human activated protein C
[APC]). Severe thrombocytopenia might be a risk factor for serious
bleeding under this therapy. The median plasma concentration of
APC at steady state is 0.045 µg/ml. A previous study revealed an
APC-dependent reduction of CD62P on the platelet surface
exclusively after activation with recombinant tissue factor.
However, the amounts of APC used were high, above steady-state
concentrations (0.5–20 µg/ml), and the effect of APC in
therapeutic concentrations on the expression of platelet receptors
has not yet been studied systematically.
Objective To evaluate the influence of drotrecogin alfa (activated)
on  in vitro expression of platelet receptors at a therapeutic
concentration.
Methods Citrated blood was drawn from healthy blood donors
(n = 22, 45.5% male, age 38 ± 13 years [mean ± SD]). Exclusion
criteria were smoking, diabetes and use of drugs interfering with
platelet function. Blood samples were adjusted with APC to final
concentrations of 0.045 µg/ml APC (group 1, therapeutic dose)
and 0.225 µg/ml APC (group 2, fivefold therapeutic dose),
respectively. The control group received no additional APC. To
evaluate platelet reactivity, samples were activated with 5 µM
thrombin-receptor-agonist-peptide-6 (TRAP-6; Bachem,
Heidelberg, Germany) or 2.5 µM adenosine-di-phosphate (ADP;Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
Sigma, Taufkirchen, Germany). Samples were incubated for 10 min
at 37°C with fluorescence-labeled monoclonal antibodies (mAB)
against CD62P (fluorescein isothiocyanate, FITC), CD41
(phycoerythrin [PE]), CD42b(PE), CD45(FITC) (all from Beckman-
Coulter, Krefeld, Germany) or PAC-1(FITC) (Becton Dickinson, San
Jose, CA, USA). Analyses were performed in a flow-cytometer
(Epics XL; Beckman-Coulter). The mean fluorescence intensity was
calculated for all mAB except CD45. After gating granulocytes, the
percentage of CD45/41-positive complexes was counted. Both
calculations were run using the WinMDI software. Statistics for
intergroup differences were performed by one-way ANOVA.
Results APC in group 1 had no significant influence on platelet
activation, with and without stimulation. In group 2, CD62P and
CD45/41 showed a slight but nonsignificant decrease.
Conclusion This study demonstrates that therapeutic plasma
concentrations of drotrecogin alfa (activated) have neither an
influence on expression of platelet activation markers nor on
platelet–granulocyte complexes in vitro. Thus, a disturbance of
primary hemostasis seems unlikely.
P111 Disturbed alveolar fibrin turnover during pneumonia is associated with reduced activated protein C levels in lungs
G Choi, P Bresser, M Levi, T van der Poll, M Schultz
Academic Medical Center, Amsterdam, The Netherlands
Critical Care 2004, 8(Suppl 1):P111 (DOI 10.1186/cc2578)
Background In pneumonia alveolar fibrin turnover is disturbed by
activation of coagulation and inhibition of fibrinolysis. The role of
natural coagulation inhibitors, such as activated protein C (APC), in
lung inflammation is unknown.
Methods In nine patients with unilateral pneumonia (four
community-acquired [CAP], five ventilator associated [VAP])
bronchoalveolar lavage fluid (BALF) was obtained from both the
infected and the contralateral noninfected lung. BALF levels of
coagulation (thrombin–antithrombin complex [TATc]), fibrinolysis
(plasminogen activator activity [PAA]), and levels of APC were
determined. Ten healthy subjects and 10 mechanically ventilated
patients without pneumonia served as controls.
Statistics The Wilcoxon signed-ranked test was used for paired
samples from the same patients; the Mann-Whitney U test was
used for comparisons with controls.
Results Higher levels of TATc and lower levels of PAA were found
in infected lungs compared with noninfected lungs and lungs from
controls (P < 0.05). Protein C and APC concentrations were
significantly decreased at the infected site (P < 0.01). See Fig. 1.
Conclusion Pneumonia is characterized by a strong procoagulant
shift at the site of infection, caused by local activation of
coagulation, inhibition of fibrinolysis, and low levels of APC.
Figure 1
Horizontal lines, median ± interquartile range from healthy (upper
panels) and mechanically ventilated (lower panels) controls.
P112 Predictability of disseminated intravascular coagulation based on the decrease rate of platelets
H Miyauchi, A Hagiwara, A Murata, T Masuda, H Masuda, S Shimazaki
Kyorin University, School of Medicine, Tokyo, Japan
Critical Care 2004, 8(Suppl 1):P112 (DOI 10.1186/cc2579)
Purpose To investigate whether the decrease rate of platelets is useful
for early diagnosis of disseminated intravascular coagulation (DIC).
Subjects and methods  A retrospective clinical study was
performed in 454 consecutive patients who were admitted to our
intensive critical care unit between 1 June and 1 October 2003.
The patients whose platelet count decreased to be less than
1 0×1 0 4/µl during the course of a disease were regarded to be in
a state of pre-DIC, and the relation between the subsequent
decrease rate of platelets (∆PLT) and the occurrence of DIC was
investigated. ∆PLT was obtained as follows: (platelet count when
platelets started to decrease – minimum platelet count
subsequently observed / the number of days required to observe
the minimum platelet count after platelets started to decrease).
Result The platelet count decreased to be less than 10 × 104/µl in
41 out of 454 patients during their hospital stay. Among these
41 patients, 28 (70%) developed DIC. There was no significant
difference in age, sex, APACHE II score, SOFA score, or frequency
of systemic inflammatory response syndrome between DIC and
non-DIC patients. When the platelet count, the International
Normalised Ratio, the fibrinogen level, the fibrin/fibrinogen
degradation product (FDP) value, and the most abnormal white
blood cell count in non-DIC patients were compared with those
observed at the time of DIC onset in DIC patients, only the FDP
value was significantly higher in DIC patients (non-DIC:DIC,
8.49 ± 3.40 µg/ml:59.6 ± 86.2 µg/ml;  P < 0.05).  ∆PLT was
significantly higher in DIC patients (6.55 ± 8.41/µl/day) than in
non-DIC patients ([2.24 ± 1.87] × 104/µl/day).Conclusion The patients who had less than 10 × 104/µl platelets
and whose platelets decreased by 6.55 × 104/µl/day on average
had a strong possibility to develop DIC.
Available online http://ccforum.com/supplements/8/S1
P113 Drotrecogin alfa (activated) reduces the plasma levels of N-terminal prohormone atrial natriuretic peptide and N-terminal
prohormone brain natriuretic peptide as markers of cardiac depression in septic patients
U Hoffmann1, M Brückmann1, C Liebetrau1, S Lang1, T Bertsch1, M Borggrefe1, C Putensen2, S Schröder2, K Haase1
1University Hospital Mannheim, Germany; 2Department of Anesthesiology, Bonn, Germany
Critical Care 2004, 8(Suppl 1):P113 (DOI 10.1186/cc2580)
Background The family of natriuretic peptides comprises several
structurally related 22–53 amino acid peptides, such as atrial
natriuretic peptide (ANP) and brain natriuretic peptide (BNP),
which are vasoactive peptides that have vasodilator and diuretic
properties and play an important role in cardiovascular
homeostasis. The salutary cardiovascular effects of natriuretic
peptides suggest that ANP and BNP have a pathophysiological
significance in cardiac depression in septic patients. Aim of the
present study was to determine plasma levels of the stable
N-terminal prohormone forms of ANP (Nt-proANP) and BNP
(Nt-proBNP) in septic patients treated with and without
Drotrecogin alfa (activated). Troponin I (TNI) as a parameter for
cardiac dysfunction was also evaluated.
Patients and methods  Nt-proANP, Nt-proBNP and TNI levels
were measured in plasma samples from 40 septic patients at day 1
of severe sepsis and from 25 septic patients treated with
Drotrecogin alfa (activated) by ELISA methods. Statistical analysis
was performed with the unpaired Students t test.
Results The mean SAPS II scores from septic patients on day 1
treated with and without Drotrecogin alfa (activated) were
comparable (SAPS II score mean = 32). Significantly lower
concentrations of NT-proBNP (P = 0.0075) and NT-proANP
(P = 0.0366) were measured in the patients treated with
Drotrecogin alfa (activated) as compared with the patients not
receiving Drotrecogin alfa (activated). TNI values were significantly
lower (P < 0.05) in septic patients treated with Drotrecogin alfa
(activated) (mean ± SD = 3.3 ± 7.2 ng/ml) as compared with
untreated patients (mean ± SD = 0.3 ± 0.97 ng/ml). There was a
correlation between NT-proBNP and NT-proANP values
(r = 0.6381,  P < 0.001). Septic patients with NT-proBNP levels
>1600 fmol/ml have a 3.7-fold higher risk of death than patients
with NT-proBNP levels <1600 fmol/ml (P = 0.05).
Conclusion  Nt-proANP and Nt-proBNP levels are significantly
lower in septic patients treated with Drotrecogin alfa (activated).
Nt-proBNP can serve as a predictor for survival in septic patients.
Drotrecogin alfa (activated) may influence cardiac depression in
septic patients by controlling the pathways of NT-proANP and
Nt-proBNP production. The beneficial effect of Drotrecogin alfa
(activated) on cardiac function is also reflected by lower TNI values
in this patient group.
P114 The efficacy of Drotrecogin alfa (activated) during a global, single-arm, open-label trial in adult patients with severe sepsis
(ENHANCE): comparisons with PROWESS
J Vincent1, G Bernard2, J Dhainaut3, M Levy4, A Wheeler2, W Macias5
1Erasme University Hospital, Brussels, Belgium; 2Vanderbilt University, Nashville, Tennessee, USA; 3Cochin Institute, Paris, France; 
4Brown University, Providence, Rhode Island, USA; 5Eli Lilly, Indianapolis, Indiana, USA
Critical Care 2004, 8(Suppl 1):P114 (DOI 10.1186/cc2581)
Background Treatment with Drotrecogin alfa (activated) (DrotAA)
in a phase 3 clinical trial (PROWESS, n = 1690) was associated
with a significant survival advantage and favorable benefit–risk
profile compared with placebo in adult patients with severe sepsis.
A global, single-arm, open-label trial of DrotAA in adult patients
with severe sepsis was subsequently conducted at 361 sites in
25 countries (ENHANCE, n = 2378). Here, the efficacies of
DrotAA in ENHANCE and PROWESS were compared, with all-
cause mortality at 28 days as the primary study endpoint.
Methods Inclusion/exclusion criteria were similar to PROWESS.
Patients eligible for participation had a known or suspected
infection, met three or four criteria defining systemic inflammatory
response syndrome and one or more acute sepsis-induced
(<48 hour duration) organ dysfunctions. Patients were classified
by the time interval from the first documented organ dysfunction to
administration of DrotAA (time-to-treatment), for patients that had
received DrotAA within 24 hours (n = 1128) versus >24 hours
(n = 1246) after the first documented organ dysfunction.
Results Figure 1 shows overall Kaplan–Meier survival curves for
PROWESS and ENHANCE (28-day percent mortality shown).
Survival curves for patients receiving DrotAA were essentially
Figure 1identical for PROWESS and ENHANCE through 28 days. These
results were maintained in patient subgroups of baseline APACHE II
score of 25 or more (23.0%, n= 430 vs 27.4%, n= 432) and two
or more organ dysfunctions (25.2%, n= 894 vs 28.6%, n= 1110).
Conclusions Survival curves for patients receiving DrotAA were
similar between the PROWESS and ENHANCE trials. Early
treatment was associated with greater mortality benefit. The global
ENHANCE reinforces the benefits of DrotAA observed in
PROWESS.
Acknowledgement This research was supported by Eli Lilly and
Company, Indianapolis, IN, USA.
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P115 Drotrecogin alfa (activated) in the subgroup of patients with multiple organ dysfunction (MOD) during a global, single-arm,
open-label trial in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS
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Critical Care 2004, 8(Suppl 1):P115 (DOI 10.1186/cc2582)
Background Drotrecogin alfa (activated) (DrotAA) was associated
with a significant survival advantage and a favorable benefit–risk
profile in a phase 3 clinical trial (PROWESS, n = 1690) in adult
patients with severe sepsis. The EMEA approved DrotAA for
treatment of adult patients with severe sepsis and multiple organ
failure. ENHANCE (n = 2378) was a single-arm, open-label trial of
DrotAA in adult patients with severe sepsis. We compared relative
efficacies of DrotAA in ENHANCE and PROWESS in the
subgroup of patients with MOD.
Methods Inclusion/exclusion criteria were similar to PROWESS.
Patients with MOD in ENHANCE and PROWESS were identified
and compared (ENHANCE, n = 2008; PROWESS DrotAA,
n = 634; PROWESS placebo [PBO], n = 637). Baseline
characteristics, 28-day all-cause mortality, safety, and the effect of
time of treatment were assessed.
Results Age (years), mean (SD): ENHANCE, 60 (17); PROWESS
DrotAA, 61 (17); and PBO, 62 (16). Males: ENHANCE, 58%;
PROWESS DrotAA, 56%; and PBO, 57%. Recent surgery:
ENHANCE, 38%; PROWESS DrotAA, 31%; and PBO, 33%.
Organ dysfunctions: ENHANCE, 3.0 (0.9); PROWESS DrotAA,
2.9 (0.9); and PBO, 2.8 (0.9). APACHE, mean (SD): ENHANCE,
22.9 (7.3); PROWESS DrotAA, 25.7 (7.5); and PBO, 25.9 (7.8).
Ventilator support: ENHANCE, 86.1%; PROWESS DrotAA,
79.8%; and PBO, 82.9%. Vasopressor support: ENHANCE,
81.7%; PROWESS DrotAA, 71.5%; and PBO, 73.9%. Total
SOFA, mean (SD): ENHANCE, 10.3 (3.2); PROWESS DrotAA,
9.7 (3.1); and PBO, 9.6 (3.1). Twenty-eight-day mortality:
ENHANCE, 27.1%; PROWESS DrotAA, 26.5%; and PBO,
33.9%.  Serious bleeding during infusion: ENHANCE, 3.7%;
PROWESS DrotAA, 2.4%; and PBO, 1.3%.
Similar results were observed in the MOD subgroup as in the
overall population. ENHANCE MOD patients tended to have lower
APACHE scores but greater organ support at baseline compared
with PROWESS patients. Mortality was similar for DrotAA-treated
patients in ENHANCE and PROWESS, and both were lower than
PROWESS placebo patients. Serious bleeding was numerically
higher in ENHANCE than in PROWESS. Patients treated within
24 hours of the first organ dysfunction had lower 28-day mortality
(25.2%,  n = 894) than those treated after 24 hours (28.6%,
n = 1110).
Conclusions Results from the global ENHANCE reinforce the
benefit–risk profile of DrotAA observed in the PROWESS MOD
subgroup. In addition, earlier treatment (≤24 hours) appears to be
associated with lower mortality.
Acknowledgement This research was supported by Eli Lilly and
Company, Indianapolis, IN, USA.
P116 The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult
patients with severe sepsis (ENHANCE): comparisons with PROWESS
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Background A global, single-arm, open-label trial of Drotrecogin
alfa (activated) (DrotAA) in adult patients with severe sepsis was
subsequently conducted at 361 sites in 25 countries (ENHANCE,
n = 2378). Reported here are 28-day all-cause mortality and safety
data.
Methods Inclusion/exclusion criteria and the definition of serious
adverse events (SAE) were similar to PROWESS. Patients at high
risk of bleding were excluded from participation. SAE bleeding
rates, including intracranial hemorrhage (ICH), during the study
drug infusion period (infusion period + 1 day) were determined and
the all-cause mortality was assessed at day 28.
Results Serious bleeding rates and fatal event rates for
PROWESS and ENHANCE are presented in Table 1. Overall
28-day mortality: PROWESS placebo = 30.8%, PROWESS
DrotAA = 24.7%, ENHANCE DrotAA = 25.3%. As in PROWESS,
bleeding was the most common drug-related complication
associated with DrotAA. A total 48.9% of SAE bleeding events
were adjudicated as procedure-related. In ENHANCE, the ICH rate
during infusion was 0.6% (n = 15), of which five (0.2%) were fatal.
ICH rates for placebo vs DrotAA in PROWESS were 0% and
0.2% (n = 2, both fatal), respectively. A higher postinfusion rate of
serious bleeding was observed in ENHANCE, suggesting a higher
overall background bleeding rate, relative to PROWESS.Conclusions Twenty-eight-day survival was similar in
PROWESS and ENHANCE. Serious bleeding events during
infusion of DrotAA were slightly more frequent in ENHANCE
than in PROWESS; the proportion of fatal bleeding events was
the same. However, the background bleeding rate in ENHANCE
may have been higher. The ENHANCE safety and efficacy data
are highly consistent with PROWESS, and reinforce the
favorable benefit–risk profile of DrotAA in patients with severe
sepsis.
Acknowledgement This research was supported by Eli Lilly and
Company, Indianapolis, IN, USA.
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Table 1
PROWESS: PROWESS: ENHANCE:
placebo DrotAA DrotAA
Total n 840 850 2378
During infusion
Serious bleed 1.0 (n = 8) 2.4 (n = 20) 3.6 (n = 85)
Fatal event 0.1 (n = 1) 0.5 (n = 4) 0.5 (n = 11)
Postinfusion
Serious bleed 1.1 (n = 9) 1.2 (n = 10) 2.9 (n = 70)
Values are shown as rates (%) unless otherwise indicated.
P117 Early treatment with Drotrecogin alfa (activated) was associated with reduced hospital resource use in adult severe sepsis
patients with two or more organ dysfunctions at baseline: results from ENHANCE
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Background In a phase 3 trial (PROWESS, n = 1690),
Drotrecogin alfa (activated) (DrotAA) was associated with a
significant survival improvement and favorable benefit–risk profile
compared with placebo in adult patients with severe sepsis
receiving standard supportive care. A global, single-arm, open-
label trial of DrotAA in adult patients with severe sepsis
(ENHANCE, n = 2378) was subsequently conducted at 361 sites
in 25 countries, and hospital resource usage was assessed with
respect to the timing of DrotAA administration.
Methods Inclusion and exclusion criteria were similar to
PROWESS. Patients eligible for participation had a known or
suspected infection, met three or four criteria defining systemic
inflammatory response syndrome and one or more acute sepsis-
induced (<48 hour duration) organ dysfunctions. Days in the ICU,
days in the hospital, and days of ventilator use were monitored,
starting from time of DrotAA infusion. Patients were classified with
respect to the time interval from the first documented organ
dysfunction to administration of DrotAA in the intent-to-treat
population with two or more organ dysfunctions at baseline that
had received DrotAA within 24 hours after the first organ
dysfunction (time 0–24 hours, n = 894) vs more than 24 hours
after first organ dysfunction (time 24–48 hours, n = 1110).
Results Table 1 describes patients with two or more organ
dysfunctions at baseline. Administration of DrotAA within 24 hours
of the first organ dysfunction was associated with reductions in
days in the ICU, hospital length of stay, and mechanical ventilator
use, relative to patients receiving DrotAA from 24–48 hours after
first organ dysfunction.
Conclusion Earlier treatment with DrotAA was associated with
reduced hospital resource use and decreased length of stay in
patients with two or more organ dysfunctions at baseline. These
data suggest that the timely administration of DrotAA may have
important clinical and economic value.
Acknowledgement This research was supported by Eli Lilly and
Company, Indianapolis, IN, USA.
Table 1
Time: Time:
Days (median) 0–24 hours 24–48 hours P value
ICU days 11 13 0.003
Hospital days 19 23 0.005
Ventilator days 6 9 <0.001
P118 Early treatment with Drotrecogin alfa (activated) was associated with reduced hospital resource use in adult severe sepsis
patients with an APACHE II score of 25 or greater at baseline: results from ENHANCE
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Background In a phase 3 clinical trial (PROWESS, n = 1690
patients), Drotrecogin alfa (activated) (DrotAA) was associated
with a significant survival improvement and favorable benefit–risk
profile compared with placebo in adult patients with severe sepsis
receiving standard supportive care. A global, single-arm, open-
label trial of DrotAA in adult patients with severe sepsis
(ENHANCE, n = 2378) was subsequently conducted at 361 sites
in 25 countries, and hospital resource usage was assessed with
respect to the timing of DrotAA administration.
Methods Inclusion and exclusion criteria were similar to
PROWESS. Patients eligible for participation had a known or
suspected infection, three or four of the criteria defining the
systemic inflammatory response syndrome, and one or more acutesepsis-induced (<48 hour duration) organ dysfunctions. Days in
the ICU, days in the hospital, days of ventilator use, and days of
vasopressor use were monitored, starting from the time of DrotAA
infusion. Patients were subclassified with respect to the time
interval from the first documented organ dysfunction to
administration of DrotAA (time-to-treatment). Time-to-treatment
was considered in the intent-to-treat population with an APACHE II
score of 25 or more at baseline that had received DrotAA within
24 hours of the first organ dysfunction (n = 430) vs those that
received the drug more than 24 hours after first organ dysfunction
(n = 432).
Results Data presented are from severe sepsis patients with an
APACHE II score of 25 or more at baseline. The administration of
DrotAA within 24 hours of the first observed organ dysfunction was
associated with significant reductions in days in the ICU (median
ICU days = 10 for time: 0–24 hours, 14 for time: 24–48 hours;
P = 0.006), mechanical ventilator use (median ventilator days = 7
for time: 0–24 hours, 10 for time: 24–48 hours; P < 0.001), and
vasopressor use (median vasopressor days = 2 for time:
0–24 hours, 3 for time: 24–48 hours; P = 0.003), relative to
patients receiving DrotAA after more than 24 hours from first organ
dysfunction. Median days in the hospital were lower in patients
receiving DrotAA within 24 hours of first organ dysfunction, but the
difference was not statistically significant (median hospital
days = 18.5 for time: 0–24 hours, 22 for time: 24–48 hours;
P = 0.103).
Conclusion Earlier treatment with DrotAA was associated with
reduced hospital resource use in patients with an APACHE II score
of 25 or more at baseline. These data suggest that the timely
administration of DrotAA may have important clinical and economic
value.
Acknowledgement This research was supported by Eli Lilly and
Company, Indianapolis, IN, USA.
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P119 Age and number of organ dysfunctions are associated with early mortality in patients suffering from severe sepsis treated
with recombinant human activated protein C
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Introduction It has been shown that age and number of organ
dysfunctions (OD) correlate with outcome of patients suffering
from severe sepsis (SS). Recently, the PROWESS study (phase III,
double-blind, placebo-controlled trial) had demonstrated that
recombinant human activated protein C (rhAPC) reduces the
absolute risk of 28-day all-cause mortality by 6.1% in patients
suffering from SS. As a result in Mexico, from August 2002 until
October 2003, 206 patients have been treated with rhAPC. The
present study is to identify the main variables that contribute to
early mortality (first 8 days) in patients treated with rhAPC.
Methods Data from 206 patients treated with rhAPC from
58 public and private medical institutions all over Mexico were
analyzed retrospectively. Age, origin of SS, number of OD, timing
of rhAPC administration, andcomplications during rhAPC were
used as independent variables. Cross-tabulation and chi-square
analysis were performed to identify those variables that contribute
to mortality at 8 days of SS.
Results Intra-abdominal sepsis was the most common origin of SS
(46.6%), followed by postoperative sepsis, pneumonia and others
(28.6%, 19.4% and 5.3%, respectively). There were no differences
in mortality about patients treated in public hospitals compared with
patients treated in private hospitals. The mean age of patients
treated was 58.80 years (19–89 years). The mean of OD was 2.78
(1–6), the mean of timing administration of rhAPC was 50.94 hours
(4–504 hours), and global mortality at 1 week was 31.6%. Age was
associated with mortality; patients younger than 41 years had
14.7% mortality, in contrast with patients older than 65 years with
48.3% mortality (P = 0.000). The number of OD was associated
with mortality; patients with one OD had 21.4% mortality in contrast
with 37.7% mortality in patients with three or more OD (P = 0.040).
Patients younger than 41 years with one OD had 0% mortality, two
OD 11.8% and three or more OD 21.4%; patients between 40 and
65 years with one OD had 25% of mortality, two OD 20.0% and
three OD 33.3%. Patients older than 65 years with one OD had
25% of mortality, two OD 50% and three or more OD 50%
(P = 0.003). Bleeding was observed in 4.7% of patients, and one
dead by cerebral haemorrhage associated with rhAPC (0.48%) was
reported.
Conclusions Age and the number of OD are highly associated
with mortality at 1 week of SS on patients that were treated with
rhAPC. Patients suffering from SS have to be treated at an early
stage of sepsis.
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Introduction Neuroaxial anaesthesia reduces the risk of
postoperative complications, but in high-risk patients undergoing
major abdominal surgery the benefits of neuroaxial anaesthesia
are less clear [1,2]. A significant proportion of patients develop
sepsis following laparotomy. Recently Drotrecogin alfa (activated)
has been shown to reduce the risk of death from sepsis [3]. Due
to the increased risk of bleeding the presence of a neuroaxial
catheter is an absolute contraindication to its use. We
hypothesized that the presence of a neuroaxial catheter excludes
a significant number of septic patients from receiving this
potentially beneficial therapy.
Method All patients admitted to our unit over a 1-year period
following major intra-abdominal surgery were reviewed. Among
those with neuroaxial catheters, data were collected on systemic
inflammatory response syndrome (SIRS) criteria, presence ofinfection, organ failure and hospital survival. Sepsis was defined
according to the Critical Care Medicine Consensus Committee.
Results See Table 1. Sixty-seven patients were admitted following
major abdominal surgery. Of these, 57 (85%) had neuroaxial
catheters. Of these, 14 developed sepsis (25%). The mortality in
this group was 8/14 (57%). In our unit, patients receiving
Drotrecogin alfa had a mortality of 29% (expected 53%).
Conclusion The mortality in patients with sepsis in our group
undergoing major abdominal surgery was comparable with that
observed in the PROWESS study (0.57 vs 0.52) [3]. Given that
Drotrecogin alfa has been shown to reduce the risk of death by 6%
and that neuroaxial anaesthesia confers little survival benefit
following major abdominal surgery, avoiding the use of or early
removal of catheters in sepsis may confer a significant increase in
survival.
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Table 1
Sepsis among patients with neuroaxial catheters after intra-abdominal surgery
Death +  Neuroaxial  SIRS  Zero organ  One organ  Two  Three organ  Four  Total 
sepsis catheter ≥ 2 failures failure organ failures failures organ failures deaths
Number of patients 8 (14%) 57 (100%) 51 (89%) 20 (36%) 10 (18%) 14 (25%) 13 (23%) 0 15 (26%)
P121 Use of national guidelines for the introduction of Drotrecogin alfa (activated)
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Introduction The Scottish Medicines Consortium approved the use
of Drotrecogin alfa (activated) (Xigris©) in October 2002 and
recommended that a register of patients receiving the drug be kept.
The Scottish Intensive Care Society (SICS) developed guidelines
for the use of this innovative therapy, suggesting that patients
should have three or more of the systemic inflammatory response
syndrome (SIRS) criteria in the presence of infection, at least two
acute organ failures and an APACHE score of at least 25 [1].
Methods The Council of the SICS agreed that an audit of the use
of Xigris© be conducted once it was licensed. The Scottish
Intensive Care Society Audit Group (SICSAG) implemented this
study on behalf of the SICS. Information manuals containing the
guidelines and data collection methodology were introduced
throughout Scottish ICUs. The guidelines were also made available
in an interactive format on the ICU audit system (Ward Watcher,
Critical Care Audit Ltd, Yorkshire, UK) and provided clinicians with
an electronic tool to help determine fulfilment of criteria.
Pharmacists and ICU staff informed the SICSAG whenever the
drug was administered. Attempts to review records of all patients
receiving the drug in the first 10 months were made by a nurse
from the audit group.
Results Between October 2002 and August 2003, 102 patients
received the drug. Complete records were available for data
validation in 92 (90%) of the recipients. Of these recipients, 90
(97.8%) fulfilled the recommended criteria for SIRS, 87 (94.6%)
for infection and 81 (88%) had at least two organ dysfunctions.
The range in APACHE scores was wide, from 5 to 43. Over one-
half (57.6%), however, had APACHE scores greater than 24
(mean 25.5, median 26). Overall, 49 recipients (53.3%) fulfilled all
the criteria as suggested in the guidelines. Based on our
prospective audit, conducted over a 5-month period in 2002 [2],
we expected that in the region of 300 patients might meet the
criteria in this time period.
Conclusion Early use of this drug has been stable month-on-
month. Overall use has been less than anticipated but has shown
marked variation between units. Consultants generally follow those
aspects of the guidelines relating to SIRS criteria and organ
dysfunction but seem reluctant to base prescribing decisions on
APACHE score.
Acknowledgement Supported with a grant from Eli Lilly.
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Introduction The PROWESS [1] study reported a 6.1% reduction
in risk of death at 28 days with Drotrecogin alfa use. We wished to
review the hospital mortality of all critically ill patients treated within
48 hours of two organ failures with Drotrecogin alfa since its
introduction into our clinical practice. We therefore undertook a
prospective case-controlled study.Method Fifteen patients who received Drotrecogin alfa were each
matched for ICNARC diagnostic category and APACHE II score
with two historical controls. These were selected from patients
admitted prior to the availability of Drotrecogin alfa. Following
successful matching, the mortality was unblinded.
Results The two groups (control and Drotrecogin alfa) had
comparable APACHE II scores (25.5 vs 25.7) and risk of death at
admission (0.52 vs 0.54), respectively [2]. The mortality was 60%
for historical controls and 27% for those receiving Drotrecogin alfa.
The standardised mortality ratios were 1.14 and 0.49, respectively
(chi-squared P < 0.05).
Conclusion Protocol-driven Drotrecogin alfa treatment in septic
patients appears to confer a survival benefit in a UK district general
intensive care unit. The absolute mortality reduction of 33% was
considerably higher than that in PROWESS [1].
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Objectives To assess the epidemiology and prognosis of
thrombocytopenia (TP) in ICU patients.
Design A monocentric retrospective analysis of data prospectively
collected in a databank.
Setting A 10-bed adult medical ICU in a university hospital.
Patients Three hundred and twenty-five consecutive ICU patients
admitted for >24 hours between January and December 2002
were included.
Measurements and main results TP was defined by two
consecutive platelet counts <150 G/l. The main outcome measure
was ICU mortality. The main reason for ICU admission of TP
patients were acute respiratory failure (n = 37), shock (n = 21),
sepsis (n = 18), coma (n = 13), acute renal failure (n = 12),
metabolic disorders (n = 9), scheduled surgery (n = 5), acute
poisoning (n = 4), trauma (n = 3), miscellaneous causes (n = 4). In
the overall population, the mean platelet count upon admission was
314 ± 114 G/l. TP was observed in 126/325 (39%) and present
on admission in 89 patients, with a mean count of 97 ± 340 G/l.
ICU-acquired TP occurred with a median delay of 4.7 days (range
2–26 days) in 37/126. The ICU mortality was 29% (n = 37) in the
TP population and 9% (n = 19) in the nonTP population. Bone
marrow aspiration was performed in 35/126 TP patients. Before
TP, a previous red blood cell (RBC) transfusion was recorded in
seven cases, a previous plasma infusion in two cases, and prior
exposure to heparin in 25 cases. The diagnosis of heparin-induced
TP was excluded in 17/25 cases, unlikely in three cases, possible
in three cases and very likely in two cases. TP was related to
sepsis in 51 cases, to disseminated intravascular coagulation in
28 cases (among these, 14 were associated with sepsis), to
central megacaryocyte depletion in five cases, and to
hemophagocytic histiocytosis in four cases. A combination of two
or more of these mechanisms was observed in 23 cases. In
57 patients, the etiology of TP was undetermined or related to
another cause. In univariate analysis, TP was significantly
associated (all P < 0.01) with higher SAPS II score (50 ± 22 vs
40 ± 20), higher SOA score (8.6 ± 4.3 vs 4.7 ± 4), need for renal
replacement therapy (39% vs 20%), need for invasive mechanical
ventilation (51% vs 36%), higher length of stay (11 ± 13 days vs
7 ± 6 days) and ICU mortality (29% vs 9%). No statistical
difference was detected in patient characteristics between the two
TP populations (TP present on admission or ICU acquired). Twenty-
eight TP patients required platelet transfusions, and 81% of the
311 RBC concentrates and 85% of the 70 plasma concentrates
administered during the study were infused to TP patients.
The presence of TP indicates a subgroup of patients with high
mortality, which accounts for most of the blood product-related
costs in the ICU.
P124 Central venous catheter (CVC) placement in patients with bleeding disorders (BD)
F Klein, J Díaz, E Duronto, P Klin
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Introduction Previous series showed that CVC placement under
standardized techniques could be safe in patients with BD without
its correction. Moreover, BD correction with hemoderivates might
be risky and expensive.
Objectives To study prospectively the incidence of complications
and the financial impact derived from CVC placement in patients
with BD without its previous correction.
Methods A total of 203 CVC in 121 patients were placed during a
32-month period. BD were defined as a prothrombin time (PT) of
less than 50%, and/or an activated partial thromboplastin time
(aPTT) of 50s or more (range 35–45s), and/or a platelet count
(PC) <100,000/mm3. External or internal bleeding were considered
CVC placement-related complications. The internal jugular vein,
subclavian vein and femoral vein were the chosen insertion sites.
Procedure-related transfusion requirements, surgical corrections orlengthening of hospital stay were defined as major complications.
Fresh frozen plasma (FFP) and platelet units (PTL) required for
correction of BD were estimated by standard formulas.
Results The mean age was 47.7 years (14–74 years) with a
male/female ratio of 1.7. The internal jugular vein was the insertion site
in 80.3% of patients. The APACHE II score was 16.5 ± 7.8 (2–40).
Three operators performed 91.6% of the procedures. There were no
mortality or major complications associated with CVC placement,
with 10 patients showing local hematomas. Results for PT (%) were
50 ± 24.8 (1–114), for aPTT (s) 53.6 ± 29.9 (16–180) and for PC
(/mm3) 115,571 ± 89,516 (5000–475,000) (mean ± SD). The
average PC in patients with thrombocytopenia was 56,133/mm3.
FFP and PTL units saved, and local and US saved charges
according to published payment rates are depicted in Table 1.
Conclusions The need for coagulopathy correction and the levels
of coagulation tests to be considered safe for CVC placement are
still a matter of debate. In our study population no previous
correction was shown to impose an increased risk.
Available online http://ccforum.com/supplements/8/S1
Table 1
Mean ± SD Total units Saved US$ Saved pesos
FFP 2.6 ± 3.5 553 38,566 35,945
PTL 3.08 ± 3.88 650 32,188 42,250
1103 70,754 78,195
P125 Thrombocytopenia in medical–surgical ICU patients
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Background Thrombocytopenia may be a marker of severe illness
or a predictor of poor outcome in critically ill medical–surgical ICU
patients.
Objective To estimate the prevalence, incidence, risk factors for,
and consequences of thrombocytopenia (defined as platelets
<1 5 0×1 0 9/l).
Design A longitudinal cohort study from January 2001 to January
2002.
Setting A 15-bed medical–surgical ICU in Hamilton, Canada.
Methods We enrolled consecutive patients age >18 years
expected to be in the ICU for >72 hours. Patients were excluded if
they had an admitting diagnosis of trauma, orthopedic surgery,
cardiac surgery, pregnancy, or palliative care. To identify
independent risk factors for thrombocytopenia and mortality, we
used backwards stepwise elimination Cox regression analysis.
Results Of 261 patients (mean APACHE II score = 25.5 ± 8.4),
116 (44%, 95% confidence interval [CI] = 38–51%) had
thrombocytopenia (27% [22–33%] on ICU admission, and 17%
[13–22%] developed it during the ICU stay). Patients with
thrombocytopenia versus those without were more likely to require
mechanical ventilation (100% vs 87%, P = 0.05) and platelet
transfusion (7% vs 0%, P = 0.03), and less likely to receive heparin
(18% vs 31%, P = 0.02). Among 34 risk factors, the independent
risk factors for thrombocytopenia development during the ICU was
ASA or nonsteroidal anti-inflammatory drug use (hazard ratio
[HR] = 3.0, 95% CI = 1.4–6.5) and dialysis (HR = 3.0 [1.1–7.1]);
conditions such as severe sepsis were not predictive. Among 261
patients, 33 (13%) patients had 36 heparin-induced
thrombocytopenia tests (serotonin release assay); none were
positive. Patients who ever developed thrombocytopenia versus
those who did not had a long stay ICU stay (12 days vs 8 days),
but a similar hospital stay (30 days vs 23 days), ICU mortality (31%
vs 24%), and hospital mortality (46% vs 34%). A platelet count
<150 × 109/l was not independently predictive of mortality after
adjusting for age and illness severity (HR = 1.0 [0.6–1.7]),
whereas platelet count <50 × 109/l was (HR 8.3 [3.8–18.3]).
Conclusions In medical–surgical ICU patients, thrombocytopenia is
common, associated with an increased duration of ICU stay, but not
an increased risk of mortality until the platelet count is <50 × 109/l.
Acknowledgements  Supported by the Canadian Institutes for
Health Research and Lilly Canada.
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Objectives A trauma database was reviewed to characterize the
appropriateness of transfused blood products (packed red blood
cells [RBC], platelets [PLT], fresh frozen plasma [FFP],
cryoprecipitate [CRY]) in actively, massively bleeding trauma
patients in the first 48 hours of their admission.
Setting  The trauma database at Sunnybrook and Women’s
College Health Sciences Centre, University of Toronto, Toronto,
Canada, a regional, level one, trauma centre.
Methods  Two hundred and seventy-five consecutive patients
receiving 10 or more units of packed red blood cells in the first
24 hours of admission to the hospital, from January 1992 to
December 2001, were reviewed from the trauma database.
The criteria used to determine the appropriateness of transfused
blood products in the first 48 hours of their admission were
according to the American Society of Anesthesiologists [1]:
hemoglobin >80 g/l, platelet count >50 × 109/l, InternationalNormalised Ratio (INR) <1.5, fibrinogen >1.0 g/l. Inappropriately
transfused units of blood products were counted as those blood
units administered despite the last laboratory reading meeting the
aforementioned criteria. Each assessment period time frame and
clinical action extended from 15 min after the last laboratory data
until 15 min after the next laboratory data.
Data collection Laboratory data (hemoglobin value, platelet count,
INR, fibrinogen level) and transfusion data (packed RBC, PLT, and
FFP, CRY) in the first 48 hours of admission were collected.
Results See Table 1.
Conclusions  There may exist substantial inappropriate blood
product transfusion in the treatment and resuscitation of trauma
patients. However, it is also possible that routine laboratory
measurements are not sensitive enough indicators of
appropriateness for this patient population; that is, patients
frequently may have active bleeding without the opportunity for
laboratory samples to be obtained. The potential causes for the
former include lack of knowledge of the existing guidelines, decision
of not to follow the guidelines, or overcorrection of coagulopathy.
Possible solutions include: the redistribution of guidelines to various
departments of a hospital (operating room, emergency room, critical
care); cell saver techniques; accepting lower blood pressures in
select patients; use of antifibrinolytics; use of factor VIIa.
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Table 1
Total blood product units (RBC, PLT, CRY, FFP) administered 12,421
Total inappropriate units (RBC + PLT + CRY + FFP) administered 6026
Percentage of total units that were inappropriately administered 48.51%
Total RBC units administered 5158
Total RBC units inappropriately administered 2981
Percentage of red blood cell units inappropriately administered 57.79%
Total PLT units administered 3176
Total PLT units inappropriately administered 2201
Percentage of PLT units that were inappropriately administered 69.30%
Total CRY units administered 1729
Total CRY units inappropiately administered 238
Percentage of CRY units inappropriately administered 13.77%
Total FFP units administered 2358
Total FFP units inappropriately administered 606
Percentage of FFP units inappropriately administered 25.70%
P127 Hemoglobin solutions: use in surgical patients
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Hemoglobin-based oxygen carriers (HBOCs) are solutions that can
match the oxygen-carrying capacity of red blood cells (RBCs), and
several HBOCs have reached advanced stages of development and
clinical testing. One of the potential mechanisms by which HBOC
solutions may be effective in reducing transfused blood may be a
result of the fact that in hemorrhagic conditions, replenishing lost iron
is difficult. Although the oxygen-carrying capacity of most HBOC
solutions may be quite transient, they are rapidly metabolized, and free
iron is potentially scavenged by multiple mechanisms to subsequently
stimulate erythropoiesis and reticulocytosis. Unfortunately, diaspirin-
linked HBOC solutions reported a higher mortality in trauma patients.
Regrettably, the trauma patient population is a heterogeneous group
of patients and, similar to therapeutic trials in sepsis, trauma patients
represent a group with an extremely high morbidity and mortality
incidence that can potentially complicate interpreting data.
Bovine hemoglobin represents an interesting alternative because
of its availability and large quantity. A 500-kg steer has
approximately 35 l blood with 12 g/dl hemoglobin (total-body
hemoglobin content 4.2 kg), and bovine blood is available as an
unlimited supply. Hemopure, a bovine product, is approved for
veterinarian use in the United States, and for humans in South
Africa. Multicenter, randomized, phase III, controlled trials have
demonstrated the safety and efficacy of HEMOPURE® (Biopure
Corporation), also known as HBOC-201. The product is
ultrapurified to remove any plasma proteins, RBC stroma, and
potential pathogenic material. During the manufacturing process,
cross-linking and polymerization stabilize the hemoglobin molecule,
which increases its vascular persistence as well as the efficiency of
oxygen transport to tissue.
Results from clinical trials indicate that HBOC-201 can be used as
an oxygen ‘bridge’ for patients experiencing anemia due to surgical
blood loss until their own red blood cells are replenished. HBOC-
201 is generally well tolerated and is approved for use in South
Africa, where it is indicated for use in adult surgical patients whoare acutely anemic and to eliminate, delay, or reduce the need for
allogeneic RBCs. A Biologics License Application for HBOC-201
is currently under review by the United States Food and Drug
Administration.
Selected website Bleedingweb.com
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Introduction Recombinant human erythropoietin (rhEPO) has
been shown to decrease the packed red blood cell (PRBC)
transfusion requirement by about 20% among ICU patients
admitted for longer than 48 hours. Despite this, its use has not
been widely instituted, in part due to its cost.
Methods A decision analytic Markov process was designed to
model anemia management strategies for patients admitted to the
ICU for >48 hours. The model compared two strategies: standard
care versus standard care plus administration of rhEPO, 40,000 U
weekly. Probabilities, costs and outcomes were derived from
longitudinal studies of ICU patients, current Canadian medical costs
and a randomized trial of rhEPO versus placebo for ICU patients.
The model measured ICU costs arising from administration of
PRBC and rhEPO, long-term costs of infection and effectiveness in
reducing infection. The base-case data included: rhEPO cost
$439/40,000 U, PRBC cost $616/U, median ICU length of stay
4 days, overall probability of PRBC transfusion 0.6 per patient per
admission and mean number PRBCs transfused 3 U per patient.
Long-term costs of infection (hepatitis C or HIV) were estimated at
$200,000 per infection. All costs are expressed in US dollars.
Results The mean cost per patient using the rhEPO strategy was
$1030 vs $1323 for no rhEPO. Fewer units of PRBCs were
administered in the rhEPO arm, resulting in a lower infection rate.
rhEPO use was therefore both less expensive and more effective
(i.e. it was the dominant strategy). One-way sensitivity analyses
revealed that administration of rhEPO remained the preferred
strategy provided that the PRBC cost was greater than $186/U or
that the rhEPO cost was less than $1455/40,000 U. These results
can be generalized: provided that the cost of rhEPO
<2.4 × cost 1 U PRBC, the rhEPO strategy will be preferable.
Further, the advantage of treatment with rhEPO was maintained
down to an expected transfusion rate of 1.1 U PRBC per patient
per admission. Decreasing the probability of infection or increasing
the long-term cost of infection did not significantly affect the model.
Conclusion The management of chronic anemia among ICU
patients admitted >48 hours using rhEPO appears to be cost-
effective, provided that the rhEPO cost is less than 2.4 times the
cost of 1 U PRBC. This effect is retained at low expected
transfusion rates and with changes in the cost or risk of infection
arising from blood administration.
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Background During sepsis the impairment of gut microvascular
perfusion and activation of leukocytes lead to mucosal damage and
aggravation of systemic inflammation. Recently, hydroxyethyl starch
(HES) has been shown to attenuate deterioration of skin
microcirculation in endotoxic hamsters [1]. This study investigates
the effects of fluid resuscitation with HES or isotonic saline
solution (NaCl) on intestinal microvascular perfusion in a rat model
of normotensive endotoxemia.
Methods In anaesthetized rats (n = 7 per group), normotensive
sepsis was induced by a continuous infusion of lipopolysaccharide
(LPS) (1.5 mg/kg/hour). After 1 hour of LPS infusion, HES 130/0.4
(16 ml/kg) or NaCl (66 ml/kg) were infused for a 1 hour period.
Using intravital microscopy, the functional capillary density and
erythrocyte velocity were measured in the mucosa of the terminal
ileum at baseline, after 1 hour of endotoxemia and 3 hours after
fluid resuscitation. Intestinal injury was assessed histologically. In
another set of experiments the leukocyte–endothelium interaction
was determined in mesenteric venules 3 hours after fluid
resuscitation.
Results Functional capillary density was significantly higher in
animals that received HES (994/mm2 vs NaCl 826/mm2,
P ≤ 0.001), whereas erythrocyte velocity was not altered
considerably in either group. Histologic grading revealed severe
mucosal atrophy in the NaCl but not in the HES group (P < 0.001).
The number of rolling leukocytes was notably higher in NaCl as
compared with HES animals (26/min vs 50/min, P ≤ 0.05).
Conclusion The results show beneficial effects of HES on
microvascular perfusion and mucosal cellular integrity of the gut. A
possible mechanism may be the inhibition of the leukocyte–
endothelium interaction in the mesenteric circulation.
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Objective The aim of this study was to investigate the effect of fluid
resuscitation with 4% modified fluid gelatine (GEL) versus 6%
hydroxyethyl starch (HES) on extravascular lung water (EVLW) and
oxygenation in patients with septic shock and acute lung injury (ALI).
Design A prospective randomized double-blinded clinicial trial.
Setting A 20-bed intensive care unit in a university hospital.
Patients Thirty hypovolemic patients (intrathoracic blood volume
index [ITBVI] <850 ml/m2) in septic shock with ALI were
randomized into HES and GEL groups (15 patients each).
Interventions For fluid resuscitation 250 ml/15 min boluses
(maximum 1000 ml) were given until the end point of ITBVI
>900 ml/m2 was reached. Repeated haemodynamic measure-
ments were performed at baseline (tb), at the end point (tep) then
at 30 and 60 min after the end point was reached (t30, t60). The
xardiac output, stroke volume, EVLW, and oxygen delivery was
determined at each assessment point. For statistical analysis two-
way ANOVA was used.
Measurements and results The ITBVI, cardiac index, stroke
volume index, and oxygen delivery index increased significantly at
tep and remained elevated for t30 and t60, but there was no
significant difference between the two groups. EVLW, although
moderately elevated, remained unchanged, and there was no
significant difference between the groups (HES: tb, 8 ± 6 ml/kg;
t60, 8 ± 6 ml/kg; GEL: tb, 8 ± 3 ml/kg; t60, 8 ± 3 ml/kg). The
PaO2/FiO2 did not change significantly over time or between
groups (HES: tb, 207 ± 114 mmHg; t60, 189 ± 78 mmHg; GEL:
tb, 182 ± 85 mmHg; t60, 182 ± 85 mmHg). The increase in the
ITBVI by 100 ml/s of infusion was similar in both groups (HES.
26 ± 19 ml/m2 vs GEL. 30 ± 19 ml/m2).
Conclusion The results of this study indicate that both HES and
GEL infusions have similar haemodynamic effects in septic shock,
without increasing the EVLW or worsening oxygenation.
P131 6% 130/0.4 versus 6% 200/0.5 hydroxyethyl starch: effects on plasma volume and capillary leakage in a porcine model of
septic shock
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Objectives Septic shock is characterised by loss of intravascular
fluid due to capillary leakage syndrome (CLS) [1]. We have
recently reported that the administration of 200/0.5 hydroxyethyl
starch (HES) stabilised the plasma volume (PV) in a porcine septic
shock/CLS model, suggesting the intravascular persistence of
artificial colloids despite CLS [2]. In the present study we
compared the effects of 6% HES 130/0.4 and 6% HES 200/0.5
on PV and CLS in porcine septic shock.
Methods In a prospective randomized, controlled laboratory study,
14 fasted, anaesthetised, mechanically ventilated animals
(22.9 ± 2.8 kg) received 0.75 g/kg body weight faeces into the
abdominal cavity to induce sepsis and were observed over 6 hours.
Animals were randomised to volume replacement therapy with 6%
HES 130/0.4 (n = 5), 6% HES 200/0.5 (n = 5), and compared
with a nonseptic control group receiving 6% HES 130/0.4 (n =4 ) .
The infusion rate was titrated to maintain a central venous pressure
of 12 mmHg. PV was determined using chromium-51-tagged
erythrocytes and standard formulae. The albumin escape rate
(AER) was calculated using iodine 125-labelled albumin. The
cumulative fluid balance (CFB), systemic haemodynamics and
oxygenation were measured until 6 hours after induction of sepsis.
Statistical comparison was performed using the Wilks Lambda test
and the Ryan–Einot–Gabriel–Welsh F test.
Results See Table 1.
Conclusion In our porcine septic shock model, both 6% HES
130/0.4 and 6% HES 200/05 stabilised PV. Additionally, in
comparison with 6% HES 200/05, 6% HES 130/0.4 significantly
reduced capillary leakage.
Acknowledgement This study was supported by a grant of B.
Braun Melsungen.
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Table 1
6% HES 6% HES
Parameter 130/0.4 200/0.5 Control
PV: 51Cr (ml/kg)
Preshock 59.1 ± 6.3 59.5 ± 7.2 60.6 ± 2.1
6 hours 58.3 ± 9.0 51.0 ± 7.7 69.4 ± 4.6
AER (%), 6 hours 37.5 ± 4.9* 44.5 ± 2.8*,# 0.0 ± 4.9
CFB (ml/kg), 6 hours 82 ± 19* 96 ± 4* 23 ± 4
*P < 0.05 vs control; #P < 0.05 HES 130/0.4 vs HES 200/0.5.Available online http://ccforum.com/supplements/8/S1
P132 Improvement of pancreatic tissue oxygenation and survival rate and time after isovolemic hemodilution with hydroxyethyl
starch plus bovine hemoglobin in swine with acute pancreatitis
M Freitag, T Strate, A Gottschalk, O Mann, C Rempf, J Izbicki, T Standl
University Hospital Hamburg-Eppendorf, Hamburg, Germany
Critical Care 2004, 8(Suppl 1):P132 (DOI 10.1186/cc2599)
Introduction Acute hemorrhagic necrotizing pancreatitis (AP) is
still an essential problem with a high mortality. Disturbed
microcirculation and as a consequence decreased tissue
oxygenation is a crucial effect in the cascade from the self-limiting
mild edematous to the often fatal form of AP. The aim of the study
was to evaluate the therapeutic approach of isovolemic
hemodilution (IHD) with hydroxyethyl starch (HES) alone and in
combination with HBOC-301 and with Ringer’s solution with
regard to pancreatic tissue oxygen tensions and survival in pigs
suffering from acute pancreatitis.
Methods After approval of the local ethics committee, 39 pigs
were anesthetized, endotracheally intubated and normoventilated
(FIO2 = 0.3). After laparotomy and splenectomy the pancreatic
duct was cannulated. The pancreatic tissue oxygen tension (tpO2)
was measured using a silicon catheter (Licox Medical Systems,
GMS, Germany). After 30 min equilibration, AP was induced by a
combination of intravenous cerulean and intraductal
glycodeoxycholic acid. Fifteen and 75 min after induction of AP,
animals were randomized and isovolemically (PAOP constant)
hemodiluted with 10% HES 200.000/0.5 plus HBOC-301
(+ 0.6 g/dl plasmatic hemoglobin; Oxyglobin®, Biopure, USA)
(HES/HBOC group), 10% HES 200.000/0.5 (HES group) or
Ringer’s solution (RINGER group) to a hematocrit (Hct) of 15%.
tpO2 was measured every hour 30 min after reaching Hct of 15%.
After 6 hours catheters were removed, the abdomen was closed
and animals were extubated. After 6 days (144 hours) animals
were sacrified. Statistical analyses were performed using the
Kolmogorov–Smirnov test for normal distribution, Student’s t test
was used for normally distributed data and the chi-square test for
the survival rate (significance, P < 0.05).
Results After induction of AP, tpO2 decreased in all groups and
increased significantly after IHD with HES/HBOC in comparison
with the HES and RINGER groups (P < 0.001). tpO2 remained low
in the HES and RINGER groups and decreased after 5 hours
(P = 0.046) and 6 hours (P = 0.015) in the Ringer group in
comparison with the HES group. The survival rate at the end of the
observation period was higher in the HES/HBOC group (10/13)
(P = 0.002) in comparison with the RINGER group (2/13)
(P < 0.001), and between the HES (8/13) vs RINGER groups
(P = 0.016).
Conclusion Only IHD with HES plus HBOC-301 was able to
normalize pancreatic tissue oxygen tensions in comparison with
IHD with HES or Ringer’s solution after induction of severe AP.
The complementary strategy of IHD and additional application of
HBOC-301 as combination of rheologic and O2-delivering therapy
may represent a novel therapeutic option for the treatment of acute
pancreatitis in the future.
P133 Multicenter, randomized, double-blind trial comparing albumin and polygeline for intravascular fluid loading in patients
with cirrhosis and tense ascites treated with paracentesis
R Moreau1, D Valla1, D Golly2, Z Tellier2
1Hôpital Beaujon, Clichy, France; 2LFB, Courtaboeuf, France
Critical Care 2004, 8(Suppl 1):P133 (DOI 10.1186/cc2600)
Objectives Patients with cirrhosis and tense ascites treated with
paracentesis require repeated intravascular fluid loading with
colloid solutions. In such patients, human albumin was suggested
to be superior to a synthetic colloid for fluid loading, albeit at a
higher cost. Thus, we started a 6-month trial aimed to compare the
outcomes in patients with cirrhosis who were treated with albumin
with the outcomes in those treated with bovine-derived polygeline.
We also aimed to investigate hospital costs. This trial had to be
prematurely interrupted due to theoretical concern regarding safety
of bovine-derived products.
Methods A multicenter, randomized, double-blind trial was
conducted in patients with tense ascites who were randomly
assigned to receive intravenously either 20% human albumin or
polygeline. The prespecified primary end point was the time to a
first liver-related event (a composite of death, episodes of recurrent
tense ascites, renal impairment, hyponatremia, bacterial infection,
encephalopathy, portal hypertensive bleeding, the occurrence of
hepatocellular carcinoma, liver transplantation) during the in-trial
period (i.e. the period during which patients had only received the
assigned colloid). All events were blindly adjudicated.
Results Thirty patients were assigned to albumin and 38 to
polygeline. At baseline, all patients had therapeutic paracentesis.
The duration of the in-trial period was higher in the albumin group
than in the polygeline group (mean [± SD], 121 ± 64 days vs
77 ± 58 days; P = 0.004) due to lower frequencies of unblinded
colloid infusions and of dropout in patients assigned to albumin.
There were 24 liver-related first events in the albumin group (58.9
per 100 person-months) and 34 liver-related first events in the
polygeline group (107.4 per 100 person-months; the hazard ratio
for a first liver-related event with albumin therapy was 0.51 [95%
confidence interval, 0.30–0.88]; P = 0.016). The median time for
the first event was higher in the albumin group than in the
polygeline group (20 days [95% confidence interval, 11–46 days]
vs 7 days [95% confidence interval, 6–13 days]; P = 0.044). The
median total hospital cost was lower in the albumin group than in
the polygeline group (€1915 for a 30-day period vs €4612 for a
30-day period, respectively; P = 0.004).
Conclusion In patients with cirrhosis and tense ascites treated
with paracentesis, human albumin is more effective than polygeline
to prevent the occurrence of any first event related to liver disease.
This beneficial effect seems to be associated with a decrease in
hospitalization-related cost.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
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Background  Albumin with furosemide has been reported to
improve cardiovascular stability and oxygenation in adult
respiratory distress syndrome (ARDS) [1].
Method Fourteen patients meeting the ARDS criteria of PO2/FiO2
ratio <27 kPa (200 mmHg) plus bilateral X-ray shadowing without
cardiac cause, were recruited at the Chelsea and Westminster
Hospital, London. Oxygenation and cardiovascular parameters
were measured before (t0) and 5 min (t5) and 240 min (t240) after
rapid intravenous administration of 200 ml of 20% human albumin
solution (BPL) with 20 mg furosemide. Results were analysed by
ANOVA with Bonferonni/Dunn post-hoc significance testing, with
P < 0.05 considered significant. Albumin concentrations were
corrected for changes in plasma volume.
Results Expressed as mean (SD). Both colloid osmotic pressure
(COP) and albumin changed significantly, with significant immediate
elevation at t5 that declined by t240, although elevation above
baseline remained significant. Plasma albumin was 13(3.8) g/dl at t0,
17.4 (6.1) g/dl at t5, and 16.7 (4.7) g/dl at t240. COP was 16.1
(2) mmHg at t0, 19 (2.5) mmHg at t5 and 17.3 (2.4) mmHg at t240.
Significant changes also occurred in both PO2/FiO2 and central
venous pressure (CVP) but significant increases at t5 were not
sustained at t240. PO2/FiO2 was 19.9 (4.1) kPa at t0, 22.3
(5.8) kPa at t5, and 20.6 (6) kPa at t240. CVP was 17 (6) mmHg
at t0, 20 (5) mmHg at t5, and 18 (5) mmHg at t240.
The heart rate and cardiac output were not significantly affected by
albumin administration, although an increase in cardiac output
correlated nonsignificantly with improvement in the PO2/FiO2 ratio
at t5 (correlation 0.43) and at t240 (correlation 0.40).
Discussion  Cardiovascular stability was unaffected by albumin
and furosemide administration. An immediate improvement in
oxygenation was not sustained at 4 hours.
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P135 The use of recombinant factor VIIa as a haemostatic agent in ICU patients
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Introduction Recombinant factor VIIa (rFVIIa) is a prohaemostatic
agent that has successfully been used for the treatment of patients
with haematological malignancies and coagulopathy. It also has
been used in postsurgical patients where the coagulopathy in
combination with hypothermia and metabolic acidosis causes an
increase of mortality early post operation. Recently reported has
been the use of rFVIIa in patients with a normal coagulation
system, undergoing major surgery in order to reduce the
intraoperative bleeding and the need for transfusions. Here we
present our experience on rFVIIa use in ICU patients.
Patients and methods In the period from January 2002 to
December 2003, 16 ICU patients received recombinant factor VIIa
(10 men and six women, with the average age of 62.62 years). Of
these 16 patients, 10 were admitted in ICU post operation and the
reason for rFVIIa administration was severe bleeding, despite
surgical intervention and massive blood component transfusions.
rFVIIa was administered in six patients who had haematological
malignancies, in five of them to reduce coagulation disorders and
in one patient with coagulopathy, before undergoing an invasive
therapeutic procedure in order to prevent bleeding. These patients
were infused with 15–90 µg/kg body weight rFVIIa. To evaluate
the treatment, the prothrombin time, the activated partial
thromboplastin time (aPTT), and the fibrinogen level were
measured, as well as number of blood components transfused
before and after rFVIIa administration. The success of rFVIIa
treatment was confirmed by clinical stabilization and outcome.
Results See Table 1 for the mean values before and after rFVIIa
infusion. There were no adverse effects observed. Bleeding was
controlled in 14 patients (87.5%). From these 14 patients five died
(35.71%) and the reason was multiple organ dysfunction. Two
patients, despite the high doses of rFVIIa, died because of
continuing bleeding (12.5%).
Conclusion These results show that after treatment with rFVIIa,
coagulation parameters and blood requirements were all
decreased. The use of rFVIIa in ICU patients is a safe and effective
method to control life-threatening bleeding that cannot be
managed surgically.
Table 1
Parameter Before rFVIIa After rFVIIa
International Normalised Ratio 2.12 1.89
aPTT 70.91 44.71
Fibrinogen (mg/dl) 213.78 284
Packed red cell units 5.25 (1–18) 1.66 (1–4)
FF plasma units 4 (3–11) 2.43 (2–7)Available online http://ccforum.com/supplements/8/S1
P136 Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven®) in cirrhotic patients with upper gastrointestinal bleeding:
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Introduction Upper gastrointestinal bleeding (UGIB) is a severe
and frequent complication of cirrhosis. Preliminary results show
that rFVIIa may reduce bleeding in cirrhotic patients. This trial
aimed to determine the efficacy and safety of rFVIIa in cirrhotic
patients with variceal and nonvariceal UGIB.
Methods Two hundred and forty-five cirrhotic patients
(Child–Pugh <13; Child–Pugh A = 20%, B = 52%, C = 28%)
with UGIB (variceal = 66%, nonvariceal = 34%) were equally
randomized to receive eight doses of 100 µg/kg rFVIIa or placebo
in addition to pharmacologic and endoscopic treatment. The
primary composite endpoint was the failure to control UGIB within
24 hours postdosing, or failure to prevent rebleeding between
24 hours and day 5, or death within 5 days.
Results Baseline characteristics were similar between the two
groups. Results of primary and exploratory analyses are presented
in Table 1. In the subgroup of Child–Pugh B and C variceal
bleeders, significantly fewer patients in the rFVIIa-treated group
failed on the primary composite endpoint (P = 0.03) and the
24 hour-bleeding control endpoint (P = 0.01) compared with
placebo. rFVIIa did not improve the efficacy of standard treatment
in Child–Pugh A cirrhotic patients, and no significant effect was
found when analysing all applicable patients. Incidences of adverse
events including thromboembolic events were similar, and there
were no significant differences in 5-day or 42-day mortality.
Conclusions Exploratory analyses in Child–Pugh B and C cirrhotic
patients indicated that administration of rFVIIa was safe and
significantly reduced the proportion of patients who failed to control
variceal bleeding. Further studies are needed to verify these findings.
Table 1
Placebo rFVIIa P
Failure on composite endpoint
All patients 19/123 16/122 0.72
Variceal bleeders 16/82 8/79 0.12
Variceal bleeders Child B–C 15/65 5/63 0.03
Failure to control acute bleeding (within 24 hours)
Variceal bleeders 8/82 2/79 0.10
Variceal bleeders Child B–C 7/65 3/63 0.01
Failure to prevent rebleeding (24 hours–day 5)
Variceal bleeders 9/82 5/79 0.40
Variceal bleeders Child B–C 8/65 3/63 0.13
Failure to control acute bleeding or failure 
to prevent rebleeding within 5 days
Variceal bleeders 13/82 6/79 0.14
Variceal bleeders Child B–C 12/65 3/63 0.03
Values are shown as failures/number of patients.
P137 Use of NovoSeven® in cases with massive bleeding following surgery with extracorporeal circulation
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Critical Care 2004, 8(Suppl 1):P137 (DOI 10.1186/cc2604)
Bleeding complications still remain a real problem in patients
undergoing long-time surgery with extracorporeal circulation. In these
cases a large hemotransfusion is needed and the usual sequence
with postoperative multiorganic failure affecting patient outcome.
Recombinant activated factor VII (rFVIIa; NovoSeven®, Novo Nordisk
A/S, Bagsvaerd, Denmark) was used in 15patients undergoing open
heart surgery or surgery for aorta and aortic arch aneurysms. All patients
had normal coagulation parameters before surgery. In these patients
massive bleeding (10–20ml/min) have developed during intraoperative
or early postoperative periods, but bloodloss rate have minimal
reduction, despite infusions of fresh frozen plasma, cryoprecipitate
plasma, platelet concentrate, Trasilol and e-aminocapronic acid.
After one-time recombinant FVIIa NovoSeven administration (the
dose of rFVIIa ranged between 60 and 90 mg/kg body weight),
bleeding disappeared in 14 patients. In one patient the bloodloss
rate had been decreased from 20 to 5.5 ml/min and then repeated
NovoSeven administration (90 mg/kg body weight) stopped the
bleeding and simultaneously stabilized some hemocoagulating
parameters.
rFVIIa (NovoSeven®) may be used to effective treatment massive
bleeding and to reduce the amount of transfused blood
components in patients undergoing long-time surgery with
extracorporeal circulation.
P138 Burn variables and intensive care mortality in severe burn patients
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Introduction The evaluation of probability of death from burn injuries
would provide clinicians with an explicit basis for clinical decisions,
help them understand the relative contributions of specific prognostic
criteria and reduce reliance on clinical intuition [1]. The goal of this
study is to estimate the mortality rate and the clinical variables for early
assessment of outcome of a severe burn population.Methods We retrospectively reviewed the records of all patients
with severe burn injuries admitted to a polyvalent intensive care
unit (ICU) of a university teaching hospital from 1999 to 2001.
Information collected included age, sex, percentage of body
surface area (%TBSA) burned, SAPS II score and SOFA score on
admission, Baux score (age + %TBSA), presence or absence of
inhalation injury, need for intubation, time of first escharotomy,
length of ICU stay (LOS), and ICU mortality. Data were analysed
using SPSS for Windows.
Results Nineteen severe burn patients were considered (13 male
and six female). Their mean age was 53.5 ± 19.8 years; they had a
mean %TBSA burned of 50.1 ± 25.7, of third degree. Ten patients
(52.6%) died in the ICU; they had similar age to the survivors
(56 ± 17 years vs 50.6 ± 23.2 years, P = NS), but their values of
SAPS II and SOFA scores on admission were significantly greater
(36.5 ± 10.5 vs 25.6 ± 12.5, P < 0.05 and 4.7 ± 2.4 vs 2.3 ± 2,
P < 0.05); also the Baux score was statistically different
(123.6 ± 10.9 vs 81.6 ± 24.4, P < 0.05). The patients who died
had larger %TBSA burned than survivors (67.4 ± 21.5 vs
31 ± 13.5, P < 0.05). All patients were intubated and ventilated. All
dead patients and six survivors (66.6%) sustained inhalation
injuries. The first escharotomy was performed 17.2 ± 7.4 days from
the injury date in the patients who died and 8.2 ± 3.1 days in the
others. Moreover, the mean of LOS was increased for those who
died (34.4 ± 36.8 vs 19.5 ± 17.6, P < 0.05).
Conclusion According to other studies [2], the mortality rate of
severe burn patients remains high despite burn care having
changed considerably. We report the severity of illness on
admission to the ICU and the extent of burns as contributors to the
mortality rate. Moreover, early excision of burns seems to be
associated with better outcome.
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P139 Does the Mainz Emergency Evaluation Scoring (MEES) in combination with capnometry (MEESc) help in the prediction of
outcome in major trauma
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Introduction This prospective study examines the efficacy of the
predicting power for mortality of two different prehospital scoring
systems in major trauma. We present an improved MEES in
combination with capnometry. MEES combined with capnometry
(MEESc) is a new scoring system.
Patients and methods In a prehospital setting, values of the
MEES and capnometry (initial and final) were collected from each
patient. We added the final values of partial pressure of end-tidal
CO2 (petCO2) to the MEES scoring system and ranked them from
0 to 2 so that the final maximum sum of this scoring system would
be 30 without any change in the minimum score being 10. This
study was undertaken over 3 years (January 2000–March 2003)
and included 58 consecutive patients hospitalized for major trauma
(defined as Injury Severity Score >15) requiring intubation at the
roadside and in whom the prehospital petCO2 had been recorded.
Patients younger than 16 years old were excluded from the study.
There were 48 males and 10 females. Their ages varied from 16 to
82 years with a mean of 43.5 ± 15.7 years. For every scoring
system the sensitivity, specificity, correct prediction outcome and
area under the ROC curve was determined. The results was
compred with McNemar’s test in Z score. The significant difference
is P < 0.05.
Results For prediction of mortality, the best cutoff points were 19
for MEES and 22 for MEESc. The Youden index has the best
cutoff points at 0.51 for MEES and 0.67 for MEESc (P < 0.05).
The correct predicting outcome in percent was 71.3 for MEES and
83.5 for MEESc (P < 0.05). The area under the ROC curve was
0.72 in the MEES and 0.85 for MEESc (P < 0.05).
Conclusion There were significant differences among MEES and
MEESc. The MEESc improve the results of MEES. The prehospital
use of the improved MEESc system could be an efficient
communication protocol between the prehospital and hospital
settings.
P140 Decision-making of hemorrhagic shock patients with intraperitoneal bleeding (IPB) by ultrasonography (US): the
importance of early detection of an increase of IPB
Y Moriwaki, M Sugiyama, K Kanaya, H Toyoda, S Fujita, H Fukuyama, M Iwashita, T Kosuge, J Suzuki, N Suzuki
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Background and objective Hemorrhagic shock patients with
abdominal trauma require immediate decision-making of treatment;
laparotomy or not. If IPB is massive, we have to do a laparotomy;
and if it is little or not increasing, we need not. Emergency
transcatheter arterial embolization (E-TAE) is a more common
therapeutic procedure in Japan, compared with in European
countries. E-TAE contributes towards the avoidance of
unnecessary laparotomy. However, a patient who underwent
E-TAE is fully covered and we cannot watch the abdomen of the
patient. We can evaluate the patient’s condition only by heart rate
and blood pressure, often resulting in a lethal delay in decision-
making. Recently we evaluated the increase of IPB during E-TAE
by portable US (PUS), which is usually used for bedside
examination or out-of-hospital evaluation. The aim of this study is to
clarify the usefulness of PUS for decision-making during E-TAE
and safety of E-TAE under monitoring by portable US.
Materials and methods In our center, the angiography room is
situated close to the emergency room, on the same floor. We can
transfer the patient between these rooms within 5 min. In our
protocol for blunt abdominal trauma, shock patients with abundant
IPB should be brought to the operation room, and nonshockpatients should be treated with TAE or only rest. We evaluate the
increase of IPB in 26 cases by PUS during E-TAE in the narrow
space, where we cannot use ordinal US.
Results Before TAE, IPB was detected in 15 cases and pelvic or
lumber fracture was detected in 14 cases and renal injury or
massive retroperitoneal hematoma in five cases. The mean duration
of TAE was 106 min. An increase of IPB was detected in three
cases; one of whom was examined and treated for hepatic and
splenic arteries at first and ileac arteries later, and another patient
was transfered to the operation room immediately. In other
23 cases, we confirmed no increment of IPB by PUS and could
continue the procedure without fear of preventable death.
Conclusion E-TAE is a safe procedure under monitoring of IPB by
PUS, which can detect the increase of IPB during E-TAE.
Available online http://ccforum.com/supplements/8/S1
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Introduction  The aim of this study is to evaluate the effect of
treatment with the Molecular Adsorbents Recirculating System
(MARS) in liver failure patients.
Materials and methods In 28 patients (median age, 50.57 years),
12 cases were of acute liver failure and 16 cases of acute on
chronic liver failure, 56 times of 6–8 hour MARS intermittent
treatments were performed without any major adverse events.
Results  Significant decreases in serum total bilirubin (31.7%),
conjugated bilirubin (29.15%), bile acid (35.91%) and ammonia
(53.68%) were observed (P < 0.01), single treatments contributed
to the marked improvement of coagulapathy (prothrombin time
decreased from 32.37 ± 9.96s to 21.82 ± 10.39s, P < 0.01), and
most patients (24/28, 85.7%) achieved a remarkable symptomatic
recovery after the single treatment. The 30-day hospital survival
rate for the 28 liver failure patients was 71.4% (20/28): two
patients of acute liver failure recovered, eight cases of acute on
chronic liver failure improved and were discharged, 10 patients
were successfully bridged to liver transplantation, and eight cases
died of multiorgan failure.
Conclusion It is concluded that the MARS method can serve as
an optimistic treatment for liver failure patients with improved
immediate survival rate and inspiring bridging support to liver
transplantation.
P142 Application of the Molecular Adsorbents Recirculating System in patients with severe chronic viral hepatitis B in middle
and end stages
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Objective To summarize and evaluate the treatment effective and
survival of the Molecular Adsorbents Recirculating System (MARS)
in patients with severe chronic viral hepatitis B (SCH-B) in middle
and end stages.
Methods Sixteen patients with SCH-B in middle and end stages
underwent MARS therapy as the MARS treatment group. A
retrospective review of 16 patients chosen from previous therapy
data, also of SCH-B and clinically matched to the MARS group,
were regarded as the standard medical therapy (SMT) group, who
had been treated with general methods except MARS. The
prognosis of the two groups were studied and the treatment
effects on levels of serum total bilirubin, nonconjugated bilirubin
and mean arterial pressure (MAP) were observed in the MARS
group during a single 6–8 hour MARS treatment.
Results The single MARS treatment contributed to significant
decreases in levels of serum total bilirubin (from 547 ± 187 mmol/l
to 312 ± 118 mmol/l, P < 0.05) and nonconjugated bilirubin
(379 ± 134 mmol/l to 185 ± 68 mmol/l, P < 0.05), respectively,
and MAP was increased from 72 ± 8 mmHg to 81 ± 7 mmHg
(P < 0.05) during the MARS therapy. There were statistical
differences in prognosis and survival between the two groups: in
the SMT group, six of 12 patients in the middle stage survived
(50%), while in the MARS group the survival for comparable
middle-stage patients was 10/12 (83.3); for the end-stage
subgroup comparison, all four patients died in the SMT group but
the MARS therapy improved the survival to 25% (1/4) in its four
patients. The overall survivals of these two groups with middle-
stage and end-stage SCH-B patients were 37.5% for SMT and
68.5% for MARS (P < 0.05).
Conclusions MARS therapy effectively removed serum bilirubin
and other albumin-bound toxins, increased the MAP, and inhibited
the hepatocellular necrosis, thus contributing to organ protection.
Table 1
SCH-B SMT MARS P value
Middle stage 6/12 (50%) 10/12 (83.3%) <0.05
End stage 0/4 (0) 1/4 (25%) <0.05
Total 6/16 (37.5%) 11/16 (68.75%) <0.05Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
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Introduction Liver failure resulting from hepatitis B (HBV)
represents difficult-to-treat conditions. Molecular Adsorbents
Recirculating System (MARS) liver support is a novel therapy, but
few data on patients of HBV are available.
Methods This report is a review of MARS on patients with liver
failure suffered from HBV. Data were extracted from official
journals until September 2003; 149 patients with 347 treatments
in China were eligible with available detailed data (mean age was
44.3 ± 13.2 [15–80] years, 102 males, average treatments 2.33
per patient).
Results MARS treatments were associated with a significant
reduction of albumin-bound toxins and various cytokines, as well as
the water-soluble toxins. Most patients showed a positive response
to the therapy, proven by an increase in prothrombin time activity
and mean arterial pressure, and a decrease in hepatoencephalo-
pathy grade and Child–Turcotte–Pugh index significantly.
Eighty-four patients survived in hospital including those alive from
the liver transplantation (56.4%). Survival of the acute liver failure,
subacute liver failure and acute on chronic liver failure patients
were 62.5%, 66.7% and 54.5%, and acute on chronic liver failure
patients formed the majority (121/149–81.2%). Patients in end
stage presented the largest among the subgroups of acute on
chronic liver failure (65/121, 53.7%), and patients in the early and
middle stages gained more favorable outcomes than those in C
grade (91.7% and 75% vs 30.8%) (Table 1).
Randomized controlled studies in China are ongoing to verify the
optimal therapeutic results of MARS.
Table 1
Type Total n Survival n (Re + OLT) Death n (%)
ALF 16 10 (8 + 2) (62.5%) 6 (37.5%)
SALF 12 8 (8 + 0) (66.7%) 4 (33.3%)
AoCLF
Early stage 24 22 (20 + 2) (91.7%) 2 (8.3%)
Middle stage 32 24 (21 + 3) (75%) 8 (25%)
End stage 65 20 (18 + 2) (30.8%) 45 (69.2%)
Total 149 84 (75 + 9) (56.4%) 65 (43.6%)
ALF, acute liver failure; AoCLF, acute on chronic liver failure; OLT,
orthotopic liver transplantation; SALF, subacute liver failure.
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The early mortality after orthotopic liver transplantation (OLT)
remains relatively high. We evaluate the pretransplantation
Molecular Adsorbents Recirculating System (MARS) therapy in
reducing the relevant risk factors relating to this early mortality.
Methods Fifty adult patients undergoing OLT with MARS
preoperation therapy were studied, 28 men and 22 women with a
mean age of 52.24 (range 46–68) years.
Results Eighty treatments were performed safely. All patients
showed a positive response: the SOFA score, Glasgow Coma
Score (GCS), mean arterial pressure (MAP), TNF-α and IL-10
were improved significantly (Table 1). Eight patients recovered and
avoided OLT, eight patients died, 34 patients were successfully
bridged to OLT: the OLT outcome within 30 days was 28 kept
alive and six patients died. The stepwise logistic regression
indicated the reversible factors that had independent associations
with early mortality were creatinine, International Normalised Ratio
(INR), SOFA score, TNF-α and IL-10, with regression coefficients
of 0.315, 0.309, 0.224, 0.192 and 0.188, respectively.
We think preoperation SOFA score, creatinine, INR, TNF-α and
IL-10 are the main OLT preoperative reversible risk factors, MARS
treatment before OLT can relieve these factors significantly, hence
improving the survival rate of OLT or even avoiding transplantation.
Table 1
Parameter Pretreatment Post-treatment P value
Albumin (g/l) 35.5 ± 35.7 35.7 ± 6.8 <0.05
INR 4.66 ± 3.35 3.98 ± 3.16 <0.05
Creatinine (µmol/l) 128.67 ± 87.73 33.21 ± 22.26 <0.05
Ammonia (mmol/l) 151.31 ± 88.99 28.28 ± 20.19 <0.05
SOFA score (points) 9.72 ± 1.89 6.98 ± 2.34 <0.01
GCS score (points) 7.23 ± 1.21 13.34 ± 2.33 <0.01
MAP (mmHg) 70.5 ± 12.1 85.1 ± 10.4 <0.001
TNF-α (pg/ml) 2.83 ± 1.7 1.80 ± 1.39 <0.01
IL-10 (pg/ml) 7.80 ± 6.0 4.5 ± 4.5 <0.05
ALT (U/l) 295.7 ± 1125.4 237.14 ± 91.82 <0.05
TBIL (µmol/l) 341.16 ± 94.93 232.74 ± 169.29 <0.05
TBA (mmol/l) 162 ± 104 73 ± 51 <0.001
ALT, alanine aminotransferase; TBA, total bile acid; TBIL, total bilirubin.Available online http://ccforum.com/supplements/8/S1
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Continuous hemodiafiltration (CHDF) is a combination of diffusion
and convection mass transport effectively influencing the complex
endotoxemia typical for generalized inflammation. Positive effects
on systemic hemodynamics in patients with septic shock were
noticed because of proinflammatory mediator elimination.
Materials and methods Eighteen patients (11 male/seven female,
mean age 47.2 ± 2.0 years) with septic shock were examined. The
APACHE II score was 26.1 ± 0.6. All patients underwent
mechanical lung ventilation and inotropic support. A Swan–Ganz
catheter was used for monitoring of systemic hemodynamics. For
the CHDF procedure we used the ‘Prisma’ hemoprocessor.
Duration of the procedure was 73.8 ± 7.0 hours. The filtration
volume was 80.4 ± 1.6 l/day.
Results We studied retrospectively two groups: A (n = 13) and B
(n = 5). At the initial stage, the mean arterial pressure was equal in
both groups. At the end of the third day of treatment, we managed
to discontinue inotropic support in 60% of Group A patients,
whereas in Group B patients the dose of dopamine exceeded
25 µg/kg/min. The cardiac rate of Group B patients increased,
accordingly. We noticed satisfied cardiac indexes (CI) in Group A:
3.49 ± 0.19–3.57 ± 0.22 l/min/m2. The CI decreased from
3.14 ± 0.52 to 1.18 ± 0.49 (P < 0.01) in Group B. The CI
decrease in Group B patients was accompanied by an increased
systemic vascular resistance index, which was
3040.3 ± 387.3 dyns/cm5/m2 at the end of the third day of
treatment. The pulmonary vascular resistance index in Group A
patients was on a subnormal level (218.1–259.9 dyns/cm5/m2),
and in Group B increased to 621.2 ± 222.0 dyns/cm5/m2
(P < 0.001). The same tendency we observed for the pulmonary
arterial pressure and pulmonary artery wedge pressure. All patients
had cardiac failure that was compensated in full for the patients
Group A, and proliferated in Group B patients.
Conclusion Early application of CHDF in patients with septic
shock leads to significant improvement of systemic hemodynamics
that was important for the treatment results.
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I Iakovleva1, V Timokhov2, G Lialikova1, E Pestriakov2, O Muraviev2
1Institute of Common Reanimatology, RAMS, Moscow, Russia; 2Botkin Hospital, Moscow, Russia
Critical Care 2004, 8(Suppl 1):P146 (DOI 10.1186/cc2613)
Methods of renal replacement therapy due to the capability to
eliminate products of cytolysis are now widely used for correction
of generalized inflammation. An additional influence on the
detoxication process has an adsorption component of anti-
inflammatory mediators on the hemodiafilter membrane.
Materials Nineteen patients (nine male/10 female) 15–73 years of
age with sepsis who received continuous hemodiafiltration (CHDF)
treatment were examined. The APACHE II score was 28.3 ± 0.4.
Fifteen patients underwent mechanical lung ventilation, and 13 had
inotropic support. The mortality rate was 43.9%. Hemoprocessor
‘Prisma’ kits with membrane AN69 and solutions from ‘Hospal’
Company (France) were used for CHDF. The mean duration of
CHDF was 73.8 ± 7.0 hours with the filtration volume of
80.4 ± 1.6 l/day.
Results Concentration of TNF-α during CHDF were
386.3 ± 111.6–429.3 ± 80.7 pg/ml. A significant amount of this
cytokine was measured in all effluent samples (90.9–132.5 pg/ml).
Daily TNF-α elimination was 8.92 ± 0.94 µg. Clearance was
80.2 ± 6.3 l/day, which was one-third of the blood volume that has
been perfused through the hemodiafilter. We found a correlation
between the volume of effluent and TNF-α elimination
(r = +0.49 ± 0.04;  n = 30;  P < 0.05). The difference between
TNF-α content in the plasma volume before and after hemodiafilter,
at a mean blood speed of 150 ml/min, hematocrit of 26.7% and
plasma flow of 110 ml/min, was 17,160 pg/min. At the CHDF
speed of 55.6 ml/min, 6183 pg/min TNF-α was eliminated. The
difference between TNF-α content in plasma and effluent volume
was 10,977 pg/min, which acknowledges the receipt of significant
absorption of this cytokine on the hemodiafilter membrane during
the first 6 hours of the CHDF procedure.
Conclusion Significant amounts of TNF-α can be eliminated using
CHDF filtration and absorption, which is important in the absence
of natural hepatorenal clearance during multiple organ failure.
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The hemodynamic pattern of sepsis characterized by a high
cardiac index associated with low systemic vascular resistances
and alterations on tissue oxygenation is caused by the release of
mediators during the host-infecting microorganism interaction. We
thought that removing those endotoxins and inflammatory
mediators by plasmapheresis would improve hemodynamic
changes and tissue oxygenation.
After ethical approval for the trial was obtained, patients were
prepared for plasmapheresis. The criteria for entry to the trial were
sepsis as described by Bone and colleagues [1]. The severity of
illness and mortality rates was classified and calculated using the
APACHE II scale, MODS and SOFA. After obtaining the laboratory
data and calculating the scores, hemodynamic assessment and
tissue oxygenation calculations were performed using thethermodilution technique just before the first plasmapheresis.
Plasmapheresis was performed twice substituting with fresh frozen
plasma as a 1:1 ratio for the calculated plasma volume. The
second plasmapheresis was performed after 48 hours.
Hemodynamic assessment and tissue oxygenation calculations
were repeated before the second plasmapheresis and at the end
of the procedure (72 hours). The outcomes at 28 days were
recorded. Statistical analysis was performed with SPSS version
11.0 for Windows (Chicago, IL, USA), values are expressed as
mean ± SD and P < 0.05 considered statistically significant.
We studied 10 patients treated in the ICU with plasmapheresis.
The difference between the calculated mortality rate based on
initial APACHE II scores (52 ± 22.1), and 28-day mortality of all
patients (20%), was significant (P < 0.05). The enhancement of
APACHE II (from 19.9 ± 6.6 to 12.6 ± 8.5), MODS (from 8.6 ± 3.6
to 5.2 ± 3.4), and SOFA (from 9.1 ± 2.4 to 5.5 ± 4.3) scores
between the baseline and the end of the procedure was
statistically significant (P < 0.01). The changes in hemodynamic
parameters were not significant (Table 1). Despite the
improvements in oxygen delivery, oxygen consumption and oxygen
extraction ratio being not significant before the first
plasmapheresis, the decrease in plasma lactate level (48.2 ± 29.3)
was statistically significant at the end of the procedure
(20.7 ± 16.2) (P < 0.007), and correlated with the 28-day
mortality. The change in plasma C-reactive protein from
124.5 ± 43.2 to 36.9 ± 20.4 was also significant (P < 0.05).
As the sepsis is described as ‘malign intravascular inflammatory’
caused by mediators, the hypothesis is that removing those
mediators will improve the therapeutic efforts. We thought that in
the early stages of sepsis, plasmapheresis may be considered a
therapeutic method even during progressive sepsis that is
complicated with disseminated intravascular coagulation.
Reference
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Table 1
Before
plasmapharesis At 72 hours P
Cardiac index 4.7 ± 0.9 4.2 ± 1 NS
SVRI 1390 ± 462 1434.6 ± 192.8 NS
LVSWI 38.6 ± 10.6 45.3 ± 13.4 NS
SVRI, systemic vascular resistance index; LVSWI, left ventricular stroke
work index.
P148 Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple
organ failure
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The limitations of endotoxin hemoadsorption therapy (PMX-DHP)
and the optimal time to start PMX-DHP were examined in patients
with septic multiple organ failure with hypercytokinemia (IL-6
>1000 pg/ml). This study included 66 patients with infectious
systemic inflammatory response syndrome in whom IL-6
>1000 pg/ml before PMX-DHP therapy. These subjects were
separated into two groups, those who survived for more than
28 days after the start of PMX-DHP therapy (S group; 38 patients)
and those who did not survive (N-S group; 28 patients). Severity
of symptoms and background factors, hemodynamic parameters,
PaO2/FiO2, endotoxin, cytokines (TNF-α, IL-6, IL-1ra), and
vascular endothelial cell function-related markers (ICAM-1,
ELAM-1, PAI-1) were examined before and after PMX-DHP.
Statistical analyses were performed by chi-squared test for
background factors, with Wilcoxon’s signed rank test for
comparison within a group, and Mann–Whitney’s U test for
comparison between groups. This study was approved by the IRB
of Tokyo Medical University.
Results The APACHE-II score was 22.9 ± 6.3 and 30.7 ± 8.9, and
the SOFA score was 9.7 ± 3.6 and 12.6 ± 3.4 in the S and N-S
groups, respectively, showing significantly higher scores in the N-S
group. The number of days that had lapsed from the onset of shock to
PMX-DHP initiation was 0.8 ± 0.8 days in the S group while it was
longer (1.8 ± 1.2 days) in the N-S group. After PMX-DHP for 2 hours,
the endotoxin level decreased from 26.1 ± 20.3 to 20.3 ± 24.5 pg/ml
with statistical significance (P< 0.05) in the S group. In the N-S
group, it tended to decrease from 23.6 ± 20.3 to 10.9 ± 17.2 pg/ml.
Conclusion These results suggest that PMX-DHP could save
more lives in patients with septic multiple organ failure with IL-6
>1000 pg/ml when applied early after the onset of shock.
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Objective Very high or sustained high levels of the inflammatory
cytokines tissue necrosis factor (TNF) and interleukin (IL)-6 are
believed to be responsible for adverse clinical effects in patients
undergoing cardiopulmonary bypass (CPB). We explored, using a
mathematical model, whether modulation of this response might be
beneficial.
Methods We developed a mathematical model of the acute
inflammatory response that was calibrated from rat endotoxemia
and hemorrhagic shock data. The model accommodates a variety
of initiators of acute inflammation, provides a dynamic profile of
serum markers of inflammation over time, and expresses outcome
in as global tissue dysfunction. Irreversible dysfunction is
interpreted as death. We constructed a population of 100,000
cases that differed by level of initial stress and propensity to mount
an inflammatory response. Initial stress was chosen to result in 4%
cohort mortality and to last less than 6 hours, such as CPB. The
intervention consisted of the removal of circulating TNF, IL-6 andIL-10 over a period of 6 hours, during which stress was inflicted
and acute inflammation triggered. We equated the degree of
removal of cytokines to that observed with the application of a
biocompatible adsorbent polymer hemoperfusion column in endo-
toxemic rats.
Results Death correlated to serum IL-6 and to a lesser degree
TNF cumulative levels. Patients with the highest levels of IL-6
6–24 hours after the insult are those that will go on to die (Fig. 1).
Examination of the results show that, if the IL-6 levels were
decreased by >60% and TNF levels by >50% in the period at or
shortly after the CPB, over 99% of all patients would survive,
compared with 96% in the control arm.
Conclusions Global, nonspecific, reduction of inflammation
improves outcome in simulations of an acute inflammatory
challenge such as CPB.
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Sepsis, complicated with disseminated intravascular coagulation
(DIC), is the most frequent cause of mortality in the ICU despite
improvements in patient care [1]. Plasmapheresis is a tool to
remove endotoxins and inflammatory mediators responsible for
pathophysiology. We design a study in a small group of septic
patients complicated with DIC to evaluate the changes on coagula-
tion parameters, severity of sepsis and outcome of plasmapheresis.
After ethical approval for the trial and written informed consent was
obtained, patients were prepared for plasmapheresis. The criteria
for entry to the trial were sepsis as described by Bone [2], and DIC
[3] as described by Bick. The exclusion criteria were uncontrolled
hemorrhagia, recent (<48 hours) cardiac surgery, recent
(<48 hours) resuscitation, platelets <20,000/mm3, positive human
immunodeficiency virus serology, morbid obesity and pregnancy.
After obtaining the laboratory data and scores first, plasmapheresis
was performed using fresh frozen plasma as a 1:1 ratio for the
calculated plasma volume for each patient. The second
plasmapheresis was performed after 48 hours. The severity of
illness and mortality rates was calculated using the APACHE II
scale and the severity of DIC was calculated by the DIC score. The
outcomes at 28 days were recorded. Statistical analysis was
performed with SPSS version 11.0 for Windows (Chicago, IL,
USA), values are expressed as mean ± SD and P < 0.05
considered statistically significant.
Thirteen patients were treated in the ICU with plasmapheresis from
2002 to 2003. The difference between the calculated mortality
rate based on initial APACHE II scores (59.6 ± 21.3), and 28-day
mortality of all patients (20%), was significant (P < 0.05). The
decrease in prothrombin time and activated partial thromboplastic
time, based on initial results, were significant in 24, 48 and
72 hours (P < 0.05). The enhancement of the DIC score (from
6.2 ± 0.6 to 3.7 ± 0.9) between the baseline and the end of the
procedure was statistically significant (P < 0.01). The level of
D-dimer before the first plasmapheresis (1333 ± 972) was
decreased (638.6 ± 252.9) significantly at the end of the
procedure (P < 0.007). The increase in biological markers of
sepsis (antithrombin, protein C and protein S activity) was
statistically significant (P < 0.01). It was also found that the protein
C activity was controversially correlated with 28-day survival
(P < 0.02).
We thought that repeated plasmapheresis in the early stages of
sepsis may be considered a therapeutic method even during
progressive sepsis that is complicated with DIC.
References
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Introduction High cutoff hemofilters are characterized by an
increased effective pore size designed to facilitate the elimination
of inflammatory mediators in sepsis. This study compares diffusive
versus convective high cutoff renal replacement therapy (RRT) in
terms of cytokine clearance rates and effects on plasma proteins.
Methods Twenty-four patients with sepsis-induced acute renal
failure were studied. A polyflux hemofilter with a cutoff point of
approximately 60 kDa was used for RRT. Patients were randomly
allocated to either continuous venovenous hemofiltration (CVVH)
with an ultrafiltration rate of 1 l/hour (group 1) or 2.5 l/hour(group 2), or to continuous venovenous hemodialysis (CVVHD)
with a dialysate flow rate of 1 l/hour (group 3) or 2.5 l/hour
(group 4). IL-1ra, IL-1β, IL-6, tumor necrosis factor-α (TNF-α), and
plasma proteins were measured daily.
Results CVVH achieved a significantly higher IL-1ra clearance
compared with CVVHD (P = 0.0003). No difference was found
for IL-6 (P = 0.935). Increasing the ultrafiltration volume or
dialysate flow led to a highly significant increase in IL-1ra and
IL-6 clearance rate (P < 0.00001). Peak clearance was
46 ml/min for IL-1ra and 51 ml/min for IL-6. TNF-α clearance was
poor for both RRT modalities. A significant decline in plasma
IL-1ra and IL-6 was observed in patients with high baseline
levels. Protein and albumin loss were highest during the 2.5 l/h
hemofiltration mode.
Conclusion High cutoff RRT is a novel strategy to clear cytokine
more effectively. Convection has an advantage over diffusion in the
clearance capacity of IL-1ra but is associated with higher plasma
protein losses.
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Background The Molecular Adsorbents Recirculating System
(MARS) is a new promising artificial liver support therapy. The aim
of this study was to assess the effectiveness of MARS to remove
nitro oxide (NO) and cytokines in multiple organ dysfunction
syndrome (MODS) with severe liver failure patients.
Methods One hundred and ten single MARS treatments were
performed with a length of 6–24 hours on 39 various pathogenic
MODS patients (27 male/12 female) (see Table 1).
Results The MARS therapy was associated with a significant
removal of NO and certain cytokines such as TNF-α, IL-2, IL-6,
IL-8, and lipopolysaccharide binding protein (LBP) (see Table 2),
together with a marked reduction of other nonwater-soluble
albumin-bound toxins and water-soluble toxins. These were
associated with a, improvement of the patients’ clinical conditions
including hepatic encephalopathy, deranged hemodynamic
situation and renal and respiratory function, thus resulting in a
marked decrease of teh Sequential Organ Failure Assessment
(SOFA) score and improved outcome: 16 patients were able to be
discharged from the hospital or bridged to successful liver
transplantation. The overall survival of 39 patients was 41%.
Conclusion We can confirm the positive therapeutic impact and
safety to use MARS on various pathogenic MODS patients
associated with elevated levels of NO and cytokines.
Table 1
Complication n (%)
Renal failure/hepatorenal syndrome 28 (71.8%)
Disseminated intravascular coagulation  7 (17.9%)
Brain edema/hepatoencephalopathy above grade II 28 (71.8%)
Respiratory failure/acute respiratory distress syndrome 19 (48.7%)
Cardiovascular dysfunction 21 (53.8%)
Table 2
Parameter Pretreatment Post-treatment P value
NO (µmol/l) 58.0 ± 22.9 25.2 ± 19.0 <0.01
TNF-α (µg/l) 4.83 ± 2.6 1.70 ± 1.25 <0.01
IL-2 (ng/l) 6.35 ± 2.13 4.25 ± 1.13 <0.01
IL-6 (pg/ml) 394.9 ± 134.5 108.0 ± 117.3 <0.01
IL-8 (ng/ml) 1.20 ± 0.63 0.52 ± 0.15 <0.01
LBP (µg/ml) 16.2 ± 8.1 8.2 ± 5.1 <0.01
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Introduction It is important for ICU physicians to predict the
mortality of acute renal failure (ARF) in the first 24–48 hours. For
this the SHARF II score at 0 and 48 hours has been developed [1].
This study will look at short-term and long-term morbidity and
mortality with different modes of treatment in ARF.
Methods A prospective multicentre randomised clinical trial. The
target population was 1600 consecutive adult patients with ARF.
Patients needing renal replacement therapy (RRT) were
randomised to either slow extended daily dialysis (SLEDD) or
continuous venovenous hemofiltration (CVVH). Randomisation was
done according to the SHARF II0 score (<30, 30–60 and >60).
Interim study endpoints were hospital morbidity and mortality.
Results Interim analysis after 996 patients: age 66 ± 15.1 years,
62% male, SHARF II0 64.9 ± 32.6, SHARF II48 64.1 ± 32.2,
SOFA0 8.4 ± 4.1, SOFA24 6.5 ± 5.1, APACHE II 23.5 ± 10.6.
Diagnosis of ARF was medical in 67.9% and surgical in 32.1%.
Cause of ARF was prerenal in 43.2%, and renal in 51.5%. Cause of
renal ARF was ATN in 90.9%, and AGN in 5%. There were 13.8%
of patients in SHARF category 1 (<30), 24.8% in category 2
(30–60) and 52.2% in category 3 (>60). The higher the SHARFscore, the higher the APACHE II and SOFA score. RRT was
needed in 59% of patients (2/3 randomised), 39% of them received
continuous RRT while 61% received SLEDD. The main reason for
choosing another treatment was hemodynamic instability (24%) or
coagulation disturbance (25%). Outcome analysis (481 patients)
showed a mortality of 56.5%, 2.9% developed ESRD, 10.2% had
partial recovery and 30.4% had complete recovery of ARF. Mortality
was 46% in conservative treatment versus 64% in CVVH and 68%
in SLEDD. Figure 1 shows the mortality in the different SHARF
categories. The ICU and hospital length of stay was higher in
patients with RRT. Observed mortality was lower than expected in
non-RRT but paralleled the expected in RRT.
Conclusion The interim results of an ongoing study show that the
SHARF score, with parameters at 0 and 48 hours, has good
predictive value in estimating prognosis in ARF patients. Overall
mortality was 56.5%, and 59% needed RRT. Mortality was the
same regardless of RRT used. Major problems lay in recruiting
centers using both techniques equally. The randomisation rate is
lower than expected.
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Many Emergency Department patients with acute rhabdomyolysis
are admitted to hospital to observe for development of renal failure.
We examined factors associated with a normal admission serum
creatinine, and a normal post-hydration creatinine, to determine
which patients had low risk of development of renal failure.
Methods This is a retrospective study of 144 consecutive patients
with a diagnosis of rhabdomyolysis seen in our Emergency
Department over 44 months. A ‘normal serum creatinine’ was
defined as less than 1.5 mg/dl (133 µum/l). Laboratory data
included the initial and peak creatine kinase (CK), the anion gap,
calcium, phosphate, potassium, blood urea nitroben (BUN), white
blood cell count (WBC), urine toxicology screen, and hematocrit. A
second hematocrit collected following hydration was compared
with the first to approximate the percentage of initial volume
depletion. A second creatinine was also taken following hydration
(median 10 hours after admission). Patients with obvious renal
insufficiency defined as a creatinine > 4 mg/dl (354 µm/l) and
patients with peak CK < 1000 were excluded. Multivariate logistic
regression analysis was performed using small STATA 7.0. For
continuous variables, data were dichotomized based on an upper
limit of normal values (phosphate, potassium, BUN) or low limit
(calcium); and median values of the anion gap, hematocrit,
percentage decrease in hematocrit, WBC, and CK.
Results Significant independent predictors of a normal first
creatinine are presented in Table 1. The most powerful
independent predictor of a normal post-hydration creatinine was a
normal admission creatinine (odds ratio [OR] = 31, confidence
interval [CI] = 6.6–145, P = 0.0001). An elevated BUN and a CK
greater than 10,000 were negative predictors of a normal second
creatinine (OR = 0.20, CI = 0.06–0.65, P = 0.008, and
OR = 0.21, CI = 0.07–0.61, P = 0.004).
Conclusion A normal admission creatinine was associated with
WBC <11.0, the absence of cocaine or amphetamine, less than
18% volume depletion, a normal BUN and a normal calcium. A
normal first creatinine was a very strong predictor of a normal
second creatinine after hydration. This suggests that otherwise
healthy patients with uncomplicated rhabdomyolysis and a normal
first creatinine who can hydrate themselves orally may be safely
discharged from acute emergency care after correction of volume
deficits.
Table 1
Variable OR 95% CI P value
WBC < 11.0 6.1 1.8, 21 0.004
Cocaine/amphetamine 8.4 2.2, 32 0.002
18% hematocrit drop 7.0 1.9, 25 0.003
Calcium, 8 mg/dl 9.8 1.2, 79 0.032
Blood urea, 23 mg/dl 12.4 2.3, 65 0.003Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P155 The correlation between creatine kinase and myoglobin in critical ill patients with rhabdomyolysis
TS Mikkelsen1, P Toft1,2
1ICU, Aarhus, Denmark; 2Odense University Hospital, Denmark
Critical Care 2004, 8(Suppl 1):P155 (DOI 10.1186/cc2622)
Purpose Following rhabdomyolysis there is a risk of acute renal
failure (ARF). The nephrotoxic molecule is myoglobin (M). In clinical
practice, creatine kinase (CK) is, however, measured to estimate the
risk of ARF. It is often stated that the elimination of M is
unpredictable [1]. The aim of the present study was therefore to
investigate the correlation between CK and the effector molecule M.
Methods and materials From 1 January 2003 until 30 June 2003
we prospectively measured CK and M in all patients in the ICU
suspected of rhabdomyolysis. To investigate the observed trends
further, we retrospectively studied all patients submitted to our ICU
within the last 4.5 years with a plasma M >5000 µg/l. Forty-two
patients were included.
Results Plasma M peaked on average 0.6 ± 0.4 days before CK.
In the 76% of the patients M and CK increased in parallel and both
decreased exponentially T½ (M) 22 ± 10 hours and T½ (CK)
26 ± 7 hours (Fig. 1.) In 17% of the patients an isolated increase in
M was observed. In the majority of these patients abdominal
complications was found. In 7% of the patients an isolated
increase in CK was observed, typically in relation to mobilisation of
the patients. ARF was treated with continuous venovenous
haemofiltration.
Discussion In the majority of patients with rhabdomyolysis, M and
CK increase and decrease in parallel. Medium-sized molecules
such as M are transported directly from the muscle to the blood,
while large molecules such as CK are transported with the
lymphatic system. Therefore an isolated increase in plasma CK
might be observed following mobilisation. An isolated increase in
plasma M ought to raise suspicion of abdominal complications.
Conclusion In patients with rhabdomyolysis, measurement of the
nephrotoxic molecule M can be used to predict the risk of ARF.
Reference
1. de Meijer, et al.: Serum CK as predictor of clinical course in
rhadomyolysis: a 5 year extensive case survey. Intensive Care
Med 2003, 29:1121-1125.
Figure 1
P156 Prediction of the clinical course of rhabdomyolysis in patients with initial creatine kinase <1000 U/l
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We routinely screen patients with severe muscular exertion for the
presence of rhabdomyolysis. We evaluated the significance of a
low initial creatine kinase (CK), and factors associated with a rising
CK in this group.
Methods Consecutive patients with rhabdomyolysis were
indentified over 44 months. A subgroup analysis of those with
acute exertional rhabdomyolysis and initial CK <1000 U/l
identified two groups: patients whose CK values remained stable,
and those whose CK values rose to greater than 2000 U/l. No
one was excluded. Student’s t test and the Fisher exact test were
used to analyze continuous and categorical variables,
respectively.
Results See Table 1. Of 36 patients with CK <1000 U/l, 15
(33%) had a rising CK. This was significantly associated with
elevation of the anion gap and increased frequency of moderate to
large urine test for heme. The stable CK group had a significantly
higher blood urea nitrogen (BUN). In all cases the anion gap
resolved with sedation and hydration, which is clinically consistent
with acute lactic acidosis. Five of the 15 patients in the rising CK
Table 1
Stable CK, Rising CK,
mean mean
Group (95% CI) (95% CI) P value
Number patients 21 15
CK peak 983 21,500
White cell count 13.6 (11.2–16) 16.8 (12–21.7) 0.16
First hematocrit 49 (47–51) 47 (44–50) 0.19
% change hematocrit 27 (19–36) 24 (18–30) 0.52
Anion gap 19 (15–22) 27 (23–32) 0.004
BUN (mg/dl) 28 (20–36) 16 (13–19) 0.01
First creatinine 2.3 (1.9–2.8) 2.0 (1.8–2.3) 0.25
Second creatinine 1.3 (1.1–1.6) 1.6 (1.6–1.9) 0.22
Rising creatinine 2/19 5/15 0.20
Urine large–moderate 7/19 13/15 0.005
Urine small–negative 12/19 2/15
Cocaine–amphetamine 14/17 11/15 0.68
CI, confidence interval.group had a rising creatinine, compared with 2/17 in the stable CK
group. No one required hemodialysis.
Conclusion In patients with acute exertional rhabdomyolysis, a
rising CK was significantly associated with initial elevation of the
anion gap and large to moderate urine test for heme. We believe
the anion gap reflected the intensity of anaerobic metabolism in
injured muscle.
Available online http://ccforum.com/supplements/8/S1
P157 Continuous venovenous haemofiltration in neonates
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Objective To review our experience of continuous venovenous
haemofiltration (CVVH) in neonates requiring renal replacement
therapy
Methods Twenty-two neonates who received CVVH between
September 1997 and September 2002 were retrospectively
identified and the following data extracted from their records: age,
gestation, body weight diagnosis, number of failed organs,
indication for renal replacement therapy (RRT) and site and nature
of vascular access. Additionally, we recorded the maximum
haemofilter blood flow, mean filter life and complications
associated with achieving vascular access or running CVVH.
Results Twenty-two neonates received CVVH, either as the sole
form of RRT (18 patients) or on the abandonment of PD (four
patients). The median gestational age was 37 weeks (range
34–40 weeks). Patient weight ranged from 2.3 to 4.7 kg (median
2.7 kg). In 18 cases CVVH was initiated for a combination of
acidaemia, fluid overload and electrolyte disturbance. In three
cases metabolic acidaemia secondary to an inborn error of
metabolism was the indication. In one case fluid overload alone
triggered therapy. The median number of failed organs was three
(range 2–5). Venous access was achieved via the femoral vein in
12 cases, the subclavian in three cases, the internal jugular in six
cases, and the umbilical vein in one case. Cannulation was
achieved with 5 or 6.5 Fr double-lumen catheters. The median
duration of CVVH was 47 hours (range 20–336 hours). A median
of three filter changes were required per patient run (range 0–10)
and the median filter life was 24 hours (range 30 min–145 hours).
CVVH was complicated by haemothorax in one patient, profound
hypotension on initiation of filter flow in one case and pericannula
bleeding requiring infusion of coagulation products in one case.
Each complication was rapidly corrected.
Conclusion CVVH can be successfully initiated in the neonatal
population with a low incidence of morbidity or technical difficulty.
P158 Renal replacement in critically ill patients: the age factor
F Occhigrossi, V Angeloni, R Rocca, A Filippini, P Assisi, M Podestà
San Giacomo Hospital, Rome, Italy
Critical Care 2004, 8(Suppl 1):P158 (DOI 10.1186/cc2625)
The aim of this study was to assess the efficacy of the renal
replacement therapy adopted in our ICU for patients who were
affected by acute renal failure after their admission to the ICU, and
to evaluate the role of age in relation to renal function and surviving
probability.
During a period of 18 months (February 2002–July 2003), we
treated 22 patients with acute renal failure by means of continuous
renal replacement therapy. The patients, 17 males and 13 females
were divided into two groups: one group of patients (group A)
younger than 65 years; a second group (group B) older than
65 years. Group A was made up of 14 patients, 10 suffering from
polytrauma and four from acute pancreatitis, and a mean age of
42 ± 9 years. The second group was made up of 16 patients, who
underwent major surgical interventions, four after open heart
surgery, four after gynaecological surgery and eight after
abdominal surgery with a mean age of 76 ± 11 years. All the
patients got into our ICU for acute respiratory failure and needed
mechanical ventilation. Oliguria has been diagnosed when the
urine output was less than 400 ml/day. The acute renal failure was
due to hypotension and sepsis; the renal replacement therapy was
started when an oliguria and/or a volemic overload were observed.
All patients were treated with a slow low-efficient daily dialysis
(SLEDD) single pass adapted to each patient with a low flow
therapy for 10–12 hours in order to obtain a good haemodynamic
stability and ensure an urea clearance of 45–60 l/day and Kt/V
weekly >6. Statistical analysis was made with ANOVA and logistic
regression.
The patients’ ICU length of stay was 16.3 ± 5.9 days for group A
and 24.4 ± 10.8 for group B. The SLEDD therapy lasted
10.3 ± 3.9 days for group A and 19.7 ± 7.1 days for group B. The
Qb was 150–200 ml/min, the Qd 60–100 ml/min and the mean
ultrafiltration 150 ml/hour. The caloric intake was
32.7 ± 7 kcal/kg/day with a proteic intake of 1.9 ± 0.5 g/kg/day.
Six patients of group A (42.8%) and 11 patients of group B
(68.7%) died. All the survivors recovered renal function.
Sepsis is the most relevant reason for acute renal insufficiency and
mortality in critically ill patients. According to our experience
SLEDD can be considered a safe and efficacious treatment for
these patients: it allows an aggressive volemic removal and an
adequate nutritional support coupled with haemodynamic stability
and uremic control. The logistic regression shows that age,
severity of illness and amount of organs affected were independent
risk factors for poor outcome.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P159 Acute renal failure requiring dialysis in very old critically ill patients
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Acute renal failure (ARF) is common in critical care patients. One
risk factor for ARF is age. However, access to dialysis is often
limited in older patients, due to their worse prognosis. We report
our experience in dialyzing old patients, and compare them with
younger patients with ARF in our unit. Since September 1994, we
recorded all dialyzed patients, treated with intermittent dialysis
(IHD), continuous dialysis (CRRT) or both, depending on clinical
decisions. For IHD we use a Fresenius 4008 E machine and
polysulfone dialyzers. For CRRT, we first used a DM 08 Fresenius
machine and, from 2001, a Diapact-CRRT Braun machine, with
polysulfone hemofilters. Since 1994, we have had 163 patients,
68.4% males, mean age 60 (range 15–92) years. Mean
APACHE II score at admission was 21.6. Eighty-three percent
needed mechanical ventilation, 53% were primarily surgical and in
74% there was a relevant infection or sepsis.
From the total, 52 patients (32%) were older than 75 years (mean
age 83 ± 4 years). In this group, 79% were male, 83% needed
mechanical ventilation, 54% received nephrotoxic agents,
including radiocontrast, 58% were primarily surgical and 72% had
sepsis. Compared with younger patients, older patients were more
often males, and had higher APACHE score (23.2 versus 20.6,
P < 0.05) and mortality (55.8% versus 40.5%, P < 0.05).
In the older group, the main differences between survivors and
nonsurvivors were the incidence of sepsis (79% in nonsurvivors
versus 60% in survivors), and the type of patient (nonsurvivors
69% surgical versus survivors 43% surgical). Age, use of
mechanical ventilation, and APACHE score were not different
between survivors and nonsurvivors. Regarding modality of
dialysis, CRRT was used in 13 patients, with 11 deaths (84%). In
contrast, the mortality of younger patients treated with CRRT was
47%. As for ARF outcome, 100% of nonsurvivors maintained ARF
at death. In contrast, none of the survivors required dialysis at
discharge of the hospital. Throughout the years, dialysis was more
often considered: 52% of the older patients dialyzed were
admitted after 2001, and more often also, CRRT was used (only
two CRRT before 2001 in the older group).
In conclusion, ARF is common in old patients. Even though ARF
and dialysis are associated with high mortality, still 44% of old
patients submitted to acute dialysis survive, and are discharged
free of dialysis. With time, more old patients will be admitted to
ICUs and treated with dialysis. As other authors have concluded,
age should not be used as an isolated factor for deciding to treat
ARF with dialysis.
P160 Outcome in critically ill medical patients requiring renal replacement therapy for acute renal failure: comparison between
patients with and without hematologic malignancies
D Benoit, E Hoste, P Depuydt, F Offner, N Lameire, J Decruyenaere, K Vandewoude, F Colardyn
Ghent University Hospital, Belgium
Critical Care 2004, 8(Suppl 1):P160 (DOI 10.1186/cc2627)
Background. Starting renal replacement therapy (RRT) for acute
renal failure in critically ill patients with hematologic malignancies
(HM) is controversial because of the poor outcome and high costs.
The aim of this study was to compare the outcome of critically ill
patients requiring RRT with and without HM as well as to assess
whether the presence of HM is independently related to a higher
mortality in this population.
Methods We retrospectively collected data on all consecutive
patients requiring RRT at the Ghent University Medical Intensive
Care Unit (ICU) between 1997 and 2002, and analyzed the impact
of the presence of HM on the mortality rate within 6 months after
ICU admission by Cox proportional hazard models.
Results Fifty of the 222 (22.5%) consecutive patients with HM
admitted to the ICU over the study period required RRT compared
with 248 of the 4293 (5.8%) patients without HM (P < 0.001).
Among patients requiring RRT, those with HM had higher crude
ICU mortality rates (80% vs 55.7%, P = 0.001), inhospital mortality
rates (84% vs 66.1%, P = 0.017) and 6-month mortality rates
(86% vs 74.5%, P = 0.09) compared with those without HM.
However, patients with HM were more severely ill (APACHE II,
30 ± 10 vs 26 ± 9, P = 0.017), more often required mechanical
ventilation (88% vs 77.5%, P = 0.02) and had longer duration of
hospitalization before admission (median [interquartile range] of
7 days [1–21] vs 0 days [0–2], P < 0.001) compared with those
without HM. In a multivariate analysis only the APACHE II score
(hazard ratio [HR] 1.04; 95% confidence interval [CI] 1.02–1.06,
P < 0.001), vasopressor use (HR 1.97; 95% CI 1.28–3.02,
P = 0.002) and a duration of hospitalization >2 days before ICU
admission (HR 1.5; 95% CI 1.1–2, P = 0.009) were associated
with a poor outcome. The presence of HM was not associated with
a poor outcome (HR 1.07; 95% CI 0.73–1.57, P = 0.78).
Conclusion Withholding RRT to critically ill patients with HM is
unjustified. The decision to start RRT in these patients should be
based upon the severity of illness and the duration of
hospitalization before admission to the ICU.
P161 Risk factors for acute renal failure in critically ill children: a prospective descriptive epidemiologic study
D Bailey, F Gauvin, V Phan, C Litalien, A Merouani, J Lacroix
Hopital Sainte-Justine, Montreal, Canada
Critical Care 2004, 8(Suppl 1):P161 (DOI 10.1186/cc2628)
Introduction There are no prospective studies on incidence, risk
factors and clinical outcome of acute renal failure (ARF) in
critically ill children. The aim of this study was to characterize
the risk factors, to determine the incidence rate and to estimatethe clinical outcome of ARF in pediatric intensive care unit
(PICU).
Methods We conducted a prospective descriptive study of 1047
consecutively admitted children over 1 year, in a tertiary university
PICU. Clinical data were recorded daily, until death or discharge
from the PICU. ARF was defined as doubling of serum creatinine.
Risk factors for ARF were estimated comparing ARF patients
versus non-ARF (nARF) by calculating the relative risk (RR) and
95% confidence interval (95% CI).
Results Among 985 admissions available for analysis, there were
44 episodes of ARF (4.5%). Mean age (months) was higher in the
ARF patients compared with the nARF (111.0 ± 74.9 versus
72.3 ± 68.6;  P < 0.001). Significant risk factors for ARF were
(RR; 95% CI): age >12 years old (3.5; 1.5–7.7), admission
PRISM score >10 (4.0; 1.6–10), shock (7.1; 3.4–14.6), and
organ dysfunction (hematologic, cardiovascular and neurologic).
Mortality was higher in ARF patients; 29.6% versus 2.3%
(P < 0.001).
Conclusion  Incidence of ARF is important in the PICU, and is
associated with significant mortality. Risk factors are multiple and
could be preventable. This is the first prospective epidemiologic
study that focuses on pediatric ARF in PICU. A multicentric study
is planned to confirm these results.
Available online http://ccforum.com/supplements/8/S1
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Background The recently proposed RIFLE classification of acute
renal failure (ARF) (Acute Dialysis Quality Initiative, www.ADQI.net)
has yet to be evaluated in a general ICU population. RIFLE defines
three grades of severity of ARF on the basis of either urine output
(U) or an acute increase in serum creatinine (C): 
r i s k=C×1.5 or U <0.5 ml/kg/hour × 6 hours; injury=C×2  o r
U <0.5 ml/kg/hour × 12 hours; and failure=C×3 ,  C≥4 mg/dl,
U <0.3 ml/kg/hour × 24 hours, or anuria × 12 hours.
Patients and methods We prospectively collected data for all
patients admitted to an ICU from 1 July 2000 to 30 June 2001 at
the University of Pittsburgh Medical Center, a tertiary hospital with
>120 ICU beds serving medical, surgical, trauma, neurologic, and
transplant patients. We tested two hypotheses: (1) increasing
RIFLE class corresponds to decreasing ICU occurrence and
increasing hospital mortality; and (2) patients classified by C or U
criteria have similar occurrence and mortality. We classified
patients according to their worst class on C or U criteria. For
baseline C, we selected the lower of the admission C and the
predicted C (based on age, sex, and race, using the Modification
of Diet in Renal Disease formula).
Results A total of 5754 admissions and 5313 patients were
evaluated. Occurrence and mortality are presented in Table 1.
Conclusions RIFLE criteria appear clinically sensible with
increasing mortality. Unfortunately, C and U criteria alone yield
different results, and occurrence decreases only when C criteria
are used alone.
Table 1
RIFLE criteria C criteria only U criteria only
ICU occurrence (%)
No ARF 32.0* 60.8* 29.3*
Risk 12.1 13.1 11.1
Injury 26.5 10.6 31.8
Failure 29.4 15.6 27.8
Hospital mortality (%)
No ARF 6.7** 6.7* 7.0**
Risk 8.9 12.9 8.7
Injury 11.1 23.8 10.9
Failure 26.4 34.7 27.7
*P < 0.01, **P < 0.01, not for R vs I.
P163 Early goal-directed therapy in patients with end-stage renal disease
M Donnino, E Shirazi, C Wira, B Nguyen, G Jacobsen, K Floyd, E Rivers
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Introduction Patients with end-stage renal disease (ESRD) on dialysis
are at increased risk for infection, yet few studies in sepsis focus on
this population. The current study evaluates early goal-directed therapy
(EGDT) for ESRD patients with severe sepsis and septic shock.
Methods This is a post-hoc analysis of a randomized, prospective
trial of patients presenting to an urban Emergency Department
(ED) with severe sepsis and septic shock. Patients were enrolled in
the study if they had two or more systemic inflammatory response
syndrome criteria plus hypotension or lactic acidosis (>4 mmol/l).
Patients were randomized to either conventional care or EGDT that
included resuscitation to goals of central venous pressure (CVP)
between 8 and 10, mean arterial pressure (MAP) between 65 and
90, and central venous oximetry (ScvO2) greater than 70%.
Results Ten patients with ESRD were in the control group and eight
in the treatment group. Baseline hemodynamic (heart rate [HR],
MAP, CVP, ScvO2) and severity of illness scores (APACHE, MODS,
SAPS) were not different between groups. Seven out of 10 patients
in the control group died compared with 1/8 in the EGDT group
(P < 0.05). At 6 hours, the HR and CVP remained equal between
groups, but a statistically significant rise in ScvO2 and MAP was
found between groups (P < 0.05). Additionally, the treatment group
displayed a significant fall in lactate, APACHE, MODS, and SAPS
scores (P < 0.05). The difference in ScvO2, lactate, and severity of
illness remained significant at 72 hours (P < 0.05).
Conclusion EGDT is both safe and efficacious for patients with
ESRD, resulting in reduction of both morbidity and mortality. Thisimprovement in outcome can be explained by eradication of global
tissue hypoxia by aggressive resuscitation guided by goal-directed
care. Although EGDT was performed for only 6 hours in the ED,
the physiologic benefits persisted between groups at 72 hours.
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Objective Although the simple closure/omental patch (SC) has
been standard procedure for perforated duodenal ulcer (PDU) in
most institutes in Japan, this procedure was originally performed
for poor-risk patients. Basic evaluation concerning the SC has
been insufficient and the SC has been performed based on only
experience. Gastrointestinal endoscopic examination (GF) makes it
possible to evaluate such fine structures. However, it is not known
whether the early endoscopic examination after SC is safe or not.
The aim of this study is to clarify the macroscopic findings of the
healing process after the SC for PDU.
Materials and methods We perform the SC for patients with
PDU, without stenosis, and without prominent ulcer ridge. We start
medication of H2-RA (or PPI) just after operation, and oral feeding
4–5 days after operation independent of postoperative GF. Eleven
patients with PDU who were treated with the SC underwent
postoperative GF at the 4th–16th postoperative day and the
healing process was examined. We do not perform radiographic
examination of leakage from anastomosis. All 11 patients were
informed that we could be convinced of the healing process with
some unknown risk.
Results In three of 11 patients, GF findings showed an active
stage and a healing stage. In two of them, the surgical technique
was thought to be insufficient (the distance between the stitch and
the edge of the ulcer was insufficient), and in the other patient
postoperative GF was performed on the 4th postoperative day
because of transfer to another minor hospital. The other eight
patients showed a scar phase with good granulation and without
exposure of stitches. Iatrogenic perforation, bleeding, and severe
abdominal pain during or after postoperative GF was not seen in all
cases.
Conclusion Postoperative GF in the early phase after SC is useful
and safe for evaluating the healing process of the SC for PDU. We
can start oral intake 1 week after this surgical procedure.
P165 Changes in glucagon kinetics and processing in patients with acute pancreatitis
K Tanjoh, R Tomita, K Kinoshita
Nihon University School of Medicine, Tokyo, Japan
Critical Care 2004, 8(Suppl 1):P165 (DOI 10.1186/cc2632)
Aim The kinetics of the pancreatic hormone glucagon in patients
with acute pancreatitis have not been investigated as carefully as
those of insulin, in spite of its crucial influence on energy
metabolism. In the present study, we studied the kinetics of
glucagon and glucagon-related peptides assessed by radio-
immunoassay. Furthermore, the molecular forms of these peptides
were examined using gel filtration chromatography, and the
glucagon processes in the pancreas and intestine in the early
stage in patients with acute pancreatitis were investigated.
Methodology Fourteen patients with acute pancreatitis were
enrolled in this study. Eight had severe pancreatitis (group S) and six
had mild pancreatitis (group M). Ten healthy volunteers were also
enrolled as normal controls (group C). Serum levels of glucagon and
glucagon-related peptides were assessed on the second admission
day in groups S and M, and in an early morning fasting state in
group C, using glucagon nonspecific N-terminal (glucagon-like
immunoreactivity [GLI]) and specific C-terminal (immunoreactive
glucagon [IRG]) radioimmunoassays. The molecular forms of these
peptides were also estimated using gel filtration chromatography.
We then discuss the glucagon processes based on these findings.
Results Serum GLI and IRG in groups S and M were significantly
higher than those of group C (P < 0.01), while those in group S
were also significantly higher than those in group M (P < 0.05). In
all patients in groups S and M, except for only three in group S, a
peculiar glicentin-like peptide (GLLP) (molecular weight about
8000) other than pancreatic glucagon was observed in IRG gel
filtration chromatography, which was clearly absent from group C.
Conclusion The kinetics and processing of glucagon in patients
with acute pancreatitis were quite different from those of healthy
subjects. In patients with acute pancreatitis, the peculiar
processing of glucagon proceeded in the intestine quite differently
from ordinary glucagon processing either in the pancreas or in the
intestine, generating a peculiar GLLP.
P166 Cytokines may predict outcome at acute pancreatic patients with pulmonary failure: the beneficial role of somatostatin
M Sosolceva, S Stojanova, M Licenovska, M Gjorceva
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Critical Care 2004, 8(Suppl 1):P166 (DOI 10.1186/cc2633)
Introduction Acute pancreatic patients with lung injury have high
mortality rate. Despite pretreatment with imipenem, inflammatory
response is present generally and locally thanks to the cytokines
that are responsible for systemic inflammatory response syndrome
(SIRS) and multiple organ disfunction syndrome (MODS).
Aim of the study Evaluating acute pancreatic patients, to confirm
cytokine involvement in the appearance of pulmonary failure and to
investigate the effect of somatostatin on some cytokines
associated with lung injury.Materials and methods In a 1-year prospective clinical study we
examined 22 patients with severe pancreatitis acuta. Eleven of
them (group I) were treated early with somatostatin (0.1 mg every
8 hours for 7 days). The second group was treated with standard
therapy. The pulmonary failure was assessed on the basis of
radiographic findings, computerised tomography scans,
bacteriological diagnosis of endotracheal aspirates and acid–base
abnormalities. Serum concentrations of IL-1, IL-6 and TNF-α were
determined during the time course of the study, as were white
blood cell counts, amylases, transaminases, urea and creatinin.
Results All 22 patients developed MODS and all laboratory
parameters as indicators of SIRS were increased. Serum
concentrations of IL-1, IL-6 and TNF-α were elevated in all
patients, but with high significance difference (P < 0.03) in
14 patients who developed pulmonary failure (three from group I
and all 11 patients from group II). The peak serum concentrations
of cytokines were found in patients from group II with the most
increased value for IL-6. Lung injury treated with mechanical
ventilation (14 patients), pulmonary drainage (six patients) and
even decorticating (three patients) correlated with increased serum
value of IL-6. Changes in chest radiographs depended on the
increased values of all cytokines and the more severe was lung
injury, the higher were the values. Comparison between the
patients from group I and those from group II showed significant
differences in the values of cytokines, with the values being higher
in group II. Serum concentration of cytokines were significantly
higher (P < 0.05) in five patients who died (all of them with
pulmonary failure) compared with those who survived.
Conclusion High cytokine values are associated with development
of pulmonary failure and increased mortality at acute pancreatic
patients. Initial aggressive treatment with somatostatin decreases
cytokine release and may predict good outcome in these patients
by reducing the appearance and severity of pulmonary failure.
References
1. Mozo G, et al.: Lung changes and cytokine levels in a model of
experimental acute pancreatitis. Rev Esp Enferm Dig 2002, 94:
53-66.
2. Mayer J, et al.: Inflammatory mediators in human acute pan-
creatitis: clinical and pathophysiological implications. Gut
2000, 47:546-552.
3. Jambrik Z, Gyongyosi M, Hegyl P, et al.: Plasma levels of IL-6
correlate with hemodynamic abnormalities in acute pancre-
atitis in rabbits. Intensive Care Med 2002, 28:1810-1818.
Available online http://ccforum.com/supplements/8/S1
P167 Effects of abdominal compression on respiratory parameters in normal volunteers
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Objectives To analyse the effects of 10% and 15% of the baseline
abdominal circumference compression with a band in the
respiratory rate (RR), tidal volume (TV), forced vital capacity (FVC)
and maximal inspiratory pressure (MIP) and maximal expiratory
pressure (MEP) in normal volunteers.
Methods Twenty-six normal volunteers, mean age of 24 years,
14 female and 12 male, in spontaneous breathing were submitted
to abdominal circumference measurement. Thereafter, we
obtained their RR, TV, FVC, MIP and MEP. Then, we repeated the
measures after compression of abdomen using an external band
to achieve –10% and –15% of the basal abdominal
circumference. Then, we took out the band and measured the
respiratory parameters again.
Results See Table 1.
Conclusion The abdominal compression of –10% and –15% with
an external band decreased TV, MIP and MEP (the last one only
with –5% compression) and did not affect RR and FVC.
Table 1
Baseline Abdominal compression Abdominal compression Baseline
compression of 10% of 15% compression
Abdominal circumference (cm) 81.7 ± 9.3 →* 73.7 ± 8.6 →* 69.6 ± 8.2 →* 81.7 ± 9.3
Respiratory rate 15.2 ± 2.4 → 15.65 ± 2.1 → 16.23 ± 2.3 → 15.69 ± 2.7
Tidal volume (ml) 517 ± 109 →* 456 ± 86 → 458 ± 157 →* 543 ± 105
Forced vital capacity (ml) 4146 ± 870 → 4097 ± 906 → 3973 ± 880 → 4113 ± 963
Maximal inspiratory pressure (cmH2O) 111 ± 27 →* 96 ± 27 → 94 ± 28 →* 109 ± 29
Maximal expiratory pressure (cmH2O) 115 ± 27 → 104 ± 28 → 101 ± 28 →* 116 ± 29
*P < 0.005.
P168 The risk factors for intra-abdominal hypertension in a mixed population of critically ill patients
D Chiumello1, N Brienza2, J Cohen3, M Ranieri4, A Wilmer5, M Malbrain6
1Policlinico IRCCS, Milano, Italy; 2Policlinico Hospital, Bari, Italy; 3Rabin Medical Center, Petah Tikva, Israel; 4Le Molinette Hospital, Torino,
Italy; 5Gasthuisberg, Leuven, Belgium; 6Ste Elisabeth Hospital, Brussels, Belgium
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The intra-abdominal pressure (IAP) is an important indicator of the
patient’s physiologic status because even a slight increase of IAP
can have deleterious effects.
The aim of this study was to evaluate in all the new patients
admitted to general ICUs, during 4 weeks, the incidence of IAP
and the possible associated risk factors.At admission, the APACHE II score, etiologic factors (abdominal
surgery, hemoperitoneum, abdominal infection, massive fluid
resuscitation, ileus, pneumonia andbacteraemia), predisposing
conditions (acidosis, polytransfusion, coagulopathy, sepsis and
liver dysfunction) and type of admission were evaluated. The IAP
was measured twice every day for 7 days, or less if the patient was
ICU-discharged or death occurred.
Two hundred and sixty-five patients were enrolled from 13 ICUs:
mean age 62.8 ± 17.7 years, body mass index
25.9 ± 17.7 kg/m2, APACHE II 17.8 ± 8.7, IAP 9.7 ± 5.0 mmHg,
medical patients 132 (49.8%), surgical patients 71 (26.8%),
emergency patients 42 (15.8%), trauma patients 20 (7.6%); 62
patients died in the ICU (23.4%). Intra-abdominal hypertension
(IAH) was classified as a mean IAP of 12 mmHg or more at
admission. There were 80 (30.2%) patients with IAH and 185
(69.8%) without IAH.
The only independent risk factors present at admission significantly
related to IAH were the number of organ failures (odds ratio
[OR] = 1.5, confidence interval [CI] = 1.1–2.0), the abdominal
surgery (OR = 2.6, CI = 1.4–5.1), ileus (OR = 2.6, CI = 1.4–4.7)
and liver dysfunction (OR = 3.2, CI = 1.6–6.5).
These data suggest that either an abdominal problem or the
number of organ failures are associated with the IAH.
Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P169 Early abdominal and pulmonary neutrophil accumulation and activation in patients with secondary peritonitis: 
a compartmentalized response
O van Till, V den Broeder, T Out, P Bresser, R Lutter, M Schultz, D Gouma, M Boermeester
Academic Medical Center, Amsterdam, The Netherlands
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Introduction The inflammatory response in secondary peritonitis is
hypothesized to be compartmentalized. Occurrence of organ
failure determines the outcome in patients with this disease. The
lung is frequently involved in multiple organ failure. The aim of this
study is to determine the role of neutrophil migration and activation
in three different compartments (abdominal, circulatory, pulmonary)
during secondary peritonitis.
Methods Patients with secondary peritonitis (n = 31) were
analyzed and eight short ventilated controls (1 day postoperative)
and seven long ventilated controls (5 days or more). Patients were
included only if their APACHE II score exceeded 10 points (mean
17.5, range 11–31). Blood, abdominal fluid and bronchoalveolar
lavage fluid were sampled on the day of the index operation for the
elimination of the infectious focus (= day 0), on day 2 and day 3.
Leukocytes were counted and differentiated. Parameters assessed
were the chemokine IL-8, myeloperoxidase (MPO), a measure for
neutrophil activation, and albumin and alpha-2-macroglobulin, to
measure lung permeability.
Results All assessed parameters were significantly higher in
abdominal fluid than in the other two compartments (up to 100-fold
in cell counts and 1000-fold in IL-8 concentrations compared with
blood; P < 0.0001). Leukocyte count, neutrophil count/percentage
and IL-8 concentrations were also significantly higher in the lung
compared with blood or plasma values (P < 0.05). The absolute
number, percentages and activity (MPO concentration) of
neutrophils in the lung were higher at all time points in peritonitis
patients (even day 0) compared with short ventilated controls
(P < 0.05). Alveolar membrane permeability, as measured by the
relative coefficient of excretion (a ratio between albumin excretion
and alpha-2-macroglobulin excretion ratio) was increased in
peritonitis patients at all time points.
Discussion Neutrophil accumulation and activation in the
abdominal cavity and the pulmonary compartment in patients with
peritonitis is likely to be compartmentalized. In various
compartments of the body, the host defense systems vary in extent
and nature. An impressive pulmonary response develops early in
secondary peritonitis: Neutrophils are activated and lung
permeability is increased above normal values.
P170 Intraperitoneal placement of a microdialysis catheter in patients with gastrointestinal anastomosis: preliminary results of a
prospective study
I Ginosatis, P Tzardis, P Stefanidis, E Kriticos, J Tierris, V Laopodis
Red Cross Hospital, Athens, Greece
Critical Care 2004, 8(Suppl 1):P170 (DOI 10.1186/cc2637)
Aim The aim of the present study is to evaluate the safety and the
efficacy of monitoring patients undergoing gastrointestinal surgery
with a microdialysis catheter, as compared with the traditional
clinical and laboratory methods.
Materials and methods Ten patients undergoing gastrointestinal
operations with enterectomy and anastomosis were prospectively
studied. The gastrointestinal microdialysis catheter was placed in
the peritoneal cavity intraoperatively just before closure.
Microdialysate samples were collected every 4 hours and analyzed
with a colorimetric method for glucose, glycerol, lactate and
pyruvate. These markers are connected with tissue ischemia as
well as the lactate/pyruvate ratio. These data were compared with
clinical findings and blood tests.
Results In eight patients with an uneventful postoperative course,
the results of microdialysis were in accordance to the
corresponding clinical and laboratory findings. In two patients with
postoperative septic complications, the results of microdialysis
notably anteceded the other markers. No complications related to
the placement of the microdialysis catheter was noted.
Conclusions These preliminary results indicate that microdialysis
is safe and effective in detecting septic complications in patients
with gastrointestinal tract anastomosis and shows a time
advantage over the classical monitoring technique.Available online http://ccforum.com/supplements/8/S1
P171 Coefficient of variation (COVA) during continuous intra-abdominal pressure (IAP) and abdominal perfusion pressure (APP)
monitoring
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Introduction Definitions for intra-abdominal hypertension (IAH)
and abdominal compartment syndrome (ACS) stand or fall with the
reproducibility and accuracy of the IAP measurement. The aim of
this study is to validate a novel fully-automated continuous
technique to measure IAP via a balloon-tipped catheter connected
to an IAP monitor (Spiegelberg, Hamburg, Germany) versus a
novel bladder FoleyManometer (Holtech Medical, Copenhagen,
Denmark), and to look for the COVA (SD divided by mean) for IAP
and APP during different 24 hour monitoring periods.
Methods IAP was estimated using two different methods: via the
bladder (IBP) with a FoleyManometer and via a balloon-tipped
gastric catheter (IGP) connected to an IAP monitor. For each
24 hour period, 12 measurement were noted. In total 645 paired
measurements were performed in 15 sedated and mechanically
ventilated ICU patients.The male/female ratio was 1/1, age
60 ± 9 years, APACHE II score 20.2 ± 8.6, and SAPS II score
49.4 ± 16.7.
Results The values for IAP (mmHg) were 9.7 ± 3.2 (IGP) vs
9.8 ± 3.1 (IBP), and 72.1 ± 16.5 for APP. There was a good
correlation: IBP = 0.85 × IGP + 1.6 (R2 = 0.79,  P < 0.0001).
Bland and Altman analysis showed good agreement: IGP was
almost identical to IBP with a mean bias of –0.1 ± 1.5(SD) mmHg
(95% confidence interval [CI], –0.2 to 0); the limits of agreement
(LA) were –3.1 to 2.9 mmHg (95% CI, –3.3 to –2.9 for the lower
LA and 2.7 to 3.1 for the upper LA). The COVA was 18.7 ± 7.4%
for IGP and 17.1 ± 12.7% for IBP. The global bias (IAPmax minus
IAPmin) was 5.6 ± 2.6 mmHg for IGP and 3 ± 2.4 mmHg for IBP,
the global variance (GLOVA), defined as global bias divided by the
mean, was 61.6 ± 26.9% for IGP and 32.8 ± 24.3% for IBP. The
COVA, global bias and GLOVA were 14.5 ± 6%,
32.8 ± 12.8 mmHg and 46.5 ± 17.9%, respectively, for APP.
Conclusion Estimation of IAP via IGP or IBP is feasible. The novel
IGP method is less time consuming, fully automated
(autocalibration), and allows a continuous trend. The
FoleyManometer offers a cost-effective alternative. Both are
accurate and reproducible. The COVA for the obtained parameters
in sedated patients is around 15–20% in a 24 hour period and thus
varies substantially. These variations may even be more pronounced
in nonsedated patients. Therefore IAP and APP are continuous
variables like any other pressure and should be monitored as often
as possible during the day to adapt treatment accordingly.
Figure 1
P172 Inter-relation between splanchnic ischaemia measured by air-tonometry and renal function
A Henniger, F Brunkhorst, K Reinhart, T Uhlig
University of Jena, Germany
Critical Care 2004, 8(Suppl 1):P172 (DOI 10.1186/cc2639)
Background and goal of study Air tonometry is a common
method to examine splanchnic hypoxia, which often is a predictor
of severe clinical complications such as sepsis or renal failure.
Urodilatine is one of the indicators of renal function. A
retroperspective case–control study was conducted considering
whether there is an inter-relation between splanchnic ischaemia
and renal function.
Patients and methods  After approval of the local ethics
commitee, 39 intensive care patients have been studied. The age
of the patients diverged from 37 to 98 years (median age
64 years). Hemodynamic variables, including continuous cardiac
output, air-tonometric variables via a nasogastric tube (Tonocap
Datex, Helsinki, Finland), arterial lactate, urine production, heart
rate, central venous pressure (CVP) and mean arterial pressure,were measured every hour. Furthermore, renal values, such as
urodilatine, ANF and urine excretion have been assessed after 6, 7
and 8 hours.
The increase of the CO2 gap values within the first 6 hours was
determined by curve estimation and correlated (bivariate
correlation) with indicators of renal function using Spearman’s rho
and Pearson correlation. The CVP increase within the first 6 hours
was assessed similar to the CO2 gap increase.
Results and discussion Between air tonometry values and renal
function, a significant contiguity (P < 0.05) was found.
A bivariate correlation level of –0.356 (P = 0.039) between the
CO2 gap increase and urine urodilatine assessed after 7 hours
resulted. Spearman’s rho was –0.358 (P = 0.044) between the
CO2 gap increase and urodilatine extraction, and was 0.407
(P = 0.014) between the CO2 gap increase and urine excretion
after 7 hours.
The strongest correlation was found between the CO2 gap
increase and the urodilatine–creatinine ratio (–0.503, P = 0.012).
There was no correlation between CO2 gap increase and serum
creatinine. There also was no appreciable inter-relation between
CVP increase and CO2 gap increase (Pearson = 0.000,
P = 0.999; Spearman’s rho = 0.047, P = 0.778).
Furthermore the time of ventilation correlates positively with the
CO2 gap increase (0.326, P = 0.043).
Conclusion This study suggests the CO2 gap increase to be a
predictor for decreasing urodilatine values indicating renal failure.
Therefore air tonometry is helpful, tendentially detecting
deterioration of renal function as sign of multiorgan failure.
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P173 Influence of elevated abdominal pressure (EAP) on lung mechanics and gas exchange during PCV with and without
spontaneous breathing
R Bensberg, D Henzler, V Fackeldey, R Dembinski, R Rossaint, R Kuhlen
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Critical Care 2004, 8(Suppl 1):P173 (DOI 10.1186/cc2640)
Introduction EAP may lead to compromise of chest wall mechanics
and worsening of lung mechanics and gas exchange. Temporary
relief may further lead to reperfusion injury. We investigated the
effects of EAP and reperfusion injury on respiratory system
mechanics and gas exchange under pressure controlled ventilation
(PCV) without and with spontaneous breathing.
Methods In a porcine model, EAP was set to 30 cmH2O by CO2
insufflation twice for 9 hours each, with a pressure relief of 3 hours
between and at the end. Anesthetised pigs (46.3 ± 3.3 kg)
received PCV (n = 10) or biphasic positive airway pressure
(BIPAP) (n = 10) with positive end expiratory pressure of
5 cmH2O, allowing up to 20% spontaneous of total ventilation, and
were randomly assigned to the control group (n = 4) without EAP
or the EAP group (n = 6) in each mode. Measurements of lung
mechanics and gas exchange were performed every 2 hours.
Results In the control group, no changes were observed with time
or between modes. For results of the EAP group see Table 1.
During the second EAP phase lung mechanics deteriorated further,
and returned to baseline value after pressure relief only with
BIPAP. In both modes, oxygenation after the last pressure relief
was worse than baseline.
Conclusion An EAP applied twice for 9 hours each worsened the
chest wall and lung mechanics and impaired gas exchange
regardless of the ventilation mode. These changes were not
completely reversed after pressure relief. If spontaneous breathing
was present during BIPAP, there was less impairment of lung
compliance and oxygen delivery, but this did not lead to differences
in gas exchange.
Table 1
PIP VE RR WOBtot Cdyn PaO2 PaCO2 DO2 VO2 Shunt Deadspace
PCV
P a b d=0 2 2±2 † 7 . 8±0 . 8 † 2 7±3 * 4 8 . 8±8 . 5 † 29.1 ± 4†* 1 3 6±2 1 † 3 5±6 †* 461 ± 182 187 ± 43 4.2 ± 5.2 43.2 ± 17.6
Pabd = 30 43 ± 5* 7.1 ± 0.9 29 ± 2* 91.0 ± 14.5 9.5 ± 0.9* 108 ± 24 49 ± 10* 508 ± 129* 193 ± 58 10.9 ± 11.3 46.4 ± 7.8
BIPAP
P a b d=0 2 0±3 † 7 . 7±0 . 6 † 3 7±1 5 † 49.8 ± 15.4 34.2 ± 7.7† 1 3 5±2 6 † 3 9±5 † 505 ± 170 162 ± 34† 5.9 ± 7.2 51.2 ± 11.3
Pabd = 30 39 ± 5 7.1 ± 0.6 56 ± 11 98.9 ± 22.9 11.2 ± 2.2 105 ± 31 61 ± 20 622 ± 212 205 ± 42 8.4 ± 7.0 51.2 ± 9.1
*P < 0.001 for PCV vs BIPAP. †P < 0.01 for PABD = 0 vs 30. Cdyn, dynamic compliance; DO2, oxygen delivery; Pabd, abdominal pressure; PIP,
peak inspiratory pressure; RR, respiratory rate; VE, expiratory minute ventilation; VO2, oxygen consumption; WOBtot, total work of breathing.
P174 Intra-abdominal pressure (IAP) and hypoperfusion of splanchnic organs after major abdominal surgery
V Sramek, M Masek, S Chalupnik, J Zak, P Suk, D Zvonickova, H Valouchova
Faculty Hospital St Anna, Brno, Czech Republic
Critical Care 2004, 8(Suppl 1):P174 (DOI 10.1186/cc2641)
Introduction An increased IAP plays a leading role in
hypoperfusion of splanchnic organs after major abdominal surgery.
Patients and methods Patients undergoing major (>2 hours)
abdominal surgery were eligible. After induction of anaesthesia, aurinary catheter and a gastric tonometry tube were inserted.
Postoperatively all patients were admitted to the surgical ICU. IAP
was measured in the urinary bladder (50 cm3 saline) after transfer
to the ICU (T0) and then at T1, T6, T12, T18, and T24. Air
tonometry was monitored automatically (Datex, Finland) in 10-min
intervals, and arterial blood gases analysed at the same intervals.
IAP was measured to allow calculation of pCO2gap. At T1 and T6
the indocyanine green (ICG) plasma disappearance rate (PDR)
was measured with LIMON (Pulsion, Germany) after injection of
0.25 mg/kg ICG. This abstract summarises data of the first five
patients undergoing elective colonic resection due to cancer. Data
are presented as median (range). Nonparametric ANOVA for
repeated measures was used for statistical analysis and P < 0.05
considered significant.
Results Five patients aged 70 (48–72) years underwent
uncomplicated operations of >2 hour duration in combined
general and epidural anaesthesia and were extubated in the
operating room. In all epidural analgesia was given during the
study. At T0 IAP was 11 (8–14) mmHg and did not change
significantly during the study: T1 9 (8–10), T6 9 (7–11), T12 9
(8–11), T18 11 (10–16) and T24 12 (2–15) mmHg. Only two
patients had an increased IAP >15 mmHg at T18 and T24,
respectively. In these patients the abdominal perfusion pressure
(MAP–IAP) at critical timepoints was >70 mmHg without use of
vasopressors. At T0 the pCO2gap was –0.1 (–0.7–0.3) kPa and
developed as follows: T1 0.3 (0.1–1.3); 0.6 (–0.3 to 1,9); T12 0.2
(–0.2 to 1.8); T18 0.6 (0.3–0.9) and T24 0.2 (0–0.4); time effect
NS. pCO2gap >1 kPa was measured four times in three patients —
at these timepoints a corresponding IAP was 10 mmHg maximum.
The ICG PDR was normal in all patients 33.6 (24.2–36.4)%/min at
T1 and did not change significantly up to T6 (27.5 [22.9–29.2]
%/min).
Conclusion Our pilot data suggest that, in patients after
uncomplicated colonic surgery, an increased IAP to clinically
significant values is rare. Hypoperfusion of gastric mucosa and liver
hypoperfusion/dysfunction is also very rare.
Acknowledgement Supported by IGA grant 7144-3.
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P175 Nonoperative management of patients with abdominal compartment syndrome
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Background Organ dysfunction attributable to intraabdominal
hypertension, known as abdominal compartment syndrome (ACS),
has been recognised as a source of morbidity and mortality in the
ICU. Decompressive laparatomy is considered as the sole definite
therapy of ACS. However, no randomised trial has been performed
to assess the role of surgery.
We studied the characteristics and outcome of critically ill patients
with ACS treated nonoperatively, and focused on the natural
course of organ dysfunction.
Methods We retrospectively studied patients with ACS (intra-
abdominal pressure [IAP] ≥18 mmHg and at least one organ
failure) admitted to our medical and surgical intensive care unit
over two consecutive years (2001–2002). We focused on organ
failure at the time of the raised IAP and on its evolution in patients
who did not undergo a decompressive laparatomy.
Hemodynamic instability was defined as dependence on
vasopressor therapy, respiratory failure as P/F <300 and renal failure
as creatinine level >2 mg/dl or a 50% increase from baseline.
Results We found 24 episodes of ACS in 23 patients that were
managed nonoperatively. The mean age of patients was
57 ± 14.6 years. APACHE II score on admission was 22.8 ± 8.2.
The highest detected IAP was 29 ± 8.2. ACS was found after
intra-abdominal processes (pancreatitis, ischemic colitis, and
other) in 47% (11/23) of cases, after abdominal surgery or trauma
in one-third (8/23), and in a minority (4/23) after other conditions
(such as burns). Hemodynamic instability was present in 87%
(20/23) of cases, respiratory failure in 96% (22/23) and renal
failure in 87% (20/23). The majority of patients had multiple organ
failure (91% [21/23]).
Mortality was 26% (6/23), patients that died had a higher
APACHE II score on admission (28.5 ± 8.3 vs 20.8 ± 7.4 in the
survival group [P = 0.04]), but the incidence of organ failure and
the highest recorded IAP were not significantly different.
At discharge, organ function returned to basic levels in all survivors
(medium length of stay 13).
Conclusion In a group of critically ill patients with ACS treated
nonoperatively, the mortality was 26%. Patients that survived were
discharged from the ICU without organ dysfunction. We conclude
that selected patients with ACS may not require decompressive
laparatomy, but will respond to nonoperative observation and
supportive therapy.
P176 Blood flow changes during septic shock compared with controlled stepwise blood flow reduction in the superior
mesenteric artery: effects on microcirculatory blood flow in the small intestine
V Krejci1, L Hiltebrand2, S Jakob1, G Sigurdsson3
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Introduction Splanchnic ischemia due to sepsis or hemorrhage is
believed to be involved in the pathogenesis of multiple organ
dysfunction syndrome. In previous studies performed in our
laboratory we have studied microcirculatory blood flow of the
small intestinal mucosa in a porcine model of septic shock [1].
We have demonstrated that microcirculatory blood flow (MBF)
was redistributed from the jejunal muscularis towards the mucosa.
The aim of this study was to measure changes in MBF in the
jejunum during stepwise occlusion of the superior mesenteric
artery (SMA).Methods Data from the sepsis group have been extracted from a
previously published study [1]. Swiss landrace pigs (30 kg) were
anesthetized and mechanically ventilated. Cardiac output (CO)
was measured using thermodilution and SMA flow with ultrasonic
transit time flowmetry. MBF was measured in the jejunal mucosa
and muscularis using laser Doppler flowmetry. In the septic shock
group (group S, n = 11), sepsis was induced by fecal peritonitis. In
the SMA occlusion group (group O, n = 8), SMA flow was reduced
in steps of 15% using an occluder.
Results Results are presented as percent of baseline (mean ± SD,
*P < 0.05 compared with baseline, †P < 0.05 mucosa vs
muscularis). During septic shock, the CO, SMA flow and MBF of
jejunal muscularis decreased to 56 ± 13%*, 47 ± 13%* and
36 ± 17%*†, respectively, while the MBF in jejunal muscularis
remained virtually unchanged (86 ± 20%†). In nonseptic animals,
stepwise occlusion of the SMA to 42 ± 4%* of baseline produced
a decrease of muscularis blood flow to 43 ± 12%*† while mucosal
blood flow decreased less, to 65 ± 24%*†.
Conclusion During reduced regional blood flow, microcirculatory
flow decreased less in the intestinal mucosa than in the muscularis,
suggesting redistribution of flow away from the muscularis towards
the mucosa, both in septic and in nonseptic subjects. Blood flow
redistribution appeared to be more pronounced in septic than in
nonseptic animals.
Reference
1. Hiltebrand LB, et al. Redistribution of microcirculatory blood
flow within the intestinal wall during sepsis and general anes-
thesia. Anesthesiology 2003, 98:658-669.
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Objective Vasopressors are recommended for circulatory support
during acute sepsis. They maintain blood pressure, but have
differing effects on cardiac output (CO) and renal blood flow
(RBF). In particular, they may impair RBF and increase the risk of
renal insufficiency. The aim of the study was to compare the effects
on RBF of five vasopressors, noradrenaline (NA), adrenaline
(ADR), dopamine (DOP), phenylephrine (PE) and vasopressin
(VP), in acute sepsis.
Methods In seven anaesthetized dogs CO and RBF were
measured directly using flow probes. The mean artery pressure
(MAP) was measured by cannulating the femoral artery. Systemic
vascular resistance (SVR) was derived. Sepsis was induced by
injecting Escherichia coli. Each vasopressor was randomly infused
at a recommended rate (Table 1) for 30 min. Percentage changes
in MAP, CO, SVR and RBF, compared with baseline, were
calculated. Data were expressed as mean (SD) and statistical
analysis was performed using one-group t tests.
Results All five vasopressors increased MAP (P < 0.01), but their
effects on CO varied, with ADR and DOP producing the greatest
increases (P < 0.01). SVR was increased by NA, PE and VP
(P < 0.01), and was decreased by ADR (P < 0.01). Whereas NA
and DOP increased RBF (P < 0.05), RFB was decreased by ADR
and PE (P < 0.05; Table 1).
Conclusion Despite similar effects on MAP, vasopressors have
different effects on CO, SVR and RBF. NA and DOP were the
most effective vasopressors in preserving RBF during sepsis, while
ADR and PE had negative effects.
Table 1
Vasopressor: MAP (%) CO (%) SVR (%) RBF (%)
NA (0.5 µg/kg/min) 33 (13) 5 (4) 28 (18) 31 (20)
ADR (0.5 µg/kg/min) 10 (5) 17 (9) –7 (4) –8 (5)
DOP (10 µg/kg/min) 14 (8) 20 (14) –2 (6) 30 (24)
PE (5 µg/kg/min) 18 (11) 1 (6) 18 (13) –6 (5)
VP (6 µ/kg/min) 20 (7) –12 (6) 32 (9) 8 (19)
P178 Epinephrine induces tissue perfusion deficit in porcine endotoxin shock: evaluation by regional CO2 content gradients and
L/P ratios
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Background We hypothesized that epinephrine (EPI) as opposed
to norepinephrine (NE) has selective adverse effects on visceral
perfusion when used to treat hypotensive endotoxin shock. We
specifically wanted to test the hypothesis that perfusion deficiency
could be detected by regional venous to arterial CO2 content
gradients (as opposed to pCO2 gradients).
Materials and methods We measured regional venous lactate
and pyruvate concentrations as well as regional CO2 exchange
over three locations of the hastrointestinal tract (stomach, small
intestine and colon) in a porcine model of prolonged hypotensive
(mean arterial pressure [MAP] <60 mmHg) endotoxin shock with
4 hours of treatment with either EPI (n = 6) or NE (n = 6) aiming at
MAP >70 mmHg. The data are presented as median (interquartile
range). Friedman’s test was used for within the group analysis of
statistical significance.
Results In 5/6 EPI-treated animals, the splanchnic blood flow
decreased regardless of the direction of change in cardiac output
(CO). Meanwhile, NE increased splanchnic perfusion concomitantly
with CO. Four hours of EPI infusion increased markedly the venous
to arterial pCO2 gradient over gastric tissue (39 [37–49] mmHg,
P < 0.05) and to a lesser extent over small intestinal tissue (19
[12–25] mmHg, P < 0.05) and colonic tissue (18 [15–24] mmHg,
P < 0.05). The CO2 content gradient, however, increased markedly
only over gastric tissue (10.8 [10.7–12.1] ml/dl, P < 0.05).Conclusions EPI, unlike NE, induced an overall relative reduction
of splanchnic blood flow and specifically reduced gastric wall
perfusion as evaluated by regional CO2 content gradients. The
lactate gradient and L/P ratio over the gastric wall increased
accordingly. These findings suggest that EPI should not be used
as a first-line vasopressor in septic shock.
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P179 Effects of arginine–vasopressin on jejunal mucosal oxygen supply in healthy pigs
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Critical Care 2004, 8(Suppl 1):P179 (DOI 10.1186/cc2646)
Introduction Arginine–vasopressin (AVP) may promote intestinal
ischemia. We studied the effects of increasing doses of AVP on
mucosal tissue oxygen tension (PO2muc), microvascular
haemoglobin oxygen saturation (HbO2), and microvascular blood
flow (PU) in a jejunal segment.
Methods A small segment of jejunal mucosa was exposed by
midline laparotomy and antimesenteric incision in 16 anesthetized,
paralyzed, and normoventilated pigs. PO2muc (Clark-type surface
oxygen electrodes), HbO2 (tissue reflectance spectrophotometry),
and PU (laser-Doppler velocimetry) were measured. Systemic
haemodynamics, mesenteric–venous acid–base and blood gas
variables, and systemic acid–base and blood gas variables were
recorded. Measurements were performed after a stabilizing period
and baseline measurements at 20-min intervals during increasing
dosages of AVP (AVP group; n = 8; 0.007, 0.014, 0.029, 0.057,
0.114, and 0.229 U/kg/hour) or saline placebo (CTRL group; n = 8).
Results AVP infusion lead to a significant decrease in cardiac
index (121 ± 31 ml/kg/min vs 77 ± 27 ml/kg/min) and systemic
oxygen delivery (13.7 ± 3.0 ml/kg/min vs 9.1 ± 3.4 ml/kg/min)
concomitant with an increase in systemic oxygen extraction ratio
(31 ± 4% vs 48 ± 10%). AVP decreased significantly
microvascular blood flow (133 ± 47 PU vs 82 ± 35 PU),
mesenteric venous oxygen tension (25.6 ± 7.1 mmHg vs
6.9 ± 2.4 mmHg) and microvascular hemoglobin oxygen saturation
(51.3 ± 9.0% vs 26.4 ± 12.2%) without a statistical increase in
mesenteric venous lactate concentration (2.3 ± 0.8 mmol/l vs
3.4 ± 0.7 mmol/l).
Conclusion Intravenously administered AVP decreases in a dose-
dependent manner intestinal oxygen supply and mucosal tissue
oxygen tension via reduction in microvascular blood flow in healthy
pigs.
P180 Early and aggressive use of high-dose norepinephrine in the treatment of septic shock
A Kapralou, D Theodorou, P Drimousis, F Archondovassilis, K Stamou, C Mpantias, G Karantzikos, S Katsaragakis
University of Athens, Greece
Critical Care 2004, 8(Suppl 1):P180 (DOI 10.1186/cc2647)
Introduction Hyperdynamic circulation of septic shock is
characterized in the hyperdynamic phase by increased cardiac
output and decreased peripheral vascular resistance, and
consequently low pressure. The use of norepinephrine as a pure
vasoconstrictor aims to increase vascular resistance and blood
pressure. There is a subgroup of patients with septic shock that
does not respond to usual or high doses of norepinephrine. Usually
in these patients different therapeutic approaches are used. In this
study, we try to evaluate the role of very high doses of
norepinephrine (≥2 µg/kg/min) in the treatment of septic shock.
Patients and methods In our department the therapeutic approach
to septic shock includes the use of aggressive haemodynamic
monitoring (pulmonary artery catheterization) and the use of
norepinephrine and/or dobutamine combination along with fluid
resuscitation. In this retrospective study we present 12 patients with
septic shock that required very high doses of norepinephrine
(≥2 µg/kg/min). All patients were catheterized with a Swan–Ganz
catheter and received adequate fluid resuscitation (pulmonary
wedge pressure ≥15 mmHg). Norepinephrine was used and titrated
to maintain mean arterial pressure >70 mmHg. In nine of 12 patients
dobutamine was added to achieve cariac index >3.5 l/min/m2.
Results Two patients never recovered from septic shock and died.
Another six patients expired at a later time from multiple organ
failure despite the fact that they improved from the shock and they
were weaned off norepinephrine during their course. Finally, four
patients survived to be discharged from the intensive care unit after
a mean 25 days of intensive care unit stay. The APACHE II score
did not differ between survivors and nonsurvivors (Table 1).Conclusion The use of very high doses of norepinephrine in the
treatment of septic shock under the guidance of aggressive
haemodynamic monitoring may improve survival in this group of
patients with very high mortality. We may need to reconsider
labeling patients with norepinephrine-resistant septic shock if the
usual doses are ineffective, and try high doses before switching to
another regimen.
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Table 1
Survivors (n = 4) Nonsurvivors (n =8 )
APACHE II score 25 (22–28) 25.5 (20–33)
SD 2.4 (22.3–27.7) SD 3.7 (22.8–28.2)
Age (years) 61.5 (45–79) 70 (63–87)
SD 14.1 (49.5–81.5) SD 8.6 (63.6–76.4)
Values are shown as mean (range).
P181 Correlation of gastric-mucosal tonometry and procalcitonin (PCT) values in intensive care patients
C Reinhardt, F Brunkhorst, K Reinhart, T Uhlig
University of Jena, Germany
Critical Care 2004, 8(Suppl 1):P181 (DOI 10.1186/cc2648)
Background and goal of study Measurement of the gastric-
mucosal tonometry difference is an indicator of splanchnic hypoxia,
which often is a predictor of severe clinical complications like
inflammation and/or sepsis. Beyond these aspects other biochemical
indicators like procalcitonin (PCT), lipopolysaccharide binding
protein (LBP), or IL-6 are suitable diagnostic markers. Therefore the
hypothesis occurs whether there is a correlation between gastric
tonometry and biochemical indicators of inflammation.
Materials and methods Twenty-six intensive care patients (five
women and 21 men) were selected after surgery. All of them
showed n increasing gastric-arterial PCO2 (CO2 gap) difference
within at least 6 hours. An increasing CO2 gap was taken as an
indicator of decreasing splanchnic perfusion. Furthermore, each
patient was matched with one postsurgery intensive care patient
without an increase of CO2 gap.
Tonometric variables via a nasogastric tube (Tonocap Datex,
Helsinki Finland), hemodynoamic variables, temperature and
arterial lactate were measured every hour.
The differences of the PCT (pct-diff), IL-6 (il_diff) and LBP (lbp_diff)
values of day 1 after surgery and day 0 were also assessed.
By means of the SAPS and APACHE score systems, the general
condition of each patient was evaluated and afterwards enrolled
into two groups (group 1, SAPS ≤5; group 2, SAPS >5). Statistical
analysis was done using covariance analysis (the time patients were
breathed in the operating room was defined as covariate).
Results and discussion The mean pct-diff was significantly higher
(adjusted mean = 2.22, P = 0.01) for the group with increasing
CO2 gap than for the decreasing group (adj. mean = 0.59).
Their was no significant difference in LBP values for both groups but a
significant one due to the general condition of the patients (adj. mean
SAPS group 1 = 20.22; adj. mean SAPS group 2 = 14.03; P= 0.13).
In IL-6 values there were also no significant differences, but the
mean for each group suggests that the il_diff values are even
higher in the group with decreasing or stable CO2 gap 1 day after
surgery (adj. mean stable-group = 41.34, adj. mean increasing-
group = –134.6; P = 0.056).
There were no other significant differences in lactate, cardiac index,
blood pressure or mean arterial pressure between the two groups.
Furthermore there was a tendential significant difference in ICU
time. Patients with increasing CO2 gap have been longer on the
ICU than other patients (mean group with increasing CO2
gap = 4642 min vs 2934 min for the other one; P = 0.094).
Conclusion The differences in the PCT values suggest that an
increase in CO2 gap measured by air tonometry is accompanied by
a later increase in PCT values. Tonometry is the earlier method to
detect aspects of inflammation.
These findings fit with the longer time on the ICU for patients with
an increasing CO2 gap.
P182 Ultrasonography and color Doppler contrast-enhanced imaging of the gallbladder in intensive care unit patients: an early
diagnosis of acute acalculous cholecystitis
K Chatzimichail, D Zervakis, A Siafaka, M Zervou, S Nanas, C Roussos
Evagelismos General Hospital Medical School, University of Athens, Greece
Critical Care 2004, 8(Suppl 1):P182 (DOI 10.1186/cc2649)
Patients in the ICU are at risk of developing acute acalculous
cholecystitis (AAC). The disease carries high morbidity and
mortality rates partly because of the difficulties of diagnosis.
Purpose To evaluate the morphology and vascularity of the
gallbladder in ICU patients examined by ultrasonography (US) and
color Doppler (CD) and contrast-enhanced (CE) study. To assess
the value of the method in the diagnosis of AAC.
Subjects and methods We prospectively examined
50 concecutive patients who were admitted to the ICU with a
variety of diagnoses. The patients were examined 7 days after
admission to the ICU. Follow-up examinations were performed
every 7–10 days. A total of 98 examinations were obtained in
50 patients. In each examination, the gallbladder was examined by
US, CD and CE study with galactose-based microbubbles (SHU
508 A Levovist). Sonographic parameters were obtained
(distention, wall thickening, containts, pericholecyctic fluid
pericholecyctic edema) and vascularity (normal, abnormal flow
signals) was estimated. The findings correlated with clinical and
laboratory parameters and histology if cholecystectomy was
performed.Results Four out of 50 patients (8%) had one sonographic
abnormality while they were in the ICU, 7/50 (14%) had two
abnormalities, 11/50 (22%) had three abnormalities, 22/50 had
four or more abnormalities and only 6/50 (12%) had no
sonographic abnormality. In 2/50 (4%) hypervascularisation was
detected in CD and CE study. Only these two patients had
surgically proved AAC.
Conclusion GB abnormalities are frequently seen on US in ICU
patients even if these patients are not suffering AAC. The
sonographic critiria are not specific. CD imaging, especially after
CE imaging, is useful for the detection hyperemia in the acute
stage of GB inflammation and may improve the accuracy of the
method in early diagnosis of AAC.
Available online http://ccforum.com/supplements/8/S1
P183 Severe abdominal sepsis in the intensive care unit
R Morar
University of the Witwatersrand, Fordsburg, South Africa
Critical Care 2004, 8(Suppl 1):P183 (DOI 10.1186/cc2650)
Objective  To investigate factors that may predict outcome in
patients with severe abdominal sepsis that required treatment in an
intensive care unit (ICU).
Design  A retrospective record review of survivors and
nonsurvivors, comparing clinical, laboratory, microbiological, and
therapeutic data, to identify specific poor prognostic factors.
Setting A tertiary referral centre.
Patients  Consecutive adult patients with abdominal sepsis
admitted to the ICU between January 2001 and December 2002.
Measurements and results  Of 54 patients studied there were
16 survivors (29.6%) and 38 nonsurvivors (70.4%). The
nonsurvivors had a significantly longer stay in the ICU (22.3 days
vs 7.9 days; P = 0.0042), had significantly more laparotomies per
patient (4.1 vs 2.4; P = 0.024), had more patients with an open
abdomen following surgery (15 vs 1; P = 0.01), had significantly
more blood transfusions (10.8 vs 2.9; P = 0.0077), and had a
significantly higher mean APACHE II score on admission (16.5 vs
10.7;  P = 0.0175). The initial surgery was performed as an
emergency procedure in 72% of patients, and of these four were
delayed for greater than 48 hours.
Of the survivors, the source was eradicated at the initial laparotomy
in 12 of the 14 patients. Most of the patients that died developed
multiorgan failure. In this regard none of the patients who survived
required dialysis, whereas 44% in the nonsurvivors were dialysed.
Nonsurvivors had more organisms isolated from the peritoneal fluid
and more bacteremic episodes. The most frequently isolated
organism from the peritoneal fluid in nonsurvivors was Escherichia
coli.
Conclusions Patients with abdominal sepsis are at risk of dying if
there is delay in surgery and if the source of sepsis cannot be
controlled at the first operation. In addition, more than four relook
laparotomies, renal failure requiring dialysis, longer ICU stay, culture
of pathogens from the peritoneal cavity and blood, higher APACHE II
score, and requirement for blood transfusion contribute significantly.
P184 Abstract withdrawn
P185 The Duffy antigen receptor for chemokines (DARC) and acute renal failure (ARF) during lipopolysaccharide (LPS)-induced
systemic inflammation
K Singbartl, S große Bockhorn, H Van Aken
UKM, Muenster, Germany
Critical Care 2004, 8(Suppl 1):P185 (DOI 10.1186/cc2652)
Background Originally known as a target molecule for plasmodium
vivax and as a blood group antigen, DARC has emerged as a
promiscuous binding site for chemokines. Besides red blood cells,
DARC is also expressed on endothelial cells, even in Duffy-
negative individuals. However, the function of DARC during
systemic inflammation remains unknown [1]. In a neutrophil (PMN)-
dependent model of LPS-induced ARF [2], we sought to assess
whether DARC plays a role in the development of organ failure
during systemic inflammation.
Methods ARF was induced by intraperitoneal injection of LPS in
wild-type mice (WT) and DARC gene-deficient mice (DARC–/–).
At 4, 12, and 24 hours after injection, blood samples were
drawn, and kidneys were removed. Plasma creatinine (Crea) as
well as blood urea concentrations served as indicators of renal
function, and renal myeloperoxidase activity (MPO) as an
indicator of total renal PMN content. Untreated WT and DARC–/–
constituted corresponding control groups. Data analysis included
ANOVA with subsequent multiple comparison analyses when
appropriate.
Results Over 24 hours, WT developed severe intrarenal ARF with
a more than threefold increase in Crea. DARC–/– on the other hand
displayed a significant protection from ARF, exhibiting only a small,
clinically irrelevant increase in Crea over 24 hours (Fig. 1). MPO
was not different between WT and DARC–/–; both groups showed
significantly elevated renal MPO after LPS injection, peaking at
4 hours (Fig. 2) and declining thereafter. Even after LPS injection,
RT-PCR failed to detect DARC mRNA expression in the kidney of
WT, whereas it could demonstrate cerebral expression of DARC
mRNA at 12 and 24 hours after LPS administration.
Conclusions We conclude that during LPS-induced systemic
inflammation, DARC plays a key role in the development of ARF.
DARC seems to act via extrarenal (i.e. systemic) mechanisms and
does not appear to alter the total renal PMN content.References
1. Blood 2002, 100:3853.
2. FASEB J 2003, 17:A797.
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P186 Pathophysiology of early ischaemia reperfusion injury of the colon in aortic surgery
N Khwaja, J Ghosh, V Howarth, M Murphy, R McMahon, P Brenchley, J Eddleston, M Walker
Manchester Royal Infirmary, UK
Critical Care 2004, 8(Suppl 1):P186 (DOI 10.1186/cc2653)
Introduction Ischaemia-reperfusion (I-R) injury of the colon has
been implicated in the systemic inflammatory response syndrome,
which may lead to multiple organ dysfunction syndrome and death.
The aim of this study was to investigate the early cellular events in
I-R injury using elective aortic surgery as a model.
Methods  Twenty patients undergoing elective abdominal aortic
aneurysm surgery were prospectively recruited. Ten underwent
conventional open repair and 10 had endovascular aneurysm
repair (EVAR). Mucosal biopsies of the sigmoid colon were taken
immediately preoperatively and postoperatively. Microscopic
examination was performed using H&E and TUNEL staining for
apoptosis, and in situ hybrdisation techniques were used to detect
IL-6 mRNA expression. Intraoperatively, systemic and splanchnic
blood was sampled in the conventional surgery group. In the EVAR
group only systemic blood was taken. Plasma was assayed for
nitrosothiols (nitric oxide donors) and IL-6.
Results There were no histological features of acute inflammation
in the preoperative or postoperative biopsies in either group. H&E
and TUNEL staining showed a 3.5-fold rise in apoptotic bodies
following conventional surgery. There was no significant change
following EVAR. IL-6 expression occurred in the colonic epithelium
localized to the base of the crypts. Splanchnic blood showed a
fourfold increase in nitrosothiols and a 22-fold increase in IL-6
within 15 min of reperfusion. Peripheral blood showed a five-fold
increase in IL-6 (Student’s t test P < 0.05).
Conclusions There is a significant increase in IL-6 release both
from the colon and in the systemic circulation following
reperfusion, which is accompanied by an increase in nitrosothiols.
The colonic epithelium is a source of IL-6. Apoptosis, rather than
necrosis, has been shown to be the principal mode of cell death in
early I-R injury.
P187 Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients
S Wort, A Rhodes, H Thomas, R Pearse, P Collinson
St George’s Hospital, London, UK
Critical Care 2004, 8(Suppl 1):P187 (DOI 10.1186/cc2654)
Introduction Risk stratification of severely ill patients remains
problematic, resulting in increased interest in potential circulating
markers, such as cytokines, procalcitonin and brain natriuretic
peptide. Recent reports have indicated the usefulness of plasma
DNA as a prognostic marker in various disease states such as
trauma, myocardial infarction and stroke. To our knowledge,
plasma DNA has not been investigated in the setting of the
critically ill patient in the intensive care setting.
Methods Fifty-two consecutive patients were studied in a general
intensive care unit. Blood samples were taken on admission and
stored for further analysis. Plasma DNA levels were estimated by a
PCR method using primers for the human β-haemoglobin gene.
Patients were followed up to 3 months.
Results Seventeen of the 52 patients investigated died within
3 months of sampling. Nineteen of the 52 patients developed
systemic inflammatory response syndrome, sepsis or severe
sepsis. Plasma DNA concentrations were found to be significantly
different between patients who died and those who survived
(nonsurvivors, median = 321.4 ng/ml, interquartile range
[IQR] = 245.3: survivors, median = 70.7 ng/ml, IQR = 67.1,P = 0.0003). In addition, plasma DNA concentrations were found
to be significantly different between patients who developed a
sepsis state and those who did not (septic patients,
median = 192.1 ng/ml, IQR = 298; nonseptic patients,
median = 73.8 ng/ml, IQR = 110.6, P = 0.03). Receiver operator
characteristic (ROC) curves were calculated for the use of plasma
DNA as a predictor of death and of sepsis (see Table 1).
Conclusions The results presented here demonstrate that plasma
DNA may be a useful prognostic marker of mortality and sepsis in
critically ill patients. Further research is clearly needed in the use of
this novel marker in the intensive care setting and into the possible
mechanisms of release/clearance of plasma DNA in disease
states.
Available online http://ccforum.com/supplements/8/S1
Table 1
Area under Standard Optimum  Likelihood
ROC curve error cutoff (ng/ml)) Sensitivity (%) Specificity (%) ratio
ITU survival 0.84 0.07 <123 80 92 10.3
Hospital survival 0.78 0.08 <81 70 87 5.6
Diagnosis of sepsis 0.69 0.07 >80 74 64 2.0
P188 Predictive markers for nosocomial infections in multiple trauma: comparison of 13 inflammation parameters
H Mitterhammer1, KH Smolle1, P Kaufmann1, R Aigner1, G Egger2
1University Hospital, Graz, Austria; 2Karl-Franzens University, Graz, Austria
Critical Care 2004, 8(Suppl 1):P188 (DOI 10.1186/cc2655)
Objective To estimate the capability of predicting nosocomial
infections of the inflammation parameters: polymorphonuclear
leukocyte (PMN) migration, white blood count, C-reactive protein,
PMN elastase, neopterin, IL-6 and IL-8, malondialdehyde, plasma
antioxidant capacity, procalcitonin, lactate and cortisol.
Setting The ICU of a surgical department.
Methods Twenty-six multiple trauma patients were enrolled in the
study, nine of whom developed infections during their hospital stay.
Inflammation parameters were measured daily until discharge from
the ICU.
PMN migration was determined in fresh, whole blood with a novel
ready-for-use membrane filter assay. The percentage of PMNs
migrating from the blood into a filter upon F-Met-Leu-Phe
stimulation was relevant. The other parameters were measured
with conventional methods. (commercially available methods).
Statistics  For each parameter, cutoffs between the groups of
infected patients before occurrence of infection and noninfected
patients were determined with receiver–operator characteristic
curves, and patients were assigned to one of two alternatives with
different specifications: did values occur that were beyond the
critical cutoffs at least on 2, 3, or 4 days; or at least on 2, 3, or
4 days in sequence, and vice versa: did such values not occur in a
patient? Contingency tables were set up for the yes–no decisions
for each specification in the infected and noninfected groups, and
sensitivity/specificity were calculated. Significance threshold was
P < 0.05 (Fisher’s exact test).
Results  The specifications with the highest significance were
taken as relevant. PMN migration below a cutoff of 6% at least
2 days in sequence occurred before infection in eight of the nine
infected patients, but only in three of the 17 noninfected patients
(i.e. a sensitivity of 88% and a specificity of 82%, P = 0.0008).
Fever ≥38°C for 3 days in sequence showed a specificity of 94%,
but a sensitivity of only 55% (P = 0.009). The other parameters
had no significant discriminative power.
Conclusions  Among a variety of related parameters, PMN
migration proved to be a sensitive predictive marker for infections.
Impaired PMN migration indicates impending infections. Early
recognition of an infection risk may help to initiate aggressive
antimicrobial therapy before clinical manifestation of infection, thus
improving therapeutic success.
P189 Procalcitonin as a marker of infection in critically ill patients
P Koukiasa, B Soulountsi, P Giallouris, A Vavlitou, M Filipescu, I Rodini, E Projia, M Bitzani
G. Papanikolaou Hospital, Thessaloniki, Greece
Critical Care 2004, 8(Suppl 1):P189 (DOI 10.1186/cc2656)
Objective To determine the value of procalcitonin (PCT) as a
marker of infection in critically ill patients with systemic
inflammatory response syndrome (SIRS) at any time during their
ICU stay.
Materials and methods We prospectively studied 23 patients that
suffered SIRS after their admission in a 23-bed general ICU.
Patients were divided in two study groups according to the time of
the onset of SIRS. Group A: eight patients (APACHE II score
19 ± 6, age 56 ± 18 years) who had SIRS within 7 days after
admission; and group B:14 patients (APACHE II score 17 ± 8, age
51 ± 19 years) who had SIRS after the first week of stay in ICU.
Clinical and laboratory measurements recorded for three
consecutive days included temperature (T), white blood count
(WBC), erythrocyte sedimentation rate (ESR), C-reactive protein
(CRP) and PCT. Infection was confirmed by positive blood,
bronchoalveolar lavage, urine or other body fluid cultures.
Statistical analysis To evaluate differences between studied
groups, a t test was used. Cutoff values for PCT were determinedusing Youden’s index. The sensitivity, specificity, positive predictive
value (PPV) and negative predictive value (NPV) of PCT were also
estimated.
Results Infection was confirmed in four (50%) patients in group A
and in 11 (79%) patients in group B. the serum concentration of
CRP, WBC, ESR and T was similar in both groups, as well as
between septic and nonseptic patients within each group. The PCT
value in group A did not differ significantly in comparison with
group B (7.1 ng/ml vs 0.5 ± 0.3 ng/ml, P = 0.06). However, septic
patients in group A had significantly increased PCT values compared
with septic patients in group B (9.48 ± 11 ng/ml vs 0.49 ± 0.3 ng/ml,
P < 0.05). The best cutoff value, sensitivity, specificity, PPV and NPV
for PCT in groups A and B are presented in Table 1.
Conclusions During the first week of recovery in the ICU, critically
ill septic patients have increased serum PCT levels. However, PCT
cannot reliably distinguish infection in patients with SIRS. On the
contrary, in prolonged ICU stay, the diagnostic value of PCT in
differentiating septic from nonseptic patients increases. It is
important to notice that the PCT value in late septic patients is very
close to considered normal values. Further studies are needed to
determine the prognostic value of PCT in critically ill patients.
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Table 1
Cutoff Sensitivity Specificity PPV NPV
value (%) (%) (%) (%)
Group A 5 ng/ml 50 25 40 33
Group B 0.5 mg/ml 64 33 78 20
P190 Diagnostic value of procalcitonin monitoring in cardiac surgery
N Beloborodova, D Popov
Bakoulev Scientific Center for Cardiovascular Surgery, Moscow, Russia
Critical Care 2004, 8(Suppl 1):P190 (DOI 10.1186/cc2657)
Objective To study the diagnostic value of procalcitonin (PCT)
monitoring in adult high-risk patients who underwent valvular
surgery.
Methods Sixty high-risk patients (mean age 51 ± 11 years) with
two or more risk factors (severe initial condition, proinflammatory
diseases in anamnesis, repeated operations, expected
cardiopulmonary bypass [CPB] time >2 hours, age >60 years,
preceding hospitalization and antibacterial therapy) were enrolled
into the study. Besides routine clinical investigations, which were
performed daily, blood plasma samples were collected before and
at 1, 2, 3 and 6 days after surgery. PCT values were determined
using the immunoluminometric assay (LUMItest® PCT, BRAHMS
Aktiengesellschaft, Germany). All patients were divided into two
groups: Group A without and Group B with postoperative
infectious complications. All data were compared by t test and
P < 0.05 was considered statistically significant.
Results There was no difference in age, CPB and aorta cross-
clamping time between the groups. Initial PCT concentrations did
not exceed normal values (<0.5 ng/ml). Postoperatively, 14/60
(23.3%) patients developed infectious complications
(10 pneumonia, one surgical site infection [SSI], one pneumonia and
SSI, one sepsis, one pneumonia and sepsis). The ICU and hospital
stay after surgery were significantly longer in Group B compared
with Group A (5.1 and 23.9 days vs 2.2 and 17.1 days, respectively,
P < 0.05). PCT levels were significantly higher in patients with
infection during all the observation period, while the difference
between the groups in APACHE II score appeared only from the
second day postoperatively. The data are presented in Table 1.
Conclusions PCT levels are higher and remain increased for
longer in patients with postoperative infection. PCT monitoring is
useful for early diagnostics and prediction of severe postoperatice
infections in cardiac surgery.
Table 1
Group A Group B P
Day1
APACHE II 8 11 NS
PCT (ng/ml) 3.51 7.58 0.03
Day 2
APACHE II 7 12 0.01
PCT (ng/ml) 2.66 8.99 0.01
Day 3
APACHE II 6 15 0.0002
PCT (ng/ml) 1.83 5.86 0.02
Day 6
APACHE II 4 12 0.0002
PCT (ng/ml) 0.33 2.80 0.002
P191 New diagnostic marker for sepsis: soluble CD14 subtype
K Shirakawa1, S Furusako1, S Endo2, Y Yaegashi2, H Inada2
1Mochida Pharmaceutical Co., Ltd, Gotemba, Shizuoka, Japan; 2Iwate Medical University, Morioka, Japan
Critical Care 2004, 8(Suppl 1):P191 (DOI 10.1186/cc2658)
Introduction Accurate and timely diagnosis of sepsis is essential
for the treatment of the early infected patients of systemic
inflammatory response syndrome (SIRS). But current diagnostic
methods for early detection and for detection of the severity of
sepsis have low sensitivity and poor specificity. This study aimed to
develop a new diagnostic marker, serum soluble CD14 subtype
(sCD14-ST), which was first discovered as a small molecular
weight of CD14 specific for sepsis.
Methods A small molecular weight of CD14 was discovered by a
new type of soluble CD14 ELISA, which was developed with two
types of anti-CD14 antibodies and evaluated using serum samplesof patient with sepsis, SIRS, other diseases and healthy control. At
the same time, the determination of the C-reactive protein,
endotoxin, soluble CD14 (IBL-Hamburg), procalcitonin (PCT)
(BRAHMS) and SOFA scoring were also carried.
Results The new assay detected the small molecular weight of
CD14 specifically, but not the 49 kDa and 55 kDa soluble CD14 in
serum. The concentration of normal controls (71 specimens) was
27.4 ± 14.4 (mean ± SD) ng/ml and the cutoff level was
established at 57 ng/ml (mean ± 2SD). The ELISA detected
94.5% (52/55) of sepsis and 16.3% (13/80) of SIRS. The mean
concentration of sepsis and SIRS was 248.2 ng/ml and
41.4 ng/ml, respectively. Sequential study of sCD14-ST was a
significant association with the SOFA score and serum endotoxin
level. Serum sCD14-ST increased in the very early phase of
infection, and was detected much faster and easier than the blood
culture test. The new assay was not correlated to soluble CD14
(IBL-Hamburg) and PCT (BRAHMS).
Conclusion This ELISA can detect specificallyu for sepsis during
the early phase of infection and is useful for monitoring the severity
of sepsis. The small molecular sCD14-ST is a new marker for
diagnosing sepsis.
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P192 Prediction of the development of organ failures in patients with systemic inflammatory response syndrome by
determination of plasma levels of soluble E-selectin
K Okajima1, M Koga2, H Suga2, M Abe2, T Nakagawa2
1Department of Diagnostic Medicine, Graduated School of Medicine, Kumamoto University, Japan; 2Tokyo Women’s Medical University
Daini Hospital, Tokyo, Japan
Critical Care 2004, 8(Suppl 1):P192 (DOI 10.1186/cc2659)
Aim Plasma levels of soluble E-selectin (SE) were shown to be
increased in patients with septic shock as a consequence of the
endothelial cell activation by tumor necrosis factor-alpha (TNF-α).
Excessive production of TNF-α induces systemic inflammatory
response syndrome (SIRS), which might frequently lead to the
development of organ failure by activating neutrophils. The present
study was undertaken to examine whether determination of plasma
levels of SE might predict the development of organ failures in
patients with SIRS.
Methods Subjects in the present study were 39 patients with
SIRS admitted to the emergency unit. Plasma levels of SE were
determined by ELISA at admission and 1, 3, 5, and 7 days after the
admission. The normal range of SE was 3.17–32.09 ng/ml. The
presence of various organ failures was diagnosed when patients
had the SOFA score higher than 3 points in each organ
dysfunction scoring system. A two-sided Fisher’s exact test was
used to analyze the difference in the incidence of organ failure and
the mortality. P < 0.05 indicated the statistical significance.
Results and discussion SOFA scores in the first 8 days in the
emergency unit were significantly higher in patients with elevated
SE levels at admission (DAE group, n = 15) than those with normal
SE levels at admission (DAN group, n = 24). The incidence of
respiratory failure in that period was significantly higher in the DAE
group (73.3%) than in the DAN group (16.7%) (P < 0.01), and that
of renal failure was also significantly higher in the DAE group
(33.3%) than in the DAN group (0%)(P < 0.01). The mortality at
28 days after admission in the DAE group (20.0%) was
significantly higher than that in th eDAN group (0%) (P < 0.05).
These observations suggested that determination of plasma levels
of SE might be useful for prediction of the development of organ
failures, especially that of respiratory and renal failure, and the
outcome of such patients with SIRS might have the potential risk
for development of multiorgan failure.
P193 Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the expression of
adhesion molecules on human umbilical vascular endothelial cells
T Schroeder, F Neuscheler, C Karcher, H Dieterich, B Nohé
University of Tuebingen, Germany
Critical Care 2004, 8(Suppl 1):P193 (DOI 10.1186/cc2660)
Introduction Leucocyte adhesion contributes to perfusion
abnormalities and tissue damage, and during trauma, shock or
overwhelming inflammation. This study was performed to determine
whether the lipoxygenase inhibitor phenidone and derivatives
decrease the expression of adhesion molecules on stimulated
endothelial cells and attenuate leucocyte–endothelial interactions
under flow in vitro.
Methods TNF-α-stimulated human umbilical vascular endothelial
cells (HUVEC) were incubated with phenidone, 4-methyl-
phenidone, 4-4-dimethyl-phenidone, 5-methyl-phenidone, 5-phenyl-
phenidone, and indometacin. We tested the inhibition of adhesion
molecule expression (intracellular adhesion molecule-1 [ICAM-1],
vascular cell adhesion molecule-1 [VCAM-1], E-selectin) on
TNF-α-stimulated HUVEC after preincubation, coincubation and
postincubation of the derivatives. The inhibition of endothelial cell
expression was measured by flow cytometry and northern blot
analysis. Adhesion of isolated leucocytes to pretreated
endothelium was examined in a parallel plate flow chamber at a
shear stress of 1.5 dynes/cm2.
Results All cyclooxygenase and lipoxygenase inhibitors
downregulated E-selectin, ICAM-1 and VCAM-1 in a dose-dependent
manner after preincubation. Coincubation and postincubation did not
decrease adhesion molecule expression. 4-4-Dimethyl-phenidone
was the most effective compound (IC50 273 µM), compared with the
other tested cyclooxygenase and lipoxygenase inhibitors.
Lipoxygenase inhibitors decreased E-selectin expression in northern
blot analysis, whereas E-selectin expression was increased after
indometacin incubation. Similarly, leucocyte adhesion was attenuated
under flow conditions. We conclude that lipoxygenase inhibitors are
able to decrease systemic inflammatory endothelial cell response.
Conclusion Lipoxygenase Inhibitors are of therapeutical interest
for the treatment of overwhelming systemic inflammation during
shock, trauma, and sepsis.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P194 Microdialysis: an innovative new tool to detect endotoxin tolerance
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Metabolic changes in different organs in the critical state are often
subtle and remain unrecognized with conventional hemodynamic
and metabolic parameters. Since the development of the
microdialysis technique, which mimics the passive function of a
capillary blood vessel, it is now possible to examine the interstitial
space of intact tissue.
Preconditioning an animal with low doses of endotoxin has been
shown to induce endotoxin hyperresponsiveness, the so-called
‘endotoxin tolerance’. The exact pathophysiological mechanism
involved has still not been fully elucidated. It appears to represent
an essential mechanism to prevent unreasonable expansion of
inflammatory or indiscriminate immune and metabolic responses
before specific antibodies are developed. Up to this study, no data
were available about the effect of endotoxaemia with and without
endotoxin preconditioning regarding regional metabolic monitoring
by the microdialysis technique.
Materials and methods Ten pigs (25 ± 8 kg) were randomly
assigned to a control group (n = 5) and a pretreated group (n =5 )
before endotoxaemia was induced. Pretreatment consisted of
injecting incremental doses of endotoxin (SAE) on days 5–2 before
the experiment ranging from 5 ng/kg on day 5, 10 ng/kg on day 4,
30 ng/kg on day 3 to 50 ng/kg on day 2. The control group
received saline injections at the same time intervals. The day prior
to the experiment, neither group received any injection.
Discussion  The main findings of this study describe various
metabolic consequences of endotoxin preconditioning prior to
lethal endotoxin shock, but also the effects of endotoxaemia per se
on local metabolism in three tissue compartments. This was only
possible by using sequential microdialysis technique.
Molecules in the tissue (extracellular fluid) surrounding the
microdialysis capillary diffuse through the semipermeable part of
the capillary to the dialysate, which is pumped through the
capillary. Changes in the concentrations of a substrate in the
surrounding milieu are reflected by the concentration in the
dialysate. Thereby, sampling of the dialysate at different time
intervals, and subseqeuent analysis of the concentration, gives an
idea of a substrate’s concentration in the extracellular space over
the observation time.
The role of cellular metabolism during sepsis is a highly
controversial issue. While some studies suggest that tissue blood
flow is reduced during endotoxaemia (leading to cellular oxygen
debt and, consequently, to anaerobic metabolism), other studies
suggest the septic insult to be a cellular dysoxia.
Our data clearly confirm that endotoxaemia is accompanied by an
increase in metabolism in various tissues and in systemic oxygen
consumption.
P195 Serum lipids analysis in septic shock patients
S Cappi, A Nogueira, L Giusti, C Valeri, W Hoshino, M Lins
Hospital Universitario da USP, Sao Paulo, Brazil
Critical Care 2004, 8(Suppl 1):P195 (DOI 10.1186/cc2662)
Objective Not much is currently known about lipoproteins and its role
in septic shock.Many studies have recently implicated lipoproteins
with the innate immunity against lipopolysacchardie. There are many
questions of whether low values of serum lipoproteins are related to
an impaired innate immunity against endotoxin and to a poor
prognosis. We conducted a prospective study to analyze serum
lipids, glucose, triglycerides and C-reactive protein in septic shock
patients and to evaluate its possible relation with outcome.
Design A prospective observational analysis of serum of patients
meeting the criteria for septic shock.
Setting A 28-bed medico-surgical ICU in a university hospital.
Patients Eighteen patients were analyzed in the study.
Materials and methods We selected all consecutive patients who
met the criteria for septic shock in our ICU and we collected blood
samples for analysis on days 1, 3, 6, 9, and 12 or until death.We
analyzed total cholesterol, cholesterol fractions (high density
lipoprotein [HDL], low density lipoprotein, very low density
lipoprotein), triglycerides, glycemia and C-reactive protein (as a
marker of inflamation).
Statistical analysis All results are presented as the mean with
standard deviation. For analysis we divided patients into survivors
and nonsurvivors at day 12. We performed a paired Student’s t
test for differences in continuous variables, and correlation
coefficients were determined according to multiple-level regression
analysis. P < 0.05 was considered significant.
Results Our mortality rate was 60%. We had 10 patients in the
nonsurvivor group and eight patients as survivors. The two groups
had similar APACHE II scores (nonsurvivors 26 ± 6; survivors
24 ± 5; NS). At day 1 there were no statistical differences for any
of the substances analyzed. From day 3 onwards, we achieved
significant statistical differences between survivors and
nonsurvivors for total cholestherol, HDL fraction, trigycerides,
glycemia and C-reactive protein. The correlations of C-reactive
protein with the HDL fraction, total cholesterol, triglycerides and
glycemia were not good. As independent variables, we found only
glycemia and trigycerides.
Conclusions  In our patients, hypocholesterolemia, low levels of
HDL fraction, hypertriglyceridemia and hyperglicemia were
statistically significant related to a poor prognosis. C-reactive
protein did not show a good correlation with other parameters.Available online http://ccforum.com/supplements/8/S1
P196 Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome in patients with systemic
inflammatory response syndrome
P Garred1, J Strøm2, L Quist2, E Taaning2, H Madsen1
1Rigshospitalet, Copenhagen, Denmark; 2Glostrup Hospital, Copenhagen, Denmark
Critical Care 2004, 8(Suppl 1):P196 (DOI 10.1186/cc2663)
Genetic factors may predispose to increased risk for sepsis in
critically ill patients. Mannose-binding lectin (MBL) is an important
factor in innate immune defence. Accordingly, we investigated
whether MBL gene polymorphisms causing low levels of functional
MBL in the the blood are associated with the development and
progression of sepsis in adult intensive care patients. In 272 patients
with systemic inflammatory response syndrome followed
prospectively, different MBL genotypes were compared with respect
to microbiology, sepsis development, and survival. The presence of
MBL variant alleles was highly significantly associated with
development of sepsis, severe sepsis and septic shock in a gene
dose-dependent fashion. An increased risk of death was observed in
variant allele carriers. These data show that a genetic factor such as
MBL insufficiency plays an important role in the susceptibility of
critically ill patients for development and progression of sepsis, and
confer a substantial risk for fatal outcome.
P197 Upregulation of renal inducible NO synthase and proximal tubule damage during human endotoxemia
S Heemskerk, P Pickkers, L van Eijk, H van der Hoeven, W Peters, F Russel, R Masereeuw
University Medical Centre Nijmegen, The Netherlands
Critical Care 2004, 8(Suppl 1):P197 (DOI 10.1186/cc2664)
In the kidney, the free radical nitric oxide (NO) participates in
several vital processes, although excessive NO production,
through inducible NO synthase (iNOS), can be cytotoxic. iNOS is
predominantly, but only weakly, expressed in renal proximal
tubules. Animal experiments demonstrate that an induction in iNOS
expression occurs during systemic inflammation. In humans, renal
effects of endotoxemia are unknown.
The objective of the present study was to investigate the
pathophysiological role of iNOS induction in renal proximal tubules
during experimental endotoxemia in humans.
A bolus injection of 2 ng/kg lipopolysaccharide of Escheria Coli
(0113) was administered to eight healthy volunteers (four
male/four female, age 24 ± 3 years), and 11 volunteers (five
male/six female, age 22 ± 2 years) received the vehicle only
(controls). At different time points, arterial blood in urine was
collected and analyzed for nitrates/nitrites, the stable metabolites
of NO. The amount of iNOS mRNA was determined by quantitative
real-time RT-PCR from isolated cells of the urine. The urinary
excretion of both glutathione-S-transferase-α (GST-α, present only
in proximal tubular cells) and glutathione-S-transferase-π (GST-π,
confined to distal tubular cells) were measured as well.
Administration of endotoxin resulted in the expected increase of
proinflammatory cytokines (TNF-α from <0.015 to
856 ± 158 pg/ml,  P = 0.002), accompanied by fever (maximum
temperature 38.7 ± 0.3°C, P < 0.0001), flu-like symptoms and
cardiovascular changes (heart rate from 63 ± 3 bpm at baseline to
91 ± 3 bpm at t = 5 hours, P < 0.0001; and mean arterial pressure
from 96 ± 3 mmHg to 79 ± 4 mmHg, P < 0.0001). All changes
were significantly different from the control group. Blood samples
did not show a significant change in NO metabolites following the
administration of endotoxin. Twelve hours after endotoxin
administration, the urinary level of NO metabolites doubled
(P < 0.05), whereas no significant change was observed in the
control group. This effect was associated with an increase in iNOS
mRNA measured 24 hours after endotoxin administration. Urinary
excretion of GST-α increased from 0.7 ± 0.3 µmol/hour to
3.1 ± 1.3 µmol/hour at t = 12 hours (P < 0.01), whereas GST-π
remained unchanged (from 0.2 ± 0.04 to 0.4 ± 0.13 µmol/hour). In
controls, no difference in both GST-α and GST-π excretion was
observed.
Our results indicate that systemic inflammation induced by
endotoxin in humans results in upregulation of renal iNOS,
associated with proximal tubule injury.
P198 Moderate hypothermia during cardiopulmonary bypass (CPB) inhibits the intramyocardial synthesis of TNF-α α: a role of
p38 MAP kinase
M Qing, K Schmuacher, M Sokalmska, J Vazquez-Jimenez, M Seghaye
University Hospital, Aachen, Germany
Critical Care 2004, 8(Suppl 1):P198 (DOI 10.1186/cc2665)
Background and aim Moderate hypothermia during CPB inhibits
intramyocardial TNF-α synthesis. Since the expression of TNF-α
and other inflammatory mediators such as cyclooxygenase-2
(COX-2) and inducible nitric oxide synthase (iNOS) is regulated by
MAP kinases (p38 and ERK1/2 MAPK), and by the NF-κB
pathway, this study was intended to analyze the effect of moderate
hypothermia during CPB on these signaling pathways in the
myocardium.
Methods Twelve young pigs were assigned to a temperature (T°)
regimen during standarized CPB: normothermia (T° = 37°C; n =6 )
or moderate hypothermia (T° = 28°C; n = 6). Myocardial probes
were sequentially sampled from the right ventricle before, during
and 6 hours after CPB. Myocardial expression of TNF-α, COX-2,
and iNOS were detected and quantified by competitive RT-PCR
and/or western blot. Phosphorylation of p38 MAP and ERK1/2
MAP kinases, and of IκB was detected by western blot.
Intracellular localisation of TNF-α, COX-2, iNOS, and NF-κB p65
and p50 were ensured by immunohistochemical staining.
Results Both TNF-α mRNA and protein levels were detected as
soon as 30 min after initiation of CPB and before aortic clamping in
both groups, but were lower in pigs that were on hypothermia than
in the others (P < 0.05, respectively). This difference persistedduring and after CPB. The levels of iNOS and COX-2 were detected
during and after CPB but without any difference between groups.
Phosphorylation of p38 MAP and ERK1/2 MAP kinases and of IκB
was detected before, during and after CPB. Levels of phospho-p38
MAP kinase but not of ERK1/2 MAP kinase and IκB tended to be
lower in animals on hypothermia than in the others (P < 0.1).
Conclusion This study shows for the first time that cardiac surgery
induces the expression of TNF-α in the myocardium as soon as
30 min after institution of CPB, before aortic clamping. This is
associated with the activation of p38 MAP and ERK1/2 MAP
kinases and NF-κB pathway. The inhibition of TNF-α expression by
hypothermia is related to the inhibition of p38 MAP kinase.
Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P199 Acute and high-dose therapy of urinary trypsin inhibitor could inhibit vascular endothelial cell disorders in critical illness
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Introduction Urinary trypsin inhibitor (UTI) (MIRACLID®, Mochida
Corp., Tokyo, Japan), an elastase inhibitor extracted from human
urine, has been used to treat for patients with acute pancreatitis or
acute circulatory failure since more than 15 years ago in Japan.
Objective The current study was performed in order to evaluate
the efficacy of UTI for vascular endothelial disorders in critical
illness.
Materials and methods  Thirteen severe patients, who had an
APACHE II score above 20 at transportation to our emegency
room, were elected and randomly assigned to either a treated
group or a control group. The number of patients in the treated
group was five and eight patients were in the untreated group.
Maximum dose of UTI (30,000 U/ml) were administrated to
patients in the treated group at the emergency room. After
admission in the ICU, the neutrophil elastase level, IL-6 level,
thrombomodulin (TM) level, protein C level and UTI level in plasma
were examined daily until the 7th day after hospitalization. Values
are expressed as mean ± SD. An unpaired Student’s t test was
used and P < 0.05 was considered statistically significant.
Results In the untreated group, the UTI level in plasma at the 7th
day after hospitalization was siginificantly higher than that in the
treated group (96.9 ± 44.4 vs 15.6 ± 6.5 U/ml, P < 0.05). Also, the
TM level was also significantly different between the untreated
group and the treated group (6.0 ± 2.4 vs 3.6 ± 1.4 FU/l, P < 0.05)
at the 7th day. Other examination values showed no significant
differences between the two groups during their clinical courses.
Conclusion The half-time of UTI is very short (about 40 min) and
the plasma level linear decreases until 3 hours after its
administration. The difference of UTI level on the 7th day was
considered as spontaneous UTI. And vascular endothelial
disorders were recognized in the higer UTI level group at the same
day, but this group was the untreated group. This study proposes it
i important for high-dose administration of UTI at a very acute
phase in critical illness to inhibit the vascular endothelial disorders.
P200 Effects of urinary trypsin inhibitor for trauma patients
Y Deguchi, Y Soga, H Suga, T Nakagawa
Tokyo Women’s Medical University School of Medicine, Arakawa, Tokyo, Japan
Critical Care 2004, 8(Suppl 1):P200 (DOI 10.1186/cc2667)
We investigated the effect of urinary trypsin inhibitor (UTI) on the
output of plasma mean neutrophil elastase (PMNE) and cytokine.
The participants of this study are 15 trauma patients with shock on
arrival at our insutitution. We divide them in two groups: one group
is administrated 300,000 U (intravenous) UTI, and the other is the
control group. At 0, 1, 3, 5, and 7 days after hospitalization of each
group, we measured the serum levels of IL-6, IL-8, UTI, PMNE,
thrombomodulin, protein C, and the SIRS score and SOFA score
as an index of severity.
The PMNE levels in the UTI-administered group were observed to
be significantly lower than those in the control group at 1 and
3 days after hospitalization.
These data suggest that. UTI can suppress vascular endothelial
cell disorders by inhibiting the production of PMNE and by direct
inhibition of PMNE.
P201 Exosomes derived from plasma of septic patients induce myocardial dysfunction
L Azevedo1, V Pontieri1, P Tucci2, F Laurindo1
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Critical Care 2004, 8(Suppl 1):P201 (DOI 10.1186/cc2668)
Background Exosomes are small vesicles (50–100 nm) released
from cells after activation. We have previously shown that
exosomes derived from platelets of septic patients induce
apoptosis of endothelial and vascular smooth muscle cells through
a redox-dependent pathway. Since reactive oxygen species may be
involved in myocardial dysfunction of sepsis, the aim of this study
was to investigate a possible role of exosomes in sepsis-induced
myocardial dysfunction.
Methods Exosomes were separated by filtration and
ultracentrifugation of plasma from 26 septic shock patients (SSP)
and from 10 healthy volunteers. After separation, exosomes were
infused at a 0.5-fold plasma concentration in Langendorff-perfused
hearts from 22 New Zealand rabbits. In other experiments,
12 isolated rat papillary muscles were exposed to a 0.5-fold
plasma concentration of exosomes from septic patients and
healthy controls.Results Incubation of exosomes from SSP for 20 min induced a
17% and 30% reduction in positive and negative time–pressure
derivatives, respectively (n = 7, P < 0.05). Incubation of exosomes
from healthy volunteers for the same time induced a nonsignificant
9% and 19% decrease in positive and negative time–pressure
derivatives, respectively (n = 5, P = NS). This effect was 60% and
83% inhibited by L-NMMA (10–4 M). Exposure of rat papillary
muscles to exosomes from SSP caused decrease in developed
tension (3.22 ± 0.77 g/mm2 pre vs 2.86 ± 0.80 g/mm2 post, n =8 ,
P = 0.007) and in positive time–tension derivative
(31.8 ± 9.32 g/mm2/s pre vs 28.06 ± 9.31 g/mm2/s post, n =8 ,
P = 0.01). Incubation with exosomes from healthy volunteers
induced no significant difference in developed tension
(3.08 ± 0.61 g/mm2 pre vs 2.95 ± 0.72 g/mm2 post, n = 4, P = NS)
and in positive time–tension derivative (34.18 ± 6.03 g/mm2/s pre
vs 34.45 ± 6.75 g/mm2/s post, n = 4, P = NS).
Conclusion Infusion of exosomes from platelets of septic patients
induces myocardial dysfunction in isolated rabbit hearts and in rat
papillary muscle preparations. The attenuation of dysfunction after
exposure to nitric oxide (NO) inhibitor L-NMMA indicates a
possible role for NO in exosome-induced myocardial depression.
Available online http://ccforum.com/supplements/8/S1
P202 Benzisothiazole derivative inhibits toll-like receptor 4 signal transduction and prevents mice from the lethal shock
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Critical Care 2004, 8(Suppl 1):P202 (DOI 10.1186/cc2669)
Sepsis is a syndrome, a consequence of an overwhelming
systemic response to infection. It rapidly leads to organ
dysfunction, which accompanies systemic inflammation and
hematological abnormalities. In Gram-negative bacteria,
lipopolysaccharide (LPS) has a dominant role for the activation of
various cells, which secrete several proinflammatory cytokines
including TNF-α. These cytokines are also important in inducing a
procoagulant effect in sepsis. On the other hand, toll-like
receptor 4 (TLR4) is responsible for the LPS signaling and causes
the activation of NF-κB. It is clear that an inappropriate TLR
response to bacterial infection could have critical consequences.
Therefore, TLR4 signal inhibitor is attractive as a therapeutic
medication for sepsis.
The benzisothiazole derivative (M62812) was found as a TLR4
signal transduction inhibitor using the reporter gene assay system.
It also suppressed LPS-induced upregulation of proinflammatory
cytokines, adhesion molecules and procoagulant activity in human
vascular endothelial cells and/or peripheral mononuclear cells. The
half-maximal inhibitory concentrations (IC50) of this compound in
these assays were ranging from 1 to 3 µg/ml. Single intravenous
administration of M62812 (10 mg/kg) protected mice from death
in murine D-galactosamine-sensitized endotoxin shock model
(Table 1). In this model, M62812 (20 mg/kg) completely improved
the elevation of inflammatory cytokines and the hematological
abnormalities. Furthermore, M62812 (20 mg/kg) also prevented
mice from the lethal shock in murine cecal ligation and puncture
model.
LPS is a potent and predominant microbial mediator that induces
an intense inflammation and procoagulant response, which are
closely correlated events. M62812 inhibits those responses in
vitro and prevents lethal shock in animal models. Therefore, we
concluded that it will become a novel therapeutic medication for
sepsis and septic shock by inhibiting TLR4 signal transduction and
improving endothelial cell and leukocyte cell functions.
Table 1
Group Survival rate (%)
M62812, 5 mg/kg 0
M62812, 10 mg/kg 50
M62812, 20 mg/kg 90
P203 The influence of N-acetyl cysteine infusion oncytokine levels and gastric intramucosal pH during severe sepsis
S Emet, D Memis, Z Pamukçu
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Critical Care 2004, 8(Suppl 1):P203 (DOI 10.1186/cc2670)
The purpose of the present study was to evaluate the effects of
continuously infused N-acetyl cysteine (NAC) on serum cytokine
levels and gastric intramucosal pH in humans suffering from severe
sepsis.
Fifty-three patients were included to the study. After applying
150 mg/kg NAC (n = 27, NAC group) bolus intravenously for
5 min, it was continued with 12.5 mg/kg/hour intravenously for
6 hours as an infusion. The control group (n = 26, control group)
was administered the same dose of dextrose 5% solution.
Hemodynamic parameters (heart rate, mean arterial pressure),
nasopharyngeal body temperature, arterial blood gas changes
(pH, PO2, PCO2), plasma cytokin levels (IL-1β, IL2-R, IL-6, IL-8,
tumor necrosis factor-α), biochemical parameters (hematocrit,
leucocyte, thrombocyte, urea, creatinin, total billirubin, direct
billirubin, total protein, albumin, serum glutamate oxalate
transaminase, serum glutamate piruvate transaminase, sodium,
potassium) and intramucosal pH, staying time in the intensive
care unit, time of mechanical ventilation support, and mortality,
with the control group, were recorded. All measurements were
obtained at baseline (15 min before start of the study) and were
repeated immediately after, and at 24 and 48 hours after NAC
infusion. No differences were found according to these
parameters.
We found that the effect of NAC infusion did not affect cytokine
levels or patients’ outcome or gastric intramucosal pH in severe
sepsis in humans. Because of the limited number of patients in our
study and the short period of observation, our findings need to be
confirmed by larger clinical trials of NAC infused in a dose-titrated
manner. However, our results do not support the use of NAC in
patients with severe sepsis.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P204 N-Acetylcysteine inhibits peroxynitrite-mediated damage in oleic acid-induced lung injury
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Since oleic acid (OA) induces morphologic and cellular changes
similar to those observed in human acute lung injury (ALI) and
acute respiratory distress syndrome (ARDS), it has become a
widely used model to investigate the effects of several agents on
pathogenesis of lung injury. The antioxidant, anti-inflammatory and
antiapoptotic properties of N-acetylcysteine (NAC) have been
documented in many lung injury models [1]. In this study, we
evaluated the role of NAC in an OA-induced lung injury model by
measuring myeloperoxidase (MPO) activity, malondialdehyde
(MDA) and 3-nitrotyrosine (3-NT) levels in lung tissue.
Five groups (sham, NAC, OA, pre-OA-NAC and post-OA-NAC)
were determined. ALI/ARDS was induced by intravenous (IV)
administration of OA. The pre-OA-NAC group received IV NAC
15 min before OA infusion and the post-OA-NAC group received
IV NAC 2 hours after OA infusion. In both of the NAC treatment
groups, blood and tissue samples were collected 4 hours after OA
infusion, independent of the time of NAC infusion.
The MPO activity, MDA and 3-NT levels in lung homogenates were
found to be increased in the OA group, and the administration of
NAC significantly reduced tissue MPO, MDA and 3-NT levels
(P = 0.0001). Lung histopathology was also protected by NAC in
this OA-induced experimental lung injury model.
In conclusion, the present study demonstrates that oleic acid
induces myeloperoxydase activation and consequently increases
3-NT and MDA levels in lung tissue. Our data suggest that elevated
3-NT levels in lung tissue represent the role of excessive formation of
peroxynitrite and the efficacy of NAC treatment in the prevention of
peroxynitrite-mediated OA-induced lung injury. Due to its antioxidant
and antiinflammatory properties, NAC seems to be a promising
agent in treatment of critically ill patients with lung injury states.
Reference
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acetylecysteine on apoptotic lung injury in CLP-induced
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P205 Therapeutic neutralization of interferon-gamma in primates prevents lethality in Gram-negative bacteremic shock
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Background The treatment of severe sepsis and septic shock with
anticytokine therapies remains a dilemma. Although a number of
preclinical studies have shown efficacy in primate models of
bacteremic shock when administered prophylactically, these same
therapies have a much diminished effectiveness when
administered therapeutically.
Aim This study investigated whether therapeutic administration of
a novel antihuman interferon-gamma (anti-IFNγ) monoclonal
antibody (mAb) could improve outcome in a lethal model of Gram-
negative bacteremic shock.
Methods Gram-negative bacteremic shock was induced in
14 anesthetized Cynomolgus monkeys by intravenous injection of
approximately 10 (10) cfu live Escherichia coli. Treatment was
administered only after the animals developed symptoms of shock
meeting at least two of the predefined criteria: 30% reduction in
blood pressure, 30% increase in heart rate and oliguria (urine output
<1 ml/kg body weight/hour). Six of the animals received placebo
while eight were treated with 10 mg/kg humanized anti-IFNγ mAb.
Invasive hemodynamic monitoring under anesthesia was continued
for 12 hours, after which the animals were returned to their cages,
and were followed daily for clinical signs during 14 days.
Results Five out of the six placebo-treated Cynomolgus monkeys
died or required euthanasia within 24–72 hours after E. coli
challenge, while one animal survived for 5 days. In contrast, six of
the eight animals treated with the humanized anti-IFNγ mAb
survived for 7–14 days (P = 0.013 vs placebo). More specifically
within the treated group, two animals died early of sepsis (day 3
and day 4, respectively), two animals were euthanized on day 7
because of limb necrosis (caused by catheter-related thrombosis)
and not directly because of the sepsis symptoms, one animal was
euthanized on day 9 due to sepsis symptoms, and three animals
survived 14 days and appeared to be in good health. Treatment
with the anti-IFNγ mAb decreased the systemic TNF-α, IL-6 and
IL-1β response to E. coli. Furthermore, renal dysfunction,
evidenced by increased creatinine, was significantly decreased by
treatment with the anti-IFNγ mAb.
Conclusions This study demonstrates that, in a primate model of
E. coli-induced septic shock, the neutralization of IFNγ with a mAb,
administered after the onset of clinical signs of sepsis, improves
survival and attenuates the pathological changes associated with
the development of multiple organ dysfunction. This suggests that
IFNγ blockade potentially represents an effective mode of
intervention in lethal septic shock.
P206 Predicting the response to therapy from a mathematical model
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Objectives To determine the feasibility and usefulness of
computer simulations in evaluating therapeutic strategies and
patient selection in clinical trials of sepsis.
Methods We simulated an interventional trial of a neutralizing body
against tissue necrosis factor (anti-TNF) in sepsis based on a
mechanistic mathematical model that includes a bacterial infection,the host response, and a therapeutic intervention. Simulated cases
differed by bacterial load and virulence, as well as individual
propensity to mount and modulate an inflammatory response. We
submitted 1000 cases to three doses and durations of anti-TNF,
and present the results of the simulation. To evaluate the usefulness
of modeling to improve patient selection, we constructed a logistic
model with a four-valued outcome: (1) helped by treatment, (2)
survives irrespective of treatment, (3) dies irrespective of treatment,
and (4) harmed by treatment. Independent predictors were
‘measured’ at the time of disease detection and 60 min later, and
included serum TNF, IL-10, IL-6, activated protein C, thrombin,
tissue factor, blood pressure and cell counts. All results from the
statistical model are reported in a validation cohort.
Results Control survival was 62.9% at 1 week. Depending on the
dose and duration of treatment, survival ranged from 57.1% to
80.8%. Higher doses of anti-TNF, although effective, also resulted
in considerable harm (Fig. 1). Discrimination of serum IL-6 to
identify cases harmed by treatment was moderate with
ROC = 0.72, compared with 0.98 for a statistical model. Following
the statistical model’s recommendation for treatment, only 26.5%
of the cohort would have received treatment and 2.4% patients
would have been harmed, whereas indiscriminate administration
would have harmed 14.8% of patients.
Conclusions Our models points out how to improve patient
selection and how therapy could be individualized.
Available online http://ccforum.com/supplements/8/S1
Figure 1
P207 Effect of interferon gamma on sepsis-related death in patients with immunoparalysis
N Takeyama, T Tanaka, T Yabuki, K Nakatani, T Nakatani
Kansai Medical University, Osaka, Japan
Critical Care 2004, 8(Suppl 1):P207 (DOI 10.1186/cc2674)
Impaired host defense mechanisms following surgical stress such as
burn, major surgery and polytrauma are considered important for the
development of infectious complications and sepsis. We tested
whether interferon (IFN) gamma can improve monocytic and
lymphocytic functions and can reduce deaths related to sepsis. In
order to restore their antimicrobial defense capacity, recombinant
human IFN-gamma, 100 µg, was administered intravenously once
daily to six immunoparalyzed patients. Informed consent was
obtained from patients in all cases, and the study received local
hospital ethical committee approval. Intracytoplasmic Th1 and Th2
cytokine production in isolated peripheral blood mononuclear cells
was assessed by flow cytometry following in vitro activation by
phorbol myristate acetate plus ionomycin. Monocytic human
leukocyte antigen-DR (HLA-DR) expression was also measured.
Immunoparalysis was defined as a decreased level of HLA-DR
expression of monocytes <30% or a decreased level of Th1 <10%.
IFN-gamma applied to immunoparalytic patients with low monocytic
HLA-DR expression restored the deficient HLA-DR expression and
in vitro Th1 cytokine production completely within 3 days. Recovery
from immunoparalysis resulted in clearance of sepsis in four of six
patients. IFN-gamma administration in septic patients accompanied
with immunoparalysis is a new therapeutic strategy.
Table 1
HLA-DR (%)  HLA-DR (%)  Th1 (%)  Duration of IFN 
Age (years) before IFN 3 days after IFN before IFN treatment (days) Outcome Diagnosis
45 27.9 43 4 12 Dead Flame burn
72 7.5 19 3 12 Dead Ileus
30 8 21 2.2 3 Dead Pneumonia
37 25.1 33 9 12 Live Peritonitis
56 29.7 74 9 7 Live Peritonitis
75 27 56 8.9 5 Live Pneumonia
P208 Cervical spine injury: factors associated with secondary pneumonia
H Mehdaoui, H Pascal-Mousselard, P Schott, B Dubois, R Valentino, D Joachim-Arnaud
Fort De France University Hospital, Martinique
Critical Care 2004, 8(Suppl 1):P208 (DOI 10.1186/cc2675)
Pneumonia is a life-threatening complication for cervical spine
injured patients. We studied a retrospective cohort of
80 consecutive patients admitted between 1998 and 2002 in the
Emergency Department. Mean age was 43 ± 16 years, sex ratio(female/male) 0.13. Mean SAPS II score was 22 ± 10. Patients
with pneumonia were older (49 ± 16 years vs 41 ± 16 years,
P < 0.05) and had a higher SAPS II score (26 ± 10 vs 18 ± 9,
P < 0.01). The delay of admission in the critical care unit (CCU)
was higher in the pneumonia group (0.3 ± 0.7 days vs
3.2 ± 4.0 days,  P < 0.01). The delay of handling by a
physiotherapist was also higher (3.7 ± 2.0 days vs 8.1 ± 8.0 days,
P < 0.01). Pneumonia was associated with a longer period of
mechanical ventilation (10 ± 11 days vs 21 ± 13 days, P < 0.05)
and a longer stay in the CCU (8.6 ± 9.5 vs 39.2 ± 29.3,
P < 0.0001). Univariate analysis of qualitative factors is presented
in Table 1. Early mechanical ventilation, upper cervical spine
involvment and inhospital mortality were not related to pneumonia.
Overall mortality is higher in the pneumonia group.
Our study suggests that an early and aggressive handling of
patients with cervical spine injury, particularly with complete motor
deficit, could be beneficial to decrease pneumonia incidence and
its associated adverse events.
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Table 1
Odds ratio P value
Fall 3.72 (1.39–10.34) 0.01
Hypotension 3.08 (1.07–9.08) 0.05
Neurovegetative disease 5.24 (1.62–18.19) <0.001
Catecholamine infusion 5.38 (1.80–16.96) < 0.01
Atelectasis 14.99 (4.71–55.61) < 0.0001
Pleural drain 5.24 (1.62–18.19) < 0.02
Partial motor deficit 0.12 (0.04–0.36) < 0.001
Decubitus ulcer 11.68 (3.38–48.42) < 0.001
Overall mortality 10.90 (1.42–226) < 0.05
P209 Ventilator-associated pneumonia in children: evaluation of clinical pulmonary infection score in monitoring the course of
illness
F Grasso, G Chidini, L Napolitano, E Calderini
Istituti Clinici di Perfezionamento, Milano, Italy
Critical Care 2004, 8(Suppl 1):P209 (DOI 10.1186/cc2676)
In the past few years the clinical pulmonary infection score (CPIS)
has been purposed as a diagnostic tool in ventilator-associated
pneumonia (VAP). The CPIS incorporates five variables:
temperature (T°C), white blood cells (WBC), tracheal secretions,
pO2/FiO2 and RX. The range of CPIS is from 0 to 12 and its
positive predictive value (PPV) has been found >90% at a cutoff
point ≥6. Recently, the CPIS was purposed in order to monitor the
course of VAP and the efficacy of therapy.
Objective To evaluate the CPIS in diagnosis of and monitoring the
course of illness in children with VAP.
Design A retrospective observational study.
Setting Pediatric ICU in a national children hospital.
Patients Forty consecutive children admitted to the pediatric ICU
and mechanically ventilated >48 hours were observed for
developing VAP between 2002 and 2003. In patients who did not
develop VAP the study was suspended at weaning time. Fifteen
patients were enrolled who developed VAP; the diagnosis was
based on microbiological data (quantitative cultures of
bronchoalveolar lavage [BAL] fluids or mini BAL).
Data collection CPIS was collected 48 hours before diagnosis of
VAP, at diagnosis, and daily for the first week. In all patients were
evaluated the mean PAW, positive end expiratory pressure (PEEP),
PO2/FiO2, RX score, PCR, WBC, T°C and number of bronchial
suctionings/day. We have also evaluated the influence of each
parameter of CPIS on the final score. Data were analysed with the
Student t test (P < 0.05*), chi square (P < 0.05**) and univariate
analysis (correlation coefficient R2***).
Results In our population the incidence of VAP was 37%
(15/40 patients) with mortality 27% (four patients). The mean
CPIS value at the time of diagnosis was statistically higher than 48
and 24 hours before in all patients (4.9 ± 0.8 vs 7.5 ± 1.5,
P < 0.05); in 14/15 patients it was ≥6 (PPV 93%). At day 3 after
diagnosis the population was divided into two groups: patients
with CPIS ≥6 (group 1, n = 5) and patients with CPIS <6
(group 2,  n = 10). At this time between the two groups were
reported statistically significant differences in PEEP (10.5 ± 1 vs
5.6 ± 2.7,  P < 0.05*), PAW max (27.5 ± 6.6 vs 14.7 ± 8.6,
P < 0.05*), pO2/FiO2 (145 ± 10 vs 282 ± 20, P < 0.05*), PCR
reduction >30% (20% vs 50% of patients, P < 0.05**) and
microbiological positivity (80% vs 20%, P < 0.05**). pO2/FiO2
increases significantly in group 2 (P < 0.05*) and univariate
analysis revealed that only pO2/FiO2 is related to the CPIS score
(R2***0.77***); WBC, T°C, number of suctioning/day and RX
score are not related. All patients with CPIS <6 survived whereas
80% of patients with persistently high CPIS after 72 hours from
diagnosis of VAP died. The analysis of the MSOFA score revealed
significant differences in circulatory (P < 0.05*) and respiratory
(P < 0.05*) scores between those who died and survivors at day 3
and later after diagnosis of VAP.
Conclusions CPIS had an elevated PPV in diagnosis of VAP
(93%), and is an early predictor of poor outcome in patients with
VAP and allows a good monitoring of the course of illness.
Reference
1. Luna, et al.: Resolution of VAP: prospective evaluation of the
CPIS as an early predictor of outcome. Crit Care Med 2003,
31:676-682.Available online http://ccforum.com/supplements/8/S1
P210 Comparison of bronchoalveolar lavage and endotracheal aspirates culture sampling with clinical pulmonary infection
score on diagnosis of ventilator-associated pneumonia
E Güler1, F Kahveci2, H AkalIn2, M SInIrtas2, S Bayram2, B Özcan2
1STATUS, Bursa, Turkey; 2Uludag University School of Medicine, Bursa, Turkey
Critical Care 2004, 8(Suppl 1):P210 (DOI 10.1186/cc2677)
Aim Ventilator-associated pneumonia (VAP) is a common cause of
morbidity in ICU patients. There is still no evidence that invasive
bronchoscopic techniques should form part of a routine approach
to suspected VAP [1]. In our study, we compared specimen results
in terms of sensitivity and specificity that were taken with
bronchoalveolar lavage (BAL) fluid and endotracheal aspirates
(ETA) and we examined the value of clinical pulmonary infection
score (CPIS) in the diagnosis of VAP.
Materials and methods The study included 50 adult patients in
the ICU, who received mechanical ventilation for more than
48 hours, did not receive antibiotherapy and in whom VAP was
clinically suspected. Patients who have contraindications for
bronchoscopy were excluded. The VAP was defined by clinical
criteria as follows: presence of a new or progressive lung
infiltration on chest X-ray, plus at least two of the following clinical
criteria; fever 380°C or 360°C, white blood cell count
>10,000 mm3 or <5000 mm3, purulent ETA. Microbiologic
sampling procedures were performed in patients using both distal
tracheal suction and BAL. CPIS was calculated with a threshold
value of 6, enabling identification of VAP patients.
Results We determined BAL ≥104 colony-forming units (cfu)/ml in
all patients with ETA ≥105 cfu/ml and exact conformity was
achieved. We determined BAL ≥104 cfu/ml, ETA were ≥104 to
<10 5 cfu/ml in 18 patients. Although ETA results were below the
threshold level, they showed conformity with BAL results in
18 patients. We accepted BAL ≥104 cfu/ml as a reference value of
CPIS  ≥6, and we determined sensitivity of 83% and positive
predictive value of 50% during the diagnosis. When we accepted
CPIS ≥6 as a reference value, the possibility of inaccurancy of
diagnosis is high in every one of the two patients with VAP. Nearly
one patient was missed in every five patients with VAP.
Conclusions BAL results did not provide superiority in the
diagnosis of VAP when compared with the ETA. A threshold level
≥104 cfu/ml may be reduced for ETA and evaluation of CPIS alone
is not suitable for diagnosis or exclusion of VAP.
Reference
1. Fagon JY, Chastre J, Wolff M, et al.: Invasive and noninvasive
strategies for management of suspected ventilator-associated
pneumonia. A randomized trial. Ann Intern Med 2000, 132:621-
630.
P211 Ventilator-associated pneumonia with a closed versus an open endotracheal suction system
L Lorente, M Lecuona, C García, M Mora, A Sierra
Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
Critical Care 2004, 8(Suppl 1):P211 (DOI 10.1186/cc2678)
Objective To analyze the incidence of ventilator-associated
pneumonia (VAP) with a closed endotracheal suction system
(CESS) versus an open endotracheal suction system (OESS).
Methods A prospective study during 9 months. Included were all
patients who required mechanical ventilation for 12 hours or more.
At admission to the ICU patients were randomized ito two groups:
one group was suctioned with CESS, and another group with
OESS. VAP was defined according to the following criteria: a
chest radiographic examination showing new or progressive
infiltrate; new onset of purulent sputum; significant quantitative
culture of pathogen from respiratory secretions (tracheal aspirate
>10 6 cfu/ml, bronchoalveolar lavage >104 cfu/ml or protected
bronchial brush catheter >103 cfu/ml). The statistical analysis was
realized by the chi-square test and the Student t test, and we took
P < 0.05 to consider a significant difference.
Results Included were 230 patients (62% male). The mean age
was 58.2 ± 17.23 years, APACHE II score was 14.38 ± 6.41,
mortality was 14.92%. The patient distribution was: 50%
cardiac surgery, 9% cardiologic, 7% respiratory, 4% digestive,
10% neurologic, 11% traumathology, 3% intoxication, 6%
abdominal sepsis. Both groups of patients (114 with CESS and
116 with OESS) were similar in age, sex, diagnosis groups,
mortality and APACHE II score. No significant diferences were
found in the percentage of patients who developed ventilator-
associated pneumonia in global (13.79% vs 14.28%) and by
period of mechanical ventilation time, nor in the number of
ventilator-associated pneumonia per 1000 mechanical
ventilation-days in global (15.85 vs 16.12) and by period of
mechanical ventilation time. No differences were observed in
microorganism responsibles of VAP. Neither were there found
any differences in the incidence of exogenous VAP (2.79% vs
2.48%).
Conclusions We conclude that in our series, the CTSS did not
reduce the ventilator-associated pneumonia incidence, nor the
exogenous pneumonia.
P212 Clinical pulmonary infection score (CPIS) dynamics in polytrauma patients with ventilator-associated pneumonia
M Georgieva, S Milanov, M Milanov, E Gyurov
Pirogov Emergency Institute, Sofia, Bulgaria
Critical Care 2004, 8(Suppl 1):P212 (DOI 10.1186/cc2679)
Background CPIS is an accepted tool for clinical estimation of
ventilator-associated pneumonia (VAP), encompassing five
components: temperature, blood leukocytes, tracheal secretions,
oxygenation index and chest roentgenogram. VAP is considered a
frequent complication in mechanically ventilated severe polytrauma
patients. There are some current issues that highlight the influenceof VAP development on patient mortality [1]. The aim of this study
was to evaluate VAP development in severe polytrauma patients
according to CPIS criteria and on that basis to determine the
patients’ clinical course.
Design A prospective observational study.
Setting Seventeen-bed trauma intensive care unit.
Methods Thirty-one severe polytrauma patients (ISS >26 at
admission) requiring mechanical ventilation for more than 3 days
who developed VAP were enrolled. We recorded the length of stay
of all patients and examined CPIS criteria daily for a period of
10 days after pneumonia occurrence. Patients were divided into
subpopulations according to the severity of post-traumatic
complications. We calculated the mean 10-day CPIS value for
each patient. We considered CPIS >5 points to be indicative for
VAP.
Results The period that VAP occurred was between the 5th and
8th ventilator day. We observed that the clinical course of VAP
depended on the severity of the post-traumatic complications.
Patients with no post-traumatic complications had a mean 10-day
CPIS value of 4.5. Patients with severe complications had a mean
10-day CPIS value of 5.3, 7.1, 8.1 and 8.4 for patients with single
organ failure (survival rate 100%), for patients with pulmonary
contusion (survival rate 65%), for patients with severe sepsis
(survival rate 26%) and for patients with multiple organ failure
syndrome (>2 organs involved, survival rate 17%), respectively.
The VAP resolution was shorter in patients with an adequate initial
antibiotic therapy.
Conclusion These data suggest that in the length of 10 days, we
could have a precise estimation for the severity of VAP and its
dynamics. Mean CPIS values showed good correlation with the
degree of post-traumatic complications. CPIC dynamics could
serve as a good clinical tool for determination of whether the
patient would recover or we might expect a bad outcome.
Reference
1. Baughman R: Diagnosis of ventilator-associated pneumonia.
Curr Opin Crit Care 2003, 9:397-402.
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P213 Ventilator-associated pneumonia: do patients that initiate mechanical ventilation outside the intensive care unit do worst?
I Previgliano, P Marchio, D Ceraso
Hospital General de Agudos J.A. Fernandez, Buenos Aires, Argentina
Critical Care 2004, 8(Suppl 1):P213 (DOI 10.1186/cc2680)
Objective  To assess whether the incidence of ventilator-
associated pneumonia (VAP) is greater in the patients with initiated
mechanical ventilation (MV) in the Emergency Room (ER)
compared with those that receive it in the intensive care unit (ICU)
Study design A prospective cohort study.
Inclusion criteria Patients that initiated MV from more than
12 hours in the ER or in the ICU.
Data collected Age, sex, APACHE II score, MV initiation place,
time in the ER, coming in different from the ER, VAP defined
according to the ATS criteria, bacterial diagnostic procedures,
germs, duration of the MV, length of stay at the hospital and at the
ICU, and final destination (as death or discharge).
Statistical analysis The chi-squared test and two-tailed Student t
test. P < 0.05 was considered significant.
Results From 1 August 2000 to 30 September 2001, 137 patients
originated from the ER and 77 patients originated from other
surgical or medical wards (OW) were admitted to the ICU. Both
groups had no differences in sex (ER 74 males, OW 48 males,
P = 0.92), age (ER 50 ± 20 years, OW 55 ± 16 years, P = 0.06),
APACHE II score (ER 23.5 ± 16.7, OW 21.4 ± 18.3), hospital
length of stay (ER 46, OW 52, P = 0.62), ICU length of stay (ER
12 ± 13, OW 17 ± 23, P = 0.06), days of MV (ER 8 ± 10, OW
11 ± 16,  P = 0.12) and mortality (ER 50%, OW 55%). VAP
incidence was 26% (36/137) in the ER group and 21% (16/77) in
the OW group (P = 0.36). VAP incidence according to 1000 days
of MV was 29 × 103 for the complete set, 30 × 103 in the ER group
and 19 × 103 in the OW group (P = 0.07). VAP diagnosis was
done by means of fiberoptic bronchioalveolar lavage (BAL) in 50%,
nonfiberoptic BAL in 19% and tracheal aspiration in 31%. The early
VAP incidence was 27% in the ER group and 25% in the OW
group (P = 0.83). There were significant differences in the isolated
germs in these groups (100% multiresistant germs in the OW
group, P = 0.02). In the late VAP there were also differences due to
Candida spp. isolation in 22% of the cultures (P = 0.03).
Conclusion The initiation of MV in a setting different than the ICU
is not related with a higher incidence of VAP. Patients coming from
medical or surgical wards have a higher prevalence of
multiresistant germs in early VAP and of Candida in late VAP.
P214 Predictors of disease severity are similar for respiratory syncytial virus (RSV)-positive and RSV-negative induced
respiratory failure
E Davis, K Deem, R Mehta, M Marsh
PICU, Southampton General Hospital, UK
Critical Care 2004, 8(Suppl 1):P214 (DOI 10.1186/cc2681)
Introduction There are no reproducible parameters to predict the
duration of ventilation and length of stay for RSV-induced
respiratory failure in previously healthy children. Tasker [1] found
an alveolar–arterial gradient (AaDO2) >400 with mean airway
pressure (MAP) >10 in the first 24 hours, and an AaDO2 >300
with MAP >10 over the subsequent 24 hours identified RSV-
positive cases at risk of a prolonged stay. Another study found an
AaDO2 >253 in the first 24 hours to be the best predictor of
developing severe disease with the need for a prolonged stay.
Methods Data were collected from 118 cases of respiratory failure
in a regional pediatric ICU over four RSV seasons. Forty-six were
excluded with an alternative diagnosis; of the remaining 72 cases
of bronchiolitis, 52 were RSV-positive (six not ventilated), and 20were RSV-negative. Of the 46 ventilated RSV-positive, three had
congenital heart disease, four had chronic lung disease, and one
had been treated in a different unit prior to admission. Of the 20
RSV-negative cases, three had congenital heart and/or chronic
lung disease. Both groups were assessed against Tasker’s criteria
and a multiple regression model used to identify predictive markers
with length of ventilation as the dependent variable.
Results The median ages in the RSV-positive and RSV-negative
groups were 0.13 (25th and 75th percentiles 0.05 and 0.23) and
0.11 (0.06 and 0.17), respectively. The length of ventilation was
normally distributed with a mean (SD) of 110 (75) hours for the
positive group and 110 (84) hours for the negative group. Mean
(SD) lengths of stay of 7 (4) and 6 (4) days, respectively. The mean
(SD) length of ventilation for those with AaDO2 >400 within the
first 24 hours was 127.7 (77.2) hours, AaDO2 >300 for
24–48 hours was 127.2 (84.4) hours and AaDO2 >253 in first
24 hours was 122 (75.7) hours. Using Pearson’s correlation the
maximum MAP at 24 hours, 24–48 hours and the maximum ever
were identified as potential predictive factors (P = 0.017, 0.037
and 0.038), for both the RSV-positive and RSV-negative groups.
The maximum positive inspiratory pressure (PIP) at 24–48 hours
may be predictive for RSV-positive (P = 0.079) and RSV-negative
groups (P = 0.077). The multiple regression model found the
maximum PIP between 24 and 48 hours in the combined group
(RSV-positive and RSV-negative) to be an independent predictor
of length of ventilation (P = 0.032), confirming the findings.
Conclusion We have shown that the factors predicting severity of
RSV-positive and RSV-negative respiratory failure are similar. We
were unable to confirm the findings of previous studies suggesting
that these are institute specific. In our institute a high MAP within the
first 48 hours provides a predictive factor that can guide the clinician
when talking to the parents and may help resource planning. A
multicentre study in the UK is unlikely to yield more useful information.
Reference
1. Tasker RC, Gordon I, Kiff K: Acta Paediatr 2000, 89:938-941.
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P215 Hand washing compliance in the intensive care unit
I Qushmaq, M Meade
McMaster University, Hamilton, Canada
Critical Care 2004, 8(Suppl 1):P215 (DOI 10.1186/cc2682)
Background Nosocomial infections constitute a major problem
and challenge in the critical care area. Compliance is a variable
and estimated to be less than 50%. In a study by Petite and
colleagues, the compliance varied from 10% before patient care to
22% after patient care.
Association for Professional in Infection Control guidelines suggest
that hands be washed with soap and water or be disinfected for at
least 15s: before and after patient contact or after contact with
source of microorganism or after removing gloves.
Objectives To measure the hand washing compliance among
health care workers in the four teaching intensive care units in
Hamilton, Ontario, Canada
Design A prospective, observational study
Setting Four intensive care units in a teaching hospital in Hamilton,
Canada.
Participants Fifty-nine percent nurses, 25% physicians (including
intensivists and rotator residents), and 18% respiratory therapists.
Main measurements Direct observation of compliance with hand
washing of 115 heath care professionals.
Results One hundred and fifteen health care workers were
observed. The average compliance with hand hygiene
recommendations ranged between 0% before patient contact to
57.4% after patient contact (95% confidence interval [CI],
48.3–66.0). In logistic regression analysis the effect of the
caregiver on the use of hand hygiene is significant (P = 0.041). We
chose a nurse as the reference group to compare the other group
with: noncompliance was high among residents (odds ratio [OR],
0.321 [95% CI, 0.107–0.964]), staff intensivists (OR, 0.458 [95%
CI, 0.131–1.602]), respiratory therapies (OR, 2.051 [95% CI,
0.667–6.304]). Only the OR of resident to nurse is significant (CI
does not cross 1.0).
When we entered the site to the model, the effect of site on hand
hygiene is significant (P = 0.036). When we entered both
caregiver and site into the logistic regression model at the same
time, neither of them display a significant effect on the hand
hygiene (caregiver P = 0.059, site P = 0.053).
Conclusion Compliance with hand washing was consistent with
previous reports in the literature. Poor compliance among residents
suggest that education and a role model by intensivists may be
useful. Variation in compliance between site to site in the city may
suggest that an increased workload affects the hand hygiene
compliance.
P216 Positive blood cultures in critically ill patients: incidence and impact on outcome
G Frank
Hospital Wiener Neustadt, Austria
Critical Care 2004, 8(Suppl 1):P216 (DOI 10.1186/cc2683)
During the year 2001, 283 patients were admitted to our intensive
care unit (ICU). Forty-one patients had at least one positive blood
culture (BC) during their ICU stay. These 14.5% of all patients
required 52% of all treatment days. We found a good correlation
between the length of ICU stay and the ratio of patients with
positive BCs (Fig. 1) and with catheter-related bloodstream
infections (CBI) (Fig. 2). Seventy-four patients (26%) stayed for
more than 7 days in the ICU (required 75% of all treatment days).
In one-half of these patients a positive BC was found. These
37 patients had a comparable SAPS II score at admission to the
37 patients not getting a positive BC, but they had a doubled ICU
mortality and a doubled ICU length of stay (LOS) (Table 1).Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
Table 1
LOS >7 days All No positive BC With positive BC
Number of patients 74 37 37
SAPS II mortality (%) 28.7 29.1 28.3
ICU mortality (%) 20.3 13.5 27.0
Hospital mortality (%) 31.1 24.3 37.8
LOS (days) 23,7 14.9 32.5
Figure 1 Figure 2
P217 Methicillin-resistant Staphylococcus aureus infection acquired in intensive care: a prospective study of infection and
outcome
C MacNeil, E Curran, J Kinsella, M Booth
Glasgow Royal Infirmary, UK
Critical Care 2004, 8(Suppl 1):P217 (DOI 10.1186/cc2684)
Methicillin-resistant  Staphylococcus aureus (MRSA) was first
described in 1961 and has been associated with increasing health
care associated infection and chronic ill health. This study was
designed to examine the relationship between mortality and
intensive care acquired MRSA infection.
Between the years 2000 and 2002, prospective data was
collected from the intensive care database (Wardwatcher), the
infection control database in our hospital and the regional MRSA
reference laboratory. ICU-acquired MRSA infection was defined as
MRSA infection diagnosed after 72 hours in the ICU. Any patient in
whom the source of MRSA was questionable was included in the
group where MRSA acquisition was attributed to the ICU.
During the period of the study 1107 patients were admitted to
intensive care. Twelve patients without valid APACHE II scores
were excluded from the study. The rate of ICU-acquired MRSA
infection was 5.8%.
In the general ICU population the mean length of stay was
6.1 days. In the group with ICU-acquired MRSA infection the mean
length of stay was 17.1 days. The mean time at which MRSA
infection was acquired in the ICU was at 8.9 days.
Patients with ICU-acquired MRSA infections were compared with
the general ICU population. Both groups had a mean APACHE II
score of 22.5 and comparable mean predicted hospital mortality
rates: 42.6% (MRSA group) and 42.2% (general group). Mean
actual hospital mortality was 40.9% in the MRSA group and
41.6% in the general group.
In our unit, acquisition of MRSA infection during het ICU stay does
not affect ICU outcome or hospital mortality. MRSA infection
occurs in patients who have a longer than average length of stay in
the ICU.
P218 Incidence of multidrug-resistant bacteria in a general ICU: 1-year study
C Kydona, G Malamis, N Sidiropoulou, C Tsiotras, E Papazafiriou, N Gritsi-Gerogianni
Hippokration Hospital, Thessaloniki, Greece
Critical Care 2004, 8(Suppl 1):P218 (DOI 10.1186/cc2685)
Introduction The aim of this study was to find the incidence of
multidrug-resistant bacteria in a general ICU of the largest public
hospital in Greece. Sporadic outbreaks of Gram-negative bacteria
resistant to imipenem are being reported with increasing frequencyworldwide, so it has become an emergency to improve the use of
antimicrobial agents.
Methods During the period November 2002–November 2003
(1 year) all patients of the ICU were retrospectively included in the
study. Several factors, concerning the secondary infections, were
noted: age, diagnosis at admission, APACHE score, time of
hospitalization, origin of the positive culture of the microbe,
resistance and outcome.
Results Among the 395 patients hospitalized at this period,
108 suffering from several diseases had positive cultures
(27.34%). Fifty-eight of them have shown recovery (R group)
(53.7%), whereas 50 patients have died (D group) (46.3%). Mean
age was 57.04 years (53.66 years in the R group vs 60.96 years in
the D group). Mean time of hospitalization was 16.5 days
(15.73 days in the R group vs 17.48 days in the D group). Mean
APACHE II score was 21.2 (20.68 in the R group vs 21.86 in the
D group). Among 215 positive cultures, 56 were bronchial
cultures, 84 blood cultures, 29 venaekatheter cultures, 19 ascites
fluid cultures, three cerebrospinal fluid cultures and four wound
cultures. Eleven patients had positive venaekatheter culture and
blood culture at the same time. Referring to the 108 patients, there
was in 62.96% Acinetobacter baumannii, in 24.07%
Pseudomonas aeruginosa, in 20.37% Klebsiella pneumoniae, in
8.33% Enterococcus Faecalis, in 5.56% Staphylococcus aureus,
and in 4.63% Candida albicans isolated.  A. baumannii was
multiresistant (MULTI-R) against antibiotics in 17.65% of patients
(or in 11.65% of cultures), or with intermediate sensitivity only in
Gentamycin (GENT-I) in 8.82% of patients (7.77% of cultures).
Generally, 25% of patients had MULTI-R or GENT-I A. baumannii
(19.42% of cultures). In the D group, 36.36% had MULTI-R or
GENT-I  A. baumannii (23.73% of cultures): 24.24% MULTI-R
(13.56% of cultures), 15.15% GENT-I (10.17% of cultures).
Oppositely, in the R group, only 14.29% had MULTI-R or GENT-I
A. baumannii (13.64% of cultures): 11.43% MULTI-R (9.09% of
cultures), 2.86% GENT-I (4.55% of cultures). P. aeruginosa was
MULTI-R in 42.31% of patients (44.12% of cultures): in 54.55% of
the D group (55.56% of cultures) vs 33.33% of the R group
patients (31.25% of cultures). K. pneumoniae was sensitive only in
imipenem or cotrimoxazole in 7.69% of the R group and only in
kinolones in 11.11% of the D group patients.
Conclusions No vancomycin-resistant Enterococci, methicillin-
resistant S. aureus or vancomycin-resistant S. aureus were isolated
in our unit and that is encouraging. Nevertheless, an important
percentage of multidrug-resistant A. baumanii, P. aeruginosa and
K. pneumoniae was identified in long-term ICU patients, which
probably was the reason for their poor outcome. Measures are
certainly needed to prevent or delay the appearance of resistant
strains.
Available online http://ccforum.com/supplements/8/S1
P219 A 6-month study of infections and antibiotic resistance pattern in a Greek intensive care unit
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Introduction Severe infections and resistance of microorganisms
to broad-spectrum antibiotics constitute a major concern for ICU
physicians. Our purpose was to record the microorganisms usually
responsible for infections in our ICU and their pattern of resistance
to antibiotics during a 6-month period.
Patients and methods We performed a prospective study
between 1 June 2003 and 1 December 2003, including all patients
hospitalized for more than 48 hours. Infections presented during
this period were recorded as well as the sensitivity of
microorganisms to special antimicrobial agents.
Results A total of 65 patients were included in the study (53 men,
12 women) with a mean age of 54.6 years. The mean ICU stay was
24 days. One hundred and fifty-one infections were recorded:
ventilator-associated pneumonia (62.3%), primary bacteremias
(22.5%), catheter-related infections (9.4%), meningitis (1.3%) and
surgical infections (2%). Microorganisms most commonly isolated
were: Pseudomonas aeruginosa (33.7%), Acinetobacter baumannii
(28.5%),  Klebsiella pneumoniae (14%), and Staphylococcus
epidermidis (7.8%). Patterns of resistance were as follows:
P. aeruginosa was sensitive to ceftazidime in 16.7% of cases, to
imipenem in 38.4%, to ciprofloxacin in 10.2% to piperacillin/
tazobactam in 62.8% and to colistin in 98.7%. A. baumannii was
sensitive to imipenem in 61% of cases, to ampicillin/sulbactam in
51.5% and to colistin in 76.5%. K. pneumoniae was sensitive to
imipenem in 74% of cases, to piperacillin/tazobactam in 48% of
cases and to colistin in 88.8%.
Conclusion Significant resistance of Gram-negative
microorganisms to broad-spectrum antibiotics is noticed, posing
important therapeutic problems. Change of antibiotic policy and
strict hand hygiene are some of the measures that could possibly
help us face this ominous situation.
P220 Increase in methicillin-resistant Staphylococcus aureus acquisition and change in pathogen pattern associated with
outbreaks of severe acute respiratory syndrome (SARS)
F Yap
Prince of Wales Hospital, Hong Kong, China
Critical Care 2004, 8(Suppl 1):P220 (DOI 10.1186/cc2687)
The pattern of endemic pathogenic isolates and the rates of
acquisition of methicillin-resistant Staphylococcus aureus (MRSA)
were evaluated in our 22-bed ICU during a SARS outbreak. This
period was characterized by a change in patient case-mix, high use
of steroids, change in the pattern of antibiotic prescribing, upgrading
of infection control precautions, and wearing gloves all the time.
These changes were associated with an increase in the isolation of
MRSA,  Candida and  Stenotrophomonas species. On the other
hand,  Pseudomonas and  Klebsiella species, which used to be
endemic, had disappeared. The MRSA ICU acquisition rate was
significantly increased during SARS (25.3% vs 5.0% in 2000, 3.8%
in 2001, 2.9% in 2002, P < 0.001). This showed that changes
within an ICU during a SARS outbreak could lead to a change in the
pathogen pattern, and a significant increase in MRSA acquisition.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
Table 1
2001 2002 1–2 2003 SARS P
MRSA (%) 6.9 6.2 6.9 16.3 <0.001
Candida (%) 0.59 0.79 1.43 11.9 <0.001
Pseudomonas (%) 6.5 7.7 8.1 0 NS
Stenotrophomonas (%) 2.8 3.1 3.1 11.2 <0.001
Klebsiella (%) 2.8 5.1 3.8 0 NS
P221 Validation of the Belgian surveillance data of ICU-acquired nosocomial infections
I Morales, C Suetens
Scientific Institute of Public Health, Brussels, Belgium
Critical Care 2004, 8(Suppl 1):P221 (DOI 10.1186/cc2688)
Introduction  The Belgian national surveillance of nosocomial
infections in intensive care units (ICU) was set up in 1996 in
collaboration with the Belgian Society of Intensive Care Medicine.
The validation followed in 2001. The objective was to evaluate the
sensitivity, specificity, exhaustiveness and accuracy of the
nosocomial pneumonia (PN) and bacteraemia (BAC) data reported
by Belgian ICUs to the National Surveillance program (NSIH).
Methods The sample size was calculated at 1300patient charts
(904negative files and 268infections) to achieve an estimated
sensitivity of 65% (±10%) and specificity of 99.5% (±0.5%).
Forty-five hospitals were selected randomly from a list of quarterly
participants between 1997 and 2001. All reported PN and BAC
patient charts were selected. False-negative PNs were estimated
on reported noninfected patients (approximately 20% of total
negatives). False-negative BACs were identified matching a list of
ICU admissions with a list of positive blood cultures. The golden
standard was the surveyors’ opinion. Surveyors, trained NSIH team
members, reviewed charts without prior knowledge of their
surveillance status. Discrepant charts were double-checked by
another surveyor. If still discordant, they were then discussed with
the clinician and/or infection control practitioner to determine
sources of discordance.
Results Up to now 33hospitals have been visited from 2001 to
2003. Preliminary results are presented in Table1.
Global exhaustiveness was 81.2% for patients staying more than
48hours in the ICU. False-negative pneumonia was more
frequently not documented by microbiology. Also, there was a
strong correlation between internal quality of the data (missing or
discordant values in surveillance database) and external validity.
Conclusion Specificity was high although sensitivity was quite low.
BAC was more accurately reported than PN. The lack of sensitivity
might be related to factors such as the perception of the
surveillance as an external control instrument, the professional
background of the data collectors, and poor knowledge of the
protocol (e.g. the case definitions). Validation is crucial for
credibility of data, provides an opportunity for personal technical
assistance, and should be implemented on a continuous basis in
surveillance programmes.
Table 1
Sensitivity Specificity
(95% confidence interval) (95% confidence interval)
PN 53.7% (45.4–61.9) 98.5% (97.7–99.1)
BAC 60.9% (44.5–75.4) 99.4% (98.2–99.7)
P222 Daily interruption of central venous catheters in critically ill ICU patients
P Myrianthefs1, E Boutzouka2, L Louizou2, A Retzoulas2, I Samara2, G Baltopoulos2
1KAT Hospital, Kifissia, Greece; 2KAT Hospital, Athens, Greece
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Introduction ICU patients require a central venous catheter (CVC)
for solutions, and drug administration, transfusions of blood and
blood products as well. The purpose of the study was to
investigate the frequency of daily interruptions of CVC in critically ill
patients. Catheter-related blood stream infections, especially due
to  Staphylococcus epidermidis, may be related to hand
manipulation of the CVC during catheter interruptions.
Materials and methods We included 20 critically ill patients
having more than 14 days of hospitalization. We retrospectively
recorded the number of catheter interruptions per 8-hour shift and
then per 24 hours. We totally collected 500 catheter-days.
Patients were grouped according to APACHE II score (group A
≥ 15 and group B < 15) on admission.
Results The mean ICU stay was 26.4±3.7 days. Illness severity
on admission was SAPSII score 52.9±0.4, APACHEII score
20.9±0.2 and TISS 34.2±0.2. Daily interruption is presented in
Table1.
Group A had a statistically significant higher (P<0.05) number of
CVC interruptions per day. During the study we recorded
16acquired positive blood cultures (eight Staphylococcus
species, four S.epidermidis) and 13positive catheter tips (fourStaphylococcus species, two S.epidermidis). We confirmed five
catheter-related infections (0.5% of catheter-days), which is within
CDC guidelines.
Conclusions Each patient is subjected to a significant number of
CVC interruptions per day, which could be related to blood stream
infections and specifically to S.epidermidis due to hand
manipulations during CVC interruptions.
Available online http://ccforum.com/supplements/8/S1
Table 1
First Second Third
8-hour shift 8-hour shift 8-hour shift Total
Interruptions 7.9±0.2* 7.6±0.2 7.3± 0.2 22.7±0.4
Solutions 1.5± 0.05 1.7±0.1* 1.4±0.06 3.1±0.1
Drugs 5.6±0.1 5.6±0.1 5.8±0.1 16.7±0.3
Transfusions 2.9±0.2 2.8±0.2 2.7±0.4 3.4±0.2
Other solutions 1.8±0.07 1.7±0.1 1.8±0.1  3.2±0.1
*Statistically significant difference P< 0.05.
P223 Central venous catheter-related infection in critically ill patients
L Lorente, R Galván, M Martín, C García, M Mora
Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
Critical Care 2004, 8(Suppl 1):P223 (DOI 10.1186/cc2690)
Objective To analyze the incidence of catheter-related local
infection (CRLI) and catheter-related bloodstream infection
(CRBSI) of central venous catheters (CVC) in critically ill patients.
Methods A prospective study of patients admitted to the ICU from
1 May 2000 to 31 October 2001. A multiple proportion
comparison of CRLI and CRBSI incidence density between the
different catheter accesses was performed using the Fisher–
Freeman–Halton exact test. P < 0.05 was considered significant.
Results During this period of time 988 patients (60.12% male)
were admitted to the ICU. The mean age was 55.63 ± 18.49 years,
APACHE II score was 13.65 ± 5.83, and mortality was 14.37. The
number of patients with CVC, the number of CVC and the days on
risk for each CVC were: global, 890, 1608 and 11,378; peripheral
access, 257, 331 and 2169; jugular, 618, 698 and 4131;
subclavia, 321, 432 and 3862; femoral, 111, 147 and 1216. The
number of CRLI and CRBSI per 1000 days of catheterization were:
general, 4.74 and 1.40; peripheral access, 2.30 and 0.92; jugular,
6.29 and 0.97; subclavia, 1.81 and 1.29; femoral, 13.15 and 4.11.
Femoral venous access had the highest incidence density of CRLI
(13.15/1000 catheter-days, P < 0.01) and CRBSI (4.11/1000
catheter-days,  P < 0.05). Jugular venous access had a higher
incidence density of CRLI (6.29/1000 catheter-days, P < 0.01)
than subclavian or peripheral access. The 16 CRBSI were due to
the following microorganisms: five Staphylococcus cogulasa
negativo, three Staphylococcus aureus, one Streptococcus
faecalis, one Bacillus spp, two Escherichia coli, one Enterobacter,
one Pseudomonas aeruginosa, two Candida albicans.
Conclusions CDC guidelines for the prevention of catheter-related
infection notice that the subclavian is preferable to femoral and
jugular venous accesses. Our data support these recommendations,
but also suggest a new refinement; namely that a peripherally
inserted central catheter is preferable to femoral and jugular
accesses, and that jugular is preferable to femoral venous access.
P224 Catheter-related infection of arterial catheters in critical care
L Lorente, R Galván, M Martín, J Villegas, M Mora
Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
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Objective To describe the incidence of catheter-related local
infection (CRLI) and catheter-related bloodstream infection
(CRBSI) of arterial catheters (AC) in critically ill patients.
Methods A prospective study of patients admitted in a 24-bed
medical–surgical intensive care unit of a 650-bed university
hospital, from 1 May 2000 to 31 October 2001, and who had
some AC. A multiple proportion comparison of CRLI and CRBSI
incidence density between the different catheter accesses was
performed using the Fisher–Freeman–Halton exact test. P < 0.05
was considered significant.
Results During this period of time 988 patients (60.12% male)
were admitted in the ICU. The mean age was
55.63 ± 18.49 years, APACHE II score was 13.65 ± 5.83, and
mortality was 14.37%. Patient distribution was: 49.69% cardiac
surgery, 8.60% cardiologic, 12.14% neurologic, 11.84%
traumathology, 7.29% respiratory, 6.58% digestive, 2.93%
intoxication. The number of patients with AC, the number of AC
and the days on risk for each AC were: global, 817, 1231 and
7171; radial, 753, 1057 and 5763; femoral, 111, 125 and 1091;
pedia, 27, 30 and 226; humeral, 16, 19 and 91. The number of
CRLI and CRBSI per 1000 days of catheterization were: general,
0.97 and 0.41; radial, 0.86 and 0.34; femoral, 1.83 and 0.91;
pedia, 0; humeral, 0. Femoral arterial access had higher
incidence density of CRLI (1.83/1000 catheter-days, P = 0.001)
and CRBSI (0.91/1000 catheter-days, P = 0.001) than radial
access. The three CRBSI were due to the following
microorganisms: two Staphylococcus cogulasa negativo, one
Staphylococcus aureus.Conclusions CDC guidelines for the prevention of catheter-related
infection make no recommendation about the arterial catheter site.
Our data suggest that any arterial site is preferable to the femoral
arterial access.
Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P225 Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine as a prevention of catheter
colonization in the intensive care unit setting: a prospective randomized study
L Camargo, G Büchele, A Marra, R Cal, J Sousa, F Machado, A Sogayar, V Michels, E Silva, M Martino, E Knobel, L Poli
Hospital Albert Einstein, São Paulo, Brazil
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Introduction Central venous catheters (CVC) are frequently used in
the intensive care unit (ICU) setting. A wide number of strategies have
been studied to prevent colonization and infection related to CVC.
One of them is the use of antimicrobial-impregnated catheters, but a
positive effect has been shown primarily for triple-lumen catheters.
Objective To compare the incidence of CVC colonization in two
groups of patients using a double-lumem central venous catheter
impregnated with chlorhexidine and silver sulfadiazine or the
standard one.
Patients and methods Patients who undergo insertion of a
double-lumen CVC in the ICU were randomized to receive either a
central venous catheter impregnated with chlorhexidine and silver
sulfadiazine or the standard one. The catheters tips were cultured
by the roll-plate method after removal.
Results One hundred and nine patients enrolled with successful
insertion of 109 catheters, 51 of them impregnated (group 1) and
58 standards (group 2). There were no statistically significant
differences between the groups in age, seven infection-related risk
factors, ICU diagnosis, mean SOFA score, insertion sites, duration
of catheterization, wrong location at X-ray, signs of allergy, and
catheter colonization rates. The mean times of duration of
catheterization in group 1 and group 2 were 15.1 ± 9.5 days and
13.5 ± 8.1 days, respectively (P = 0.3). The mean SOFA scores in
groups 1 and 2 were 5.04 ± 2.9 and 4.9 ± 3.1, respectively
(P = 0.8). The colonization rates were 29.4% (15 catheters) in
group 1 and 34.5% (20 catheters) in group 2 (P = 0.5). Thirty-one
catheters presented Gram-positive cocci, four of them associated
with Gram-negative bacilli and tyree with fungi. Three catheters
presented Gram-negative bacilli alone and one catheter presented
fungi alone in the roll-plate.
Conclusion This comparative study between a double-lumen
central venous catheter impregnated with chlorhexidine and silver
sulfadiazine and the standard one did not show any statistically
significant difference in colonization rates between the two groups.
P226 Routine screening for Candida colonization
C Triboulet, G Duquenne, Y Breton, A Chehab, S Winnock
Wyeth, Bordeaux, France
Critical Care 2004, 8(Suppl 1):P226 (DOI 10.1186/cc2693)
Infections caused by Candida spp. are a major cause of morbidity
and mortality in critically ill patients. Although colonization with
Candida spp. precedes and leads to infection [1], routine
screening for Candida colonization is not recommended. In this
observational retrospective study, based upon the results of a
systematic screening for Candida colonization, we address the
controversial issue of the management of fungal threat in the ICU.
Patients All incoming patients admitted in a 12-bed digestive
(medical and postsurgical) ICU, presenting with an organ
dysfunction or a severe inflammatory response to their primary
disease (C-reactive protein >150 mg/l) were routinely scheduled
for a weekly screening for fungal colonization. A colonization index
(CI) was computed for every patient. In 2000, a pre-emptive
antifungal therapy was administered to all patients with CI >0.5.
and subsequently interrupted when CI <0.5. Due to economic
concerns and reports of increasing resistance to antifungal drugs,
we changed our therapeutical strategy in 2001 [2]. As a result, in
2002 an antifungal therapy was administered only for probable or
patent infections. Evolution of CIs, candidemia and the total cost of
therapy are reported for 2000 and 2002.
Results See Table 1. The CI decreased in 92% of patients
receiving pre-emptive therapy. In all patients but one, fluconazole
was the drug used for pre-emptive therapy.
Discussion Despite the limits of our study, we can conclude:
severely ill medical and postsurgical patients with digestive
diseases are at risk for fungal infection and candidemia. Screening
for fungal colonization allows an early determination of patients at
risk for fungal infection. Pre-emptive treatment efficiently lowers the
level of colonization. A small number of costly curative antifungal
treatments may prove more expensive than a greater number of
pre-emptive cheaper treatments.
References
1. Pittet: Ann Surg 1994, 220:751-758.
2. Llewelyn: Intensive Care Med 2001, 27:S10-S32.
Table 1
Number of 
Number of  Number of  Candida glabrata Number of 
Year admissions screenings SOFA max Age (years) Number treated and krusei candidemia Cost (€)
2000 764 115 8 67 44 12% 0 33234
2002 653 123 7 71 19 9.1% 7 52044Available online http://ccforum.com/supplements/8/S1
P227 IL-10 plasma and bronchoalveolar lavage levels used as markers of candida bronchopneumonia during fungal sepsis
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Introduction and aims Nosocomial bloodstream fungal infections
by Candida species in ICU has risen dramatically in the past two
decades. In fact, fungal infections in the critically ill patient are
difficult to diagnose and are associated with a high mortality rate.
The high concentration of some proinflammatory cytokines
registered in the serum and in bronchoalveolar lavage (BAL) of
patients with severe bronchopneumonia and the different kind of
host response during fungal infections are well defined. Our aim is
to correlate the IL-10 serum and BAL levels in criticaly ill patients
with confirmed bronchopneumonia associated with candidiasis or
bacterial sepsis and to research whether these levels consent to
prove the fungal origin of severe pneumonia associated with
severe sepsis.
Materials and methods Involved patients were admitted for more
than 48 hours in the ICU. We enrolled 28 patients subdivided into
two groups: (group A) 18 patients with severe sepsis with bacterial
bronchopneumonia and (group B) 10 patients with sepsis and
confirmed candidemia with bronchopneumonia. We registered
IL-10 levels in standardized blind nonbronchoscopical
bronchoalveolar lavage (b-NB-BAL) and in serum at admission and
than 1, 3 and 7 days after treatment. We measured cytokines by an
ELISA assay.
Results At present we have registered 28 patients aged from 51
to 91 years. Data (mean ± SD) are presented in Table 1.
Conclusions The value of IL-10 confirms the results obtained by
other authors on mice. In humans this correlation could be
explained by the suppressive effects of high levels of IL-10 on
mononuclear phagocyte activity against candida and methicillin-
resistant  Staphylococcus aureus. In candidiasis with severe
bronchopneumonia the precocious increase of IL-10 levels, both in
bronchial and in serum, represents confirmation of fungal sepsis
and a negative predictive value in order to predict the development
of multiorgan failure and death.
Reference
1. Tavares D, et al.: Increased resistance to systemic candidiasis
in athymic interleukin 10 depleted mice. J Infect Dis 2000,
182:266-273.
Table 1
Group A Group B
(IL-10 pg/ml) (IL-10 pg/ml)
Serum BAL Serum BAL
Admission 105.9 (63)* 38 (8)* 359.9 (28)* 195 (48)*
7 days 43.9 (6)* 28.7 (14) 143.9 (27)* 58.6 (17)
*P < 0.01.
P228 Invasive aspergillosis in a medical ICU: the spectrum of disease in 89 nonhaematology patients
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Using criteria designed for invasive aspergillosis (IA) in neutropenic
patients, the present study aimed to determine the impact of IA in
different groups of nonhaemato-oncological ICU patients. It is a
retrospective analysis of all patients that were hospitalized in the
17-bed medical intensive care unit (MICU) between January 2000
and January 2003.
The inclusion criteria were one or more of the following:
microbiological evidence of aspergillosis during stay in the MICU
(any positive culture or positive circulating galactomannan) or
histopathological evidence of aspergillosis (including autopsy). IA
was classified as proven, probable or possible, according to the
EORTC/MSG definitions. Aspergillus isolation from a nonsterile
site in patients without appropriate clinical setting was considered
as ‘colonization’.
Between 2000 and 2003, 89 of 1850 patients (4.8%) fulfilled the
inclusion criteria.
There were 37 chronic obstructive pulmonary disease patients,
nine patients with solid organ transplant recipients, 17 patients
with autoimmune diseases, six cirrhosis patients and 20 patients
with miscellaneous diseases. Following the EORTC/MSG criteria,
the patients were classified as proven IA (n = 30), probable IA
(n = 37), possible IA (n = 2) and ‘colonization’ (n = 20). Mean
SAPS II score was 52 with a predicted mortality of 48.6%. Overall
mortality was 80% (n = 71). Mortality in the proven and probable
groups was 96.7% and 86.5%, respectively. Among the
18 patients who survived, 10 just had ‘colonization’ with
Aspergillus and did not have risk factors for IA.
Postmortem examination was done in 47 out of 71 patients
(67%) and 29/47 autopsies (62%) showed hyphael invasion
with Aspergillus (mainly the lung as target organ). Among the
proven cases (n = 30), 29 underwent autopsy (autopsy rate
97%), and one patient with lupus had a positive bronchial
biopsy, was treated and survived. The other autopsies were
recruited out of the probable group (n = 14, autopsy rate 44%)
and the group with ‘colonization’ for Aspergillus (n = 4, autopsy
rate 40%).
There were five out of the 30 proven cases who did not have
compromising host factors according to the EORTC/MSG
definitions (three liver cirrhosis, one pneumonia in a 95-year-old
man, one Klebsiella sepsis with multiorgan failure).
In conclusion, our study proved that IA is an emerging infectious
disease in ICU nonhaemato-oncological patients and there is a
broad group of patients, who are at risk of IA. IA was diagnosed in
patients without characteristics described in the EORTC/MSG
definitions. It seems worthwile to investigate the validity of the
available diagnosic tools in that group of patients.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P229 Sputum concentration of amikacin varies with nebulizer efficiency measured in vitro in patients on mechanical ventilators
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Background Evaluation of the clinical utility of aerosolized
antibiotics in patients with ventilator-associated pneumonia has
been hampered by the inefficiency of available nebulizers. The
Aerogen pulmonary drug delivery system (APD) is in development
for high-efficiency lung deposition of novel therapies in
mechanically ventilated patients. We compared delivery of
amikacin (AMIK) via APD vs the the Aeroneb Pro (AP), and vs the
AirLife™ Misty Neb™ (MN), in mechanically ventilated patients. We
wanted to determine how AMIK concentrations in the sputum
relate to device efficiency previously determined in vitro [1].
Methods Twelve patients on volume-cycled ventilation (various
primary diagnoses and vent settings) were enrolled. All had purulent
secretions, but no fever or X-ray evidence of pneumonia. On
separate study days (≥2 days washout), patients received sulfite-free
AMIK (125 mg/ml): 800 mg via MN, 800 mg via AP, or 400 mg via
APD (in anticipation of higher efficiency), in randomized order.
Tracheal aspirates were obtained at 15 min postdosing and amikacin
concentrations were determined. Data were compared with in vitro
measurements of lung dose using typical adult ventilator settings.
Results All treatments were well tolerated. Table 1 presents the
evaluable sputum AMIK concentrations from tracheal aspirates
normalized to the starting dose (mg/ml/mg starting dose), and in
vitro lung dose as the per cent of the total dose (means ± SD).
Sputum concentrations were greater with AP and APD than with
MN (P < 0.05). For the lung dose: APD > AP > MN (P < 0.05).
Conclusions APD delivered AMIK with greater efficiency than the
marketed nebulizers. Concentrations of AMIK in the sputum were
consistent with relative device efficiency measured in vitro. High
efficiency delivery via APD may make aerosolized AMIK a viable
part of treatment regimens for ventilator-associated pneumonia.
Reference
1. Fink JB, Uster P, Fishman R: In Vitro Evaluation of Aerosol Deliv-
ery of Amikacin During Mechanical Ventilation. Baltimore, MD:
International Society of Aerosol Medicine; 2003.
Table 1
Sputum AMIK In vitro
Device, dose concentration lung dose (%)
MN, 800 mg 7±10 7±1
AP, 800 mg 31±35 31±4
APD, 400 mg 54±71 51±11
P230 Comparison of levofloxacin (L) and cefotaxime (C) combined with ofloxacin (O) for treatment of severe community-
acquired pneumonia (CAP) in the intensive care unit
O Leroy1, P Saux2, J Bédos3, E Caulin4, Groupe d’Etude Clinique
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Objectives To evaluate, in patients with severe CAP requiring ICU
admission, the efficacy and tolerance of L (500 mg/12 hours) given
intravenously (+ oral route) during 10–14 days as a monotherapy
in comparison with an intravenous combination of C (1 g/8 hours)
and O (200 mg/12 hours).
Methods Patients included in this phase IV, prospective,
multicenter, multinational, open, and randomized (1:1) study
exhibited a severe CAP defined by usual criteria. The statistical
hypothesis was a noninferiority of L to C + O with a 2.5% a-risk
(bilateral) and a 15% maximum set difference.
Results In the modified intent-to-treat and the per-protocol (PP)
populations, there were 308 (L: 149; C + O: 159) and 271
patients (L: 139; C + O: 132), respectively. The main patients
characteristics were similar in both groups. Mean
age = 59.6 ± 16.7 years, male gender = 68.2%. Mean SAPS II
values at inclusion were 34.0 ± 15.8 (L) and 33.0 ± 13.7 (C + O).
Mechanical ventilation, during the first 2 days of inclusion was
required in 53.5% (L) vs 56.2% (C + O) patients. At least one
causal organism was identified in 55.0% (L) vs 54.1% patients
(C + O). Blood cultures were positive in 24.4% (L) and 22.1%
(C + O) documented patients. Streptococcus pneumoniae (47.6%
patients) and Haemophilus spp. (23.8% patients) were the
predominant pathogens followed by Staphylococcus aureus
(6.0%), atypicals (7.1%), and enterobacteriaceae (8.9%).
The clinical success rates, at end of treatment, in the PP
population were 79.1% (L) vs 79.5% (C + O). The difference (diff.)
was –0.4% and the 95% confidence interval (CI) was [–10.8% to
9.97%]. At the follow-up visit, 21–45 days after the end of the
treatment, the clinical success rates were 68.8% (L) vs 70.9%
(C + O) (diff. = –2.1%; 95% CI = [–14.5% to 10.25%]).
Bacteriological responses were favorable in 73.7% (L) vs 77.5%
(C + O) patients. In pneumococcal CAP, favorable responses
occurred in 75.7% and 70.3%, respectively. Incidence of death
was 12.2% (L) vs 16.7% (C + O) (P = 0.3).
In the safety analysis (n = 395 patients), no difference was found
between groups. Twenty patients in group L (10.3%) and 16 in
group C + O (8.0%) presented at least one adverse event (AE)
considered as treatment-related (P = 0.42). The treatment was
withdrawn following the occurrence of an AE considered as
treatment-related in 2.6% (L) vs 2.0% (C + O) patients
(P = 0.75).
Conclusion Levofloxacin (500 mg twice daily dose) is at least as
efficacious as the cefotaxime (1 g three times daily) + ofloxacin
(200 mg twice daily) combination for the antibiotic therapy of
patients with a severe CAP hospitalized in an ICU, with success
rates around 80%.Available online http://ccforum.com/supplements/8/S1
P231 Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
B Meyer, G Kornek, M Nikfardjam, G Delle Karth, G Heinz, G Locker, W Jaeger, F Thalhammer
University of Vienna, Austria
Critical Care 2004, 8(Suppl 1):P231 (DOI 10.1186/cc2698)
Background Linezolid is a new antibacterial agent with a broad
spectrum of activity against Gram-positive pathogens including
methicillin-resistant  Staphylococcus aureus (MRSA), vancomycin-
resistant  Enterococcus spp. (VRE) and penicillin-resistant
Streptococcus pneumoniae. The aim of this study was to determine
the pharmacokinetic characteristics of linezolid in critically ill
patients undergoing continuous venovenous hemofiltration (CVVH).
Methods Twenty patients received linezolid (600 mg intravensouly
every 12 hours). CVVH was performed using highly permeable
polysulfone membranes (PSHF 1200, Baxter, Germany and AV
400, Fresenius, Germany). The mean blood flow rate and
ultrafiltration rate were 182 ± 15 ml/min and 40 ± 8 ml/min,
respectively. Postdilution was performed. Linezolid concentrations
in serum and ultrafiltrate were determined by high-performance
liquid chromatography.
Results The mean linezolid serum concentration peak (Cmax) was
15.32 ± 3.98 µg/ml, and the mean trough level (Cmin) was
1.87 ± 1.70 µg/ml. The elimination half-life (T1/2) was
4.30 ± 1.74 hours. The total clearance (CLtot), hemofiltration
clearance (CLhf) and volume of distribution (Vd) were
9.31 ± 3.48 l/hours, 31.25 ± 12.77 ml/min and 51.30 ± 12.30 l,
respectively.
Conclusion Our results indicate that patients with severe Gram-
positive infections undergoing CVVH can be treated effectively
with a dose of 600 mg linezolid every 12 hours.
P232 Ceftazidime administered by continuous perfusion can improve the prognosis of ventilator-associated pneumonia
L Lorente, R Galván, M Martín, C García, M Mora
Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
Critical Care 2004, 8(Suppl 1):P232 (DOI 10.1186/cc2699)
Objective Ceftazidime is used for the treatment of ventilator-
associated pneumonia (VAP) due to its recognized
antipseudomonal activity. Standard ceftazidime treatment is by
intermittent perfusion (IP); however, continuous perfusion (CP)
may be advantageous since its antibacterial activity depends on
exposure time at concentrations above the minimum inhibitory
concentration. However, evidence of its clinical efficacy in the
treatment of VAP as compared with IP is limited and controversial.
Thus, the aim of the present study was to determine whether
ceftazidime by CP represents an optimization of the VAP standard
treatment.
Methods We compared a prospective cohort of patients (n = 13)
that received 4 g/day intravenous (IV) ceftzadime by CP with a
historic control group (n = 32) that received 2 g/8 hours IV
ceftazidime by IP. VAP were treated during 14 days with two
antibiotics: ceftazidime plus another (aminoglycoside or
quinolone). VAP was defined according to the following criteria: a
chest radiographic examination showing new or progressive
infiltrate; new onset of purulent sputum; significant quantitative
culture of pathogen from respiratory secretions (tracheal aspirate
>10 6 cfu/ml, bronchoalveolar lavage >104 cfu/ml or protected
bronchial brush catheter >103 cfu/ml). Differences between
groups were tested by means of the Student’s t test and exact chi-
square test by permutation, using the Statxact Software 5.0. A
significant diference was defined as P < 0.05.
Results There were no significant differences in age, sex,
diagnosis, APACHE II score, etiologic agents, bacteremia, organ
dysfunction and antimicrobial therapy between groups. The CP
group showed significantly lower clinical failure (CP, 0/13 vs IP,
15/32 [46.87%], P = 0.001) and significantly lower mortality
attributable to VAP (CP, 0/13 [0%] vs IP, 8/32 [25%], P = 0.049).
In addition, CP patients received one-third less daily dose than
those treated intermittently.
Conclusions We conclude that ceftazidime administered by
continuous perfusion, for the treatment of ventilator-associated
pneumonia, may significantly improve the clinical efficacy compared
with intermittent administration and reduce the antibiotic dosage.
P233 Continuous vs bolus administration of imipenem in critically ill patients with ICU-acquired pneumonia
S Sakka1, A Glauner1, J Bulitta2, M Kinzig-Schippers2, F Sörgel2
1Friedrich-Schiller-University, Jena, Germany; 2IBMP, Nuremberg, Germany
Critical Care 2004, 8(Suppl 1):P233 (DOI 10.1186/cc2700)
Background and goal of study Most recently, administration
modus for β-lactam antibiotics has become a matter of debate, and
continuous infusion has been suggested [1]. We studied whether
plasma concentrations of imipenem were sufficiently maintained
using a loading dose and continuous infusion regimen, and that
this regimen would be superior to a higher amount of drug given by
the standard intermittent bolus regimen.
Patients and methods We randomized 20 critically ill patients
with ICU-acquired pneumonia to receive imipenem either
2 g/24 hours by continuous infusion (CON, n = 10) or bolus
dosing (1 g every 8 hours) (BOL, n = 10). In both groups, a
loading dose of 1 g imipenem was administered, which was
followed by continuous infusion or further bolus treatment
4 hours after loading. Plasma imipenem concentrations were
measured at baseline, 4, 10, 16, 22, 46 and 70 hours. Arterial
blood samples were taken immediately prior to begin of the
continuous regimen and before each respective bolus
administration. Patients’ age (62 ± 16 vs 59 ± 16 years), SAPS II
score (43 ± 12 vs 44 ± 14) and renal function (creatinine
clearance, 128 ± 35 vs 122 ± 33 ml/min) were comparable
between both groups.Results and discussion After 4 and 10 hours, plasma imipenem
concentrations were similar in both groups. However, mean
imipenem plasma trough concentrations at the following time
points (16, 22, 46, and 70 hours) were significantly higher in CON
than BOL. For comparison, at 16, 22, 46 and 70 hours, all patients
in CON had concentrations >2 µg/ml (50% minimum inhibitory
concentration for Pseudomonas aeruginosa), while this was only
achieved in three of 10 patients in BOL. These data suggest that
continuous infusion is advantageous and its benefit should
therefore be investigated in clinical outcome studies.
Conclusion  Continuous imipenem infusion administered as 2 g
over 24 hours guarantees more sufficient plasma concentrations
when compared with a standard regimen (1 g every 8 hours) that is
associated with insufficient trough concentrations.
References
1. Lipman J: Continuous infusion ceftazidime in intensive care: a
randomized controlled trial. J Antimicrob Chemother 1999,
43:309-311.
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P234 ICU use of haloperidol prior to the 2002 SCCM sedation and analgesia guidelines
E Milbrandt, A Kersten, G Clermont, R Andrews, O Collange, M Coughlin, S Watson, D Angus
University of Pittsburgh, Pennsylvania, USA
Critical Care 2004, 8(Suppl 1):P234 (DOI 10.1186/cc2701)
Introduction Delirium occurs in as many as 80% of
mechanically ventilated (MV) medical intensive care unit (ICU)
patients and is associated with poor outcomes. MV patients
spend 43% of all ICU days in delirium, while all patients who
become delirious spend about 25% of their ICU days in
delirium. The 2002 SCCM sedation and analgesia guidelines
call for routine delirium screening and treatment with
haloperidol. We sought to understand whether these guidelines
represented a change from current practice by examining
haloperidol use in the ICUs of a large tertiary care academic
medical center.
Hypothesis We hypothesize that: (1) haloperidol is the most
commonly used antipsychotic medication in our ICUs, and (2) use
of haloperidol in patients receiving MV >48 hours is significantly
less than 80% (the rate of delirium in MV patients reported in the
literature).
Methods From 1 July 2000 to 30 June 2001 we prospectively
collected data for all patients admitted to any ICU at the University
of Pittsburgh Medical Center, a tertiary care academic medical
center with over 120 ICU beds serving medical, surgical, trauma,
neuro, and solid-organ transplant patients. We calculated overall
rates of treatment with any antipsychotic and generated mean total
and daily dose for those who received haloperidol.
Results There were 5592 ICU patients incurring 6033
hospitalizations and 6758 ICU admissions during the study period.
Of all hospitalizations, 60.4% required mechanical ventilation and
11.9% received an antipsychotic in the ICU. Haloperidol was the
most frequently used antipsychotic (79.5% of all administered
doses), with risperidone (4.7%) and olanzapine (2.3%) the next
most common. Haloperidol was given to 24.9% of MV >48 hours
patients and on 6.9% of all ICU days. MV >48 hours patients
received mean (SD) daily haloperidol dose of 10.2 (9.5) mg for 5.8
(8.0) days, or 24.0% of their ICU days.
Conclusions Only one in four MV >48 hours ICU patients
received haloperidol. When used, however, the haloperidol dose
and duration seemed to be appropriate. Either we do not
appropriately treat the majority of delirious patients and the SCCM
guidelines represent a significant departure from existing clinical
practice, or ICU delirium is not as common as the literature
suggests. Further study is needed to define the incidence of ICU
delirium in all ICU patient populations and to evaluate the impact of
treatment with haloperidol on outcomes of critical care.
P235 The safety of remifentanil administered for up to 5 days in ICU patients with neurotrauma
S Stergiopoulos1, A Karabinis2, K Mandragos3, A Komnos4, J Soukup5, B Speelberg6, A Kirkham7
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Introduction Remifentanil hydrochloride (Remi) is being
increasingly used in the critically ill. Remi-based analgesia and
sedation supplemented with propofol (P) or midazolam (Mid) was
compared with a hypnotic-based technique using fentanyl (Fent) or
morphine (Morph) in combination with P or Mid for up to 5 days in
161 mechanically ventilated neurotrauma patients.
Methods Open-label treatment with Remi, Fent or Morph was
randomised 2:1:1. Remi infusion was started at 9 µg/kg/hour and
titrated to effect. Supplemental P (days 1–3) or Mid (days 4–5)
was introduced at an infusion rate of 18 µg/kg/hour to provide
optimal sedation (SAS 1–3) and analgesia (none/mild pain). Fent
or Morph were administered with P or Mid according to routine
practice. The mean arterial pressure (MAP), heart rate (HR),
intracranial pressure (ICP) and cerebral perfusion pressure (CPP)
were measured at the time of and 10 min following dose titrations
Table 1
Remi (n = 84) Fent (n = 37) Morph (n = 40)
Bradycardiaa 5 (6%) 2 (5%) 2 (5%)
Hypotensiona 12 (14%) 4 (11%) 2 (5%)
Polyuriaa 3 (4%) 2 (5%) 0
MAP (mmHg)b 73 (18.4) 71 (20.6) 74 (19.0)
HR (bpm)b 64 (18.1) 66 (22.1) 67 (19.9)
ICP (mmHg)b* 10.8 (4.2), 12.3 (7.7), 11.2 (6.4),
n =2 0 n =1 0 n =1 2
CPP (mmHg)b* 62.8 (18.1), 70.6 (12.5), 69.3 (14.0),
n =1 6 n =7 n =1 0
aFisher’s exact test. bWeighted mean (SD). *Analysis of covariance
adjusting for baseline.and at 1–4 hour intervals. Adverse events were recorded during
the treatment and post-treatment period.
Results The median (range) duration of administration of Remi,
Fent and Morph were 47.3 (3.8–120.0), 35.2 (0.2–120.0) and
40.9 (4.5–120.0) hours, respectively. Twenty-three patients
received Remi for 5 days. Comparing Remi with Fent and Morph,
no statistically significant differences were observed in the
incidence of adverse events or haemodynamic measures. Table 1
presents the most common adverse events (≥5%) number of
patients (%), and haemodynamics.
Conclusion Remifentanil was well tolerated and provided
acceptable haemodynamic stability in intensive care patients with
neurotrauma when administered for up to 5 days.
Available online http://ccforum.com/supplements/8/S1
P236 Remifentanil-based analgesia and sedation facilitates more rapid and predictable time to neurological assessments
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Introduction Predictable pharmacokinetics and organ-
independent elimination allows remifentanil hydrochloride (Remi) to
be easily titrated to provide optimal analgesia with rapid dissipation
of effects even after prolonged infusions in critically ill patients.
Remi-based analgesia and sedation supplemented with propofol
(P) or midazolam (Mid) was compared with a hypnotic-based
technique using fentanyl (Fent) or morphine (Morph) in
combination with P or Mid for up to 5 days in 161 mechanically
ventilated neurotrauma patients.
Methods Open-label treatment with Remi, Fent or Morph was
randomised 2:1:1. Remi infusion was started at 9 µg/kg/hour and
titrated to effect. Supplemental P (days 1–3) or Mid (days 4–5)
was introduced at a Remi infusion rate of 18 µg/kg/hour to provide
optimal sedation (SAS 1–3) and analgesia (none/mild pain). Fent
or Morph were administered with P or Mid according to routine
practice. Study drugs were reduced/stopped for daily scheduled
assessments of neurological function.
Results From an observed case analysis (on log-transformed
data), the overall mean neurological assessment time (unpaired t
test) and between-subject variability (F test) around the
assessment time were significantly reduced in the Remi group
compared with Fent and Morph. Table 1 presents the median
(range) time from reducing analgesia/sedation until neurological
assessment (hours).
Conclusion The time to assessment of neurological function can
be achieved significantly faster and more predictably when using
remifentanil-based analgesia and sedation.
Table 1
Overall Day 1 Day 2 Day 3 Day 4 Day 5
Remi (n = 84) 0.5 (0.2–1.6) 0.4 (0.1–0.9) 0.5 (0.1–1.6) 0.7 (0–3.8) 0.8 (0.3–1.3) 1.0 (0.3–1.8)
Fent (n = 37) 0.7*(0.2–4.6) 0.7*(0.2–4.7) 0.9 (0–4.6) 1.0 (0.2–2.2) 1.8 (0.9–2.4) 1.8*(1.3–2.8)
Morph (n = 40) 1.0*(0.1–4.8) 0.9*(0.1–4.6) 0.7 (0.1–5.3) 1.2 (0.3–2.6) 1.3 (0.9–1.8) 1.9 (1.7–2.1)
*P < 0.05.
P237 Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically
ventilated ICU patients
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Introduction Remifentanil’s titratability and rapid organ-
independent metabolism make it ideally suited for use in critically ill
patients. Establishing safety in this population is important as
studies of remifentanil for greater than 3 days are limited. This
study compared the safety and efficacy of remifentanil-based
analgesia and sedation (RBA) with hypnotic-based sedation
(HBS), in 105 ICU patients with medical conditions requiring long-
term (up to 10 days) mechanical ventilation.
Methods One hundred and five patients were randomised to
receive either RBA or HBS. Remifentanil infusion started at
6–9 µg/kg/hour and was titrated to effect to provide optimal
analgesia and sedation. Supplemental midazolam (MID) bolus was
introduced to remifentanil at a rate of 12–18 µg/kg/hour. HBS
(MID + fentanyl or morphine at investigator’s choice) was
administered according to routine clinical practice. Adverse events
(AEs) were recorded throughout the treatment and post-treatment
period.
Results No clinical differences were observed in the incidence of
adverse events. Seventeen patients received RBA and 16 patients
received HBS for at least 10 days. Table 1 presents the AEs.Conclusions Remifentanil is well tolerated when used for periods
of up to 10 days in intensive care patients on mechanical
ventilation. No adverse events relating to prolonged recovery from
mu-opioid effects were reported.
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Table 1
RBA (n = 57) HBS (n = 48)
Total AEs 19 (33%) 16 (33%)
Total serious AEs 7 (12%) 6 (13%)
Hypotension* 3 (5%) 4 (8%)
Atrial fibrillation* 4 (7%) 2 (4%)
Septic shock* 0 3 (6%)
Vomiting* 3 (5%) 0
*Most common AEs.
P238 Decreased time on mechanical ventilation using remifentanil-based analgesia and sedation
M Malbrain1, A Karabinis2, R Morais3, S Albrecht4, D Breen5, P Parkinson6
1Algemeen Centrum Ziekenhuis Antwerpen, Belgium; 2General Hospital, Athens, Greece; 3Dubai Hospital, United Arab Emirates;
4Universitat Erlangen, Nurnberg, Gemany; 5Royal Hallamshire Hospital, Sheffield, UK; 6GlaxoSmithKline, Greenford, UK
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Introduction Remifentanil is a short acting mu-opioid agonist with a
half-life of less than 10 min and organ-independent elimination. This
study compared the safety and efficacy of remifentanil-based
analgesia and sedation (RBA) with hypnotic-based sedation (HBS),
in 105 ICU patients with medical conditions requiring long-term (up
to 10 days) mechanical ventilation. The primary endpoint assessed
whether the RBA could reduce time on mechanical ventilation.
Methods Patients were randomised 1:1 to open treatment with
either RBA or HBS (midazolam [MID] + fentanyl or morphine at
investigator’s choice). Remifentanil infusion started at
6–9 µg/kg/hour and was titrated to effect optimal analgesia and
sedation. A supplemental MID bolus was introduced at a
remifentanil rate of 12–18 µg/kg/hour. HBS was administered
according to routine clinical practice. The time from the start of
treatment to the start of the weaning process and extubation were
recorded. The sedation agitation score and pain index were
recorded throughout the study.
Results Twenty-nine (51%) RBA patients and 16 (33%) HBS
patients started weaning during the 10-day treatment period and
were extubated. The median percentage time of appropriate
analgesia/sedation was greater than 95% with both regimens.
Table 1 presents the time from the start of study drug to the start of
the weaning period and to extubation.
Conclusions Remifentanil-based analgesia and sedation
significantly decreased time on mechanical ventilation. Remifentanil
may be a useful agent in the cost-effective care of ICU patients.
Table 1
Weaning Extubation Weaning 
(hours)* (hours)* time (hours)a*
RBA 83.0 94.0 0.9
HBS 98.0 147.5 27.5
P value 0.523 0.033 0.001
*75th quantile. aTime from start of weaning period to extubation.
P239 Effect of propofol on stroke volume and shunt in patients undergoing thoracic surgery with the exclusion of one-lung
ventilation during planned operations
W Machala, W Gaszynski
Medical University, Lodz, Poland
Critical Care 2004, 8(Suppl 1):P239 (DOI 10.1186/cc2706)
Thoracic surgery usually requires anaesthesia excluding one-lung
ventilation (OLV). OLV causes the increase of shunt (Qs/QT), the
clinical exponent of which is the lowering of oxygen pressure in blood
(and the lowering of SpO2). The defence mechanism, which prevents
lowering of oxygen pressure, is hypoxic pulmonary vasoconstriction
(HPV) in the lung excluded from ventilation. The anaesthetics used for
anaesthesia (especially inhalatory ones) inhibit HPV.
Purpose The purpose of this study is the evaluation of the effect of
anaesthesia total intravenous anaesthesia (TIVA) (oxygen, air,
propofol) on shunt and some haemodynamic parameters in
patients undergoing operations connected with neoplastic lung
disease requiring OLV. Shunt and haemodynamic parameters were
evaluated using the data collected from the catheter introduced to
the pulmonary artery (Swan–Ganz catheter).
Materials and methods The study was carried out on 11 patients
(American Society of Anesthesiologists [ASA]I and ASAII)
undergoing planned operations. All the patients were
premedicated orally with midazolam. The catheter was introduced
to the pulmonary artery before the anaesthetic induction according
to the pressure curve. Patients received balanced anaesthesia that
was the combination of epidural anaesthesia in the thoracic
segment (thoracic epidural anaesthesia: fentanyl + 0.9% saline)
and TIVA (propofol according to Roberts’ schema). The heart rate,
blood pressure, SpO2, temperature in the pulmonary artery,
pulmonary artery pressure, pulmonary capillary wedge pressure,
cardiac output, cardiac index (CI) and Qs/QT were marked at nine
intervals: (I) before the induction of anaesthesia (10–30 min); (II)
immediately after the induction of anaesthesia (after checking the
tube position) — horizontal position; (III) after determining therespiratory mixture (during two-lung ventilation) — lateral position;
(IV) 5 min after starting OLV — lateral position; (V) 30 min after
starting OLV — lateral position; (VI) 5 min after starting two-lung
ventilation or immediately after the pulmonary artery ligation of the
operated lung; (VII) 30 min after starting two-lung ventilation or
immediately after pulmonary artery ligation of the operated lung;
(VIII) 5–10 min before extubation; and (IX) 15 min after extubation.
Results The obtained results were analysed statistically: SpO2
decreased substantially (IV, V), mean arterial pressure (MAP) (V),
and CO (IV) in relation to output values. A statistical increase was
noticed in the pressure in the pulmonary artery (II–V, VIII) and
Qs/QT (II–VIII), the highest in interval IV and V.
Conclusions OLV causes the increase of Qs/QT and, consequently,
the lowering of SpO2 in the 5th min (43.78%) and 30th min (35.4%)
after excluding an operated lung from ventilation. OLV is connected
with the lowering of SpO2 and increasing pressure in the pulmonary
artery. Propofol used in TIVA causes the increase of shunt —
approximately four times. Increasing Qs/QT does not cause the
critical lowering of oxygen pressure in arterial blood. During TIVA a
transitional decrease of CI and MAP was noticed.
Available online http://ccforum.com/supplements/8/S1
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P241 Accidental withdrawal of nonintravascular catheters in critically ill patients
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Objective The objective of this study was to analyze the incidence
of accidental withdrawal of nonintravascular catheters in critical
care.
Methods A prospective study of patients admitted in a 24-bed
medical–surgical intensive care unit (ICU) of a 650-bed university
hospital, from 1 May 2000 to 31 October 2001, who needed a
nonintravascular catheter.
Results During this period of time 988 patients (60.12% man)
were admitted in the ICU. The mean age was 55.63 ± 18.49 years,
the APACHE II score was 13.65 ± 5.83, and the mortality was
14.37%. Patients’ distribution was: 49.69% cardiac surgery,
8.60% cardiologic, 12.14% neurologic, 11.84% traumathology,
7.29% respiratory, 6.58% digestive, 2.93% intoxication. The
number of patients with a nonintravascular catheter, the number of
nonintravascular catheters and the days on risk for each catheter
were: orotracheal tube, 803, 883 and 6054; nasogastric catheter,
861, 1402 and 7714; vesical catheter, 874, 1182 and 7883;
thoracic drainage, 70, 98 and 529; abdominal drainage, 65, 112
and 746; intraventricular brain drainage, 68, 79 and 606; cardiac
surgery drainage, 491, 982 and 2906. The number of accidental
withdrawals of nonintravascular catheters per 100 catheters and
per 100 days of catheterization were: orotracheal tube, 5.43 and
0.79; nasogastric catheter, 24.67 and 4.48; vesical catheter, 0.42
and 0.06; thoracic drainage, 3.06 and 0.56; abdominal drainage,
4.46 and 0.67; intraventricular brain drainage, 5.06 and 0.66;
cardiac surgery drainage, 0.
Conclusions The highest accidental removal was found in
nasogastric catheters. It is necessary to develop more similar
studies, studying accidental withdrawal of nonintravascular
catheters per 100 catheters and per 100 days of catheterization, to
establish standards for monitoring assistance quality.
P242 Ketamine and midazolam mixture versus ketamine for analgesia/sedation in polytrauma patients with asthma
E Gyurov1, S Milanov2, M Milanov2
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Introduction Ketamine and midazolam are among the most
frequently used anesthetic agents. The other area of application is
ICU. Bronchodilating properties of ketamine are well established.
Unfortunately, ketamine exerts some side effects. Many
researchers use benzodiazepines to cover these undesirable
effects.
Study design A prospective controlled study.
Setting A general ICU.
Objective To prove efficacy of ketamine and midazolam as an
alternative for analgesia/sedation in asthma patients after
polytrauma.
Methods Using a model of Jahangir and colleagues [1], 14 patients
with multiple injuries and history of asthma were included during
their ICU stay (nine spontaneously breathing, five mechanically
ventilated). Patients were randomised into two groups. Group 1
patients received an infusion of ketamine and midazolam. The two
drugs were mixed in one syringe (50 mg ketamine and 5 mg
midazolam). The mean rate of infusion for ketamine was
150–250 ng/kg/hour and for midazolam was
0.015–0.03 ng/kg/hour. Midazolam was added to eliminate the
side effects of ketamine and for sedation. Group 2 patients
received an infusion of ketamine only (0.2–0.4 mg/kg/hour). The
following parameters of haemodynamics and ventilation were
monitored: heart rate, mean arterial pressure, respiratory rate,
arterial and end-expiratory PO2, arterial PO2, transcutaneous
oxygen saturation SpO2, pulmonary compliance and resistance (in
ventilated patients), and subjective perception of pain using the
visual analogue scale (VAS 1–10 points), Ramsey sedation scale
(wake and sleep levels), and rate of appearance of side effects.
Ketamine in a mixture with midazolam led to insignificant changes
in hemodynamics and only in group 2 patients were more
significant changes noted (tachycardia and mild hypertension).Respiratory function remained well maintained except in some
group 2 patients, where mild hyperventilation was noted. We
documented an increase in respiratory compliance and a reduction
in pulmonary resistance. Midazolam helped to prevent side effects
after ketamine administration but after prolonged infusion of
midazolam there were signs of an accumulation and an increase in
doses was necessary. The VAS score (between 1 and 6) was
almost similar in both groups. The Ramsey scale score was also
similar (conscious level 3) but with some cases of agitation in
group 2 patients.
Conclusions Ketamine and midazolam as a mixture are a good
alternative for analgesia/sedation in patients with asthma after
multiple injuries. We consider higher doses are needed for better
patient comfort.
Reference
1. Jahangir SM, Islam F, Chowdhury SN, Aziz L, Ghani MA: Keta-
mine infusion for postoperative analgesia: a prospective
cohort study in asthmatics. Bangladesh Med Res Counc Bull
1993, 19:21-27.
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P243 Pediatric anesthesia for magnetic resonance scan with a laryngeal mask: maintenance in case of reduced intracranial
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Introduction The aim of the study is to evaluate three different
methods in order to carry out a magnetic resonance brain scan in
children.
Materials and methods In our study we analyzed 90 ASA I–II,
nonpremedicated, children divided into three groups of 30 patients
(A, B, C). We used for all of them the laryngeal mask [1], inhalatory
induction for all three groups and three different kinds of
maintenance: inhalatory maintenance, intravenous maintenance
and maintenance with balanced anesthesia. The 30 ‘A’ children
(age 5.9 ± 4.8 years) underwent inhalatory anesthesia with
sevoflurane (1.2 MAC) in spontaneous breathing for induction and
maintenance.The 30 ‘B’ children (age 5.9 ± 3 years) underwent
inhalatory anesthesia with sevoflurane (1.2 MAC) for induction and
endovenous anesthesia with propofol for maintenance [2]. In the
30 ‘C’ children (age 5.1 ± 4.6 years) we used inhalatory anesthesia
with sevoflurane (1.2 MAC) for induction and balanced anesthesia
for maintenance [2].
Discussion We demonstrated that the discharge time using an
inhalatory maintenance in spontaneous breathing was shorter than
using a maintenance with intravenous propofol anesthesia. One of
the halogenates’ side effects is the increase of cerebral blood flow.
In patients with a reduced intracranic compliance (e.g. brain
tumors) a maintenance with a balanced general anesthesia with
sevoflurane and propofol could be more appropriate (group C).
Conclusions In all three groups we did not find any significant side
effects. In conclusion, we can positively confirm the synergy of
both inhalatory and intravenous techniques, joining the advantage
of general balanced anesthesia for the patients with a reduced
intracranial compliance.
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Introduction Some critically ill patients cannot absorb enteral
medications. We noted that intravenous (IV) Prodafalgan (PRDFG),
a recently introduced parenteral bioprecursor of paracetamol,
caused hypotension. A prospective study was conducted.
Methods The population was ICU patients requiring IV PRDFG
(rectal temperature ≥38°C, no enteral route). PRDFG (2 g) was
infused over 15–20 min. The temperature, heart rate,
systolic/diastolic blood pressure and mean blood pressure (MAP)
were recorded before, during and 15–120 min following infusion.
Interventions to correct hypotension were recorded.
Results Seventy-two events, in 14 patients, of PRDFG administra-
tion were recorded. MAP dropped significantly 15 min following
PRDFG infusion. Initiation or increase of noradrenaline occurred in
25% of the events and fluid bolus was given in 8%.
Conclusions PRDFG caused significant hypotension, requiring
active intervention in 33% of the events. This data substantiated
the anecdotal knowledge on the relationship between paracetamol
(acetaminophen) and hypotension in the critically ill and associated
it with the IV preparation.
Figure 1Available online http://ccforum.com/supplements/8/S1
P245 Intrapleural versus epidural analgesia with local anesthetics in patients with thoracic trauma
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This prospective, randomized and controlled study aimed to compare
the efficacy of two methods for analgesia in patients with chest
trauma and rib fractures: continuous epidural catheter analgesia and
regional intrapleural analgesia (RIPA). Seventy-three patients with
unilateral chest trauma were randomized into two groups. In Group 1
patients we placed an epidural catheter (level — TH 8–10), and in
Group 2 patients we placed an intrapleural catheter (level — fifth
intercostal space). We used 1% lidocain for analgesia in both groups.
The control group received intravenous analgesia with opioid. We
applied 10 ml lidocain bolus to the intrapleural catheter four to six
times per 24 hours and clamped the catheter for 10 min. For epidural
analgesia we applied 50–100 mg lidocain and started continuous
infusion at a rate of 2–3 mg/kg/hour, not exceeding a dose 400 mg
lidocain per 24 hours. We monitored the level of thermo-
hipanesthesia, the level of analgesia (Visual Aanalogue Scale —
10 points), parameters of respiratory and cardiovascular function
(respiratory rate, arterial O2 oxygen saturation [SaO2], heart rate,
arterial blood pressure, central venous pressure, ability to
expectorate). Thermohipanesthesia was unilateral and significantly
shorter in Group 2 patients, whereas in Group 1 patients it was
bilateral and of longer duration. The level of analgesia was similar in
both groups (0–4 points) but in Group 2 patients it was achieved by
more frequent applications of lidocain, which potentially is dangerous
for toxicity. The respiratory rate decreased, O2 and SaO2 increased,
and the ability to expectorate was improved. In Group 2 patients the
heart rate and arterial blood pressure remained stable, and in Group 1
patients there were episodes of tachycardia and hypotension, which
is undesirable in trauma patients. The technique of placing an
intrapleural catheter is easier.
Conclusion RIPA is an acceptable alternative to epidural analgesia
in patients with thoracic trauma.
P246 Concentration of hormones regulating water and electrolytes balance in patients after cardiac arrest
A Samborska-Sablik, W Gaszynski, J Goch, Z Sablik
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Critical Care 2004, 8(Suppl 1):P246 (DOI 10.1186/cc2713)
Background and goals The aim of the study was the assessment
of the level of hormones playing main biological functions in the
regulation of water and electrolyte balance in patents after cardiac
arrest (CA).
Materials Forty-five patients (patients) were divided into two
groups. Group I, 22 patients after CA, 17 men and five women,
age 64 ± 13 years. CA was caused by ventricular fibrillation in
14 cases and by asystolia in eight. In 16 patients CA appeared in
acute coronary syndrome. Fifty percent of patients died during
hospital treatment. Group II, 23 patients, aged 60 ± 11 years,
20 men and three women, with stable coronary artery disease.
Methods In group I vein blood samples were taken just after CA and
on two consecutive days at 8:00 am. In these patients we assessed
the concentrations of hormones: adrenocortycotropic hormone
(ACTH), cortisol (Cort), renin, aldosterone (Aldo), vasopressin (AVP)
and N-terminated natriuretic propeptyde type B (NT-pBNP). In
patients of group II, concentrations of the aforementioned hormones
were assessed once from a blood sample taken at 8:00 am. Results
were analyzed by statistical methods.
Results Data (mean ± SD) are presented in Table 1. In patients
after CA who died in hospital, compared with patients after CA
who survived, a markable higher concentration of Cort and Renin
and lower ACTH and AVP were found.
Conclusions (1) There is strong activation of hormonal
mechanisms regulating the water-electrolyte balance and
controlling blood pressure in patients after CA. (2) A high
concentration of cortisol with a concomitant improper increase of
ACTH suggests bad resolution in patients after CA.
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Table 1
ACTH (pmol/l) Cort (nmol/l) Renin (pmol/l) Aldo (pmol/l) AVP (pmol/l) NT-proBNP(pmol/l)
Group I 36.6 ± 39.4 3007 ± 5104 33 ± 85,6 1442 ± 1803 846 ± 437 43,266 ± 81,642
Group II 8.1 ± 4.4 414 ± 138 2.42 ± 1.8 527 ± 527 70 ± 46 2092 ± 2375
P <0.004 <0.000001 <0.0006 <0.02 <0.000001 <0.0002
P247 Endocrine changes in patients recovering from acute traumatic or nontraumatic brain injury: pattern and correlations with
functional outcome
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Critical Care 2004, 8(Suppl 1):P247 (DOI 10.1186/cc2714)
To clarify endocrine derangements in patients recovering from
traumatic or nontraumatic brain injury (BI), 40 patients (31 men)
having a mean age of 47 ± 17 years were investigated. BI was due
to spontaneous intracerebral hemorrhage (n = 16), trauma(n = 16), ischemic stroke (n = 7) or ruptured brain aneurysm (n = 1).
The median Glasgow Coma Score on admission in the ICU was 8
and the duration of mechanical ventilation ranged from 2 to
120 days. Patients were enrolled in the study after being transferred
in the rehabilitation unit. Hormonal assessment included the
measurement of thyroxine (T4), tri-iodothyronine (T3), thyrotropin
(TSH), cortisol, corticotropin (ACTH), prolactin, testosterone,
estradiol, insulin-like growth factor I (IGF-1), and
dehydroepiadrosterone sulphate (DHEAS). Functional outcome
was assessed with the Glasgow Outcome Scale (GOS). In the
entire patient population several endocrine abnormalities were
observed, including low T3 (n = 5), low T4 (n = 5), high TSH (n =6 )
or low TSH (n = 1), high cortisol (n = 4), low ACTH (n = 4) or high
ACTH (n = 8), high prolactin (n = 15), low testosterone (n = 11),
low IGF-1 (n = 15), and low DHEAS (n = 10). None of the patients
had cortisol levels below the local reference range for unstressed
individuals. The GOS ranged from 1 to 5 and its distribution was as
follows: GOS of 1 (n = 4), GOS of 2 (n = 15), GOS of 3 (n = 11),
GOS of 4 (n = 5), and GOS of 5 (n = 5). There were significant
correlations between GOS and T3 (r = 0.44,  P = 0.005), T4
(r = 0.35,  P = 0.02), ACTH (r = 0.43,  P = 0.007) and DHEAS
(r = 0.34, P = 0.03). In contrast, GOS did not correlate with TSH,
cortisol, prolactin, testosterone, estradiol or IGF-1 levels.
To conclude, endocrine abnormalities are common in patients
recovering from acute traumatic or nontraumatic BI and are related
to patients’ functional outcome. It remains to be defined whether
such hormonal changes are adaptive or reflect pathology.
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P248 Strict blood glucose control with insulin improves hepatic mitochondrial ultrastructure and function in critical illness
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Hyperglycemia and insulin resistance are common in critical illness.
Recently, a reduction of morbidity and mortality of patients in a
surgical ICU by maintaining normoglycemia with insulin has been
demonstrated [1]. Studies on mitochondria in sepsis [2] and other
critical illness and on hyperglycemia in diabetes [3] suggested that
the effects of this therapy on mitochondrial integrity and oxidative
stress state may contribute to the positive results of the treatment.
Twenty liver biopsies obtained postmortem from patients
randomized to intensive insulin therapy (IIT) or conventional insulin
therapy (CIT) were randomly selected for mitochondrial
investigation. Studied patients in the CIT and IIT groups were
comparable for age and type, severity and duration of critical
illness. The mean blood glucose levels were 10.5 ± 0.6 and
5.6 ± 0.4 mmol/l (P < 0.0001) on a median daily insulin dose of 31
and 45 IU (P = 0.3), respectively.
Hypertrophic mitochondria with an increased number of abnormal
and irregular cristae and reduced electron-density of the matrix were
observed by electron microscopy for seven of the nine patients in the
CIT group, in contrast to only one of the 11 IIT patients (P = 0.0018).
In addition, significantly higher activities of complex III and complex IV
of the respiratory chain and a trend for higher activities of complex I,
complex II and complex V and glyceraldehyde-3-P dehydrogenase,
an enzyme of which the inhibition by superoxide has been linked to
hyperglycemic complications in diabetes [3], were found in the IIT as
compared with the CIT group.
In conclusion, maintenance of normoglycemia with IIT appeared to
prevent ultrastructural and functional abnormalities of hepatocytic
mitochondria associated with critical illness-induced
hyperglycemia. These alterations may have contributed to the
benefits of the intervention. Further analyses are needed to link the
positive effect of IIT on mitochondrial integrity to an effect on
oxidative stress state in critical illness.
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P249 Antiplatelet use and glycaemic control in noncardiac critically ill patients with elevated Troponin T levels
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In the nonintensive care setting recognition of patients with elevated
Troponin T (cTnT) and the instigation of appropriate treatment,
including antiplatelet agents and glycaemic control, reduces the risk
of death and myocardial infarction [1]. In a surgical intensive care
unit (ICU) (62% cardiothoracic) intensive insulin therapy reduces
morbidity and mortality among critically ill patients [2].
Aims/methods A retrospective audit was performed on 180
consecutive admissions to a general (noncardiothoracic) ICU to
establish the incidence of raised cTnT (cTnT >0.1 ng/ml) and
treatment prescribed. The outcome measures were antiplatelet
use, glycaemic control and all-cause mortality during the ICU
admission. The unit protocol stated an insulin infusion should be
commenced if blood glucose (BM) >11.1 mmol/l.
Results The incidence of cardiac myocyte damage, diagnosed by
an elevated cTnT, was 62/180 (33%) with an associated all-cause
mortality rate of 32/62 patients (51.6%) vs 24/118 patients
(20.3%) in cTnT normal patients (P < 0.001). The median length of
admission was 5.5 days for patients with a raised cTnT and 3 days
for patients with a normal cTnT (P < 0.003). In 70.9% of cases, the
raised cTnT occurred within the first 72 hours of admission to the
ICU. Of those patients with an elevated cTnT, 10 patients were
already on aspirin, two on clopidogrel and 14 had clear
contraindications to antiplatelet therapy. Four patients (6%) were
prescribed aspirin and 31 eligible patients (50%) did not receive
antiplatelet therapy.
In patients with an elevated cTnT, 60/62 sets of notes were
assessed for glycaemic control. In these patients 38/60 (63.3%)
had BM >11.1 mmol/l and 59/60 (98.3%) had BM >6.1 mmol/l. A
past history of impaired glucose tolerance/diabetes mellitus was
present in 12/38 (31.6%) of patients with an elevated BM
>11.1 mmol/l. Insulin therapy was not commenced in 6/38patients with BM >11.1 mmol/l. In 19/32 (59.4%) of patients
prescribed insulin there was a delay in infusion commencement
(median 3.5 hours, range 1–9 hours). Hypoglycaemia (BM
<2.2 mmol/l) was documented in 3/32 patients receiving insulin. The
mortality rate was high in all patients with a raised BM (BM
6.1–11.1 mmol/l, mortality 12/21 (57.1%) vs 20/38 (52.6%) for BM
>11.1 mmol/l; NS). The one patient without an elevated BM survived.
Conclusions Elevated markers of cardiac myocyte damage are
common in critically ill patients and are associated with an
increased mortality rate. The use of antiplatelet agents and
optimisation of glycaemic control in this group might reduce
morbidity and mortality. The aetiology of raised cTnT in the critically
ill and specific treatment outcomes requires further investigation.
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P250 Insulin requirement in the first 24 hours of intensive care admission predicts outcome
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Insulin requirement (in mainly cardiothoracic surgical patients) is
suggested as being more strongly associated with ITU mortality
than poor glycaemic control [1]. We prospectively recorded insulin
administration (soluble human insulin, by infusion; Actrapid®; Novo
Nordisk) in consecutive general ITU patients admitted over a
1-month period to our unit where guidelines are set to attempt to
achieve an arterial blood glucose concentration between 4.5 and
8.0 mmol/l. Patients were subsequently divided into two groups
according to whether or not they required insulin during the first
24 hours. Blood glucose was measured using the Radiometer®
ABL System 625 or 700 blood gas analysers. Samples were taken
at least every 2 hours.
Ninety-eight patients were included in the study: 51 received no
insulin, 47 received insulin at some time during the first 24 hours of
admission and patients were grouped accordingly. There were no
patients with a history of diabetes in the ‘no insulin’ group and 10
in the ‘insulin’ group. The mean (SD) number of hours patients who
received no insulin were recorded as having a blood glucose >8.0
was 0.40 (1.41) and for the 47patients who received insulin 4.74
(4.77). The mean (SD) total insulin dose in the first 24hours for the
‘insulin’ group was 38.4 (57.3) IU. Mortality in the ‘no insulin’ group
was 13.1% and in the ‘insulin’ group 19.1% (chi-square 1.238,
P > 0.20). There were no deaths among the previously diagnosed
diabetic patients. When these patients were excluded from the
analysis the mortality was 13.1% and 32.1%, respectively (chi-
square 2.78, P < 0.10, P > 0.05).
The mean (SD) length of stay in the ITU was 4.12 (6.90) days in
the ‘no insulin’ group and 6.77 (8.89) days in the ‘insulin’ group
(one-tailed t test, unequal variance, P = 0.05).
Conclusion An increased length of stay in ITU is predicted if
insulin is required to maintain blood glucose <8.0 mmol/l in the
first 24 hours of ITU admission. An increased mortality may be
predicted if insulin is required to maintain blood glucose
<8.0 mmol/l in the first 24 hours of ITU admission in nondiabetic
patients.
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Background Similar to cardiac surgery patients, medical–surgical
critically ill patients may benefit from avoiding hyperglycemia. Our
objective was to evaluate the feasibility of a randomized trial of
target glucose ranges 5–7 mmol/l or 8–10 mmol/l.
Setting A 15-bed medical–surgical ICU.
Methods We randomized patients ages >18 years if they were
expected to be in the ICU for >72 hours and had serum glucose
>10 mmol/l. Patients were excluded if they had diabetic ketoacidosis,
hypoglycemia, liver disease, or were palliative. Patients had concealed
allocation to a target glucose range of 5–7 mmol/l or 8–10 mmol/l.
Arterial catheters were used for sampling. Dedicated glucometers
were calibrated daily to the laboratory measurement. We used enteral
nutrition as early as possible; total parenteral nutrition was used in five
patients. Insulin SC and oral hypoglycemic agents were prohibited.
We mixed 50 U Humulin R in 50 ml 0.9% NaCl and began infusions at
0.5 U/hour; infusions were titrated according to pretested algorithms.
Preceding this pilot was a survey of ICU staff, a glucometer reliability
study, and a multidisciplinary educational program.
Results The feasibility sample size was 20 patients. The
APACHEII score was 32 (10.2); 14 were insulin-dependent pre-
ICU, and all 20 patients were medical admissions. A total of 758 of
1607 values (47.2%) were in the 5–7 mmol/l range, and 256 of
660 values (40.2%) were in the 8–10 mmol/l range. Glucose
<2.5 mmol/l developed nine times; treatment included 0.5 A 50 g
dextrose/100 ml H2O on six occasions and stopping the insulin
infusion in each case. No adverse consequences were observed.
Conclusions In ICU patients with high illness severity, glucose
values were in two target ranges most of the time, using well-
accepted initiation and maintenance insulin infusion algorithms.
A large randomized trial of glycemic control is feasible in this
population, examining clinically important outcomes. However,
this will require more intensive measures to achieve target
values.
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P252 Acute hyperglycemia impairs platelet receptor expression but not platelet aggregation in vitro
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Introduction Elevated blood glucose concentration is an important
factor for mortality and morbidity in critically ill patients. Previously, a
randomized controlled trial showed that a blood glucose level of
about 6 mmol/l is associated with less multiorgan failure and a
significantly higher survival rate compared with levels above
8 mmol/l. Platelets play a crucial role in hemostasis and inflammation.
However, the effect of short-term elevated blood glucose levels on
platelet activation has not yet been evaluated systematically.
Objective  To evaluate the influence of blood glucose levels on
platelets in vitro.
Methods Citrated blood samples were drawn from healthy blood
donors (40% male, age 38 ± 13 years [mean ± SD]). Exclusion
criteria were smoking and the use of drugs interfering with platelet
function. Blood samples were adjusted with glucose (Sigma,
Taufkirchen, Germany) to final concentrations of 5 mmol/l (control
group), 10 mmol/l (group 1) and 15 mmol/l (group 2), respectively.
Samples were incubated for 10 min at 37°C with fluorescence-
labeled monoclonal antibodies against CD62P, CD41, CD36, or
CD42b (all: Beckman-Coulter, Krefeld, Germany). To evaluate
platelet reactivity 2 and 6 µM thrombin-receptor-agonist-peptide-6
(TRAP-6; Bachem, Heidelberg, Germany) or 5 and 10 µM
adenosine-di-phosphate (ADP; Sigma, Taufkirchen, Germany)
were added. Analyses were performed in a flow-cytometer (Epics
XL; Beckman-Coulter). The mean fluorescence intensity was
calculated. Determination of platelet aggregation was performed
by the turbidimetric procedure (BCT, Dade Behring, Marburg,
Germany). Aggregation was induced with ADP (200 µM/l),
collagen (2 mg/l) and epinephrine (100 µM/l; all Dade Behring).
Statistics for intergroup differences were performed by one-way
ANOVA.
Results  The initial blood glucose concentration was
5.0 ± 1.1 mmol/l. The blood glucose level had no significant
influence on the expression of CD36 and CD62P, with and without
stimulation. By contrast we observed a significant decrease in
expression of CD42b in group 2 compared with the control group
(unstimulated, P < 0.001; TRAP-6, P = 0.005; ADP, P = 0.012). A
similar observation was made for CD41 expression (unstimulated,
P < 0.001; TRAP-6, P < 0.05; ADP, P < 0.001). Also in group 1, a
significant decrease in CD41 expression was observed after ADP
stimulation. No significant differences were seen by aggregometry
with either agonist.
Conclusion This in vitro study demonstrates that elevated blood
glucose levels reduce expression of platelet receptors CD41 and
CD42b. In contrast, platelet function measured by aggregometry
showed no impairment. We conclude that acute hyperglycemia
does not lead to lowered platelet function.
P253 Evaluation of glucose intolerance in acutely ill severe patients by means of an artificial pancreas
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Purpose To verify the importance of both the M value (glucose
disposal rate measured by the glucose clamp method [GC]) and
the I/E ratio (administered insulin/energy [glucose] ratio) measured
by means of a bedside-type artificial pancreas (STG-22) in acutely
ill severe patients.
Materials and methods Thirty-four patients in whom blood
glucose (BG) levels were controlled by means of the artificial
pancreas (aim of BG control: 150 mg/dl) were investigated. The
first measurement of GC was performed in acute conditions for all
the patients, and the second measurement was done 1 week after
the first measurement for 20 patients. GC was performed with a
clamped BG level of 80 mg/dl and an insulin infusion rate (IIR) of
1.12 and 3.36 mU/kg/min. M1/M3 and I1/I3 indicate the M value
(mg/kg/min) and blood insulin level (µU/ml) when the IIR is
1.12/3.36, respectively (normal value of M1: 5–10). M1/I1 and
M3/I3 were calculated as the indicator of insulin sensitivity (IS).
Patients were classified in four groups (A, B, C, D) according to
M1 and the I/E ratio (mU/kcal): A, M1 <5 and 30 <I/E ratio; B, M1
<5 and I/E ratio <30; C, 5< M1 and I/E ratio <30; D, 5 <M1 and
30 <I/E ratio. The following parameters were studied: (1)
administered energy (glucose) (E), (2) administered insulin (I), (3)
SOFA score, (4) M value, (5) daily mean BG level (BGm), (6)
blood C-peptide reactivity (CPR), (7) IS, (5) insulin clearance (IC)
(ml/kg/min).
Results (1) There was negative correlation between the I/E ratio
and M1/M3 (r = –0.31/r = –0.44). (2) Comparison between A (M1,
3.3 ± 1.1; I/E ratio, 55 ± 20; n = 23) and B (M1, 3.5 ± 0.8; I/E
ratio, 18 ± 9; n = 11): there was significant difference in I
(P < 0.005), BGm (183 ± 16 vs 153 ± 18, P < 0.005), and IC
( 1 9±7  v s  1 4±4 ,  P < 0.05), but no significant difference in E, M1,
CPR, IS, and SOFA score. (3) Comparison between C (M1,
7.3 ± 1.7; I/E ratio, 12 ± 8; n = 15) and D (M1, 7.8 ± 2.2; I/E ratio,
62 ± 44; n = 5): there was a significant difference in I (P < 0.005)
and BGm (145 ± 21 vs 168 ± 16, P < 0.05), but no significant
difference in E, M1, M3, CPR, IS, IC, and SOFA score.
Interpretation The I/E ratio was a daily measurable indicator of
glucose tolerance. However, there was discrepancy between the
M value and the I/E ratio in some patients (groups B, D). the
mechanism of the discrepancy was unclear, but the influence of IC
and/or an increase of glucose metabolism by BG itself (ex. mass
action effect, activation of glucose transporter-2, etc.) in group B,
and a decrease of that in group D was speculated, because the M
value was measured under a BG level of 80 mg/dl, while the I/E
ratio was under BG control aiming at 150 mg/dl.
Conclusions Measurement of both the M value and the I/E ratio
was considered to be useful not only for the evaluation of glucose
tolerance, but also for further understanding of the mechanism of
glucose intolerance in acutely ill severe patients.Available online http://ccforum.com/supplements/8/S1
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‘Tight’ glycaemic control in perioperative or critical ill patients may
carry the risk of hypoglycaemia. However, a blood glucose target of
4.5–6.1 mmol/l has been shown to benefit critically ill, mainly
postcardiothoracic surgery patients where, unusually, all patients
were given glucose infusions from admission (200–300 g/24 hours).
Of the ‘tight’ group, 5.2% had inconsequential hypoglycaemic
episodes (blood glucose <2.2 mmol/l). The perceived risk of
hypoglycaemia in starved patients receiving insulin to achieve ‘tight’
glycaemic control is a widespread concern. We report safety
monitoring in our ongoing prospective, double-blind, randomised
controlled study (the Does Additional Glucose Make A Difference?
trial) investigating whether initial additional glucose infusion improves
outcome in critical care patients receiving a ‘tight’ glycaemic control.
Patients received 50% glucose or 0.9% NaCl at 20 ml/hour until full
nutrition was taken. We monitored for excess hypoglycaemic
episodes in our NaCl group. We set a 5% acceptable incidence of
blood glucose <3.0 mmol/l and 0% for adverse consequences.
Hourly arterial line samples were tested by regularly calibrated
Accu-check® (Roche Diagnostics) bedside monitors. Insulin
(Actrapid®; Novo Nordisk), 50 U in 50 ml of 0.9% NaCl, was
administered by continuous infusion and boluses according to an
algorithm. The study period was the time that study infusions were
given. Investigators remained blinded.
Complete data was obtained from 113 patients (63 and 50 in each
group) of 127 who gave informed consent according to local
medical ethics guidelines. No adverse incidents or deaths were
recorded in patients with incomplete data. There were no
differences between the groups in (group 1 [mean, SD], group 2
[mean, SD]): age (66.7, 14.9), (67.1, 12.7), body mass index
(77.3, 16.2), (79.8, 12.4), APACHE II score (13.8, 12.2), SOPRA
(30.4, 12.2), (33.3, 10.5), admission reason (87%, 92% cardiac
surgery) or death in the ITU (3.2%, 2%).
Total hypoglycaemic (<3.0 mmol/l) and hyperglycaemic
(>12.0 mmol/l) episodes (total hours of study period) and mean
(SD) hours outside the prescribed range (4.5–6.1 mmol/l) for each
patient during the study period are presented in Table 1.
Tight glycaemic control appears safe in patients receiving either
50% glucose or 0.9% NaCl at 20 ml/hour.
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Table 1
Mean (SD)
hours outside
Group Hypoglycaemia Hyperglycaemia prescribed range
1 2 (1261) 20 11.3 (6.4)
2 3 (938) 19 8.0 (3.8)
P255 Cortisol deficiency in critically ill patients after major trauma
G Schleicher, G Richards
Johannesburg Hospital, Sloane Park, South Africa
Critical Care 2004, 8(Suppl 1):P255 (DOI 10.1186/cc2722)
Introduction Severe injury with activation of the systemic
inflammatory response syndrome stimulates the release of cortisol
from the adrenal cortex. Relative cortisol insufficiency is well
described in critically ill patients, especially in severe sepsis, and is
associated with increased mortality. There is conflicting data
regarding the effect of major trauma and haemorrhagic shock on
endogenous cortisol levels and the effects of early relative cortisol
deficiency.
Materials and methods We measured random cortisol levels in
20 patients with severe trauma and haemorrhagic shock who were
admitted to the ICU after initial resuscitation and emergency
surgery. Injury severity scores (ISS), fluid and blood product
requirements, inotrope requirements after fluid resuscitation, and
mortality at 28 days were also measured. Relative cortisol
deficiency was defined as a random cortisol level <400 nmol/l.
Results Six out of 20 (30%) patients had a cortisol level
>400 nmol/l. This group of patients had a mean (± SD) ISS of
18 (± 7) and a mean cortisol level of 606 nmol/l (± 155). None
required inotropic support, and mortality was 0/6 (0%). Fourteen
out of 20 (70%) patients had a cortisol level <400 nmol/l. This
group of patients had a mean ISS of 28 (± 7.5) and a mean
cortisol level of 253 (± 89). Six out of 14 (43%) required
inotropic support, and the mortality was 3/14 (21.5%). These
patients also had significantly higher fluid and blood product
requirements.
Conclusion Cortisol deficiency is common in patients after major
trauma and is associated with a higher ISS, increased fluid and
blood product requirements, increased inotrope requirements, and
increased mortality. These patients may benefit from early steroid
replacement therapy.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P256 The hypothalamic–pituitary–adrenal axis in critical illness: responses to the low-dose corticotropin (ACTH) stimulation test
and human corticotropin-releasing hormone (hCRH)
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The objective of this study was to investigate the functional
integrity of the hypothalamic–pituitary–adrenal axis in critical illness
by stimulating with the low-dose ACTH stimulation test (LDST) and
hCRH. The study included 16 (15 male) mechanically ventilated
patients, having a mean age of 52 ± 19 years. Underlying
diagnoses included major operation (n = 7), multiple trauma
(n = 5), stroke (n = 3), and pancreatitis (n = 1). Patients were
enrolled in the study 3–14 days after initiation of mechanical
ventilation. Median APACHE II and SOFA scores at the study day
were 13 (range: 8–23) and 5.5 (range: 4–12), respectively. All
patients underwent stimulation first with the LDST (1 µg) and then
on the following day with 100 µg hCRH. ACTH and cortisol
concentrations were determined from –15 to 120 min after hCRH.
Normal cortisol responses to the LDST and hCRH were defined as
peak plasma concentrations above 18 µg/dl and 20 µg/dl,
respectively. An appropriate ACTH response to hCRH was
considered if a twofold increase in ACTH was observed. In the
entire patient population, baseline cortisol (mean ± SD) was
15.1 ± 7.1 µg/dl and stimulated cortisol (median) was 21.4 µg/dl
following the LDST. Four (25%) of the 16 patients had subnormal
stimulated cortisol levels after the LDST. These four patients also
had subnormal peak cortisol concentrations following hCRH.
Analysis of the individual ACTH responses in the four patients
revealed two patterns: in three patients a twofold to eightfold
increase in ACTH was noted, whereas one patient failed to
augment appropriately ACTH levels (peak ACTH was 1.60 times
the baseline value).
In conclusion, a significant (25%) subset of critically ill patients has
evidence of diminished cortisol production following dynamic
stimulation with the LDST. This disorder is mostly due to primary
adrenal dysfunction, but also to hypothalamic–pituitary failure.
P257 Adrenal hyporesponsiveness to the low-dose stimulation test (LDST) is associated with a higher mortality in early sepsis
and/or septic shock
I Dimopoulou1, M Zervou2, S Tsagarakis2, E Duka2, C Augustatou2, M Tzanela2, S Orfanos1, P Alevizopoulou2, N Thalassinos2, 
C Roussos2
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Critical Care 2004, 8(Suppl 1):P257 (DOI 10.1186/cc2724)
The aim of the study was to determine the status of the
hypothalamic–pituitary–adrenal axis in critically ill patients with
early sepsis and/or septic shock and to investigate whether
adrenal responses are related to mortality. Forty-two patients
(32 male; median age 62 years; range 17–82 years) had cortisol,
corticotropin (ACTH) and dehydroepiandrosterone sulphate
(DHEAS) levels measured at onset of sepsis and/or septic shock.
Adrenal responsiveness was assessed by the LDST. A peak
cortisol <18 µg/dl on the LDST was considered as representing
an inadequate response. For the entire patient population,
hormone concentrations were as follows (median or mean ± SD
values): baseline cortisol 17.8 µg/dl, stimulated cortisol
24.8 ± 9.4 µg/dl, increment in cortisol 5.9 ± 4.4 µg/dl, ACTH
21.2 pg/ml and DHEAS 1553 ± 1157 ng/ml. Eight (19%) of the
42 patients had inadequate cortisol responses following the LDST.
Overall, 21 patients died and 21 patients survived. There were no
differences between survivors and nonsurvivors with regard to
baseline cortisol (17.2 vs 18.9 µg/dl, P = 0.20), stimulated cortisol
(23.5 vs 25.1 µg/dl,  P = 0.94), ACTH (20.1 vs 26.1 pg/ml,
P = 0.48) or DHEAS (1754 ± 1333 vs 1352 ± 939 ng/ml,
P = 0.26) levels. In contrast, nonsurvivors had a lower increment in
cortisol following the LDST compared with survivors (4.2 ± 3.5 vs
7.5 ± 4.7 µg/dl, P < 0.05).
In conclusion, a substantial (19%) proportion of patients has
evidence of adrenal hyporesponsiveness at onset of sepsis and/or
septic shock. Attenuated adrenal responses are associated with a
higher mortality rate in such patients.
P258 The effect of Etomidate on corticotropin stimulation test to diagnose relative adrenal insufficiency in septic shock
Z Mohammad, R Kersting, B Afessa
Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Critical Care 2004, 8(Suppl 1):P258 (DOI 10.1186/cc2725)
Introduction Patients with septic shock were recently found to
have relative adrenal insufficiency. Etomidate is known to inhibit
11-beta hydroxylase, which could interfere with the cortisol
response to corticotropin.
Hypothesis Patients who receive Etomidate before the
corticotropin stimulation test will have higher incidence of relative
adrenal insufficiency.
Methods In this retrospective study, the electronic records of the
1207 patients who had serum cortisol levels drawn between
March 2002 and August 2003 were reviewed and 163 patients
who had a short corticotropin stimulation test done during an ICU
admission because of septic shock were identified. Our cohort
was divided into those who received Etomidate or not before the
corticotropin stimulation test. The incidence of relative adrenal
insufficiency was compared between these two groups. Data
collected included demographics, presence of relative adrenal
insufficiency, presence of coagulopathy, the use of steroids or any
medication known to interfere with cortisol synthesis, use of
Etomidate and the time interval between the administration and the
cosyntropin test, history of adrenal/pituitary disease, and mortality.Relative adrenal insufficiency was defined as a response of 9 µg/dl
or less after corticotropin stimulation. Septic shock was defined by
the ACCP/SCCM criteria. Comparisons between groups were
made using the chi-square test.
Results The patient mean age was 64.6 years; 97% were white,
and 58% were male. Coagulopathy was found in 66% of the
patients. Ten patients were on dexamethasone before the test.
None of the patients were on any medication known to interfere
with the test. There was no patient with previous history of
adrenal/pituitary disease. Of the 46 patients who received
Etomidate, 36 (78%) were diagnosed as having relative adrenal
insufficiency compared with 58/117 (50%) patients who did not
(P = 0.0008). Relative adrenal insufficiency was noted in 79% of
the patients who received Etomidate within 6 hours compared with
78% of the patients who received Etomidate later than 6 hours of
the test (P = 0.9246). The mortality rate was 53% (50/94) in
patients with relative adrenal insufficiency compared with 61%
(42/69) in patients without relative adrenal insufficiency
(P = 0.3287).
Conclusion There is an increased incidence of relative adrenal
insufficiency after Etomidate administration in septic shock
following Etomidate administration. This increased incidence is
unrelated to the time interval between Etomidate administration
and the corticotropin test.
Available online http://ccforum.com/supplements/8/S1
P259 Is there any place to corticotropin test in sepsis?
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During the past years, the use of corticosteroid therapy (CT) in
patients with sepsis and septic shock became usual.
Aim To know whether the corticotropin (ACTH) test is really useful
before starting corticoids.
Patients and methods During 2 years (September 2001–August
2003) were enrolled all patients with septic shock requiring high
doses of vasoactive agents. The ACTH test is performed each time
before we start corticosteroids (300 mg hydrocortisone daily). The
normal value of basal cortisol level (BCL) is 200 g/l in patients with
septic shock [1].
Results Ninety-four patients were enrolled, mean age 47 years,
SAPS II score 3919. CT is begun at the 10th hour on average. The
result of the ACTH test allowed us to distinguish four groups of
patients (Table 1). Forty-three patients have a relative adrenal
insufficiency: normal or high serum cortisol level (CL) but with a
weak increase after ACTH (<90 g/l). Twenty-five patients have a
low BCL and a weak response to ACTH. In these cases
hydrocortisone is maintained for 5 days. If we consider the BCL,
only 30 patients should have corticosteroids instead of 68.
We analysed the same data using the Cooper algorithm [2]
(Table 2). Nineteen patients have a low CL. Thirty-one patients
have a relative adrenal insufficiency. If we consider only the value of
BCL, 19 patients will be treated by corticosteroids instead of 68.
Discussion According to the Cooper algorithm, the BCL helps us
to identify three groups of patients, those with low CL where CT is
very likely; the group with a high BCL where CT is unlikely to be
useful, and a group with an intermediate value of CL in which CT is
necessary only if there is no increase after the ACTH test. So if we
do not practice the ACTH test, there is a group of patients that will
receive corticosteroid abusively. Can we consider a cutoff value of
the BCL as 340 g/l?
Conclusion The BCL may be useful alone to identify patients that
need CT, but we should continue to practice the ACTH test until
we have enough data to confirm this.
References
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Table 1
Cortisol level ∆ Maximum ≤90 µg/l ∆ Maximum >90 µg/l
≤200 µg/l 25 5
>200 µg/l 43 21
Table 2
Cortisol level ∆ Maximum ≤90 µg/l ∆ Maximum >90 µg/l
<150 µg/l 16 3
150–340 µg/l 31 20
>340 µg/l 21 3
P260 Does the antioxidant level increase after the treatment of exacerbation of chronic obstructive pulmonary disease every time?
A Balkan, H Turkan, M Ozkan, A Sayal, A Aydin, N Demirci
GMMA, Ankara, Turkey
Critical Care 2004, 8(Suppl 1):P260 (DOI 10.1186/cc2727)
Background and goals Chronic obstructive pulmonary disease
(COPD) has been increasingly recognized as a systemic disease.
The hormonal, metabolic and musculoskeletal implications of the
generalized processes involving oxidative stress, inflammatory
mediators, cytokines, and endocrine hormones have only begun to
be understood. The aim of this study was to assess of changes in
oxidant stress during the treatment of exacerbation of COPD.
Materials and methods We measured erythrocyte (E) and
plasma (P) glutathione peroxidase (GPx), malondialdehyde
(MDA) and superoxide dismutase (SOD) on the pretreatment
period and the post-treatment period in 20 patients with acute
exacerbation of COPD. Twenty healthy smokers and 20
nonsmokers having no history of lung disease served as control
subjects.Results Data are presented in Tables 1 and 2.
Conclusions Our results were not consistent with early reports
about the same topic. We thought that treatment does not
increase the antioxidant level every time, although the clinical
improvement is achieved. Therefore, our results suggest that,
considering an increase in antioxidant capacity shows tissue
improvement, GPx, SOD and MDA levels can be used as a marker
of prognosis and of the success of treatment of the exacerbation of
COPD.
Reference
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Table 1
Pretreatment Post-treatment
Parameter COPD COPD P
E-GSH-Px (U/ml) 4.78± 0.17 2.79± 0.09 0.000 (<0.001)
P-GSH-Px (U/ml) 0.63± 0.03 0.55± 0.03 0.067 (<0.1)
E-SOD (U/ml) 592.20± 21.57 456.75± 27.30 0.000 (<0.001)
P-SOD (U/ml) 231.20± 21.57 199.75± 27.30 0.067 (<0.1)
E-MDA (nmol/ml) 34.50± 11.68 45.20± 2.61 0.017 (<0.05)
P-MDA (nmol/ml) 2.60± 0.13 3.15± 0.18 0.031 (<0.05)
Table 2
Parameter Post-treatment COPD Healthy smokers Nonhealthy smokers P
E-GSH-Px (U/ml) 2.79± 0.09 2.98± 0.17 3.43± 0.25 0.059 (<0.1)
P-GSH-Px (U/ml) 0.55± 0.03 0.58± 0.04 0.57± 0.04 0.796 (>0.05)
E-SOD (U/ml) 456.75± 27.30 298.20± 20.21 333.60± 27.87 0.000 (<0.001)
P-SOD (U/ml) 199.75± 27.30 167.20± 20.21 178.60± 27.87 0.069 (>0.05)
E-MDA (nmol/ml) 45.20± 2.61 34.65± 2.80 36.8± 2.74 0.059 (>0.05)
P-MDA (nmol/ml) 3.15± 0.18 2.14± 0.12 2.30± 0.10 0.000 (<0.001)
P261 Antioxidant enzyme activities in patients with severe sepsis
F Novak, M Hynkova, H Lubanda, O Novakova, A Zak
Charles University, Prague, Czech Republic
Critical Care 2004, 8(Suppl 1):P261 (DOI 10.1186/cc2728)
Background Severe sepsis with systemic inflammatory response
caused by excessive secretion of proinflammatory mediators is
associated with significant morbidity and mortality. Experimental
evidence suggests that reactive oxygen species may be important
mediators of cellular injury during sepsis.
Objective To assess antioxidant enzyme activities in critically ill
patients with sepsis compared with control patients without sepsis
and to evaluate changes of antioxidant enzyme activities in the
convalescent period after successful treatment of sepsis.
Patients and methods It is a prospective case–control study in a
medical adult intensive care unit with 13 beds. Routine venous
blood samples were obtained from septic patients (n = 16, age
26–80 years) with APACHE II score >10 without antioxidant
treatment and from 16 age-matched, sex-matched hospitalised
control patients without clinical and laboratory signs of sepsis.
Paired convalescent samples taken 1 week after recovery were
available in five patients. We measured the activity of superoxide
dismutase with copper and zinc (EC 1.15.1.1, CuZn-SOD) in
erytrocytes, based on superoxide generation by xanthine oxidase
and tetrazolium reduction. The activity of paraoxonase (EC 3.1.8.1,
PON1) in serum with paraoxon and phenylacetate, and the serum
concentrations of total, high-density lipoprotein (HDL) cholesterol
and C-reactive protein were also measured. We considered
P < 0.05 to be statistically significant.
Results There was higher CuZn-SOD activity (mean ± SEM,
30,332.5 ± 2369.9 U/g Hb) in septic patients in comparison with
healthy controls (23,192.2 ± 1078.7 U/g Hb; P = 0.01). On the
other hand, PON1 activity measured with paraoxon
(5.58 ± 0.71 U/ml) resp. phenylacetate (17,642.3 ± 1501.1 U/ml)
was lower in sepsis when compared with controls
(9.55 ± 0.93 U/ml resp. 29,181.1 ± 2198,6 U/ml; P < 0.01 resp.
P = 0.001). After recovery there was no difference in activity of
both CuZn-SOD and PON1 of patients and controls. Moreover, we
found positive correlation between activity of PON1 and level of
total and HDL cholesterol in sepsis and after recovery. We
observed no age and sex dependence in activity of both enzymes
in septic patients and controls.
Conclusion Patients admitted to the intensive care unit with
severe sepsis exhibit abnormal anitoxidant enzyme activities.Available online http://ccforum.com/supplements/8/S1
P262 Scavengers prevent lung injury but do not improve the survival during sepsis in rats
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Purpose To assess the efficacy of scavengers on lung injury
during intra-abdominal sepsis in rats.
Methods The Sprague–Dawley rats (male, 200–250 g) underwent
cecal ligation and puncture (CLP); the cecum was punctured with
a 18-gauge needle through and through to obtain two holes, and
gentle pressure was applied on the ligated cecum to exteriorize a
small amount of feces, followed by closure of the abdominal
incision. Five hours later, these animals were then injected
intraperitoneally with polyethylene glycol absorbed catalase;
scavengers of hydrogen peroxide (A group), dimethyl sulfoxide;
scavenger of hydroxyl radicals (B group), polyethylene glycol
absorbed superoxide dismutase; scavengers of superoxide ions, or
saline (control group). Survival was evaluated for 24 hours after
CLP, and then surviving animals were sacrificed with carbon
dioxide inhalation for outcome. The lung protein synthesis was
evaluated with a nitrotyrosine/tyrosine ratio and oxidative damage
in DNA was evaluated with the 8-oxodeoxyguanosine/
deoxyguanosine ratio in the homogenized lung tissue, which were
measured by HPLC. Neutrophil accumulation in the lung was
evaluated with myeloperoxidase activity (MPO), intracellular
adhesion molecule-1 (ICAM-1) expression on these cells in the
lung was evaluated with pathological examination.
Results MPO, ICAM-1 expression, the nitrotyrosine/tyrosine ratio
and the 8-oxodeoxyguanosine/deoxyguanosine ratio were
significantly lower in all the scavenger-treated groups (A, B, C)
than in the saline-treated group. However, there was no difference
in the survival rate in all the groups (A, 33.3%; B, 20%; C, 0%;
control, 27.7%).
Conclusion Scavengers attenuate neutrophil accumulation and
lung injury, but do not improve survival. These results suggest that
factors other than lung injury may be responsible for mortality in this
rat model of sepsis. However, additional studies of both superoxide
in the early phase and late assessment of outcome are indicated.
P263 Early postoperative substitution procedure of the antioxidant ascorbic acid (AA) in postoperative intensive care unit (ICU)
patients
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Critical Care 2004, 8(Suppl 1):P263 (DOI 10.1186/cc2730)
A postoperatively reduced concentration of AA in plasma
(<45.5 µmol/l) is common due to increased metabolic requirements.
Positive effects of AA in the postoperative period are well known
(e.g. radical scavenger activity); hence there is an indication for the
substitution of AA. However, the dosage commonly recommended
for substitution during clinical nutrition is not adequate. Therefore, a
postoperative AA substitution procedure ‘overnight’ to normal values
in plasma was investigated in this randomized, prospective study on
a postoperative ICU in a university hospital.
Fifty-seven electively operated patients were assigned to a control
group or an intervention group. In all patients the AA plasma
concentration was analysed preoperatively and on the first three
postoperative days. Patients of the intervention group received AA
intravenously ‘overnight’ up to four times within 12 hours
depending upon the initial AA concentration (<34.1 µmol/l
[4 × 500 mg AA]; <56.8 µmol/l [2 × 500 mg AA]; <68.2 µmol/l
[1 × 500 mg AA]).
The preoperative and postoperative AA values on the first
postoperative day did not differ between both groups. However,
the postoperative plasma concentration was lowered
(<45.5 µmol/l) in 82.4% of all patients.
In the intervention group, the dosage regime increased the AA
plasma concentration to >45.5 µmol/l in 89.6% overnight.
In conclusion, the investigated substitution procedure is sufficient
to increase the AA plasma concentration overnight to high normal
values in postoperative ICU patients.
P264 Trace minerals in critically ill patients: a forgotten cause of delayed recovery?
B van der Hoven, J Schoonderbeek, C Groeninx van Zoelen
Erasmus University Medical Center, Rotterdam, The Netherlands
Critical Care 2004, 8(Suppl 1):P264 (DOI 10.1186/cc2731)
Introduction The aim of this pilot study was to assess the possible
deficiency of the standard nutrition protocol, based on the daily
recommended doses (DRD) in the literature [1], in the surgical ICU
for trace minerals. An intervention with extra supplements given in
addition to the standard formula was evaluated.
Methods A prospective, observational pilot study in a surgical ICU of
a tertiary referral centre. Forty-eight intensive care patients with two
or more organ failures were included in the study (APACHE II score
24.2 ± 7.9). All patients received total parenteral nutrition according
to a standard protocol. Plasma measurements of manganese,
selenium and zinc were performed before and after 7 days of extra
supplementation with a commercial formula containing one DRD1 of
each element (Addamel® N; Fresenius Kabi, ‘s-Hertogenbosch, The
Netherlands). Twenty-five patients were also screened for copper
and chromium levels and their response to supplements.
Results The overall daily caloric intake in the week before inclusion
into the study was 1693 ± 841 kcal and during the study period
2211 ± 543 kcal (P = 0.002). Copper as a substantial element in the
normal function of oxidative enzyme systems (so-called ‘cupro-
enzymes’) and in plasma primarily bound to ceruloplasmine, an acutephase protein, is difficult to interpret in critically ill patients. However,
levels at the start were normal (14.5 ± 6.3 µmol/l,
n = 10.0–30.0 µmol/l) and could be raised significantly
(17.4 ± 4.6 µmol/l, P = 0.004). Ceruloplasmin levels were within the
normal range and did not change significantly over the study period
(0.34 ± 0.11 g/l,  n = 0.24–0.62 to 0.37 ± 0.10 g/l, P = 0.414).
Manganese is part of the mitochondrial superoxide dismutase and
important for the metabolic effects of vitamin K. In our population
normal starting levels were found (30.5 ± 13.7 nmol/l,
n = 2–37 nmol/l) and were raised significantly (37.0 ± 16.3 nmol/l,
P = 0.021). Selenium as a co-factor in the erythrocyte glutathion
peroxidase complex has a protective role against peroxides. (Very)
low baseline levels were found (0.53 ± 0.22 µmol/l,
n = 0.8–1.8 µmol/l) and the supplement, although double the DRD,
could not normalize this (0.71 ± 0.28 µmol/l), but the improvement
was statistically significant (P < 0.0001). Albumin as the transport
protein for selenium was low and did not change significantly
(20.9 ± 6.0 g/l,  n = 35–50 to 21.1 ± 6.5 g/l, P = 0.959). Zinc
metabolism and physiology are subject to debate. Zinc deficiency,
however, is known for impaired wound healing, alopecia and
immunologic dysfunctions. Almost all patients were deficient at the
start (8.6 ± 3.6 µmol/l,  n = 11.5–23.5 µmol/l), and then
supplementation did result in significant improvement, but only just to
normal levels (11.4 ± 2.6 µmol/l,  P < 0.0001). Chromium is a co-
factor in insulin metabolism and glucose utilisation. Plasma levels are
difficult to assess, because of their biologic significance. However,
starting levels were high (86 ± 52 nmol/l, n = 9.6–50 nmol/l) and
were raised nonsignificantly (90 ± 45 nmol/l). The chromium-
transporting protein transferrin was low and did not change
significantly (1.3 ± 0.9 g/l, n = 2.0–3.5 to 1.3 ± 0.4 g/l, P = 0.475).
Conclusions A significant percentage of ICU patients have trace
mineral deficiencies, despite well-dosed parenteral (and/or enteral)
feeding regimens. Low plasma levels are not unequivocal to
interpret [2], but our results support a more prominent role for
research and re-evaluation of the current recommended nutrition
standards for ICU patients.
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P265 Selenium and zinc plasmatic levels in intensive care patients
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The study was aimed at investigating plasmatic levels of zinc (Zn)
and selenium (Se) in critical care patients, and the influence of
standard supplementation of those elements on such levels.
Materials and methods One hundred and eighty-one measure-
ments were made in 55 patients. They were divided into two
groups: CARDIO group, 18 patients after cardiovascular surgery,
well nourished, without supplementation of trace elements; ICU
group, 37 patients in acute protein catabolism with daily average
suplementation of 0.89 mmol (70 mg) Se and of 107 mmol (7 mg)
Zn. On days 0, 2, 3 and 7 of the hospitalization the following
factors were monitored: (1) plasmatic levels of Se and Zn using
atomic absorption spectrophotometry and electrothermic
atomisation, and (2) prealbumin, albumin and CRP turbidimetrically,
orosomucoid nephelometrically. By means of the last four
parameters the prognostic nutritonal index (PINI) was calculated.
Reference values Se 0.58–1.82 mmol/l, Zn 10.9–18.4 mmol/l,
PINI ≤1.0, CRP 0–10 mg/l.
Statistical methods Multiple regression analysis, one-way
ANOVA, Bonferroni multiple comparison test, Kruskal–Wallis
multiple comparison Z value test.
Results Mean values and standard deviations for both groups of
patients on days 0, 2, 3, and 7 were as follows. CARDIO group:
Zn (mmol/l): 13.1 ± 2.8, 5.5 ± 2.0, 8.1 ± 1.8, 9.4 ± 2.5,
Se (mmol/l): 0.39 ± 0.22, 0.24 ± 0.15, 0.24 ± 0.14, 0.29 ± 0.16.
ICU group: Zn mmol/l: 8.2 ± 2.6, 8.6 ± 2.3, 8.7 ± 2.7, 8.7 ± 3.3,
Se (mmol/l): 0.26 ± 0.20, 0.28 ± 0.15, 0.30 ± 0.14, 0.42 ± 0.24.
The markers of inflamation were as follows: CARDIO group: PINI:
9.0 ± 32, 28 ± 36, 103 ± 69, 36 ± 25, CRP (mg/l): 18 ± 38,
78 ± 41, 160 ± 89, 70 ± 41. ICU group: PINI: 236 ± 284,
181 ± 188, 115 ± 218, 110 ± 181, CRP (mg/l): 193 ± 145,
177 ± 127, 116 ± 193, 101 ± 112.
Zinc In the CARDIO group significant elevation of CRP and PINI
prove the acute metabolic response to trauma, and their changes
corespond to dynamics of Se and Zn levels. The decrease of Zn
between the first and second investigation was significant
(P < 0.001). The inverse dependence between Zn:CRP was also
significant (P < 0.001, r = –0.387). For the ICU group the decrease
of Zn levels is characteristic, lasting under Zn substitution. Neither
the Zn:CRP relation, nor Zn:PINI were significant.
Selenium Levels in both groups were significantly decreased. In
the CARDIO group the inverse dependency between Se:CRP
(P < 0.01, r = 0.306) was again significant. In the ICU group there
was significant dependence for the Se:CRP relation (P < 0.001,
r = –0.293) and Se:PINI (P < 0.001, r = –0.308).
Conclusions With respect to low Se and Zn levels in critical patients,
their monitoring and higher than usually recommended substitution in
indicated cases seems raesonable and directs our future work.
P266 Significant hypophosphatemia following major cardiac surgery: incidence and consequences
J Cohen, A Kogan, G Sahar, S Lev, B Vidne
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Significant hypophosphayemia (SH) may be associated with
respiratory and cardiac complications but has not been targeted as
a reversible cause of these complications following cardiac
surgery.Patients and methods We prospectively studied all patients
(n= 566, males 388, females 178, mean age 65.5 [11.1] years)
undergoing major cardiac surgery (coronary artery bypass grafting
[CABG] 75.4%; aortic valve replacement 5.1%; aortic valve
replacement + CABG 5.8%; mitral valve replacement 6.8%; other
6.9%) over a 6-month period. Phosphate levels were measured
preoperatively, on admission to the ICU, and on the first postoperative
day. Two groups were defined according to the ICU admission level:
SH, level <0.48 mmol/l; and a control group, normal range
0.8–1.45 mmol/l. Preoperative, intraoperative and postoperative data
were collected in all patients. SH was treated with intravenous
sodium or potassium phosphate (0.08 mmol/kg) over 6–12 hours.
Results SH was found in 34.3% (mean level 0.29 [0.13] vs 0.84
[0.11]). Preoperative data are presented in Table 1, and the
postoperative course in Table 2. The phosphate level tended to be
lower in the SH group on the first postoperative day (0.6 [0.15] vs
0.81 [0.10]), suggesting inadequate repletion.
Conclusions As SH after cardiac surgery appears to be common
and associated with major morbidity, levels should be routinely
monitored.
Available online http://ccforum.com/supplements/8/S1
Table 1
Parameter SH (n = 194) Control (n = 372) P value
Risk score 17.9 (12.1) 16.1 (10.9) NS
Bypass (min) 117.4 (21.4) 110.5 (12.8) NS
Cross-clamp (min) 59.1 (10.9) 55.3 (13.3) NS
Units blood 2.2 (1.1) 1.8 (0.9) 0.05
Units platelets 6.2 (2.4) 2.1 (1.3) 0.01
Table 2
Parameter SH (n = 194) Control (n = 372) P value
Ventilation (days) 2.1 (1.7) 1.1 (0.9) 0.05
Atrial fibrillation (%) 28.4 31.1 NS
ICU stay (days) 2.6 (2.9) 2.1 (2.7) NS
Inotrope use (%) 16 10.9 0.05
Hospital stay (days) 7.8 (3.4) 5.6 (2.5) 0.05
Mortality (%) 5.2 4.6 NS
P267 Pseudohyperkalemia during the onset of critical illness
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In everyday practice we observe a difference between the potassium
levels measured by routine biochemistry and by the gas analysis
machine. This is expected since the former measures serum
potassium while the later measures plasma potassium. The
serum/plasma potassium concentration difference is related to the
patient’s platelet count and increases to statistically significant levels
in thrombocytaemia.We measured the serum/plasma potassium
difference of ICU patient within the first 6 hours of their admission
and compared it with the difference measured in chronically severely
ill (uremic) patients, as well as a group of healthy volunteers.
We measured the serum potassium (SKA), plasma potassium
(PKA), serum/plasma potassium difference (SPdif-A = SKA – PKA),
age and platelet (PLT) count in 50 ICU patients (Group A). They
had been previously healthy and had suffered a major catastrophe
(road traffic accident, gastrointestinal bleed, major trauma) less than
6 hours from the measurements.We also measured the serum
potassium (SKB), plasma potassium (PKB), serum/plasma
potassium difference (SPdif-B = SKB – PKB), age and PLT count in
31 chronic uremic patients on renal replacement therapy (Group B).
The patients had come for treatment as scheduled, with no
evidence of any other acute disease.
The same variables (SKC, PKC, SPdif-C) were measured in
20 healthy volunteers (Group C). Blood samples were obtained from
the radial artery. Serum potassium was collected in a Vacutainer
tube, Plasma potassium in a syringe treated with heparin, and
platelet counts were measured in EDTA-treated plasma samples.
Potassium level were measured using the same equipment.
Results  Group A: male/female = 37/13, age (years) = 63 (19),
PLT × 1000/µl = 259 (83), SKA (mmol/l) = 4.31 (0.57), PKA
(mmol/l) = 3.69 (0.52), SPdif-A (mmol/l) = 0.62 (0.23). Group B:
male/female = 25/6, age = 59 (15), PLT = 235 (66), SKB = 4.89
(0.85), PKB = 4.55 (0.81), SPdif-B = 0.34 (0.16). Group C:
male/female = 10/10, age = 49 (11), PLT = 220 (62), SKC = 4.14
(0.52), PKC = 3.90 (0.48), SPdif-C = 0.24 (0.12). There was a
significant difference of SPdif between Group A/Group B,
Group A/Group C and Group B/Group C (P < 0.001).
Conclusions We suggest that plasma potassium is more reliable
than serum potassium in the critically ill, since the latter depends on
the platelet count. We should evaluate the patient and act
according to the plasma levels, since pseudohyperkalemia is more
likely, even for normal platelet counts.The higher Spdif observed in
the critically ill implies that a number of their platelets is not counted
with conventional methods, probably because they are activated
and aggregate during the initiation of the acute phase reaction.
P268 Risk factors for myelinolysis following correction of severe hyponatremia in the ICU
P Vacher, F Thiollière, A Hamzaoui, L Boyer, D Moreau, B Souweine
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Myelinolysis (ML) may be related to an excessively rapid correction
of hyponatremia, but no study has clearly demonstrated this
assumption. We prospectively analyzed the determinants of ML
following correction of severe hyponatremia.Materials and methods All patients admitted to a 10-bed university
medical ICU between July 1995 and March 2003 with
hyponatremia (<120 mmol/l) were included. A cerebral
computerised tomography (CT) scan was performed within 2 days,
and a cerebral magnetic resonance imaging (MRI) scan was
systematically planned at 1 month. ML diagnosis was ascertained
when hyperintense lesions were present on the T2 sequence in any
area considered normal on the initial imaging. Clinical and biological
data were assessed every 6 hours until correction of natremia.
Therapeutic options were left to the discretion of the intensivists.
Results Forty-six patients were elligible (hyponatremia and initial
CT scan), 22 were studied (12 refusals, six deaths, five lost, one
claustrophoby). MRI-documented ML occured in seven patients
(31.8%). Characteristics of patients with and without ML were
comparable with regards to age (56 years vs 55 years, P = 0.9),
gender, IGS II (34 vs 27, P = 0.17), ICU length of stay (14.5 days
vs 7 days, P = 0.19), aetiology of hyponatremia (primary polydipsia
50%, inappropriate ADH secretion 30%, iatrogenic 20%), thyroid
dysfunction (0 vs 2), medications before admission (diuretics,
angiotensin-converting enzyme inhibitors), Glasgow coma score
(13 vs 12, P = 0.65), incidence of mechanical ventilation (2 vs 1,
P = 0.2), and occurrence of new neurological symptoms during the
ICU stay. No patient died. Six parameters were associated with ML
in univariate analysis: chronic use of psychoactive drugs (7 vs 8,
P = 0.05), hypertonic NaCl infusion (7 vs 5, P = 0.005), total NaCl
intake for ICU day 1 (15.5 ± 12.4 vs 2.8 ± 1.3, P = 0.02), initial
kaliemia (3.2 ± 1.1 mM vs 4.1 ± 0.6 mM, P = 0.05), hypokaliemia
during correction of natremia (4 vs 1, P = 0.02) and ICU day 1 total
water intake (1867 ± 1411 ml vs 804 ± 269 ml, P = 0.013).
Neither the correction rate of natremia (0.4 ± 0.23 mM/hour vs
0.53 ± 0.3 mM/hour, P = 0.37) nor plasma osmolality or corrected
natremia on admission were associated with occurence of ML
Conclusion Despite a slow correction rate of hyponatremia, ML
remains a frequent (31.8%) complication of severe hyponatremias,
especially in case of chronic psychotrope use, initial hypokalemia,
and excessive precocious administration of sodium or water.
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Objectives To test the hypotheses: (1) that chloride accounts for
an increasing proportion of the base deficit with treatment in
diabetic ketoacidosis (DKA), and (2) that the perceived
discrepancy between changes in the anion gap and bicarbonate/
base deficit during treatment is primarily due to the chloride effect.
Methods A retrospective cohort study of children <16 years
(n = 18) admitted for acute management of DKA to two paediatric
ICUs. Stewart’s physicochemical theory was used to calculate the
independent effect of chloride on the bicarbonate and base deficit
via a linear regression model. This model was then used to: (1)
quantify the effect of chloride on the base deficit, and (2) evaluate
the relationship between change in the anion gap and both
bicarbonate and base deficit before and after correction for chloride.
Results Eighteen children (median age 12.7 years, weight 43 kg)
were followed for 20 hours after initiation of therapy (insulin and
fluid resuscitation). There was a steady improvement in pH over
this time (mean pH 6.97–7.31). However, at 20 hours a significant
base deficit persisted (mean 10.1 mmol/l), despite the anion gap
having normalised (mean 33.7 to 16.4 mmol/l). The base deficit at
this time was almost exclusively due to hyperchloraemia (98%).
The relationship between changes in the anion gap and both
bicarbonate and base deficit improved dramatically, approaching
one-for-one after correction for chloride (slope 0.99, r2 = 0.96 and
slope 1.14, r2 = 0.95, respectively).
Conclusions Chloride has a confounding effect on the
interpretation of the base deficit and bicarbonate during the
treatment of DKA. This does not occur with the anion gap, which
may be a better marker to track resolution of ketoacidosis and
should therefore be incorporated into treatment guidelines.
Figure 1Available online http://ccforum.com/supplements/8/S1
P270 Does the nutritive status influence on the outcome of sepsis in children with cancer?
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Introduction Sepsis results in mortality in children receiving
chemotherapy for malignancies. The influence of undernutrition on
outcome in patients with neutropenia and sepsis is not clearly
understood.
Setting A 10-bed specialized ICU in the Belorussian Center for
Paediatric Oncology.
Objective To estimate the influence of nutritive status on the
severity of septic complications and mortality in children with
neutropenia.
Methods We have followed prospectively 104 cases of sepsis
(33 cases of sepsis, 36 cases of severe sepsis and 35 cases of
septic shock, according to ACCP/SCCM criteria) among
neutropenic children aged from 2 to 16 years, with
myeloproliferative diseases and solid tumors. The mean PRISM II
score at the time of ICU admission for patients with sepsis was
9.17 ± 5.9, for severe sepsis was 19.46 ± 5.92, and was
28 ± 7.29 for patients with septic shock. We compared the
percent of weight loss during the period of chemotherapy before
sepsis onset among survivors and nonsurvivors. The control group
included 25 children with leukemia and lymphoma, matching by
age, gender and duration of treatment, and without septic
complications. For the statistical analysis a t test was used.
Results A decrease of body mass between 5.2% and 28% (mean
11.7 ± 6.45% weight loss during the previous 3.5 months) was
found in 75.8% patients with sepsis, 77.7% with severe sepsis
and 87.5% with septic shock. The differences in nutritional
condition among survivors and nonsurvivors with weight loss and
sepsis are summarized in Table 1.
In the control group weight loss was found in 37.1% patients, and
the mean level of weight loss was 4.05 ± 1.48%, which was
significantly (P < 0.05) lower than in patients with sepsis. There
was no mortality in the control group. The mortality rate in patients
with sepsis was 21.2%, in severe sepsis was 61%, and in septic
shock was 85.7%.
Conclusion Significant differences (P < 0.05) in weight loss
between survivors and nonsurvivors were found in all groups of
patients. Weight loss during chemotherapy for cancer is a risk
factor associated with an increase of morbidity and mortality
Table 1
Weight loss (%)
Survivors Nonsurvivors P value
Sepsis 6.96 ± 3.45 13.37 ± 6.1 <0.05
Severe sepsis 8.36 ± 2.57 17.8 ± 5.47 <0.05
Septic Shock 5.58 ± 1.05 12.38 ± 6.1 <0.05
P271 Three-month experience of an outpatient office of nutritional support after evaluation of body synthesis with bioelectrical
impedance analysis under the auspices of the ICU
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Objective To show our experience gained during a 3-month
service of an outpatient office of nutritional support under the
auspices of the ICU. We examined body synthesis with the
bioelectrical impedance analysis (BIA) apparatus in relation with a
medical history and nutritional habits, and we tried to find any
significant difference in body components according to their main
disease.
Materials and methods Seventy-seven patients were examined
and we obtained their BIA analysis (64 females [F], 13 males [M]).
We categorised the patients in groups from Group A, as control, to
Group H, according to their disease owing to which they wanted to
know their body profile. We present their BIA values (body mass
index [BMI], TBW, FM, ECM, BCM, ECM/BCM, PA, and BMR),
giving descriptive statistics about age, height, and weight.
Group A: healthy persons, 37/77. Group B: thyroid disease, 6/77.
Group C: arterial hypertension, 4/77. Group D: hyperlipidemia,
4/77. Group E: diabetes mellitus, 3/77. Group F: postmenopausal
syndrome, 3/77. Group G: combined diseases, 13/77. Group H:
others, 8/77. Then we applied a t test between Group A and each
of the other Groups B, C, D, E, F, G, and H, between males and
females of group A.
Results Demographic data are similar between groups. Mean
values for each group and parameter measured are: Group A: BMI
27.78 (M = 30.10, F = 27.03), TBW 39.33 (M = 51.17,
F = 35.53), FM 23.37 (M = 22.97, F = 23.50), PA 6.03
(M = 6.79,F = 5.79), ECM 25.5 (M = 30.91, F = 23.81), BCM
28.19 (M = 39.00,F = 24.71), ECM/BCM 0.94 (M = 0.82,
F = 0.97), BMR 1506.76 (M = 1847, F = 1397). Group B: BMI
29.38, TBW 34.88, FM 29.36, PA 6.06, ECM 22.7, BCM 24.9,
ECM/BCM 0.91, BMR 1401.67. Group C: BMI 29.65, TBW
40.95, FM 26.8, PA 6.02, ECM 26.9, BCM 29.05, ECM/BCM
0.96, BMR 1532.5. Group D: BMI 28.4, TBW 34.7, FM 26, PA
6.76, ECM 21.2, BCM 26.4, ECM/BCM 0.82, BMR 1450.
Group E: BMI 25.36, TBW 44.16, FM 14.9, PA 6.43, ECM 27.43,
BCM 32.9, ECM/BCM 0.8, BMR 1656.6. Group F: BMI 30.4,
TBW 37.6, FM 31.56, PA 6.2, ECM 24.36, BCM 27.06,
ECM/BCM 0.9, BMR 1473.3. Group G: BMI 31.9, TBW 36.07,
FM 30.93, PA 5.86, ECM 23.96, BCM 25.3, ECM/BCM 0.96,
BMR 1416.15. Group H: BMI 24.56, TBW 36.2, FM 19.1, PA 6.4,
ECM 22.5, BCM 26.8, ECM/BCM 0.8, BMR 1466.2. SPSS8
statistical analysis revealed t-test statistical significant differences
of TBW, PA, ECM, BCM, ECM/BCM, and BMR between male and
female participants of group A. The t test between the control andother groups, showed a significant difference (P < 0.05) only
between group A (female) and group D of the PA, ECM/BCM
values as well as of the BMI value of groups A and G.
Conclusion BIA measurements of body synthesis are important and
a useful tool for the nutritional support of medical patients. The
existence of such an outpatient office gave the opportunity to 5/77
patients having chronic cachectic disease to undergo home nutrition
with appropriate enteric formulas, 3/77 patients with morbid obesity
to be on a strict weight loss program with one balanced meal and
two meal substitutes, and 52/77 patients to receive advice about
modification of their eating habits plus limitation of caloric intake.
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Objective To determine the changes in resting energy expenditure
(REE), body temperature and jugular bulb oxygen saturation
(SjVO2) of the patients with brain injury or brain death.
Methods Fifty-two patients with Glasgow Coma Scale score <6
admitted to our intensive care unit between October 2002 and
November 2003 were included in the study. Among these patients
Group 1 (n = 26) included patients with brain death. This group
was divided into two subgroups later. Group 1a (n = 13) consisted
of the patients with brain death when they were included in the
study and Group 1b (n = 13) consisted of patients who progressed
to brain death during their intensive care unit stay although they
were initially not brain dead. Group 2 (n = 26) consisted of the
patients with brain injury but no brain death. REE using indirect
calorimetry, SjVO2 and body temperature was recorded daily and
simultaneously during the first 5 days of the study. REE values
were expressed as the percentage of basal metabolic rate
(BMR%) calculated using the Harris–Benedict equation.
Results There were no differences in terms of age, APACHE II
score at admission, reason for coma and BMR between Group 1
and Group 2 (P > 0.05). Mean body temperatures were
35.6 ± 0.9°C and 37 ± 0.6°C (P < 0.01), mean SjVO2 values were
90.3 ± 9.9% and 77.9 ± 10% (P < 0.01) and mean REE values
were 1542 ± 580 kcal (97 ± 26.8% of mean BMR) and
1963 ± 600 kcal (117 ± 29.2% of mean BMR) (P < 0.05) in
Group 1 and Group 2, respectively. In Group 1b, the mean body
temperature was lower and the mean SjVO2 was higher than the
values before brain death (P < 0.05). In this group, although the
mean REE was lower than the value before brain death, this
difference was not statistically significant (P = 0.07).
Conclusion In this study, we found that the mean value of REE
was 17% higher than the BMR in the patients with brain injury. The
mean REE and body temperature was lower and the mean SjVO2
was higher in the brain-dead patients than in the patients with no
brain death.
P273 Changes in cytokine concentration during enrichment of early enteral nutrition with lactic acid bacterium (Synbiotic 2000)
after major abdominal surgery
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Background and aims There is evidence that early enteral
nutrition (EEN) enriched with lactic acid bacteria (LAB) and
prebiotics may impair the immune response and improve the
clinical course of patients undergoing major abdominal surgery.
Reduced translocation of potential pathogen bacteria in the gut
and changes in the immune system may be responsible for this
appearance. The aim of this randomised double-blind trial was to
investigate the changes in concentration of cytokines of patients
receiving either EEN enriched with LAB or placebo.
Patients and methods Thirty-three patients undergoing either
pylorus-preserving pancreaticoduodenectomy or Whipple’s
operation were enrolled. EEN enriched with either LAB (Synbiotic
2000™) (n = 17) or placebo (n = 16) was supplied after double-
blind randomisation for a period of 5 days beginning the day before
the operation. Samples were taken before surgery as well as
postoperatively on days 1, 4 and 8. The plasma samples were
centrifuged and quickly frozen to –70°C. The concentration of
cytokines was measured by the specific ELISA technique (OptEIA
Human set, Pharmingen, USA) in standard procedure.
Results IL-6 increased in both groups until day 1, significantly. In
further progress a decrease could be seen. In contrast, IL-12
decreased after the operation and increased until day 8 to nearly
the same level as at the onset of the investigation (placebo group
36.27 ± 48.67 pg/ml; verum group 56.58 ± 69.43 pg/ml).
Simultaneously, the amount of interferon gamma (IFNγ) decreased
postoperatively in the verum group and increased in the placebo
group. But all differences seen were only tendencies, no
significance could be shown.
The concentration of IL-10 increased after the operation. However,
there was a higher increase from the day before surgery until day 4
in the verum group than in the placebo group.
Summary and conclusion Enrichment of EEN with LAB seems to
have no significant influence on the known postoperative increase of
IL-6 or the decrease of IL-12 concentration. In contrast, the LAB
supply seems to impair the amount of IL-10 and IFNγ. Further
investigations are necessary to elucidate the underlying mechanisms.Available online http://ccforum.com/supplements/8/S1
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Introduction In modern intensive care medicine there is a strive for
enteral nutrition (EN) since it has been shown to protect gut mucosal
function, to reduce infective morbidity, to hasten recovery from illness
and to contribute to a lower mortality rate. EN requires a functioning,
intact gastrointestinal tract, may cause diarrhoea and has an
attendant risk of pulmonary aspiration. Further, data indicate that
discrepancies between prescription and delivery of EN carry a risk of
undernutrition. We therefore designed this study, with the aim to
identify discrepancies between prescribed and delivered nutrition
and to evaluate benefits and problems associated with EN and
parenteral nutrition (PN). We also compared the actual amounts of
fat, glucose and nitrogen delivered with calculated requirements.
Methods Data on nutritional supply (energy intake, amount
glucose, fat and nitrogen) and gut function (diarrhoea, gastric
retention and vomiting) were registered daily for all patients
admitted to the ICU during 6 weeks. Patients treated for less than
3 days were excluded. Energy requirements were calculated
according to the Harris–Benedict equation and the nitrogen (N)
demand was set as 0.15 g/N/kg. Data are based on 267 treatment
days, and are presented as mean ± SEM.
Results Twenty-six out of 74 patients stayed in the ICU for
>3 days, and were thus included in the study. On average,
patients received adequate amounts of energy (around
1500 kcal/day) from the third day, and throughout the study period.
Of the energy delivered, fat accounted for 20–30%. The daily N
supply was approximately 14 g. There was a good correlation
between prescribed and administered amounts of enteral nutrition
(R2 = 0.90). Of the total amount of energy delivered 53% was
administered enterally. Bowel function was considering normal for
151/241 days (63%). Daily registrations of gut function
demonstrated diarrhoea (11%), gastric retention (29%) and
vomiting (2.5%).
Conclusions EN was gradually increased, according to our
nutrition guidelines, and predominated after the first 7 days. The
energy input was usually adequate within 3 days after admission.
EN was generally well tolerated with few complications. Diarrhoea
was most frequent) in the enterally fed patients and gastric
retention was common among patients given PN. The correlation
between prescribed and received amounts of enteral feed was
high.
P275 Enteral nutrition in adult ICU patients: optimizing the outcome using computer-assisted individualisation of nutritional support
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Background The aim of this study is to develop a standardized
procedure for assessing patients’ nutritional needs and providing
individualized enteral nutrition (EN) regimens by using a software
tool that can accomplish this task in a fast, safe, yet simple way.
Methods The study took place in the Surgical Intensive Care Unit of
the University Surgical Department of Hippocration Hospital. The
procedure involves input of patient data such as age, weight, and
sex, along with data relevant to the clinical status of the patient, as
well as treatment details. Specialized software can then analyze this
data, determine nutritional parameters by implementing evidence-
based equations, and calculate accurately an individual patient’s
daily nutritional needs in total energy, protein, hydrocarbons, fat,
vitamins, minerals as well as the concentrations of each nutrient and
total EN volume that will be administered on a 24-hour basis. The
software was designed for monitoring the administered regimen
and alarm in any case of mismatched calculation (according to the
underlying disease, the clinical status and the nutritional parameters
of the patient), and for informing the user about any metabolic
complication that is likely to occur (according to the laboratory tests
of the patient). For the purpose of this study, computer-calculated
EN regimens were administered to 30 randomly selected patients in
our unit and were then compared with the regimens, which would
be administered without the help of the computer.
Results  There were large differences in EN calculated by the
computer, while a number of times the computer designated the
use of a different preparation in order to better suit the patient’s
nutritional needs. There was a reduction of the time consumed for
the calculations (65%), and a decrease in false calculations (20%),
whereas the early recognition of metabolic complications increased
to 40%. The utilization of specialized software seemed to be able to
help health professionals to select an optimal EN regimen and to
estimate the appropriate fluid volume according to patient needs.
Conclusion  Implementation of this software enables health
professionals to overcome the burden of calculations, while it can
also accomplish labeling, statistic analysis, and record
management, thus allowing the provision of individualized EN to
become an efficient standard routine procedure. It promotes a
simple, fast, and safe way of providing individualized nutritional
support and the quality of nutritional services would certainly
benefit from its routine clinical application.
P276 A new method to place an enteral feeding tube for transpyloric feeding in infants
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It is difficult to achieve transpyloric placement of an enteral feeding
tube in infant cases. We have found a new method to place an
enteral diet tube for postpyloric feeding in infants.
Materials and methods The patient will be intubated. A 5.5 mm ID
nasoenteric feeding tube, a drawn scale on the surface, with an
inner wire stylet is inserted and advanced through the esophagusinto the gastric lumen. Then, a specially made 3.0–4.0 mm ID
intratracheal tube with a cuff is connected to a Bodai connector,
used for the fiberscope, whose proximal end is sealed except for a
small hole to insufflate oxygen.
After placing this composed tube into the esophagus transorally, a
3.0 mm OD fiberscope will be inserted into this composed tube
and the distal end will be lead into stomach. The cuff is inflated in
order to fix a position to prevent a leakage of air insufflated into the
gastric lumen.
After inflation of the gastric cavity by air, the distal orifice of the
enteral feeding tube is advanced distally into the duodenum under
direct view by the fiberscope. The distance from antrum can be
determined by the scale on the tube.
The method was tried for four patients and all trials succeeded
without complications, and continuous postpyloric enteral feeding
was safely begun immediately.
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P277 Enteral nutrition affects nitric oxide levels in both peripheral blood and liver tissue in an experimental model of
postoperative sepsis
K Kotzampassi1, G Kolios2, P Manousou2, G Notas2, N Tsagarakis2, H Papanastasiou1, E Kouroumalis2, E Eleftheriadis1
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Background Sepsis is a common postoperative complication,
leading to the augmentation of the oxidative stress induced by the
operation itself. Numerous studies have emphasized the role of
nitric oxide (NO) in influencing hepatic function during sepsis.
Aim and methods The present study was designed to investigate
the role of enteral nutrition on the postoperative sepsis-induced
NO production, as an index of oxidative stress. Five groups of
10 male Wistar rats were subjected to midline laparotomy and
feeding gastrostomy. Ten rats were allowed to recover from
operation stress for 10 days and served as controls. The remaining
40 rats were allocated to receive through gastrostomy either
enteral feeding (Fresubin-HP Energy, Fresenius-Kabi, 2 ml/hour,
75 kcal/day) or water for 24 hours, after which they were
subdivided into two other groups by intraperitoneal injection of
10 mg/kg  Escherichia coli lipopolysacchardie (LPS) (Difco
0111:B4; Sigma Chemicals) or placebo. Two hours later all rats
were sacrificed, having first been subjected to blood and liver
tissue sampling. The NO production was quantified by measuring
the total nitrite plus nitrate concentration in serum samples and in
liver tissue homogenates, by means of a spectrophotometric
method that uses a modification of the Griess reaction. NO
synthase mRNA expression was examined in the homogenate of
liver tissue in RNAzol by RT-PCR.
Results A basal production of NO was found in the serum of
control rats. The operation itself was found to induce a significant
increase (P < 0.01) of NO levels in the serum and the injection of
LPS further induced NO levels (P < 0.001). Enteral feeding was
found to significantly decrease (P < 0.01) NO levels in both
groups. In contrast, NO in liver homogenates was found
significantly increased (P < 0.05) in enteral nutrition plus LPS-
treated rats compared with placebo feeding plus LPS.
Interestingly, LPS was found to induce inducible NO synthase
(iNOS) mRNA expression in liver tissue, regardless of the enteral
feeding, while liver from placebo (no LPS) treated animals did not
express iNOS mRNA.
Conclusion These findings indicate that early enteral feeding leads
to a reduction of the circulating NO levels induced by operation and
sepsis, but increases hepatic NO levels, probably via the effect of
the LPS-induced iNOS on the increased L-arginine uptake.
P278 Short-term lung metabolic effects of middle-chain triglyceride/long-chain triglyceride-containing lipid emulsions in
patients with post-traumatic acute respiratory distress syndrome
S Milanov, M Milanov, M Georgieva
Pirogov Emergency Institute, Sofia, Bulgaria
Critical Care 2004, 8(Suppl 1):P278 (DOI 10.1186/cc2745)
Enhanced lipid peroxidation is a contributing factor for oxidative
stress in patients with acute respiratory distress syndrome (ARDS).
middle-chain triglyceride (MCT)/long-chain triglyceride (LCT)-
containing fat emulsions have lower polyunsaturated fatty acid
content, higher concentrations of antioxidants (alpha-tocopherol)
and reduced susceptibility to peroxidation reactions compared with
LCT-containing fat emulsions, which possess strong
proinflammatory and oxidative damage potential [1]. The aim of this
study was to compare pulmonary metabolic effects of these two fat
emulsions. We prospectively measured intrapulmonary oxygen
consumption (VO2ipulm), lung lactate production (LLP), glucose
flux trough the lung (GF), energy expenditure (EE) and respiratory
quotient (RQ) in 26 adult post-traumatic ARDS patients, receiving
conventional fat emulsion. At study entry patients were randomly
switched from LCT to MCT/LCT lipid emulsion. The patients in the
LCT group (n = 13) continued to receive conventional 20% LCT-
containing fat emulsion, and in the MCT/LCT group (n = 13) a
20% MCT-containing fat emulsion was started. In both groups fat
emulsion was infused in doses of 1 g/kg/day. VO2ipulm was
estimated by subtracting the calculated VO2 using the reverse Fick
method from the whole body VO2 using indirect calorimetry (Datex
Ohmeda M-COVX metabolic monitor). All measurements and
calculations were performed simultaneously after achieving steady-
state conditions in 2-hour periods for 24 hours. The overall
mortality in this setting was 64%. We found substantial increases
in VO2ipulm as a component of the whole body VO2 in both
groups (median 29.3%; interquartile range 26.2–34.1%). In the
MCT/LCT group there was an abrupt (mean value 26 ± 11 min)
and sustained significant increase in EE (mean 3.4 ± 0.3 kcal/kg)
with a maximal corresponding increase in whole body VO2 on the
6th hour. VO2ipulm showed a constant decline, reaching minimum
median values of 20.4% (interquartile range 17.1–22.4%) of the
whole body VO2 on the 8th hour. The absolute value of VO2ipulm
also decreased from 2.1 ± 0.4 ml/kg/min to 1.3 ± 3 ml/kg/min.
These changes were not accompanied by significant variations in
LLP, GF and RQ. We concluded that the observed decrease inVO2ipulm in the MCT/LCT group with concomitant increases in
whole body VO2 and EE without any significant changes in RQ,
LLP and GF is indicative for increased oxygen consumption for
metabolic purposes outside the lung. These data suggest that
infusion of a MCT-containing fat emulsion could lead to a
significant decrease of oxygen used by the lung for nonmetabolic
purposes (i.e. free radical formation from lipid peroxidation). The
observed positive short-term metabolic effects of MCT/LCT-
containing fat emulsions could have potential clinical applications
in reducing oxidative damage, caused by a large inflammatory
mass of the lung in ARDS patients.
Reference
1. Adolph M: Lipid emulsions in parenteral nutrition. Ann Nutr
Metab 1999, 43:1-13.
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P279 Pathophysiology of renal injury in patients with acute rhabdomyolysis associated with sympathomimetic drug abuse
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Recognizing the ischemic effects of sympathomimetic toxins on
various vascular beds, we hypothesized that renal insufficiency in
the setting of cocaine and amphetamine-related rhabdomolysis is
associated with direct ischemic injury to renal tubules that is
independent of the extent of muscle damage and volume depletion.
Methods This is a retrospective study of consecutive patients with
a diagnosis of rhabdomyolysis seen in our emergency department
over 44 months. Data included blood urea nitrogen (BUN), white
blood cell count, urine toxicology screen and hematocrit. The
change in a second posthydration hematocrit was used to
approximate the degree of initial volume depletion. Creatine kinase
(CK) and creatinine levels were followed serially. Patients with
obvious renal failure on presentation, defined as a first creatinine
equal to 4 mg/dl (354 µm/l) were excluded. Statistical analysis
utilized the two-tailed Student t test for continuous variables and
the Fisher Exact test for categorical variables.
Results See Table 1. Two groups were identified, 79 patients who
tested positive for cocaine or amphetamine and 52 who tested
negative. Nine of 79 patients in the ‘tox’ group and 2/52 patients in
the ‘no tox’ group had obvious renal failure and were excluded
(P = 0.12).
Conclusion Despite lower CK values suggesting a smaller amount
of myoglobin delivery to the kidneys, and despite any demonstrable
difference in markers of volume depletion such as BUN and
percentage of dehydration, patients in the ‘tox’ group still had
higher admission creatinine levels. Our findings suggest that
vasoactive sympathomimetic drugs of abuse have an ischemic
effect on the kidneys that is independent of the effects of
myoglobin deposition and volume depletion.
Table 1
Variable ‘Tox’ (n = 70) ‘No tox’ (n = 50) P value
First hematocrit 45 (44–46) 43 (42–45) 0.07
% hematocrit drop 18 (14–23) 16 (12–21) 0.59
BUN (mg/dl) 20 (16.3–23) 20 (15.5–24) 0.88
First creatinine 1.8 (1.6–2.0) 1.4 (1.2–1.6) 0.005
Second creatinine 1.4 (1.2–1.6) 1.3 (1.1–1.5) 0.32
First CK 10,700 46,600 0.0013
High CK 17,700 61,000 0.0014
Data are mean (95% confidence interval).
P280 The sepsis syndromes in the emergency department
N Shapiro
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Background The ACCP/SCCM established uniform criteria for
defining the sepsis syndromes: systemic inflammatory response
syndrome (SIRS), sepsis, severe sepsis, and septic shock.
Subsequent studies showed increasing mortality with each
successive syndrome. The utility of these definitions and mortality
rates are not known for an emergency department (ED) population.
Furthermore, the mortality rates at 1 year have not been previously
reported.
Null hypothesis The sepsis syndrome definitions will predict
increasing mortality with each syndrome for both 28-day inhospital
mortality and 1-year mortality.
Methods A prospective, cohort study of consecutive adult patients
(age >18 years) at risk for infection (indicated by physician
ordering a blood culture) in the ED of an urban university hospital.
The study period was 1 February 2000–1 February 2001. ED
charts were prospectively reviewed. The following definitions were
applied: SIRS/sepsis, the presence of two or more of hypothermia
(T <36°C) or hyperthermia (T >38°C), tachycardia
(>90 beats/min), tachypnnea (>20 breaths/min) or hypoxia (pox
<90%), and leukocytosis (>12,000) or bandemia (>10%); severe
sepsis, sepsis plus organ dysfunction; septic shock, sepsis plus
hypotension (systolic blood pressure <90) after a 10–20 cm3/kg
fluid challenge. The outcomes were 28-day inhospital mortality and
1-year mortality. The 95% confidence interval [CI] was calculated
where appropriate, and Duncan’s Multiple Range Test for
comparison of mortality rates between groups (alpha = 0.05).
Results Of 3926 eligible patients, 3763 (97%) were enrolled in
the study. The overall 28-day inhospital mortality rate was 4.6%,
and the 1-year mortality was 24% for all patients. Of these, 1850
(49%) had no SIRS criteria with 2.6% (95% CI = 1.9–3.3%)
28-day mortality, 715 (19%) patients had SIRS/sepsis with 1.8%
(0.8–2.8%) 28-day mortality, 1144 (30%) had severe sepsis with
8.5% (6.9–10%) 28-day mortality, and 54 patients had septic
shock with 28% (16–40%) 28-day mortality. The 1-year mortality
rates were: no SIRS = 21% (19–23%), SIRS/sepsis = 11%
(8–13%), severe sepsis = 36% (33–39%), and septic
shock = 57% (44–71%). Duncan’s test showed no differencebetween the no SIRS and SIRS/sepsis groups for either 28-day
inhospital mortality or 1-year mortality. The severe sepsis group
and septic shock group had a sequential increase in both mortality
outcomes that were significantly higher than each group
(P < 0.05).
Conclusions In ED patients at risk for infection, patients with
severe sepsis, and septic shock are at increasing risk of short-term
and long-term mortality, while patients with SIRS/sepsis did not
demonstrate significantly higher mortality rates than the no SIRS
group. The mortality rates in this ED population were lower than
those reported in previous ICU populations.
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P281 Major airway trauma: a 5-year study in four hospitals in the Middle East
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Introduction Airway trauma is rare but morbid. It is encountered
with increasing frequency because of improvements in prehospital
care and early initiation of the Advanced Trauma Life Support. This
study aims to give a description of patients with airway trauma, to
help provide data for better emergency services and delayed
managements of this type of trauma.
Methods and materials This retrospective, cross-sectional study
was conducted in four university hospitals in Tehran, Iran; from
1997 to 2002 the study was conducted with 28 patients. Age, sex,
mechanism of trauma, site of trauma, clinical manifestations, length
of hospitalization, complications, mortality and treatment outcome
were the main subjects extracted from the units. SPSS 10.01 was
used for analysis.
Results Twenty-two (78.6%) patients were males and eight
(21.4%) patients were female. The mean age was
33.1 ± 2.2 years. Eight (28.5%) cases presented with blunt
trauma, 19 (67.8%) with penetrating trauma and one case had
inhaled burning chemical agent. Twenty-two (78.6%) of cases had
injuries in cervical airways and the remaining six (21.4%) in
thoracic airways. Subcutaneous emphysema (50%, seven cases),
dysphonia and dyspnea, each with an incidence rate of six
(42.8%), were the most frequent manifestations. A total of 85.7%
of our patients underwent surgical treatment. The mean length of
hospitalization was 5 ± 2 years. The total rate of incidence for
complications was 14.2%; two (7.2%) cases of wound infection,
one (3.5%) case with anastomosis dehiscence and one (3.5%)
case with a collapsed lung after thoracotomy. The mortality rate
was 10.7% (three patients). The treatment outcome assessed
excellent in 80% of cases, good in one (3.8%) case, acceptable in
one (3.8%) case and poor in three (11.5%) cases.
Discussion Young men were more at risk for airway trauma,
especially the penetrating types. A lower mortality and favorable
treatment outcome is outstanding in this study. The rate of
complication is average. Studies on nonsurgical treatments and
autopsy-based studies for airway trauma are suggested for
complementary results.
P282 Cardiac damage in carbon monoxide poisoning
B Yelken
Osmangazi University Medical Faculty, Eskisehir, Turkey
Critical Care 2004, 8(Suppl 1):P282 (DOI 10.1186/cc2749)
Background Cardiac dysfunction including arrhythmias and
myocardial ischemia have often been reported in carbon monoxide
poisoning. An appropriate diagnostic approach is crucial to assess
carbon monoxide (CO) cardiac damage [1]. QT dispersion (QTd)
is a measure of inhomogeneous repolarization and is used as an
indicator of arrhythmogenicity.
Objectives The aim of the present prospective study was to
evaluate the relationship between the patients’ age and QT
dispersion of the surface ECG in carbon monoxide poisoning.
Methods Carbon monoxide intoxication was confirmed in
40 patients by arterial blood gas analysis. Patients were subdivided
into two groups according to age <35 years (Group I) or age
>35 years (Group II). QT dispersion was measured by surface
electrocardiogram and Bazzet’s formula was used to correct the
QTd for heart rate (QTcd). Measurements of QT intervals were
calculated at admission and in 24-hour and 72-hour ECGs (after
admission).
Results There were no significant differences between Group I
and Group II with regard to gender and carboxyhemoglobin levels.
On admission, the QTd, QTc, and QTcd intervals in Group I were
significantly increased compared with Group II, but not the QT
interval. There were no significant differences in QT interval
measurements between Group I and Group II 72 hours after
admission.
Conclusion Although QT dispersion increased in patients with CO
poisoning, age-related increases in QTd in the absence of QT
interval prolongation may address this group as high risk.
Table 1
Group I Group II P value
QT interval (ms)
Admission 347 ± 10 381 ± 13 0.06
24 hours after admission 354 ± 8 377 ± 12 0.24
72 hours after admission 369 ± 7 378 ± 6 0.37
QTd interval (ms)
Admission 73 ± 7 110 ± 12 0.017
24 hours after admission 75 ± 10 124 ± 21 0.034
72 hours after admission 75 ± 9 61 ± 7 0.283Available online http://ccforum.com/supplements/8/S1
P283 Anesthesia-assisted opiate detoxification (AAOD) for heroine addicts during 24-hour ICU admission: complications and
results for opiate abstinence at 1-year follow-up
C de Jong
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Critical Care 2004, 8(Suppl 1):P283 (DOI 10.1186/cc2750)
Aim (1) To list addiction-related health problems in a group of
67 patients addicted to heroin and/or methadone, who were treated
with AAOD during 24-hour ICU admission. (2) To evaluate
complications of AAOD on the day of treatment and during the first
week after AAOD. (3) To evaluate the effect of our post-AAOD
treatment programme, consisting of naltrexone combined with
cognitive behavioural therapy (CBT) for 1 year after AAOD, on
abstinence from opiates, on employment, on training and education,
and on criminal behaviour 1 year after the AAOD treatment.
Methods A retrospective descriptive study of the files of patients
who had an AAOD between 10 March 2000 and 10 March 2002.
Data was analysed using the χ² test.
Results (1) The average length of opiate addiction in this group of
67 patients (57 men) was 12.8 years. Sixty-one patients (91%)
were in methadone programmes for an average 8.2 years. Thirty-
five patients (52%) had three or more failed detoxifications.
Nineteen patients (28%) were underweight (body mass index
<20), and 29 (43%) had mild to moderate respiratory problems.
Thirty patients (45%) had used intravenous drugs, of whom 13
(43%) were hepatitis C-positive, seven (23%) were hepatitis
B-positive, and three (10%) were positive for hepatitis B and
hepatitis C. No HIV-positive patients were found. (2)
Complications after AAOD: vomiting (more than two times per day)
in 10 patients (15%), diarrhoea (more than three times per day) in
three patients (4%). No aspiration pneumonia or renal failure was
seen. One patient was admitted to a hospital for 2 days to prevent
dehydration. (3) The results for abstinence, employment, training
and education, and criminal behaviour are shown in Table 1.
Conclusion (1) Although the majority of patients in this group
made use of methadone programmes, they still often suffered from
health problems common to intravenous drug users such as being
underweight, respiratory problems and hepatitis B and hepatitis C.
No HIV-positive patients were found. (2) Complications after
AAOD were infrequent and not severe. (3) AAOD and naltrexone
combined with CBT as provided by our clinic leads to opiate
abstinence in 70% of patients after 1 year and to a significantly
higher participation in employment, training and education, and a
significant decrease in criminal activities.
Table 1
n = 67 Before AAOD 1 year after AAOD
Opiate abstinence (%) 0–0 47–70
Employment (%) 32–48 46–69, P < 0.02
Education (%) 2–3 8–12, P < 0.001
Criminal behaviour (%) 56–84 15–22, P < 0.001
P284 Emergency treatment of esophago-gastric lesion in caustic ingestion patients
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Background and aim The ingestion of caustic substance can
produce severe injury not only to the esophagus, but also to the
gastrointestinal tract and can even result in death. The degree and
extent of damage depends on several factors like the type of
substance, the quantity, and the intent; the quantity is a prognostic
value: 20–50 ml = severe, >50 ml = very severe. In the acute phase,
perforation and necrosis may occur often with devastating
consequences on the esophagus and the stomach; the injuries are
associated with high mortality and morbidity rates when mediastinitis,
gastrobronchial fistula,chemical peritonitis, or perforation of the
gastrointestinal tract occurs. Perforation may occur in the late phase,
especially with the ingestion of alkaline solution, because the
inflammation invades more deeply with the continuous release of
OH– after coming into contact with protein.Long-term complications
include stricture formation in the esophagus, antral stenosis and the
development of esophageal carcinoma. The aim of this study is to
evaluate whether early diagnosis and surgical treatment are essential
to improve the prognosis.
Methods From November 2000 to November 2003 six patients.were
admitted to our department, mean age 38 ± 10 years, with a 1:1 male
to female ratio. The average time between the caustic ingestion and
admission to the emergency ward was 5 ± 2 hours. The ingested
substances were alkali in 80.9% and acid in 19.1% of the cases.The
blood gas examination, endoscopy, computed tomography, and
chest-abdominal X-ray were performed. They requested an
orotracheal intubation and ventilatory support; antibiotic therapy was
early initiated with metronidazole and tazobactan-piperacilline and an
optimal hemodynamic stabilization was achieved. A combined
surgical procedure was performed: in the acute phase, laparoscopic
esophageal–total gastrectomy, open cervicotomy, cervicostomy,
percutaneous enterostomy for enteral nutrition, while the gastric–
esophageal reconstruction was performed subsequently.
Results Blood gas examination showed the mean pH was
7.22 ± 0.14 and the mean base excess was –10.0 ± 6.5.
Endoscopy revealed multiple deep brownish–black ulcers (four
patients) and perforation (two patients). Chest X-ray revealed air
bubbles close to inferior the IIIrd part of the oesophagus while
abdominal X-ray revealed no perforation. The ICU stay was
20 ± 7 days. Complications included: four cases of postoperative
complications, including in the first surgical procedure break-up of
enterostomy (n = 1) and in the reconstruction phase anastomosis
pseudo-diverticula (n = 1), and anastomosis leakage (n = 2 died).
The surgical mortality was 33%. All patients tolerated oral intake
well after surgery; a high-protein and hypercaloric diet seemed to
be beneficial for patients.
Conclusions Early laparoscopic surgical treatment improved the
prognosis in these severe cases.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P285 B-type natriuretic peptide testing reduces time to discharge in patients presenting with acute dyspnea (the BASEL study)
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Background In patients with pulmonary disease it is often
challenging to distinguish exacerbated pulmonary disease from
congestive heart failure (CHF). B-type natriuretic peptide (BNP)
levels are significantly higher in CHF as compared with
exacerbated pulmonary disease.
Methods This study evaluated the predefined subgroup of
226 patients with a history of pulmonary disease included in a
prospective randomized controlled trial of BNP testing for the
emergency diagnosis of acute dyspnea. Patients were randomly
assigned to a diagnostic strategy with (n = 119, BNP group) or
without (n = 107, clinical group) the use of BNP levels provided by
a rapid bedside assay. The time to discharge and the total cost of
treatment were recorded as the primary endpoints.
Results Baseline demographic and clinical characteristics were
well matched between groups. Comorbidity was extensive,
including coronary artery disease and hypertension in one-half of
the patients. The primary discharge diagnosis was CHF and
exacerbated obstructive pulmonary disease in 39% and 33%,
respectively. The use of BNP levels significantly reduced the need
for hospital admission (81% vs 91%, P = 0.034). The median time
to discharge was 9.0 days in the BNP group as compared with
12.0 days (P = 0.001) in the clinical group. The total cost of
treatment was $5764 (95% confidence interval, 4450–7078) in
the BNP group as compared with $7665 (95% confidence
interval, 6448–8882; P = 0.038) in the clinical group (Fig. 1).
Inhospital mortality was 8% in both groups.
Conclusion Used in conjunction with other clinical information,
rapid measurement of BNP reduced the time to discharge and
total treatment cost of patients with a history of pulmonary disease
presenting with acute dyspnea.
Figure 1
P286 Patient outcomes following prehospital rapid sequence intubation for medical emergencies
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Introduction  Prehospital rapid sequence intubation (RSI) is an
intervention utilized for airway management in noncardiac arrested
patients. We report patient outcomes following prehospital RSI
utilized for medical emergencies.
Hypothesis Airway management with prehospital RSI for medical
emergencies improves patient outcomes.
Methods  A retrospective, observational evaluation of a RSI
database reflecting a 40-month experience with prehospital RSI
performed for medical emergencies. Data was compiled from
advanced life-support ambulance services from five distinct,
suburban–rural cities all utilizing identical RSI protocols with
training conducted by a single individual. RSI was indicated for
Glasgow Coma Scores <8, rapidly declining respiratory and/or
hemodynamic status, or persistent hypoxia or unresponsiveness in
the presence of assisted ventilation and oxygen therapy. Etomidate
and succinylcholine were the agents utilized for sedation and
paralysis, respectively. Laryngoscopy was limited to 30s with no
more than three intubation attempts permitted. Medical records
from the initial receiving hospital were reviewed for patients
meeting prehospital RSI criteria.
Results  Eighty-seven patients underwent prehospital RSI for
medical emergencies. Outcome data is available for 71/87
(82%). Neurologic (30 patients), respiratory (21 patients) and
drug overdoses (15 patients) comprised the most common
indications for RSI. Twenty-seven out of 71 (38%) died as a
result of their underlying medical conditions, which included
14/30 neurologic, 10/21 respiratory and 0/15 drug overdose
patients. Six patients, all with respiratory distress, experienced
cardiac arrests immediately following RSI, none of whom were
resuscitated. Patients surviving their neurologic event required
prolonged rehabilitation. No patient demonstrated evidence for
aspiration pneumonia related to RSI. In the same time period,
outcome data is available for 58 patients meeting RSI criteria but
not receiving the intervention. Fifteen out of 58 (28%) died as a
result of their underlying conditions and not airway management
interventions.
Conclusion RSI does not appear to significantly improve patient
outcomes when utilized for medical emergencies. Respiratory
emergency patients are at high risk for RSI-related cardiac
arrest. Justifying this intervention in our nonurban practice is
difficult.Available online http://ccforum.com/supplements/8/S1
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Objectives The purpose of this study was to identify the patients
who frequently use the emergency department (ED), to estimate the
percentage of the overall department’s workload and to determine
why they choose the ED over other sources of medical care.
Methods A retrospective study of regular attenders to the A&E
Department at Xanthi General Hospital was obtained from 1 July
2003 to 30 November 2003. Frequent ED patients were identified as
having more than four ED visits in this period. Age, sex, investigation
performed, presenting complaints and disposal were analysed.
Results The A&E Department at our hospital sees approximately
70,000 patients/year. The period the study was obtained, 29,732
new patients visited the department. Seventy-one patients
presented 386 times, accounting for 1.3% of the department’s
workload. Sixty-five per cent of visits were for existing or recurrent
medical problems. This group of patients had a 14.5% admission
rate to the hospital compared with 9.3% for the general ED
population during the study period.
Conclusion This group of patients usually can have access to
other medical sources of primary care, but they use ED for
complaints they believe need immediate attention. A significant
number of this group were admitted to the hospital. The
department’s workload and the cost, for investigations performed
and inhospital admissions, are discussed.
P288 Pivotal role of bystander cardiopulmonary resuscitation in pediatric drowning incidents
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Background The earliest possible provision of basic and
advanced life support techniques are traditionally emphasized for
resuscitation in drowning incidents. However, previous studies
have also indicated that performance of cardiopulmonary
resuscitation (CPR) by bystanders is particularly critical in
drowning. The purpose of this study was to evaluate, in a
prospective manner, the relative contribution of bystander CPR in
terms of ultimate survival following critical drowning events in
children.
Methods From 1990 to 1999, all 9–1–1 incidents related to
childhood (ages 0–14 years) drowning events were examined
prospectively in a metropolitan US sunbelt city (population
2 million) using a comprehensive Utstein-style database. The at-risk
population (ages 0–14 years) averaged 418,000 during the study.
Results In the finite population studied, two-thirds of all (adult and
child) submersion incidents involved children, totaling 420 cases
(mean = 42 children/year; annual incidence = 10.0 per 100,000),
with 72% (n = 303) occurring in those aged 5 years or younger
(20.2 per 100,000/year). In certain years, this younger cohort
comprised as many as 87% of cases. Most cases (65%) occurred
in summer and 83% between 12:00 and 8:00 pm (none
12:00–7:00 am). The site was a pool in 75% of cases (n = 317)
with 64% of these at apartments. Only 19% involved tubs/spas
(annual range = 6–34%) and 5% were in buckets, toilets, bayous,
lakes, and creeks. Of the 420 total cases, one child was found
dead on-scene and 234 clearly required resuscitative efforts (using
strict criteria). Bystanders performed CPR in 82% of these
resuscitation cases (n = 193) and 72% of these children survived
long-term (99% neurologically intact). However, if a child remained
apneic/pulseless by the time emergency services arrived (average
response = 5 min), less than 5% were revived (none neurologically
intact). Of 94 total deaths, two-thirds occurred in pools.
Conclusions In certain venues, submersion incidents can account
for a large number of per-capita childhood deaths, and immediate
basic bystander CPR, not advanced life support, is the most
definitive resuscitative action for children with drowning-related
incidents. Considering that most drowning incidents in this study
occurred in residential pools and in those aged 5 years or younger,
supervision, safety barriers and knowledge/performance of
bystander CPR appear to be the major factors in prevention of
childhood drowning deaths.
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The Arresto CardioRespiratorio Ospedaliero (ACRO) (Inhospital
Cardiac Arrest Prevention) group is a multiprofessional team
constituted of intensivists, cardiologists, emergency physicians and
critical care nurses involved in treatment and prevention of
inhospital cardiac arrest (IHCA) of the Health System of Florence
(six hospitals; 1600 beds; 850,000 inhabitants). In the past the
ACRO group focused its efforts on early defibrillation: most of the
personnel has been trained in basic life support and advanced
cardiac life support and defibrillators have been placed at each
floor of the hospitals. But about 2/3 of IHCA cases are sustained
by asystole (A) and pulseless electrical activity (PEA), conditions
with a low percentage of positive cardiopulmonary resuscitation.
Most of these IHCA do not occur unexpectedly: 80% of patients
have documented clinical deterioration (increase of respiratory
rate, lowered blood pressure, altered level of consciousness) in the
6–12 hours preceeding IHCA. On the basis of these data, theACRO group has recently planned a project to prevent IHCA by
early detection and treatment of clinical deterioration. The project
is based on a periodic assessment of all the in-ward patients at risk
by the Modified Early Warning Score (MEWS), a simple clinical
score based on six parameters (systolic blood pressure, heart rate,
respiratory rate, level of consciousness, diuresis, temperature).
Ward patients at risk are those admitted with an acute abdomen,
pancreatitis, trauma, patients with coexisting medical conditions,
those undergoing major surgery, patients following ICU discharge
and patients causing a concern to nursing and medical staff. High
values of MEWS (>3) or a sudden increase of the score will
trigger a closer patient assessment, the need to recheck MEWS
on the next observation and/or the alert of the internal emergency
medical team; the patient will be admitted to the ICU or high-
dependency unit, if necessary. To evaluate the feasibility of the
project, in particular to assess the impact on nursing workload and
to quantify the number of patients with deteriorating clincal
conditions, we performed a survey in the two main hospitals of our
area. On two different working days (18 June 2002 and 3 February
2003) we assessed the MEWS in all the in-ward patients. During
the survey were evaluated 850 patients, 413 the first day and 437
the second day, with a mean time of examination of 5 min 40s.
Two hundred and forty patients (28,3%) had a MEWS of 0, 308
(36.3%) had MEWS of 1, 158 (18.6%) had MEWS of 2, 72
(8.5%) had MEWS of 3, 34 (4%) had MEWS of 4, 18 (2.1%) had
MEWS of 5 and 19 (2.2%) had MEWS >5.
Present results indicate that MEWS assessement is simple and
does not interfere excessively on nursing workload, so it could be
routinely used on a large number of patients. The high percentage
of patients with signs of possible clinical deterioration (values of
MEWS >3; about 17%) seems to justify our project; further
confirmation will be provided by the results of the follow-up of
these patients, which is ongoing.
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Aim To compare the incidence of pre-arrest signs in patients
suffering unexpected cardiac arrest in different types of hospitals.
Methods We reviewed the records of the patients who suffered
unexpected cardiac arrest during an 18-month period in a tertiary
teaching hospital, in a tertiary trauma hospital and in two secondary
hospitals. Data on patient characteristics and observations and
interventions during the 8 hours preceding cardiac arrest were
collected. The findings were evaluated against the calling criteria of
the Medical Emergency Team (MET) [1].
Results In the four hospitals, 110 patient records were reviewed.
Fifty-six of the cardiac arrests occurred on a ward and 25 (45%) of
these patients fulfilled MET calling criteria. The mean time from the
first documented abnormal vital sign to the arrest was 3.8 hours
(range 0.25–8.00 hours).The proportion of patients meeting MET
criteria differed significantly between the tertiary teaching hospital,
the two secondary hospitals and the trauma hospital (14%, 27%,
69% and 80%, respectively; chi-square P < 0.001). The most
frequent criteria were respiratory distress, SpO2 <90% on oxygen
and systolic blood pressure <90 mmHg. Of the patients suffering
cardiac arrest elsewhere than on a ward (i.e. coronary care unit),
22% fulfilled MET criteria, but these patients received immediately
intensive treatment.
Conclusion The incidence of pre-arrest signs and thus the
potential benefit of a MET, which is called when certain criteria
fulfils, appears to vary considerably between hospitals of different
types.
Reference
1. Buist MD, et al.: BMJ 2002, 324:387–390.
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In cardiopulmonary resuscitation, securing the airway is of
paramount importance. Even if intubating the trachea can still be
seen as the gold standard, it is still reserved for experts and
healthcare professsionals. However, the insertion of a laryngeal
airway device offers — compared with bag-valve face ventilation —
the opportunity to ventilate a patient effectively. Moreover, it can
also be placed easily by lay responders.
We put forth the hypothesis that a laryngeal airway device can be
placed intuitively without any background knowledge about the
device. A simple but well-directed training programme can even
improve the performance. The aim of the study was to investigate the
intuitive use of different airway devices by first-year medical students.
Methods  Devices tested were the LMA-Classic and the LMA-
FastTrach. Subjects embodied were 139 medical students. They
were evaluated on an airway trainer regarding, mainly, the time until
correct placement of the device, the number of attempts and the
initial tidal volume. The trachea of the the mannequin was therefore
connected with a volumeter. An initial tidal volume <150 ml was
considered insufficient and excluded from further data analysis. A
second evaluation was done after a specific training programme.
Results Twenty from 79 subjects out of the LMA-Classic group
and 11 from 60 subjects out of the LMA-FastTrach group had an
initial tidal volume <150 ml. The measured tidal volume was
673.7 ± 133.1 ml for the LMA-Classic and 1057.7 ± 158.5 ml for
the LMA-FastTrach. The mean time to correct placement was
55.5 ± 29.6s for the LMA-Classic and 38.1 ± 24.9s for the LMA-
FastTrach. In the second evaluation, initial tidal volume <150 ml
was recorded in 14 out of 79 subjects for the LMA-Classic and in
six out of 60 subjects for the LMA-FastTrach. The time to correct
placement decreased significantly, with 22.9 ± 13.5s for the LMA-
Classic and 22.9 ± 19.0s for the LMA-FastTrach. The measured
tidal volume was 777.6 ± 367.9 ml for the LMA-Classic versus
1018.4 ± 50.7 ml for the LMA-FastTrach.Conclusion Untrained layperson are able to use different airway
devices and can therefore provide effective ventilation even without
having any detailed background knowledge about the instrument.
Minimal theoretical instruction and practical skill training of 2 hours
overall can improve the students’ performance significantly. This
result underlines the idea of implementing laryngeal airway devices
into basic life support (BLS). Specific BLS programmes combined
with airway management need to be developed. Value has to be
put on general instructions. Describing specific technical details is
not useful. Keeping the instructions to lay persons as simple as
possible will additionally lead to more acceptance and motivation
on performing BLS.
Available online http://ccforum.com/supplements/8/S1
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Introduction Nifekalant (NIF) is predominantly a Vaughan Williams
Class III antiarrhythmic agent that is synthesized in Japan as a pure
K channel blocker without a negative inotropic effect [1]. NIF has
been the most effective antiarrhythmic drug recommended for
patients with ventricular fibrillation (VF) resistant to some other
antiarrhythmic drugs in Japan. However, whether NIF improves the
rate of successful resuscitation after out-of-hospital cardiac arrest
with shock-resistant VF has not been determined. Our preliminary
study found a significant improvement in the proportion of patients
surviving to the emergency department following out-of-hospital
cardiac arrest in NIF-treated patients [2]. Our protocol is as
follows: for out-of-hospital cardiac arrest patients with shock-
resistant VF or pulseless VT (after three or more precordial
shocks), epinephrine (1 mg bolus) and then NIF (0.3 mg/kg bolus
followed by 0.4 mg/kg/hour infusion) are administered. We
showed 31% of out-of-hospital cardiac arrest patients with shock-
resistant VF could survive by treatment with this protocol [2]. We
will show the details of the clinical course of successfully
recovered patients treated with this protocol.
Case A 70-year-old man with acute onset of chest pain developed
VF within 2 hours of symptom onset when driving his car. He was
initially treated by an ambulance team with basic life support
measures, including the delivery of thre shocks. When the patient
arrived at hospital, VF was prolonged. We provided advanced
cardiac life support measures, and administered NIF according to
our protocol and did more shocks, resulting in stabilization of VF.
An angiography after return of spontaneous circulation showed an
inferior acute myocardial infarction. The patient could be discharge
with full recovery (cerebral performance category 1 [good cerebral
performance]).
Conclusion Nifekalant is a possibly effective antiarrhythmic agent
for patients suffering from cardiac arrest with shock-resistant VF.
References
1. Kamiya J, et al.: Drug Development Res 1993, 30:37.
2. Toyama H, et al.: J Cardiol 2003, 42:S338.
P293 Comparison of automatic vs semiautomatic automated external defibrillators used by laypersons
S Beckers, M Fries, J Bickenbach, M Derwall, R Kuhlen, R Rossaint
University Hospital, Aachen, Germany
Critical Care 2004, 8(Suppl 1):P293 (DOI 10.1186/cc2760)
Background The survival rate in cases of cardiac arrest depends
mainly on the availability of and the time to defibrillation. It is widely
accepted that the use of automated external defibrillators (AED) by
trained medical or nonmedical personnel improves survival rates.
So far there have been no definitive recommendations about the
content and duration of teaching programs.
Methods and results  As laypersons, all 236 first-year medical
students in their first weeks of medical formation were chosen to
demonstrate the use of semiautomatic and automatic AED in mock
cardiac arrest scenarios without any instructions. The students
were evaluated once, followed by a second test 1 week later after
attending specified instructions. Comparing time to shock between
semiautomatic and automatic AED, the subjects were significantly
faster during both evaluations using the semiautomatic device
(77.5 ± 20.5 vs 85.2 ± 17s; P ≤ 0.01 and 55 ± 10.3 vs
59.6 ± 9.6s;  P ≤ 0.01). A total of 92.4% subjects with the
semiautomatic and 95.8% with the automatic demonstrated a safe
usage.
Conclusions Untrained laypersons are able to use semiautomatic as
well as automatic AED fast, safely and sufficiently. After one use and
nonspecific instructions to the used device, improvements of their
practical performance is significant. These findings encourage
simplifying technology for AED in future and it reinforces that design,
construction and visual aids have an effect on the performance of the
users. Further development of simple devices with clear and obvious
visual and audible instructions has to be done.
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Background Passengers who have ventricular fibrillation, the
most common mechanism, aboard commercial aircraft rarely
survive, and can be treated effectively only with prompt
defibrillation. The objective of this study was to assess the
impact of making automatic external defibrillators (AEDs)
available for use on a major Latin Ameica airline for passengers
with cardiac arrest.
Methods In 1998, Varig Brazilian Airlines began the onboard
defibrillation program with AEDs. Flight attendants were trained inthe use of the defibrillator and applied the device when passengers
had a lack of consciousness, pulse, or respiration. A portable
monitor (Biolog 3000; Micromedical) was added and an
electrocardiogram that was obtained during each use of the
device. We analyzed data on all 18 instances in which the
defibrillators were used between May 1998, and October 2002.
Results AEDs were used for 18 patients. The administration of
shock was advised in nine patients who had electrocardio-
graphically documented ventricular fibrillation, and no shock was
advised in the remaining patients (sensitivity and specificity of the
defibrillator in identifying ventricular fibrillation, 100%), 50% of the
rhythm was pulseless electrical activity (probably the ‘silent dead’).
The first shock successfully defibrillated the heart in nine patients
(100%).
Conclusions The expansion of the knowledge of the AEDs and the
corrected implantation of the chain of survival ‘on board’ will
increase the extense of recovery of cardiopulmonary arrest victims
in aircrafts.
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Evidence exists in the literature, mainly in experimental studies, that
internal cardiac massage is superior to external cardiac massage,
generating higher coronary and cerebral perfusion pressures,
producing higher resuscitation and survival rates, and decreasing
neurological sequels. The need for a large thoracotomy and the
technical difficulties implied in its accomplishment have
contributed to this technique not being used. The current study is
an evaluation of a new device for minimally invasive direct cardiac
massage — before cardiac surgery when ventricular fibrillation was
induced in humans. After induction of the ventricular fibrillation
there was a 1-min period of cardiac massage with the device. The
device was positioned in the left hemithorax and the cardiac
massage was begun at the frequency of 100/min. Analyzed in
10 patients were: cardiac output, myocardial blood flow, and aorta,
right atrium, and coronary perfusion pressures. The aorta diastolic
and coronary perfusion pressures generated by the device were
very high; an increase of 27.15 ± 4.55 mmHg in the coronary
perfusion pressure from the moment of the 1-min cardiopulmonary
resuscitation (CPR).
In conclusion, the device increased haemodynamic parameters in
1-min CPR, before cardiac surgery.
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Objective To develop an understanding of the public’s attitude
concerning witnessed cardiopulmonary resuscitation (CPR).
Intervention A random telephone survey gathered demographic
information about 408 respondents who rated their level of
agreement to questions concerning witnessed CPR using a five-
point scale.
Results The respondents ranked their level of agreement in the
manner presented in Table 1. Age, level of education, income level,
perceived health status, and end-of-life planning did not correlate
with the responses. Married and widowed respondents, in
contradistinction to others, believe that witnessed CPR would
benefit the patient (P = 0.023). Respondents desiring CPR were
more prone to believe that significant others should be allowed
during CPR as opposed to those not desiring CPR (P = 0.005).
They are more apt to want others present with them while
undergoing CPR than those declining CPR (P = 0.002). They also
felt more strongly that the presence of significant others during
CPR would benefit the patient (P = 0.018) and family or friends
Table 1
“I believe family members or friends have the right  36.5% (n = 149) strongly agree, 10.3% (n = 42) agree, 22.4% (n = 90) neither agree nor 
to be present in the room while a loved one is  disagree, 98.8% (n = 37) disagree and 20.6% (n = 84) strongly disagree with this 
undergoing CPR” statement. Five respondents answered “I don’t know”
“I would want to be in the room with a loved one  37.3% (n = 152) strongly agree, 12.0% (n = 49) agree, 12.3% (n = 50) neither agree nor 
during CPR” disagree, 8.8% (n = 36) disagree, 28.2% (n = 115) strongly disagree with this statement, 
and 1.2% (n = 5) don’t know
“I would want family/friends with me if I were  29.9% (n = 122) strongly agree, 12.3% (n = 50) agree, 17.2% (n = 70) neither agree nor 
undergoing CPR” disagree, 8.6% (n = 35) disagree, 29.4% (n = 120) strongly disagree with this statement, 
and 2.5% (10) don’t know
“The presence of family/friends during CPR  24.3% (n = 99) strongly agree, 14.2% (n = 58) agree, 19.9% (n = 81) neither agree nor 
would benefit the patient” disagree, 13.75% (n = 56) disagree 22.3% (n = 91) strongly disagree with this statement, 
and 5.4% (n = 22) don’t know
“The presence of family/friends during CPR  23.8% (n = 97) strongly agree, 13.5% (n = 55) agree, 23.5% (n = 96) neither agree nor 
would benefit the family/friends” disagree, 12.5% (n = 51) disagree, 24.9% (n = 99) strongly disagree with this statement, 
and 2.2% (n = 9) don’t know(P = 0.022). The desire be present in the room with a loved during
CPR did not reach statistical significance (P = 0.078) between the
two groups.
Conclusion A large segment of the public desires witnessed CPR,
and believes it to be beneficial. Age, level of education, income
level, and end-of-life planning do not appear to influence these
beliefs. Married and widowed respondents were more apt to
consider witnessed resuscitation of benefit to the patient. People
desiring CPR are more likely to have positive feeling about
witnessed CPR. Those in poor health, not desiring CPR, are more
pessimistic about witnessed resuscitation. Although healthcare
providers have mixed sentiments, it would be wise to develop
protocols to accommodate those who wish to remain together
during CPR. Healthier individuals, married people and their
families, and those widowed will be more demanding in this matter.
The more infirm, not desirous of CPR, will be less demanding and
less inclined to avail themselves of such formal programs.
Available online http://ccforum.com/supplements/8/S1
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Introduction Health-care workers summoned to help at a cardiac
arrest arrive at different times. Providing of life support and the
process of teambuilding have to take place simultaneously. The
aim of this study was to test the hypothesis that the process of
teambuilding impairs the quality of cardiopulmonary resuscitation
during its early phase.
Methods The study took place in a high-fidelity patient simulator. A
scenario of a witnessed cardiac arrest due to ventricular fibrillation
was used that occurred after a uneventful period of 2 min. Twenty-
four teams, each consisting of three physicians, were randomly
assigned to one of two versions of the scenario: version R (reality)
mimics reality in that the arrest occurs in the presence of one
physician and the remaining two physicians are summoned to help;
in version A (all present) all three physicians were present at the
moment of the arrest. The performance of the teams was rated
using videotapes recorded during simulations. The first meaningful
measure (FMM) was defined as either precordial thump, ventilation,
cardiac massage, or defibrillation. Completion of the initial phase
(CIP) was defined as three countershocks, initiation of mask
ventilation and cardiac massage, and injection of epinephrine.
Results Both groups differed significantly in the timing of important
measures (Table 1).
Conclusions The present study was designed to unmask the
additional burden of teambuilding during the very early phase of an
emergency situation. Teams that were able to form prior to the
cardiac arrest performed significantly better than teams that had to
form during the cardiac arrest. Thus, the process of teambuilding is
associated with a significant delay in crucial measures in
cardiopulmonary resuscitation. Further research is necessary on how
to improve teambuilding in the settings of medical emergencies.
Table 1
Group Group
‘Reality’ ‘All present’ P
Time to FMM 46 ± 8 24 ± 4 0.02
Time to defibrillation 87 ± 12 49 ± 5 0.008
Time to massage 83 ± 14 69 ± 18 0.53
Time to CIP 219 ± 19 164 ± 11 0.02
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Introduction  Cardiopulmonary resuscitation (CPR) is an
emergency procedure that requires rapid and efficient response,
available equipment and personnel trained in life-saving
procedures. Since the time component is crucial for saving the
patient’s life, we must master the skills of life-saving procedures. In
2000, our hospital began implementing surprise drills in adult and
pediatric CPR. The aim of the drills is to improve the ability of
personnel in the hospital’s various departments and units to
perform CPR. In the drills, the medical and nursing staff implement
the principles of CPR that they have learned in study workshops.
Methods A doctor and a nurse who are resuscitation instructors
conduct the surprise drills using a computerized simulation
mannequin (SIM 4000). The instruction team arrives at the
department unannounced, presents a clinical scenario, observes
the way in which the department functions during the resuscitation
process, and documents its findings. At the end of the exercise, a
discussion is held with the department staff concerning the quality
of resuscitation implementation. Protocols for treatment of
potentially fatal arrhythmias are also reviewed during this session.
After the exercise, the department head receives a written report of
the quality of the CPR exercise, and recommendations for
improving CPR management. Implementing surprise drills
supplements the CPR training through which the unified language
has been introduced into the hospital.
Results  From 2000 to 2003, 50 CPR drills were conducted in
clinical departments. Each department has now experienced at
least two drills. If deficiencies were detected during the exercise,
efforts were made to correct them via departmental meetings
concerning CPR procedures and implementation, carrying out
specific actions to correct deficiencies, and by inviting the medical
and nursing staff to refresher courses in CPR (advanced cardiac
life support [ACLS] or basic cardiac life support [BLS]). A total of
1239 medical staff members participated in CPR training from
1999 to 2003, according to the following distribution: BLS, 924;ACLS, 107; pediatric BLS, 136; pediatric advanced cardiac life
support, 72. Personnel participating included: nurses, 64% (790);
staff physicians, 31% (385); part-time house physicians, 5% (61).
Summary and discussion We believe that surprise resuscitation
drills are the key to improved functioning during actual emergency
resuscitation, both on a departmental level and a general hospital
level. The benefit of surprise CPR drills lies in the examination of
the knowledge level, skills, and the ability to implement them. The
department’s readiness with equipment and instruments is
examined, together with their implementation of CPR protocol. It
should be emphasized that this exercise is efficient only after the
hospital personnel have undergone basic CPR.
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Aim To determine whether inhospital cardiopulmonary resuscitation
(CPR) of cancer patients is worthwhile.
Methods Data of all inhospital cardiac/respiratory arrests from
December 2002 to September 2003, in a 550-bed tertiary cancer
care center, were prospectively recorded using the Utstein
template. A panel of three expert oncologists independently
reviewed the medical records of these patients and grouped them
according to their disease status by a majority view as follows:
group I, patients whose disease status was being assessed;
group II, patients who received treatment to achieve cure or
disease control; group III, no treatment options offered except
palliative care. These data were retrospectively analysed with
respect to the following outcomes: return of spontaneous
circulation (ROSC), survival on hospital discharge (SOHD),
cerebral performance criteria (CPC) (scale 1–5: 1, good and 5,
coma) and survival after arrest (recorded on 1 December 2003).
Results There were 85 arrests, 71(84%) cardiac and 14 (16%)
respiratory arrests: 11 patients (13%) in Group I, 45 (53%) in
group II and 29 (34%) in group III. There was a difference of opinion
in grouping 15 patients (18%), in whom a majority opinion was
taken. Sixty-five patients (77%) were male and 20 (23%) female
with a mean age of 46.6 ± 18.9 (2–85) years. Eighty-four patients
were resuscitated, 33 (39%) patients had sustained ROSC.
Twenty-four (28%) of these patients had SOHD (three [3.52%] in
group I, 21 [24.7%] in group II, 0 in group III; P < 0.001). Twenty-
one (24.7%) patients, two (2.4%) patients and one (1.2%) patient
had good, moderate and poor CPC, respectively. On 1 December
2003, eight patients (9.4%) (one [1.2%] in group I and seven
[8.2%] in group II) were alive. The mean survival after discharge was
23.4 ± 68.4 (0–356) in those who died and 206.8 ± 101.2
(82–351) in survivors. Nineteen patients (22.4%) had a 1-month
survival, eight patients (9.4%) had a 6-month survival. None of the
patients labeled by even one expert as group III had SOHD.
Conclusion Resuscitation of cancer patients is worthwhile.
However, outcome in advanced cases (group III) is poor. Although
oncologists are not always unanimous in grouping, those patients
labeled even once as group III will not benefit from CPR
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Objectives To assess the number of patients admitted to intensive
care (ITU) post cardiac arrest (CA), their length of stay, their
outcome in ITU and their hospital outcome.
Setting A retrospective audit in a district general hospital over a
6-month period (from 1 August 2002 to 31 January 2003). Data
were obtained from the ITU Acu-base, the Resuscitation Officer
Data-Base and patients’ medical records.
Measurements and results Two hundred and fifty-three cardiac
arrest calls were made. One hundred and ninety-eight cardiac
arrests were identified and cardiopulmonary resuscitation (CPR)
was performed. CPR was successful in 51 of the 198 patients
(25.8%). A total of 52.9% (26 patients) were admitted to the ITU,
with an average waiting time of 4.8 hours. A DNAR order was ruled
out in 11 cases (21.5%) and the remaining 15 patients were
transferred to the medical ward, the coronary care unit or the high-
dependency unit. The length of CA was less than 10 min in 17 of
the 26 patients admitted to the ITU. The mortality rate for these
patients was 41.2% (seven patients). None of the nine patients
(average age 74 years) whose length of CA exceed 10 min
survived. Their length of stay in ITU ranged from 2 hours to 5 days.
ITU outcome was 61.5% (16 patients)and hospital outcome was
19.2% (five patients).
Conclusions Factors associated with a poor prognosis include
patients older than 70 years old who have suffered prolonged
cardiac arrest. Guidelines may help to select patients who would
benefit most from admission to the ITU.
Table 1
ITU admission 26
A&E 15
M&S ward 11
Waiting time (hours) 4.8
Table 2
CA >10 min A&E (four patients) M&S ward (five patients)
Age (years) 70 (55–83) 78 (64–88)
Length of stay in ITU (hours) 28 60
Dead 4 (100%) 5 (100%)Available online http://ccforum.com/supplements/8/S1
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Backgrounds and goals Mild induced hypothermia (MIH) has
become a standard in neuroprotective treatment for anoxic brain
injury after cardiac arrest. Different surface cooling protocols have
been successfully used [1].
Materials and methods We implemented MIH by use of ice-
water-soaked towels over the torso and legs in combination with
sedation/muscle paralysis to avoid shivering after prehospital
cardiac arrest in patients, age 15–80 years, with persistent coma
and lack of cardiogenic shock. The target temperature (33 ± 1°C)
was maintained for 12–24 hours. We evaluated the feasibility of
our protocol.
Results From June 2002 to October 2003 we have treated
30 patients. The median age was 52 years (15–77 years). In 58%
the initial rhythm was ventricular fibrillation. While 26 patients
received MIH after the protocol, three patients were impossible to
cool to target temperature. In one patient MIH had to be withdrawn
due to persistent malignant arrhythmias. The median temperature
course of the 26 patients in which MIH was successfully
completed is shown in Fig. 1.
The mean time to reach the target temperature was 4.5 hours
(0–12 hours). MIH was maintained for a median 13 hours
(4–26 hours). The rewarming period to 37°C took a median of
8.75 hours (3–21.5 hours). MIH treatment was followed by fever
(>37.9°C) in 23 patients (88%).
Conclusions MIH by use of our external cooling protocol is
feasible, simple and inexpensive. However, surface cooling is tardy,
imprecise and in some patients unsuccessful.
Reference
1. Nolan J: Resuscitation 2003, 57:231-235.
Figure 1
Median temperature course of 26 MIH-treated patients.
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Background and goals Mild induced hypothermia (MIH) improves
neurological recovery and survival after cardiac arrest for patients
in whom the initial rhythm is ventricular fibrillation (VF) [1]. Other
initial rhythms and cardiac arrest due to noncoronary causes may
also benefit from such treatment [2].
Materials and methods We evaluated 10 patients who received
MIH after non-VF-(asystole, pulsless electric activity) out-of-
hospital cardiac arrest (NVF-OHCA) and compared them with a
historic control (n = 9) of NVF-OHCA who as not treated with MIH.
The ICU and hospital length of stays as well as the incidence of
bad outcome were compared. Bad outcome was defined as
cerebral performance category (CPC) ≥3 or death [3].
Results Data are presented in Table 1.
Conclusion The tendency towards prolongation of length of stay
at even poor outcome suggests that a liberal MIH inclusion policy
may result in a dissatisfactory cost–benefit ratio. Further research
and larger patient numbers are needed to verify these results.
References
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Table 1
Non-MIH MIH
n 91 0
Age (years)a 61 34.5
Noncoronary cardiac arrest 33.3% (n = 3) 70% (n =7 )
ICU stay (days)a 3 5.5
Hospital stay (days)a 5 9.5
Bad outcome 88.9% (n = 8) 90% (n =9 )
a Median value.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
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Objective In this prospective study the frequency of neurological
complications causing significant morbidity and prolonging
hospitalization was assessed in adult patients who underwent liver
transplantation.
Patients and methods Fourty-five adult patients who underwent
liver transplantation between September 1997 and October 2003
were included into the study. Fourteen out of 45 patients (31%)
died during the intraoperative or very early postoperative period.
The remaining 31 patients were followed for neurological
complications during their ICU stay and after being discharged to
the ward. Computerized tomography, electroencephalography and
electromyography (EMG), were used for diagnosis when appropriate.
The clinical findings and laboratory results were recorded.
Results Neurological complications were seen in 10 out of
31 patients (32.3%). These complications were as follows: new
onset, recurrent headache (three patients), generalized seizures
(two patients), persistent tremor (one patient), central pontine
myelinolysis (one patient), dysartria (one patient), myopathy (one
patient) and mutism (one patient). The seizures encountered in the
two patients were thought to be associated with the toxic effect of
tacrolimus, an immune-suppressant drug, because the seizures
ceased after cessation of the drug. Myopathy presenting as
quadriplegia was seen in one patient in the very early postoperative
period and was diagnosed by EMG and muscle biopsy. It leaded
to prolonged mechanical ventilation, ICU stay and hospitalization.
The patient with central pontine myelinolysis lived in a persistent
vegetative state for 2 years.
Conclusion Neurological complications were observed in 10 out
of 31 patients who underwent liver transplantation. Some of these
complications were associated with the use of immune-
suppressant drugs. In conclusion, neurological complications are
frequently encountered after liver transplantation and are a cause
of severe morbidity and prolonged ICU and hospital stay.
P304 The gamma isoform of enolase (NSE) is predictive of mortality after cardiopulmonary resuscitation: comparison with
clinical neurologic examination and computerised tomography scan of the brain
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Introduction NSE is released into the cerebrospinal fluid and
blood after the occurrence of stroke and anoxia; and correlates
with the extent and duration of ischemia in animal models of stroke
and the outcome in humans, including neonates, with hypoxic
ischemic encephalopathies.
Accordingly, the objectives of the current study were (1) to assess the
prognostic significance of plasma concentrations of NSE for early
prediction of outcome in patients at risk for anoxic encephalopathy
after cardiopulmonary resuscitation (CPR), and (2) to compare the
prognostic information provided by NSE measurements with that
provided by conventional risk indicators (clinical neurological
examination and computerised tomography [CT] scan of the brain).
Results Twenty-one patients (age 62.0 years [mean] ± 16.7 [SD])
after CPR due to different reasons were enrolled up to now. Clinical
neurological examination differentiated four standardized levels of
midbrain syndrome (MBS) and two levels of bulbar brain syndrome
(BBS). CT scan of the brain, and plasma concentration of NSE on
the third day after CPR were compared. Three of the patients had
MBS I, two had MBS II, two had MBS III, one had MBS IV, no one
had BBS I and six had BBS III. In seven patients neurological
examination was not reliable due to the given anticonvulsive therapy
because of early onset of myoclonias and due to sedation due to
hemodynamic instability. The CT scan of the brain showed in eight
patients cerebral edema, in two patients ischemic lesions, and in
one patient no pathological changes. In 10 patients no CT scan
was available because of the deleterious hemodynamic situation on
the third day. The NSE level was elevated in 16 of 21 patients
(80.9 ± 69.5 ng/ml; range 17.6–224.5 ng/ml). NSE was elevated in
seven of eight patients with edema of the brain detected by CT
scan. One patient with edema of the brain had a normal NSE level
but the neurological examination showed a BBS II. Seven of eleven
patients with BBS II had elevated NSE levels. Eight patients with
elevated NSE levels died. Only two patients of those with normal
NSE level died, and one had neurological symptoms at time of
demission. In all patients except one with further neurological
symptoms who survived, NSE levels were elevated. CT scan of the
brain and neurologic examination were less sensitive than NSE in
predicting a poor outcome.
Conclusion In patients after CPR for different reasons, increased
plasma levels of NSE predict an increased risk of a poor outcome.
NSE measurements appear to provide prognostic information
complementary, and possibly superior, to that obtained from the
neurological examination and CT scan of the brain.
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Objective  To evaluate the Fisher’s Classification (FC) of
aneurismal subarachnoid hemorrhage (SAH) as a predictor of
cerebral vasospasm development.Study design A prospective database data analysis.
Inclusion criteria Patients with SAH admitted from the 1st to the
12th day after bleeding.
Data analyzed Age, sex, clinical grade according to WFNS
classification, outcome according to Glasgow Outcome Scale
(GOS), FC accomplished with the first computerised tomography
scan, and vasospasm confirmed by angiography.
Statistical analysis Positive predictive value, negative predictive
value, sensitivity, specificity, likelihood ratio for a positive test result
and likelihood ratio for a negative test result.
Results From 1 October 1990 to 1 October 2001, 1090 patients
were admitted to ENERI. Among these 443 completed the
inclusion criteria. The mean age was 48 ± 13 years, 33% were
male, 26% were in WFNS grade 1, 23% in grade 2, 24% in
grade 3, 21% in grade 4 and 6% in grade 5. The outcome was:
GOS 1: 9%, GOS 2: 1%, GOS 3: 6%, GOS 4: 9%, GOS 5: 74%.
Among the aneurysms, 359 belong to the anterior circulation (AC)
and 89 to the posterior circulation (PC). Regarding vasospasm, it
was developed in 46% of the patients, 48% in the AC group and
40% in the PC group.
Conclusion FC is not a good predictor of vasospasm development
in SAH patients treated with endovascular procedures.
Available online http://ccforum.com/supplements/8/S1
Table 1
Fisher data (spasm) Our series (spasm)
Fisher 1 0% 28%
Fisher 2 9% 41%
Fisher 3 95% 51%
Fisher 4 23% 50%
Table 2
Positive predictive value 37%
Negative predictive value 59%
Sensitivity 51%
Specificity 56%
Likelihood ratio for a positive test  0.84
Likelihood ratio for a negative test 0.87
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Background S-100 protein is an acidic calcium-binding protein
found in astroglia and Schwann cells. Recently, there have been
several reports on the relation of the severity of head injury and
serum S-100B protein levels in trauma patients, but there are few
reports about time course of S-100B protein in the early phase of
head injury. In many previous reports, S-100B was reported in
units of µg/l. Lately, a new device (YK-150) was developed that
can measure serum S-100B protein in pg/ml units.
Objective We showed the course of the concentration of serum
S-100B in the acute phase of head injury using the YK-150.
Patients and methods S-100B serum levels were determined in
10 patients (eight men, two women; mean ± SD, 50.1 ± 20.2 years).
There were two cases of severe head injuries (Glasgow Coma
Scale [GCS] <9). Blood samples were taken on admission, 24
and 48 hours after the traumas. Serum S-100B protein
concentrations (pg/ml) were measured by ELISA (Yanaihara Industry,
Tokyo, Japan).
Results  Initial serum S-100B concentrations were elevated
(minimum, 790 pg/ml; maximum, 7,749,669 pg/ml; mean,
979,666 pg/ml). All patients whose serum S-100B concentrations
compared with the first-time value decreased at the second point,
24 hours after injury (minimum, 10.1 pg/ml; maximum,
16,990 pg/ml; mean, 5994 pg/ml). After 48 hours, only two
patients showed an increase of serum S-100B concentrations and
one of these showed the highest level of serum S-100B and died
on day 28 (Fig. 1).
Discussion and conclusion Many studies have been done on
S-100B that have shown the relation between initial data and poor
prognosis. We have also shown patients with slight head injuries
who were conscious (GCS >8) and whose elevated serum
S-100B concentrations decreased in the next 24 hours. We
suspect it was only the cerebral cell damage that caused the initial
increase of serum S-100B concentrations in these head injuries. If
there is no secondary brain damage, serum S-100B
concentrations will immediately decrease. The YK-150 (Human
S-100B ELISA kit) can measure serum S-100B concentrations in
22 ± 4 hours. Using the YK-150, if we can detect a slight variation
in early-phase secondary brain damage, we can accurately predict
what changes will take place in the patient; and if so, YK-150’s
efficacy will spread even further.
Figure 1
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Background Cerebrospinal fluid concentrations of S-100B
protein, an acidic calcium-binding protein found in astrocytes and
Schwann cells, increase after central nervous system damage.
Serum S-100B protein thus has potential as a biomedical marker
of brain cell damage. Several reports show a relation between the
severity of head injury and serum S-100B protein (S-100B) levels
in trauma patients, but there are few data about S-100B in
endogenous cerebral disease.
Objective The aim of this study is to evaluate S-100B as a marker
in endogenous encephalopathy.
Methods Serum S-100B protein concentrations (pg/ml) were
measured daily by ELISA until ICU discharge in 19 ICU patients
(12 men, seven women; age 9–80 years [mean
57.1 ± 22.8 years]) with endogenous encephalopathy. The
APACHE II score and Glasgow coma scale (GCS) were used to
assess the severity; electroencephalography (EEG) and
computerised tomography (CT) were also examined. Values are
expressed as mean ± SD. The unpaired Student’s t test, or tests
of Mann–Whitney’s U, Wilcoxon signed-rank, Kruskal–Wallis and
Pearson’s correlation coefficient were used. P < 0.05 was
considered statistically significant.
Results There were 10 survivors and nine nonsurvivors with no
significant differences in age, APACHE II score or GCS. There
was no significant difference in S-100B levels on admission
between survivors and nonsurvivors, but S-100B levels were
significantly lower in survivors than in nonsurvivors from day 1
(1129 ± 1780 vs 465,370 ± 780,293, P < 0.05) until ICU
discharge (16.5 ± 15.9 vs 231,120 ± 591,110, P < 0.05). In
survivors, S-100B levels decreased from 5 day (30.1 ± 18.5) to
discharge compared with admission levels (P < 0.05); in
nonsurvivors, there were no significant changes in S-100B
compared with admission levels. There were no correlations of
S-100B levels with APACHE II score (R = 0.3, P > 0.05) or GCS
(R = –0.1,  P > 0.05), but EEG and CT abnormalities were
correlated with S-100B levels.
Conclusion Serum S-100B concentrations follow different
courses in survivors and nonsurvivors in endogenous
encephalopathy. Although similar on admission, differences in
serum S-100B protein between survivors and nonsurvivors
appeared from the first day after admission. In survivors, but not in
nonsurvivors, S-100B levels decreased until discharge. There were
also significant relationships with the severity of EEG or CT
abnormalities and S-100B levels. Serum S-100B protein could be
a useful biomedical marker for assessment of brain damage and
may predict prognosis in endogenous encephalopathy.
P308 Severe brain injury epidemiology in Western Macedonia: experience of a general hospital as the basis for planning brain
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Introduction Studies on patients with severe brain injury (SBI) are
few and are based on data from specialized centers. In Western
Macedonia the main reason for transferring trauma patients is SBI,
to a neurosurgeon with a travel time as long as 3 hours. Five
general hospitals serve the health service needs of a population of
301,522 inhabitants. Bodosakeio General Hospital covers a real
population of 100,000 and is the only one in the region backed by
an intensive care unit and 24-hour facilities for computerised
tomography scanning.
Objective The objective of this study was to evaluate the
incidence, distribution, clinical patterns and early outcome of SBI
patients admitted to our non-neurosurgical hospital, as a basis for
future efforts at improvements.
Methods Cases of SBI patients admitted to Bodosakeio hospital
(Glasgow Coma Scale ≤8) were identified retrospectively for a
23-month period (January 2002–December 2003) using data from
the District Health System of West Macedonia, the accident and
emergency unit, the hospital forms registering interhospital
transports and the intensive care unit records. Extracted data
concerned the incidence, gender distribution, age, external causes,
C–T lesions, associated injuries, early transfer and mortality at the
end of acute hospitalization. Additionally, data for the SBI
Table 1
Epidural Subdural  Cranial  Spinal  Normal 
haematoma haematoma Contusions Brainswelling fracture fracture CT Total
Number 6 6 6 5 1 5 3 32
Male/female 3/3 5/1 5/1 4/1 1/0 2/3 2/1 22/10
Mean age (years) 28.16 37 44.16 17.4 3.5 52.2 38.33 31.53
Pediatric 1 0 0 3 1 0 1 6 (18.17%)
Mortality 2 (33.33%) 1 (16.16%) 4 (66.66%) 2 (40%) 0 0 0 9 (28.1%)
Associated injuries 2 1 1 1 0 1 1 7 (21.87%)distribution throughout the five general hospitals in the region were
analyzed.
Results During the study period 1127 traumatic brain injury cases
were registered, comprising 11.22% of the Bodosakeio Hospital
Surgical Emergency Department workload. A total of 63.17% of
cases were from traffic-related causes, followed by falls (18.5%).
Over 1.96% were dead on arrival, 47.17% were discharged home
after initial assessment, leaving 50.87% to be admitted to hospital,
mainly for observation. Of these, 32 (2.83%) were classified as
having SBI and needed to be transferred to a neurosurgical unit.
The characteristics of SBI patients for Bodosakeio Hospital and
the distribution of transferred SBI patients for the five general
hospital sites within West Macedonia are presented in Tables 1
and 2.
Conclusion There is a need for strong preventive measures to
control the high incidence of SBI in the region. The mortality rates
are acceptable when compared with other reports, suggesting
adequate quality of initial stabilization and transport, and
competency and speed in the detection of candidates for surgical
decompression. Nevertheless this system may lead to some
avoidable deaths, especially in acute intracranial hemorrhage. The
optimal situation would be the presence of a neurosurgeon in the
medical team admitting patients with severe head trauma and the
concentration of injury services since no hospital receives sufficient
patients to develop and maintain expertise.
Available online http://ccforum.com/supplements/8/S1
Table 2
Hospital Cases Incidence/105
Bodosakeio 35 27.31
Kozanis 32 18.08
Kastorias 34 31.78
Florinas 18 16.34
Grevenon 16 21.08
P309 Long-term follow-up of severely brain injured patients in Martinique
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Severe brain trauma was pointed out recently by the World Health
Organisation as a worldwide problem. The aim of our study was to
evaluate the long-term outcome of severely brain-injured patients.
We studied retrospectively (2002) the data of 151 patients
admitted to critical care between 1997 and 2000. The sex ratio
(female/male) was 0.13, and mean age was 31 ± 17 years. Eighty-
nine per cent had a low socioeconomic level. Fifty-one per cent
(77 patients) were admitted during the weekend, and 57%
(82 patients) during the night. Inhospital mortality and overall
mortality were, respectively, 27% (41 patients) and 31%
(47 patients). The mean SAPS II was 35 ± 14, ISS was 22 ± 11.
Fifty-four per cent (81 patients) had a Glasgow Coma Scale <8
before admission. Twenty-five per cent (38 patients) underwent
initial surgery and 10% (15 patients) neurosurgery.
We joined the patients in order to evaluate them using the EBIS
questionnaire. Thirty-six were lost and 12 patients were excluded
because of associated diseases impairing their neurological status,
so 56 patients were evaluated. They had no significant difference
with the nonevaluated group according to the parameters already
described. The Glasgow Outcome Scale (GOS) is presented in
Table 1. Only 45% (24 patients) had a stay in a rehabilitation unit.
Seventy-one per cent (40 patients) were staying in the family
house when evaluated, 54% (30 patients) were unemployed. The
most frequent medical complication was post-traumatic seizures
(25% [14 patients]). Thirty-nine per cent (22 patients) had joints
limitations, 39% (22 patients) had balance limitations, 32%
(18 patients) had loss of visual acuity, and 45% (25 patients) had
attention impairment. When tested, 43% (22/51 patients) had
severe memory impairment. Visual and spatial memory (70%
[35/50 patients]) and planning ability (70% [35/50 patients]) were
also frequently impaired. Behavioural impairment was consecutive
to depression (61% [33/54 patients]), anxiety (63%
[34/54 patients]), or loss of emotional control (59%
[32/54 patients]). Handicaps were sphincter incontinence (11%
[6 patients]), loss of writing ability (51% [26/51 patients]), and loss
of driving ability (44% [22/50 patients]). Sixty-three per cent
(35 patients) had physical impairment (27% [15 patients]) or
mental impairment (57% [32 patients]). The impact on the family
resulted in medication therapy (34% [19 patients]), financial
impairment (27% [15 patients]), and changes in the timetable
(36% [20 patients]).
Severe brain trauma leads to a marked impairment of the patient’s
autonomy. Public health measures are necessary to organize an
early multidisciplinary approach that could improve the patient’s
rehabilitation and reintegration in the social network.
Table 1
GOS 1 GOS 2 GOS 3 GOS 4
50% (27) 37% (20) 11% (6) 2% (1)
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Introduction In patients with severe head injury the main
complication is cerebral edema and intracranial hypertension. TCD
is a noninvasive, bedside technique, which detects the blood flow
velocities in the great intracranial arteries. The aim of our study was
to investigate whether TCD is a useful technique for the diagnosis
of intracranial hypertension.Materials and methods Fifty-nine patients with severe head injury
(Glasgow Coma Scale <8) were included in our study. From these
59 patients, 49 were males and 10 females. Their mean age was
36.8 years, with a range from 12 to 71 years. In all patients, we
performed and compared concomitant intracranial pressure (ICP)
measurement with an intracranial catheter and a TCD examination.
In each TCD examination we measured the maximum, mean and
the end diastolic velocity (Vmax, Vmean and Vmin, respectively),
and we calculated the pulsatility index (PI). The mean cerebral
artery through the temporal acoustic window was used for the
TCD examinations. A total of 120 TCD examinations and ICP
measurements were recorded. We performed correlations
between Vmax, Vmean, Vmin and PI with ICP and cerebral
perfusion pressure (CPP).
Results There was no statistically significant linear correlation
between TCD velocities and ICP and between the PI index and
ICP. There was a significant correlation between Vmax and CPP
and between Vmean and CPP. The best correlation found was
between Vmin and CPP and between the PI index and CPP. Linear
correlation and regression between TCD findings and ICP and
CPP are presented in Table 1.
Conclusions TCD examination cannot be used as reliable
noninvasive method to determine a concrete number of ICP. The PI
index is more reliable than the TCD blood flow velocities to target
therapeutic strategies in patients with severe head injury, but we
must keep in mind that the PI estimates the changes of CPP over
time and not an absolute value of CPP.
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Table 1
Vmax vs ICP Vmin vs ICP Vmean vs ICP PI vs ICP Vmax vs CPP Vmin vs CPP Vmean vs CPP PI vs CPP
r –0.06726 –0.1543 –0.1241 0.01432 0.2335 0.4138 0.3626 –0.4906
r2 0.00452 0.02381 0.01539 0.0002 0.05451 0.1713 0.1315 0.2407
P 0.5718 0.1924 0.2957 0.9043 0.04648 0.0003 0.0016 <0.0001
P311 Blood flow and oxygen extraction fraction in regions of oedema following head injury
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Introduction Cerebral blood flow (CBF) is reduced around areas
of contused brain after head injury [1]. However, since the cerebral
metabolism is also reduced this may represent appropriate flow-
metabolism coupling, rather than ischaemia. Matching of CBF to
metabolism is quantified as the oxygen extraction fraction (OEF).
We performed magnetic resonance imaging (MRI) and Oxygen 15
positron emission tomography (O-PET) to quantify CBF and OEF
in regions of pericontusional oedema after head injury.
Methods After local ethical approval, five patients with severe
head injury underwent structural MRI and O-PET, in the first week
after injury. The two studies were performed in immediate
succession, with every effort made to maintain stable physiology.
The fluid attenuation inversion recovery (FLAIR) MRI sequence
provides cerebrospinal fluid-nulled, T2-weighted MRI images, on
which oedema is hyperintense. The FLAIR images were
coregistered and voxel resized to O-PET-derived maps of CBF and
OEF, using a published methodology [2]. Each patient’s
coregistered FLAIR image was inspected for the largest and most
apparent region of pericontusional oedema. These regions were
then manually outlined and applied to PET maps, and CBF and
OEF in these regions of oedema were calculated. Results were
compared with unit reference data obtained from healthy
volunteers [3].
Results Normal values of CBF and OEF obtained from volunteer
datasets for mixed grey–white regions were 35 ± 5 ml/100 g/min
and 45 ± 5%, respectively. While pericontusional regions showed
a significantly lower CBF (20.5 ± 8.3 ml/100 g/min), we observed
a wide range of values both across subjects and within individual
lesions (14.7–35 and 5.1–52.3 ml/100 g/min, respectively).
However, mean OEF values were low (35.4 ± 2.1%), with a much
smaller range of values across patients (31.8–37.5%) and
individual image voxels (24.9–41.8%). The 95% confidence
intervals for the population mean pericontusional CBF and OEF
were 10.2 and 30.8 ml/100 g/min and 32.8 and 38.1%,
respectively.
Conclusions The wide range of CBF values should make
clinicians wary of predicting the viability of tissue in regions of
pericontusional oedema. The values are all above the threshold, of
8.4 ml/100 g/min [4], for irreversible ischemia from the stroke
literature. Thresholds for irreversible ischemia after head injury are
unknown. The upper 95% confidence interval for the OEF is only
38% and the maximum OEF in any voxel was 42%, suggesting that
the reduction in CBF may be appropriate to the metabolic
demands of the tissue.
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patients: what does the first 24 hours tell us?
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Aim To determine whether there is a relationship between cerebral
perfusion pressure (CPP), intracranial pressure (ICP) and survival
in children with severe traumatic brain injury (sTBI) in the first 6 and
24 hours after ICP monitoring.
Methods We retrospectively reviewed the case notes of all
children under the age of 16 years who were admitted to the
Paediatric Intensive Care Unit in Southampton General Hospital
following a head injury in whom intracranial pressure monitoring
was undertaken over a 4-year period. ICP, CPP and mean arterial
pressure were evaluated hourly and means were calculated for the
first 6 and 24 hours after ICP monitoring. The primary outcome
measure was survival and children were categorised into three
groups; Group 1, overall functioning within the normal range;
Group 2, survival but with some neurological impairment; and
Group 3, died as a result of their injuries.
Results Of 102 children admitted to the unit during the period of the
study, following a head injury, 59 had intracranial monitors placed
within the first 24 hours. Nearly two-thirds (64.7%) were male and all
59 suffered sTBI with mean (SD) admitting Glasgow Coma Scores
of 8 (3). The crude mortality rate was 10.2%. When comparing the
mean ICP over the first 6 hours we found a significant difference
between all three groups. The mean ICPs (SD) at 6 hours were as
follows; Group 1, 10.61 mmHg (5.43); Group 2, 18.57 mmHg
(7.34) and Group 3, 42.88 mmHg (23.64) The mean (95%
confidence interval [CI]) ICP was 7.96 mmHg (CI 1.05–14.87) lower
in Group 1 than Group 2 (P < 0.05), and 24.31 mmHg (CI
13.90–34.71) lower in Group 2 than Group 3 (P < 0.05). This
difference between groups was maintained at 24 hours. Mean ICPs
(SD) at 24 hours; Group 1, 12.61 mmHg (5.12); Group 2,
20.35 mmHg (5.07) and Group 3, 44.69 mmHg (25.70). The mean
(95% CI) ICP was 7.74 mmHg (CI 1.3–33.16) lower in Group 1
than in Group 2 (P < 0.05), and 24.34 mmHg (CI 14.31–34.35)
lower in Group 2 than Group 3 (P < 0.05) at this time. There was
also a significant difference in the CPP between Groups 1 and 3,
and Groups 2 and 3 at both 6 and 24 hours, although no significant
difference was detected between Groups 1 and 2.
Conclusion This study suggests that in children a low ICP, in the
first few hours after a sTBI, is crucial to intact survival and helps to
differentiate this from a poor outcome (neurological impairment or
death). CPP did not help stratify those patients who survived
(Group 1 and Group 2). The question remains whether we can
improve outcome with aggressive measures to reduce the ICP or
increase the CPP.
P313 A comparison of a behavioural assessment tool and electrophysiological measures of recovery from coma
C Schnakers, S Laureys, S Majerus
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Critical Care 2004, 8(Suppl 1):P313 (DOI 10.1186/cc2780)
The Wessex Head Injury Matrix (WHIM) [1] is one of the rare
behavioural scales that have been designed to follow the recovery
of head-injured patients throughout the whole spectrum of altered
states of consciousness, from exit of coma to complete recovery. In
this study, we explored the validity of the WHIM in relation to other
behavioural assessment tools — Glasgow–Liège Coma Scale
(GLS) [2], Coma-Near Coma scale (CNC) [3], Western Neuro
Sensory Stimulation Profile (WNSSP) [4] — as well as in relation to
the Bi-Spectral Index (BIS), derived from electroencephalographic
measures. Twenty-nine brain-injured comatose patients (aged
21–83 years) were followed longitudinally with these behavioural
and electrophysiological measures. Overall, the evolution of the
scores on the WHIM correlated significantly with the evolution of
scores obtained by the GLS (r = 0.88;  P < 0.01), the CNC
(r = –0.8; P < 0.01), the WNSSP (r = 0.87; P < 0.01), as well as
with the BIS measure (r = 0.58; P < 0.01). Relative to the GLS,
CNC and WNSSP, the WHIM showed a particularly good
sensitivity for documenting subtle changes in recovery for patients
in a minimally conscious state. The BIS index globally evolved in
parallel to the behavioural scales. However, it showed a very bad
sensitivity as many patients in a coma or a vegetative state
presented BIS scores that were as high as those observed for
patients that had regained normal consciousness. The results
confirm the usefulness of the WHIM, especially for the assessment
of minimally conscious patients. However, even if a global relation
is observed with behavioural scales, the validity of
electrophysiological measures such as the BIS index is
unsatisfactory for the assessment of altered states of
consciousness.
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P314 Neuropsychological testing in the locked-in syndrome: preliminary results from a feasability study
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The locked-in syndrome (LIS) is characterised by complete loss of
voluntary motor output but preserved sensory input and
consciousness, as a result of a ventral pontine lesion.
Communication is only possible via spared vertical eye movements
and/or eyelid blinking. The aim of this study was to adapt standard
neuropsychological tests to an eye-response mode for use in LIS
patients. We assessed five patients in LIS for 3–6 years (age
24–57 years) and 10 controls with a modified version of the direct
and backwards digit span (working memory), the Doors and
People Test (episodic memory [1]), the Wisconsin Card Sorting
Test (executive functioning [2]), the LEXIS (phonological and
lexico-semantic processing [3]), the EVIP (vocabulary knowledge
[4]) and two new tests designed to measure sustained and
selective attention for auditory stimuli. Like the LIS patients, the
control subjects had to respond via eye movements. The results
showed that the patients’ performance was in the normal range for
most measures. However, differences of performance between
subjects have been found. This study demonstrates the feasibility
of a complete neuropsychological testing in chronic LIS survivors.
It re-emphasises the fact that LIS patients recover a globally intact
cognitive potential. Nevertheless, inter-individual differences
observed suggest the interest of this battery to detect some
deficits and then to maximize the communication between the
family, the medical staff and the patients in LIS.
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P315 The comparison of prognosis of the patients with severe head trauma in two different treatment protocols
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Objective In several institutions, intraventricular catheter (IVC)
placement and decompressive craniectomy (DC) have been
included in the treatment protocols of the patients with severe head
injury besides the conventional therapies including normoventilation,
normothermia, sedation-analgesia and osmotic diuresis. In this
study, we compared the mortality and morbidity rates of the patients
treated by two different therapy protocols in different periods
(conventional therapy group vs conventional + IVC-DC group).
Methods One hundred and seventeen patients with a Glasgow
Coma Scale score ≤8 were included in the study. The duration of
mechanical ventilation, the ICU stay, surgical procedures,
computerised tomography results, and Glasgow Outcome Scores
were prospectively recorded. Conventional therapy was performed
in 48 patients (Group I) between the years of 1997 and 2000.
After 2000, IVC placement and the DC procedure were added to
the treatment protocol and 69 patients were treated according to
this therapy protocol (Group II).
Results The groups were similar in terms of age and severity of
trauma. In Group I, 16 patients were discharged in good
neurological condition (33%), 12 patients in bad neurological
condition (25%) and 20 patients (42%) died. In Group II,
34 patients in good neurological condition (49%) and 16 patients
in bad neurological condition (23%) were discharged and
19 patients (28%) died (P > 0.05). The mean durations of
mechanical ventilation in Group I and Group II were 8.9 ± 7.6 days
and 11.8 ± 10.1 days, respectively (P > 0.05). The mean ICU stay
was18.1 ± 17.9 days in Group I and 17.8 ± 13.9 days in Group II
(P > 0.05).
Conclusion Although the prognosis of the patients in Group II
seemed better than the conventional therapy group, the difference
was not statistically significant.
P316 Subcutaneous diclofenac at low dose is very effective in treating fever with an accompanying reduction in intracerebral
pressure in NICU patients
M Cormio, C Ergoli, G Citerio, G Portella, A Pesenti
H.S. Gerardo, Monza, Italy
Critical Care 2004, 8(Suppl 1):P316 (DOI 10.1186/cc2783)
Although rigorous control of fever is the current standard of care
for the brain-injured patient, patient management strategies
currently available are often suboptimal and may be
contraindicated.
Objectives We investigated a subcutaneous very low dose of
diclofenac sodium (DCF SC) to treat fever in the NICU.
Methods DCF SC (0.17 mg/kg [≈ 1/6 fl]) was administered to
febrile patients and its effect was recorded continuously for
6 hours on the temperature (T°), intracranial pressure (ICP),
cerebral perfusion pressure (CPP), mean arterial pressure (MAP),
heart rate (HR) and diuresis. Adverse effects of DCF (allergic,
gastrointestinal and central nervous system bleeding) were
monitored.Results Thirty-five NICU patients (age 48.9 ± 19.5 years, male
64%, median Glasgow Coma Scale motor 5) (traumatic brain
injury 63%, aneurismal subarachnoid hemorrhage 20%,
postoperative 17%) were studied. Infection was clinically
suspected in all patients and in 54% of them its was confirmed by
microbiological data. We analysed a total of 177 SC doses at a
mean 185 ± 89 hours after ICU admission with a median of five
administrations per patient. The mean dose was 13.7 ± 6 mg
(0.17 ± 0.04 mg/kg). T° decreased significantly after DCF SC,
from 38.4 ± 0.4 to 37.6 ± 0.5°C (P < 0.0001), as did the ICP, from
16 ± 8 to 12.8 ± 6 mmHg (P = 0.0002). PaCO2 and SjvO2 were
not different pre and post DCF. The CPP was stable after DCF
(pre, 71 ± 15 mmHg; post, 69 ± 15 mmHg [NS]). The HR
significantly dropped (from 97 ± 21 to 89 ± 20 beats/min,
P < 0.0001). Blood gas analysis, renal and hepatic parameters
were not different after DCF SC. Diuresis was maintained and it
did not decrease much (from 175 ± 97 to142 ± 102 ml/hour,
P < 0.05). The effects of DCF on T° and ICP are shown in Fig. 1.
The effects of DCF on MAP, CPP and hourly urine output are
shown in Fig. 2.
Conclusions We conclude that DCF SC at low dosage was
advantageous and effective. It enabled good reductions in body T°
with an associated reduction in the ICP. Side effects on CPP or
MAP were minimal, and renal and hepatic functions were not
affected.
Available online http://ccforum.com/supplements/8/S1
Figure 1 Figure 2
P317 Evaluation of intracranial pressure in influenza-associated acute encephalopathy: therapeutic strategy with intracranial
pressure monitoring
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Introduction Until recently, influenza-associated acute
encephalopathy (IAE) had been rare in Europe and the United
States. Recently, however, some investigators from these regions
have reported on IAE. This severe complication of influenza is more
common in Japan and is often fatal. The mortality rate is 30% and
the rate of severe neurological sequelae is 30%. Since 2002, we
have included intracranial pressure (ICP) monitoring in the
management of infants with IAE in our center. This report
summarizes our experience with ICP monitoring of IAE.
Methods We describe four infants aged 1–5 years (two boys and two
girls) who were pyrexial and comatose or who had convulsions. Three
were healthy prior to admission but one had a craniopharyngioma.
Antibodies to influenza A virus were detected in all four patients. ICP
monitoring was started as soon as possible after admission.
Results  The patients’ cerebral perfusion pressure (CPP) was
maintained above 50 mmHg. In three cases, the ICP was
maintained below 25 mmHg. In these cases, the ICP was
controlled with antipyretic therapy and pentobarbital infusion. In
each of these cases, a computerised tomography (CT) scan of the
brain showed bilateral thalamic hemorrhage and slight edema on
the day of admission. In the other patient, the ICP suddenly
increased to more than 50 mmHg, and a vasoconstrictor infusion
(noradrenaline 0.5 µg/kg/min) was needed to maintain the CPP on
the second hospital day. The brain CT and magnetic resonance
imaging (MRI) demonstrated severe cortical brain edema, similar to
that described in the hemorrhagic shock and encephalopathy
syndrome (HSES) in Europe. All the patients survived; two made
remarkable recoveries, including the patient who needed the
vasoconstrictor infusion.
Conclusions Before instituting ICP monitoring, it was difficult to
determine the most appropriate therapy for severe IAE and
survivors usually had significant neurological sequelae. (1) The
control of CPP in patients with IAE is just as important as it is in the
management of patients with severe head injuries. (2) Based on
the ICP, the CT and MRI scans, IAE could be divided into two
groups. (3) One type of IAE seen in Japan may be related to the
HSES described in Europe.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
P318 Antithrombotic therapy in an experimental model of acute ischemic stroke in rabbits
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Background A wide variety of drugs are currently being tested for
the management of acute ischemic stroke. Glycoprotein IIb/IIIa
inhibitors and low molecular weight heparins show great
therapeutic potential in the management of acute ischemic stroke.
This trial tested the effects of enoxaparin, tirofiban and the
combination of both over infarct volume, short-term clinical
outcome, and the risk of intracerebral hemorrhage (ICH) in an
animal experimental model.
Methods An autologous fibrin-rich clot was introduced in the
common carotid artery. Two hours after embolization, placebo,
enoxaparin, tirofiban, or enoxaparin/tirofiban was infused
intravenously over 30 min. The neurologic deficit was evaluated
using a neuroscore 24 and 48 hours after the stroke. The
incidences of ICH and infarct volume were evaluated through
histologic analysis.
Results The infarct volume was larger in the placebo group than in
the enoxaparin, tirofiban and enoxaparin/tirofiban groups. The
neuroscore at 24 and 48 hours was higher for the group receiving
both drugs simultaneously. No ICH was present in any of the
groups (Table 1).
Conclusion It is probable that besides the anticoagulant and
antiaggregant effects of enoxaparin and tirofiban, other intrinsic
effects of each drug have an impact on the infarct’s volume.
Combining both drugs resulted in a synergic effect, probably due
to prevention of reperfusion damage. A slight improvement of the
short-term clinical outcome could be seen with the drugs, meaning
that with less tissue damage, better long-term clinical improvement
is expected. In this trial, none of the drugs increased the risk of
ICH. Further investigation must be done to define the right
therapeutic window of opportunity for both of these agents.
Table 1
Infarct volume  Neuroscore at  Neuroscore at 
Group Dose n (mm3) 24 hours 48 hours ICH (%)
Placebo – 9 11.62 11.7/13 11/13 0
Enoxaparin 1.5 mg/kg 6 7.97 11.83/13 12.33/13 0
Tirofiban 0.4 µg/kg 7 2.8 12.43/13 12.43/13 0
Enoxaparin/tirofiban 1.5 mg/0.4 µg/kg 5 1.33 12.75/13 12.75/13 0
P319 Role of thiopentone infusion for management of intractable status epilepicus in pediatric patients
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Introduction Intractable status epilepticus not responding to
conventional pharmacotherapy is a medical emergency. Deeper
suppression of cortical activity, documented electrocerebral
silence and titrable length of time during which such
electrocerebral silence can be maintained all make thiopentone the
ideal drug for initial management of status epilepticus [1,2]. A long-
lasting anti-epileptic drug regimen can be established during
thiopentone-induced burst suppression, which can then be
tapered and discontinued with minimal chances of recurrence.
Methods Twenty-one pediatric patients suffering from idiopathic
generalized tonic clonic disorder with age of onset of
12 months–2 years were included in the study. All patients were
admitted to the pediatric ICU after initial management in the
emergency room. Rapid sequence intubation with cricoid pressure
was done with an induction dose of 4 mg/kg thiopentone
intravenously (IV) and 1.5 mg/kg succinylcholine IV. Additional
boluses of 4 mg/kg thiopentone were administered at 5–30 min
intervals until complete areflexia was achieved, while a continuous
intravenous thiopentone infusion (0.5–4 mg/kg/hour) was
maintained and titrated to obtain electroencephalogram (EEG)
burst suppression. Continuous single channel processed EEGs
using a cerebral function analyzing monitor and an intermittent
multichannel electroencephalogram (EEG) were done. After
control of clinical and electroencephalographic seizure activity,
patients were started on phenytoin and phenobarbitone.
Thiopentone infusion was progressively tapered over 24 hours and
finally discontinued once therapeutic serum levels were achieved
for these anti-epileptic medications. Statistical values were
obtained from 2 × 2 tables of outcome versus EEG suppression
employing Fisher’s exact test with significance quantified as
P < 0.05.
Results Out of the 21 patients, 16 showed burst suppression and
five showed a ‘flat’ record. Two patients in the burst suppression
category showed recurrence of seizure activity after being
controlled initially, and none in the flat one. In these two patients,
EEG seizures recurred earlier than clinical seizures, which were
rapidly controlled with increasing the rate of thiopentone infusion.
More sustained control of seizure activity was achieved by adding
valproic acid to the anti-epileptic regimen in these two patients.
Discussion We conclude that, tightly controlled by serum levels,
carefully monitored with EEG for therapeutic efficiency, initiating
and tapering of thiopentone infusion in the ICU setting with
mechanical ventilation and hemodynamic monitoring will allow the
physician to establish therapeutic serum levels of conventional anti-
epileptic agents, to reduce the relapse rate, and to avoid themortality and long-term morbidity associated with this life-
threatening medical emergency.
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P320 Influence of dobutamine and norepinephrine and cerebral blood flow: preliminary data
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Background Severe head trauma patients are often deeply sedated
and this can cause a myocardial depression with hypotension and
low cardiac output. Hypotension is very dangerous, particularly in
patients with cerebral oedema and high intracranial pressure.
Dobutamine and/or norepinephrine are usually given to restore
myocardial performance and increase blood pressure and,
consequently, cerebral perfusion pressure (PPC). The effects of
these two drugs on the cerebral blood flow (CBF) are unknown.
The aim of this study is to measure CBF and central hemodynamics
in a group of patients with severe head trauma (Glasgow Coma
Scale <8), first using dobutamine and then norepinephrine.
Methods  Five patients have been studied. The following
parameters were monitored: intracranial pressure, jugular oxygen
saturation (SjO2), mean arterial pressure, central hemodynamic
parameters (cardiac index, central venous pressure, systemic
vascular resistances, intrathoracic blood volume, extravascular lung
water) and CBF. The CBF was measured with the TCDI technique
(COLD-system; Germany) [1]. Patients had two fiberoptic
catheters provided with a thermistor: the first inserted in the
femoral artery and the second in the bulb of the right jugular vein.
First patients had a dobutamine infusion (t1) to reach PPC
>70 mmHg (mean dosage 6.7 µg/kg/min), and then, after central
hemodynamic and CBF measurements, dobutamine was changed
with norepinephrine (0.12 µg/kg/min) (t2), trying to reach the same
PPC achieved with dobutamine. Finally, measurements were
performed with simultaneous infusion of dobutamine and
norepinephrine (dobutamine 4.2 µg/kg/min and norepinephrine
0.05 µg/kg/min) (t3), always achieving the same PPC as t1.
Results  The CBF increased significantly with norepinephrine
(median value 47.7 ml/100 g vs 72 ml/100 g; P < 0.05), but not
with the association dobutamine-norepinephrine (median value
52.5 ml/100 g). No significantly changes were observed in central
hemodynamic parameters.
Conclusions From these preliminary data it seems that dobutamine
causes a decrease of CBF compared with norepinephrine, with no
changes in central hemodynamic parameters and PPC. The
physiopathology of these results remains unknown.
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Introduction In Poland, in 2002, the number of organ donors per
one million inhabitants was 12.68, and was 8.9% higher than in
2001 (11.64/million). But still many potential organ donors are
missed. The objective of this study was to identify the major causes
of missed donors in a university hospital (600 beds) with a busy
neurosurgery ward.
Methods The Barlicki University Hospital, with an eight-bed ICU, is
located in the second biggest city in Poland, with one million
population. As the second in the city the transplantology centre
started in 2000. A retrospective audit of ICU documentation from
2000 to 2003 of patients with declared brain steam death was
conducted. After collecting the information, a computerised Excel
database was created.
Results The mean age of potential organ donors was 44.1
(SD 12.2) years. The main cause of death is cerebrovascular
accident (62.1–77.8%), second is head injury (14.8–34.5%),
and third is brain hypoxia after cardiac arrest (3.4–14.3%). The
number of actual donors increased (55.2–74.1%) and relative
refusal decreased (54.5–18.5%). The number of medical
contrindications for organ donation is low (3.6–17.2% of
potential donors). Only in 2002 five ICU patients had the clinical
symptoms of brain steam death complicated by cardiovascular
failure and it was impossible to complete the required by law
tests. Over 3 years, only one potential organ donor was
transferred from another hospital to our centre for organ
donation.
Discussion The number of potential organ donors per million of
population in Poland varies significantly from 0.5 to 34.1 (mean
12.68) depending on the region. The number of 27–29 potential
organ donors per year in our hospital is satisfactory but it can be
increased by involvement of patients with complicated brain steam
death. The number of relative refusals in Poland decreased from
10.4% in 2001 to 7.6% in 2002. In our centre the decrease is
more defined: from 54.5% in 2000 to 18.5% in 2003. This may be
related to growing support of transplantology in society. From the
beginning of transplantation in our centre we did not record refusal
of the potential donor (given before death).
Conclusions Changes in the Transplant Law allowing for organ
donation in cases of cardiovascular failure or cardiac arrest may
increase furthermore the number of organ donors. A discussion of
whether the relatives should be asked for consent is required.
There are still many small hospitals that do not cooperate with
transplant centres. The involvement of this hospitals in an organ
donation program is the major task for the coming years.
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Background In the past, many casualty patients needing ICU care
were being refused due to nonavailability of beds. Therefore a five-
bedded EICU was introduced, adjoining the Accident and
Emergency Department, to offer emergency treatment for a limited
period of 24 hours.
Aims To study the utility of EICU and the effect of change in its
admission policy.
Methods EICU patients admitted over a 20-month period were
analysed retrospectively. This was divided into: Phase I from July
2001 to October 2002 (16 months), during which period we
accepted patients transferred in from other nursing homes as well,
and Phase II from August 2003 to November 2003 (4 months),
when we accepted only emergency cases coming directly to our
casualty. Eight diagnostic categories were formulated as follows:
infection, trauma, cardiac, central nervous system (CNS),
respiratory, gastrointestinal, renal emergencies and others. Various
parameters such as inotropic requirement, procedures performed
and their final outcome were studied.
Results In Phase I, we had a total of 1322 EICU patients, of whom
117 (9%) required circulatory support in the form of inotropes, 74
(6%) required ventilatory support and 118 (9%) required invasive
monitoring. Two intra-aortic balloon pumps (IABPs) were inserted
and no haemodialysis was done. There were 168 recent myocardial
infarction (MI) patients, of whom 34 (20%) were thrombolysed.
Diagnostic categories were as follows: infections 82 (6%), trauma
73 (6%), cardiac conditions: MI 168 (13%) and non-MI 473 (36%),
respiratory 142 (11%), CNS 178 (13%), gastrointestinal 139
(10%), renal 42 (3%), and others 25 (2%). Of all these patients,
698 (53%) patients were transferred to the ICU, 467 (35%) to the
rooms, 98 (7.5%) discharged and 59 (4.5%) expired. On the other
hand, Phase II had 301 patients, of whom 43 (14%) required
circulatory support, 27 (9%) required ventilatory support and 85
(20%) required invasive monitoring. Two IABPs were inserted and
four patients were haemodialysed. Out of 31 recent MI patients, 16
(51%) were thrombolysed. Diagnostic categories were: infections
34 (12%), trauma 24 (8%), cardiac conditions: MI 31 (10%) and
non-MI 91 (30.4%), respiratory 31 (10%), CNS 40 (13%),
gastrointestinal 33 (11%), renal 15 (5%), and others two (0.6%). Of
all these patients, 153 (51%) were transferred to the ICU, 103
(33%) to the rooms, 45 (15%) discharged and three (1%) expired.
Conclusion In our study, we noted an increasing trend in the
admission of more critical patients in Phase II as compared with
Phase I, as shown by the increasing requirement for circulatory and
ventilatory support and invasive monitoring techniques. Thus, the
EICU has been helpful in providing acute emergency treatment to
patients seeking it and helped stabilise them.
P323 Treatment on a high-dependency unit and subsequent outcome following intensive care admission
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The APACHE II-derived standardised mortality ratio (SMR) is widely
used as a measure of quality of care. Treatment and resuscitation of
a patient prior to intensive care unit (ICU) admission may reduce a
patient’s APACHE II score without necessarily reducing the risk of
death. We investigated whether treatment on a high-dependency
unit (HDU) immediately prior to admission to an ICU in a university
teaching hospital influences (a) outcome in the HDU treatment
group and (b) the overall SMR of an ICU.
Methods A retrospective study of all patients admitted to an adult
general ICU eligible for APACHE II predicted mortality from 1996
to 2002. The place of care immediately prior to intensive care
admission was identified. The APACHE II-derived SMR, risk ratio
and confidence intervals were calculated for patients with prior
treatment on the HDU and for all other ICU admissions (controls).
In addition, because SMR was not constant across all strata of
predicted mortality, patients were stratified by APACHE II-
predicted mortality. An estimated odds ratio and the
Mantel–Haenzsel chi-squared test were used to compare hospital
mortality for each group.
Results A total of 2045 admissions with eligible APACHE II mortality
prediction were studied. The overall hospital mortality was 720
(35.2%). Two hundred (9.7%) admissions received prior treatment
on the HDU with a mortality rate of 44.5%. The SMRs of the HDU
and of the control group were 1.64 and 1.45, respectively. Overall,
the risk ratio of the APACHE II SMR between groups was not
significant (risk ratio [confidence interval] 1.13 [0.84–1.52]). The
estimated odds ratio for hospital mortality in the HDU group was not
significant (odds ratio [confidence interval] 1.36 [0.99–1.88]).
Conclusions  Treatment on the HDU immediately prior to ICU
admission did not appear to influence the SMR in the HDU group
or overall. We could not find evidence that the APACHE II-
predicted mortality was less reliable in patients treated in the HDU
immediately prior to ICU admission.
P324 Development of a tool to determining the number of medium care beds required for a large surgical ICU
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Rationale The minimal nurse to patient ratio for intensive care units
(ICU) was recently set to 1:2. For medium care units (MCU) this
minimal ratio is 1:4. The Therapeutic Intervention Scoring System
(TISS-28) has been used to assess nurse workload. According toReis-Miranda, one nurse can handle 46 TISS-28 points and a
TISS-28 <20 has been suggested to qualify as medium care. In
order to rationalize the use of intensive care resources in our 56-bed
surgical ICU, which has a 1:2 nurse to patient ratio, we developed a
tool for determining the required number of medium care beds.
Comparison with a 11-bed MCU, which has a 1:3 ratio, was made.
Methods A prospective observational study was designed in
which the attending nurses scored TISS on a daily basis. In
addition, ICU nurses and the attending physicians daily gave an
opinion on whether or not the patient could have been taken care
of in a MCU. Physicians were blinded for TISS scores. The label
medium care was given when both nurses and physicians agreed
on this issue. Daily TISS scores in the ICU were related to the
subjective opinion of nurses and physicians. The ethical committee
approved the study protocol.
Results All patients, except those with a burn injury, admitted to
the ICU and to the MCU during an episode of 4 months were
included, which provided 6077 patient-days in the ICU and
875 patient-days in the MCU for analysis. In the ICU the median
(P25–P75) TISS was 34 (28–40), vs 27 (22–32) in the MCU
(P < 0.0001). In the ICU, but not in the MCU, the median TISS was
significantly higher during week days than during weekends
(35 [29–41] vs 32 [28–38], respectively; P < 0.0001). Taking
actual nurse staffing into account, ICU nurses on average handled
70 TISS points and MCU nurses 81 TISS points. In the ICU, 11%
of patient-days were considered medium care by both physicians
and nurses, which translated into up to five medium care beds
within 56 ICU beds. Patient-day-labeled medium care scored
26 (23–29) for TISS, as compared with 35 (30–41) for intensive
care (P < 0.0001). A receiver–operator characteristic curve
revealed an area under the curve of 84.3% and identified a TISS of
29 as the best cutoff for medium care. Using this definition, 25% of
all ICU and 57% of all MCU patient-days would be labeled medium
care. However, this cutoff yields 19% false-positives. Using a
cutoff of 20 TISS points, only 3% of ICU patient-days and 15% of
MCU patient-days would qualify.
Conclusion Our study provided a nurse–physician consensus-
based definition of medium care, which equalled a median TISS of
26, a value approaching that of a MCU in our hospital setting.
Using such a quantitative definition of medium care allows more
rational allocation of nursing staff.
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Introduction Mortality in the UK is known to be higher in winter
than in nonwinter, but the comparative importance of variation in
case mix and increased pressure on hospitals is not clear. We
explored this issue using data from the national audit of critical
care admissions, the ICNARC Case Mix Programme.
Methods Using data from 113,389 admissions to 115 adult,
general critical care units in England, Wales and Northern Ireland
from 1995 to 2000, we investigated whether hospital mortality
following admission to critical care was higher in winter (defined as
the first working day in January–31 January) than in nonwinter
(March–November inclusive) and explored the causes of any
observed differences in terms of the case mix of admissions and
the workload of the units.
Results Crude hospital mortality was higher in winter than in
nonwinter (odds ratio [OR] 1.18, 95% confidence interval [CI]
1.11–1.25). After adjusting for case mix using the APACHE II
mortality probability, this effect was reduced but still significant
(OR 1.11, 95% CI 1.04–1.18). When additional factors reflecting
case mix and workload were introduced into the model, the overall
effect of winter was no longer significant (P = 0.08). Factors
reflecting both the case mix of the individual patient and of the
patients in surrounding beds were found to be significantly
associated with outcome. After adjustment for other factors, the
occupancy of the unit (proportion of beds occupied) was not
significantly associated with mortality.
Conclusions The excess winter mortality in UK critical care units
can be explained by the variation in the case mix of admissions.
Unit occupancy was not associated with mortality.
P326 Patient outcome after reorganization of a medical intensive care unit
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Critical Care 2004, 8(Suppl 1):P326 (DOI 10.1186/cc2793)
Introduction The outcome of patients admitted to the intensive
care unit (ICU) may be related to ICU structure and care
processes. This retrospective study aims to assess the impact of
an increase in ICU bed capacity on patient outcome.
Methods We identified 2524 patients admitted to a medical
ICU between 8 December 2001 and 14 July 2003. The ICU
initially had 15 beds (Period 1) and was staffed by a consultant,
three fellows and eight residents. On 7 August 2002, the bed
capacity expanded to 18 beds (Period 2) and on 18 December
2002 to 24 beds (Period 3). Starting 1 April 2002, a consultant
and a fellow joined the staff. We collected demographics,
admission source and diagnosis, observed ICU mortality and
length of stay (LOS), observed hospital mortality and LOS, ICU
readmission, first ICU day APACHE III score and predicted
mortality rates. We calculated the predicted ICU LOS of each
patient using a linear regression model customized for our
patient population. Excess ICU LOS was defined as the
difference between the observed and predicted ICU LOS. The
hospital mortality rate was adjusted for severity of illness.
P < 0.05 was considered significant.
Results The observed ICU LOS was shorter (Table 1) in Period 3
compared with Period 2 (P = 0.017). The excess ICU LOS wasdifferent between Periods 1 and 2 (P = 0.019), and Periods 2
and 3 (P = 0.028).
Conclusions Provided adequate physician staffing levels are
maintained, an increase in ICU bed capacity is not associated with
worse clinical outcomes in critically ill patients. This may have
implications for intensivists and policy-makers.
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Table 1
Period 1 Period 2 Period 3
(n = 852) (n = 581) (n = 1091) P value
Age (years) 60.6 63.9 62.6 0.003
APACHE III score 59.3 61 59.3 0.619
Predicted hospital mortality (%) 21.5 21.8 20.5 0.592
Observed hospital mortality (%) 19.1 21.7 18.2 0.232
Median ICU LOS (days) 1.6 1.7 1.4 0.037
Excess ICU LOS (days) –0.16 0.01 –0.14 0.04
P327 Can we identify futility of care in the sickest critically ill patients on the third ICU day?
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Introduction Various models are used to predict mortality of
patients admitted to the intensive care unit (ICU) based on the first
ICU day findings. Some of these models have developed daily
scoring systems for the subsequent ICU days. There is no
consensus regarding the definition of futility and there are no
reliable ways of identifying patients for whom ICU care is futile. The
purpose of this retrospective study was to determine whether we
can identify factors associated with futility in the sickest patients
admitted to the ICU. We hypothesized that any increase in the
acute physiology score (APS) from the first ICU day to the third
ICU day would identify very sick patients with futile care.
Methods We defined the sickest critically ill patients as those
with a first day APACHE III predicted mortality rate of 80% or
higher. Among 43,605 ICU admissions entered in the APACHE III
database from 1994 to 2002, 15,512 stayed in the ICU for 3 or
more days and 748 (1.7%) had a first day predicted mortality rate
of 80% or higher. Only 308 of the 748 patients (41%) survived
3 days in the ICU. Excluding six patients who did not authorize
their medical records to be reviewed for research, 302 admissions
were included in the study. Demographics, first and third day
APSs and probability of hospital death, and date of death were
obtained.
Results The patients were predominantly (92%) Caucasians; 54%
were male. The first and third ICU day mean APSs were 106.8 and
70.5, respectively, and predicted mortality rates were 87.8% and
86.5%, respectively. The observed hospital mortality rate was
61.3%. There was an increase in APS on the third ICU day,
compared with the first ICU day, in 34 patients (11.3%). Only two
of the 34 patients (6%) with increased APS survived to hospital
discharge, compared with 115 of 268 (43%) without increase
(P < 0.0001). Of the two patients who survived to hospital
discharge, one died within 24 hours of discharge and the second
one, who was admitted to the ICU for multiple trauma, died 3 years
after hospital discharge.
Conclusion An increase in the APS on the third ICU day of the
sickest patients identifies a group of patients whose short-term and
long-term prognoses are dismal.
P328 Base excess and lactate as predictors of mortality in medical ICU patients
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Introduction Base excess (BE) and lactate (LAC) have been used
to monitor ICU patients. Each results from different
pathophysiological derangements in perfusion, inflammation and
renal function. The individual significance of BE or LAC to predict
the outcome of the critically ill patients is still uncertain and was the
focus of this retrospective study.
Methods We retrieved 333 patients from our prospective collected
database from January to December 2000. Age, diagnosis,
APACHE II score, BE and LAC at entrance and after 24 hours of
admission were recorded. Univariate and multivariate analyses were
performed, the former being based on a matrix of collinearity
(Pearson coefficient ≥0.4 denotes collinearity) and on the results of
the univariate analysis. A receiver–operator characteristic (ROC)
curve was built to identify the best predictive value for mortality.
Results The age was 51 ± 18 years, APACHE II was 21 ± 1, BE
and LAC at admission were –6.0 ± 7.6 mmol/l and
4.9 ± 9.7 mmol/l, respectively, and the BE and LAC after 24 hours
were –5.5 ± 6.2 mmol/l and 5 ± 9.6 mmol/l, respectively. The
variations of BE and LAC were calculated as the 24 hours value
minus the admission value, and resulted in 0.4 ± 6.6 and
0.03 ± 5.6 mmol/l, respectively. The univariate analysis showed
mortality correlation to the APACHE II score (odds ratio [OR]
1.114 [1.081–1.148]), BE at entrance (OR 0.995 [0.991–0.998])
and at 24 hours (OR 0.989 [0.985–0.993]), and LAC at entrance(OR 1.000 [1.000–1.001]) and at 24 hours (OR 1.000
[1.000–1.001]). The multivariate analysis was performed with
APACHE II (OR 1.099 [1.064–1.135]), BE after 24 hours (OR
0.994 [0.990–0.999]) and LAC at entrance (OR 1.000
[1.000–1.001]). In the next step APACHE II was excluded from the
analysis due to the collinearity with BE after 24 hours and to
individualize the value of LAC and BE as a death predictor, and the
final result was BE after 24 hours (OR 0.990 [0.986–0.994],
P < 0.001) and LAC (OR 1.000 [1.000–1.001], P = 0.057). The
ROC curve resulted in a area under the curve of 0.58 to LAC at
admission and of 0.65 to BE after 24 hours, with the value of
–4 mmol/l showing a sensitivity of 70% and s specificity of 50% to
predict death.
Conclusions Lower values of BE and higher values of LAC are
associated with poor prognosis in ICU patients. In a comparative
analysis of these two variables, BE measured after 24 hours of
admission has the best discriminatory power to predict outcome.
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Aim The Paediatric Index of Mortality (PIM) is the most widely used
mortality-risk score in UK paediatric intensive care units (PICU). A
recalibrated version, PIM 2, has recently been published. Although
released in 2003, PIM 2 was derived from data collected between
1998 and 1999. We aimed to assess temporal changes in
performance of both of these scores. Specifically, we hypothesised
that the 6-year period between commencement of data collection
(1998) and publication (2003) of the revised PIM 2 score may
have allowed for significant decalibration.
Methods A prospective data collection from a single, 20-bed
tertiary PICU over 5 years (1999–2003). The standardised
mortality ratio (SMR) was calculated using the standard formula,
discrimination assessed via the area under the receiver–operating
characteristic curve (ROC), and calibration using the Hosmer–
Lemeshow goodness of fit test.
Results Scores were calculated for 4183 patient episodes
(average 800–900 admissions/year). There was no significant
temporal variation in either case mix (cardiac surgery 27–31%) or
disease severity (data not shown). Both scores discriminated well,
consistently yielding an area under the ROC curve >0.75 (Fig. 1
top). Not surprisingly, PIM demonstrated a loss of calibration
(Hosmer–Lemeshow  χ2 > 15.5,  P > 0.05) from 2000 onwards.
PIM 2 also showed a temporal trend towards decalibration that
became apparent by 2003. This trend was mirrored by a
progressive reduction in SMR (Fig. 1 bottom), such that the upper
confidence limit for the PIM 2 SMR was less than 1.00 by 2002.
Interestingly, the SMR derived from either score decreased at a
similar rate, 0.07–0.08 per year.
Conclusions Both scores continue to discriminate well between
survival and nonsurvival. As expected, PIM 2 is better calibrated
than PIM, although both appear to be decalibrating at a similar rate.
Because PIM 2 reflects the 1998–1999 standard of care, many
PICUs will currently exhibit fewer deaths than expected
(SMR < 1.00). More frequent calibration appears necessary.
Figure 1
P330 A systematic review of intensive care length of stay indicators
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A prolonged ICU length of stay (LOS) has been associated with
many medical diagnoses and conditions but it is difficult to predict
on admission to the ICU. Prolonged ICU LOS can adversely affect
patient outcomes by increasing the risk of complications, and
possibly mortality. Identification of such indicators may help to
improve ICU resource utilization (e.g. bed triage, ICU staffing).
Objective To systematically review the literature to determine
common ‘early’ predictors of ICU LOS for adult patients.
Methods A computerized search of MEDLINE, EMBASE and the
Cochrane Database was undertaken from 1966–October 2003 to
identify trials evaluating predictors of ICU LOS. Search termsincluded ‘ICU’, ‘critical care’, ‘LOS’, ‘predictors’, ‘indicators’, and
‘duration of stay’. Bibliographies of all articles retrieved were searched
for relevant articles not identified by the computerized search.
Results Five studies were identified that were published in full,
with a combined total of 16,107 patients. The definition of
prolonged LOS varied with the population evaluated (e.g.
>14 days general ICU, >5 days CVICU) and thus prevented meta-
analyses. Approximately 10% of patients had prolonged LOS as
defined by the study. Universal positive early indicators were:
emergent surgery or admission, trauma, or need for mechanical
ventilation in <24 hours. Abbreviated LOS was associated with
coma, DNR orders, and nontrauma surgical reasons for admission.
APACHE created as a predictive model for mortality consistently
did not predict LOS.
Conclusion Patients with prolonged stay form a small percentage
of ICU patients. There are few early predictors that are universally
significant or important when determining prolonged ICU LOS.
Many factors appear to be specific to subgroups and thus may
limit broad applicability of general ICU scoring systems to
specialized populations.
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Objectives Little is known about the outcome in mechanically
ventilated patients with predominantly cardiovascular and
pulmonary disorders. The multicenter BEAT Registry assessed the
outcome of all mechanically ventilated patients treated in
45 German coronary intensive care units (CICU) (33 community
and 12 university hospitals).
Methods All mechanically ventilated patients admitted to the
participating CICUs and all patients intubated and ventilated
during the CICU were included in the registry between September
2001 and June 2002. Causes for mechanical ventilation (MV),
clinical course and hospital mortality (HM) were assessed for all
patients. Noninvasive ventilated patients were excluded.
Results A total of 2372 mechanically ventilated patients were
included (mean age 68 years, 62% male, 42% cardiovascular,
22% pulmonary, 8% neurologic and 28% other reasons for MV), in
74% intubation (ITN) and MV was performed emergently. On the
first day 44% of the patients were ventilated with the bilevel
positive airway pressure modus and 39% with the continuous
positive pressure ventilation modus. Duration of MV was 2
(1–7) days, and length of CICU stay 20.5 (13–32) days. Overall,
47.3% patients died. Figure 1 shows the distribution of HM in
21 CICUs including >50 patients in the registry (range HM
33–70%). Emergent ITN, cardiopulmonary resuscitation, ITN in
hospital, shock, sepsis, pneumonia, ventricular tachycardia/
fibrillation and sudden cardiac death were associated with HM in
an univariate analysis.
Limitations Admission severity of illness was not assessed as well
as organ dysfunction during the CICU stay and causes of death.
Conclusion Mortality is high in mechanically ventilated patients
with cardiovascular and pulmonary disorders. The BEAT registry
provides important data for benchmarking and is a first step
towards quality improvement in this subset of critically ill patients
with high mortality and morbidity.
Figure 1
P332 Outcome and prognostic factors in critically ill immunocompromised patients admitted to the ICU
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Introduction Intensive care physicians are facing a growing number
of immunocompromised patients. The evidence on how
immunosuppression impacts on ICU outcome is poor. We
conducted a retrospective cohort study to compare immuno-
compromised patients with immunocompetent patients with regard
to their ICU outcome and, furthermore, to identify prognostic factors.
Methods Over a period of 36 months, 656 patients were referred
to a medical eight-bed ICU of a university hospital. Of these, 190
were categorized as immunocompromised. Immunosuppression
was defined as an absolute neutrophil count <1000/µl (n = 66) at
admission, or the administration of immunosuppressive drugs (IS)
prior to admission (n = 124). IS used usually were corticosteroids
and cyclosporine, more rarely FK 506, cyclophosphamide and
methotrexate. We recorded demographic data, reason for
admission, APACHE III score, occurrence of septic shock and the
need and duration of mechanical ventilation (MV). The primary
endpoint of the study was ICU survival. The groups were
compared by Fisher’s exact test for categorical variables and by
the Mann–Whitney U test for continuous variables (univariateanalysis). Using a multivariate logistic regression model, we
controlled for several risk factors.
Results The overall mortality was 33%. Immunocompromised
patients had a significantly higher mortality than immunocompetent
patients (45% vs 29%, P < 0.001). This difference was even more
pronounced if patients required MV (64% vs 34%, P < 0.001).
Patients with neutropenia tended to have a higher mortality than
patients with IS therapy, but this difference failed to show
statistical significance. The presence of septic shock at any time
during ICU treatment and the associated mortality from septic
shock did not significantly differ between immunocompromised
and immunocompetent patients. In multivariate analysis, lower
APACHE III scores at admission and admission for postoperative
care were independently associated with reduced ICU mortality,
whereas immunosuppression and MV were independently
associated with unfavourable outcome. Immunosuppression
remained to be associated with higher ICU mortality if the
statistical model was adjusted for APACHE III score, postoperative
care and mechanical ventilation.
Conclusion Immunosuppression is an independent risk factor of
death in the ICU. In order to develop preventive strategies, controlled
studies are needed to identify further risk factors in these patients.
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Several studies have shown that increased lactate correlates with
outcome better than oxygen-derived variables. Despite this, lactate
was not included in the APACHE II score because it was
infrequently recorded.
This study aims to compare the ability of admission lactate, lactate
at 24 hours and the APACHE II risk of death (ROD) score to
discriminate between intensive care survivors and nonsurvivors.
We also combined lactate at 24 hours with the APACHE ROD
score to obtain the best discrimination values.
Two hundred and forty consecutive admissions to a nine-bed
general intensive care unit (ITU) were prospectively investigated.
Lactate values at admission and lactate at 24 hours were recorded.
Each patient had the APACHE II ROD score calculated from data
submitted to the Intensive Care National Audit and Research
Centre. The ITU and hospital mortalities were analysed. The area
under the receiver–operator characteristic (ROC) curve was
calculated for each measure or combination of measures to test
discrimination between survivors and nonsurvivors.
The overall intensive care and hospital mortalities were 29% and
39%, respectively. Both lactate on admission and lactate at
24 hours were significantly and strongly associated with intensive
care mortality (P = 0.000 for both). Areas under the ROC curves
show that both lactate measures discriminated between survivors
and nonsurvivors (Table 1). The best discrimination is obtained by
a combination of lactate at 24 hours and APACHE probability
(obtained from a logistic regression).
The 24 hour lactate values that give 50–75% mortalities are 1.5
and 3.6, respectively. Lactate at admission and at 24 hours are
significantly strongly associated with intensive care mortality.
Seventy-five per cent of patients with a lactate value of 3.6 at
24 hours will not survive.
Conclusions The 24 hour lactate discriminates as well as the
APACHE II ROD score between intensive care survivors and
nonsurvivors, and is quicker and easier to obtain. Combining
lactate into the APACHE II ROD score appears to improve the
discriminatory power of this outcome prediction model. These data
may help in discussions regarding patient prognoses on intensive
care. In view of the strong association and discrimination between
intensive care survivors and nonsurvivors and the widespread
clinical use of lactate measurements, inclusion of the 24 hour
lactate value should be included for future scoring systems.
Table 1
Test result variable Area under 95%
ROC curve CI
Lactate on admission 0.715 0.639–0.792
24 hour lactate 0.760 0.691–0.828
APACHE ROD + 24 hour lactate 0.837 0.770–0.898
CI, confidence interval.
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Aim The evaluation of the osmolar gap of incoming patients in the
ICU as a prognostic indicator of outcome.
Materials and methods The difference between measured and
calculated osmotic pressure (osmolar gap) was recorded in
72 patients admitted to two medical–surgical intensive care units
(ICU). The measurement took place immediately after their
admission in the ICU independent of the cause of admission. The
SAPS II and APACHE II scores were recorded as well as the ICU
outcome. Patients were separated retrospectively into two groups
on an outcome basis: A = Alive, B = Dead.
Results The results are presented in Table 1.
Conclusions The osmolar gap calculated during admission as well
as the measured osmolarity may be good indicators of the ICU
mortality. Although the calculated osmolarity does not seem to be a
reliable prognostic indicator in critically ill patients, it is used in thecalculation of the osmolar gap, which seems to be a better
prognostic indicator of the ICU mortality in comparison with the
calculated osmolarity. Patients with an osmolar gap >24 at their
admission in the ICU have 53% probability of death, while patients
with an osmolar gap <14 have 28% probability of death. An
osmolar gap of 35 mosm/l at admission is related with increased
probability of death by 1.33 times (odds ratio), according to our
preliminary results.
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Table 1
Group A Group B
n 38 34
Age (years) 48.1 ± 3.5* 58.3 ± 3.7*
Sex (male/female) 26/12 27/7
Measured osmolality (mosm/l) 312.1 ± 1.8* 335.7 ± 5.8*
Confidence interval 308.4–315.6 324.0–347.4
Calculated osmolality (mosm/l) 301.6 ± 1.9 300.9 ± 2.2
Confidence interval 297.8–305.4 296.4–305.4
Osmolar gap 11.4 ± 1.4* 34.8 ± 5.4*
Confidence interval 8.8–14.0 23.8–45.8
APACHE II score 21.7 ± 1.3* 25.8 ± 1.1*
SAPS II score 47.4 ± 2.6* 58.5 ± 2.7*
Days of stay in ICU 20.6 ± 3.2* 13.4 ± 2.7*
*Statistically important difference P < 0.05 between first and second
column.
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K Wood1, A Kersten1, W Linde-Zwirble2, D Angus1, M Danis3, G Clermont1
1University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA; 2HPM, Doylestown, Pennsylvania, USA; 3National Institutes of
Health, Washington, DC, USA
Critical Care 2004, 8(Suppl 1):P335 (DOI 10.1186/cc2802)
Introduction Prior studies suggest uninsured patients presenting
to the emergency department with acute asthma receive poor
quality of care. However, we do not know whether insurance status
affects resource use and outcome after hospital admission for
patients with status asthmaticus (SA).
Methods We examined all nonfederal hospital discharges in 1999
from six US states. We selected patients hospitalized with SA and
defined severe SA as SA with ICU admission. We excluded
Medicare patients and focused on working-age adults
(18–64 years), classifying insurance as commercial, Medicaid,
and uninsured. We assigned comorbidity using the Charlson–
Deyo index. We examined the association between insurance
status and mechanical ventilation (MV), hospital costs, and
hospital mortality.
Results Of the 8.2 million hospital discharges, 62,968 (0.8%) had
SA and 9742 had severe SA, of whom 4007 (41.1%) were
working-age adults (population incidence of 10.7/100,000).
Compared with commercially insured patients (n = 2299),
Medicaid (n = 1057) and uninsured (n = 651) patients had higher
MV rates (30.1% vs 39.1% and 40.1%, P < 0.001) Hospital length
of stay (LOS), ICU LOS, mortality and mean costs were 6.2, 8.6
and 5.1 days, 3.5, 4.4 and 2.6 days, 1.9, 4.2 and 1.8% and $8800,
$12,600, & $7400, respectively, for commercial, Medicaid and
uninsured patients. Adjusting for age, comorbidity, gender, and
race, Medicaid and uninsured patients were more likely to receive
MV than commercially insured patients (odds ratio:1.51 and 1.41,
P < 0.001 for each). Mortality was also higher, but this observation
was not significant (odds ratio: 1.17, P = 0.9 and odds ratio: 2.1,
P = 0.64). Uninsured patients also incurred lower adjusted hospital
costs (P < 0.001) and hospital LOS (P < 0.001).
Conclusion In comparison with patients managed under
commercial insurance, patients admitted to hospital under no
insurance or state-subsidized insurance appear sicker, as
evidenced by higher MV rates and worse mortality. Possible
reasons include a worse spectrum of disease in these populations,
delayed presentation to hospital during an acute attack, or
restricted admission policies.
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The Mortality in Emergency Department Sepsis (MEDS) score is a
previously derived, validated, and published clinical decision rule
for predicting 28-day inhospital mortality. It is based on the
following scoring system: underlying disease with expected
fatality <30 days or metastatic cancer (six points), tachypnea or
hypoxia (three points), septic shock (three points), platelets
<150,000 (three points), bands >5% (two points), age
>65 years (two points), lower respiratory infection (two points),
nursing home resident (two points), anion gap, and altered mental
status (two points). The points are added and a risk group
assigned.
Objective The objective of this study was to assess the ability of
the MEDS score to predict 1-year mortality.
Methods A prospective observational, cohort study of consecutive
emergency department (ED) patients seen at an urban university
hospital with 50,000 annual ED visits. The study period was1 February 2000–1 February 2001. All patients, aged 18 years or
older, at risk for infection as indicated by the ED physician ordering
a blood culture were included. The MEDS score divides patients
into very low risk (0–4 points), low risk (5–7 points), moderate risk
(8–12 points), high risk (13–15 points), and very high risk
(>15 points). The raw survival figures are reported with 95%
confidence intervals (CIs) and compared with each other using
Tukey’s Test for pair-wise comparisons.
Results Of 3926 patient visits eligible for the study, 3763 (96%)
were included. The overall 1-year mortality was 24% (95% CI:
22.7–25.4%) (904/3763). The 1-year mortalities for the groups
were: very low risk 8.6% (0.08–1.2%), low 23% (1.0–3.5%),
moderate 40% (5.8–10%), high 68% (11–24%), and very high
79% (37–66%), with all groups being statistically different from
each other by Tukey’s Test for pair-wise comparisons.
Conclusions The MEDS score is a good predictor of 1-year
mortality in patients presenting to the ED with sepsis. Independent
multicenter validation is needed prior to widespread application of
this rule to test its performance in other patient populations.
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This descriptive exploratory study had the objectives to
characterize the iatrogenic occurrences and to evaluate its impact
on clinical conditions of the patients and on the nursing workload
at the intensive care unit (ICU). Data were prospectively collected
during a 3-month period, in two general ICUs of a hospital in the
city of São Paulo, using a file card to record the occurrences.
Patient’s severity and nursing workload were evaluated,
respectively, by means of the Simplified Acute Physiology Score
(SAPS II) and the Therapeutic Intervention Scoring System-28
(TISS-28). The population of the study consisted of 212 patients,
of which 47 (22.0%) were victims of 80 iatrogenic occurrences
during their stay at the ICU. Among the victim patients, 57%
suffered one occurrence, 28.0% two occurrences and 15.0%
three or four occurrences. Regarding the type of event, 27.0%
were related to pressure ulcer, followed by 24.0% and 20.0%,
respectively, regarding handling of the orotracheal cannula and two
blood catheters. The others, occurred during administration of
medicaments (13.0%), care with probes (10.0%) drains (5.0%)
and handling of equipment (1.0%). Occurrences related to
substructure were not found. Regarding the impact of occurrences
on the patient’s severity and on the nursing workload, no
statistically significant difference was found in the mean between
the SAPS II and TISS-28 scores of victim and nonvictim patients of
occurrences, during admission to the ICU. When comparing
severity and nursing workload in victim patients, before and after
the event, a difference was observed only in the mean scores of
the TISS-28 (P < 0.001). Regarding this analysis with the different
types of occurrences, a statistically significant difference was
found both in the SAPS II (P < 0.042) and TISS-28 (P < 0.001)
scores in the occurrences regarding handling of the orotracheal
cannula. The results of this investigation reinforce the need for
investments to help qualify professionals to work with the critical
patients as a major measurement for safety nursing assistance and
quality in the ICU.
P338 Medication errors: comparison of electronic and hand-written prescribing in the ICU
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The most common stage of medication error was reported in one
study to be the prescribing stage, which accounted for 56% of
errors detected [1]. Electronic prescribing (EP) with decision
support has been shown to reduce the medication error rate [2],
but no studies could be found in critical care. This study compares
the impact of this change on the medication error rate before and
after the implementation of the GE Systems QS 5.6 clinical
information system (CIS), which does not have decision support.
During the study periods, all medication errors identified by the
ICU pharmacist were recorded. Errors were identified using a
published definition [3], except abbreviations of drug names were
not regarded as errors. ICU staff were unaware that the study was
taking place. The location was a 22-bed general ICU/HDU at a
teaching hospital. Data were collected in 2002 for two periods of
9 days in total before introduction and for four periods (17 days in
total) on weeks 2, 10, 25 and 37 after CIS introduction. The total
number of drugs prescribed was recorded.
There was a statistically significant reduction in the medication
error rate following the introduction of CIS. The error rate before
CIS was 6.7% (69 errors from 1036 prescriptions) and after CIS
introduction was 4.7% (115 errors out of 2429 prescriptions)
(χ2 = 5.34, one degree of freedom [df], P < 0.03). There was
variation of the error rate with EP over time (χ2 = 21.7, three df,
P < 0.001) as the staff got used to the new system and
prescribing systems were improved. There is also strong evidence
of a linear trend (χ2 = 11.9, one df, P < 0.001). Thus the error rate
appeared to reduce with time with EP.
Figure 1In conclusion, introduction of the CIS coincided with a reduction in
the overall medication error rate, with some suggestion of a
‘learning curve’.
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It is recognised that false alarms lead to habituation among clinical
staff and to distress for patients. The goal of our work is to reduce
the number of false alarms produced by a standard patient monitor
and to provide early warning of patient deterioration based on
multiple vital signs.
Two approaches have been used. In the first (‘signal merging’),
multiple signals are merged in order to produce a more robust
derived measure. For example, cardiac and respiratory information
are extracted from the electrocardiogram and photoplethysmo-
gram, and are combined to produce more robust estimates of heart
and respiration rates.
The second (‘signal fusion’) uses a combination of advanced signal
processing methods to ‘integrate’ multiple vital signs, to develop a
global representation of patient status. The hypothesis is that if a
monitoring system can identify periods of physiological instability
preceding clinically apparent adverse events, then early warning
may result in reduced monitoring alarms, prompt treatment and
improved outcome.
Over a 3-year period at the John Radcliffe hospital in Oxford, UK,
we collected noninvasive physiological data for over 24 hours in
150 ‘high-risk’ patients, including the continuous heart rate,
respiratory rate, oxygen saturation, temperature and intermittent
noninvasive blood pressure. The system was ‘trained’ to distinguish
periods of physiological stability from instability.
Two evaluation studies have taken place. The first assessed the
signal merging technology during simulated patient transport.
Results showed that signal merging gives a more precise estimate
of respiration rate than a standard transport monitor, suggesting
that signal merging may reduce the number of false alarms caused
by external movement. The second study assessed the alarms of a
standard patient monitor versus our signal fusion technology.
Numerous standard monitor alarms were recorded that did not
correspond to physiological events, often due to signal artefact or
nonclinical events such as patient movement, but typically these
did not trigger an alert from our signal fusion technology. Signal
fusion identified physiological events that included atrial fibrillation,
elevated blood pressure, extreme distress and oxygen
desaturation.
The conclusions are that signal merging and fusion techniques may
improve robustness, reduce false-positive alarms and potentially
provide early warning of adverse physiological events.
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Introduction Frequent exposure to stressful events in the ICU may
have been associated with increased prevalence of depression
and burnout. This study was planned to assess the burnout
syndrome and its relation with depression in nursing staff of the
ICU in Turkey.
Materials and methods Mixed, surgical and internal medicine
intensive care unit (ICU) nurses and non-ICU nurses (n = 178) who
have been working in a metropolitan university (UH) and in state
hospitals (SH) for at least 1 year enrolled to the study (UH mixed
ICU n = 21, UH surgical ICU n = 19, UH internal medicine ICU
n = 17, SH mixed ICU n = 18, SH surgical ICU n = 23, SH internal
medicine ICU n = 21, UH anaesthesia nurses n = 22, UH
operating room nurses n = 37). Anaesthesia and operating room
nurses, and non-ICU nurses, were considered as control groups as
they do not take part in the follow-up of the patients. Beck
depression (0–63), and the Maslach burnout inventory adapted for
a Turkish population were used to assess depression and burnout
respectively [1,2]. The latter has three subscales: emotional
exhaustion (0–36), depersonalisation (0–20) and personal
accomplishment (0–32). One-way ANOVA with Bonferroni’s post
hoc test and the chi-square test were used and P < 0.05 was
considered significant. Pearson correlation analysis was done to
investigate the ingroup correlation of Beck depression and
subscales of the Maslach burnout inventory. Values are expressed
as the mean and SD.
Results The demographic data were similar among groups. The
Beck depression scores of the nurses in the university hospital
(16.6 ± 9) were higher than that in the state hospitals (13.1 ± 8)
(P = 0.028). The Beck depression scores of the mixed ICU nurses
in the university hospital (19.8 ± 8) were higher then that in the
non-ICU nurses (12.8 ± 7.6) (P = 0.001). Depersonalisation
scores of surgical ICU nurses in the university hospital (7.8 ± 4)
were higher than those in the non-ICU nurses (5.6 ± 3.6)
(P = 0.03). Although a significant difference was not found among
the nurses working in different ICUs in terms of the Beck
depression inventory, mixed ICU nurses had considerable
depression (mixed ICU 17.4 ± 8, surgical ICU 13.6 ± 9, internal
medicine ICU 13.5 ± 8 or non-ICU group 12.8 ± 7.6) when
considering all ICU nurses together. Positive correlation was found
in all groups between the Beck depression score and emotional
exhaustion except in the control group (P < 0.01, r >v0.52).
Conclusion Nurses operating in the ICU, especially in the mixed
ICU, may have a tendency to depression. All ICU staff should beaware of depression and burnout possibilities, and their
consequences.
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Introduction In 2002, West and colleagues reported a direct and
strong association between the quality of human resource
practices and patient mortality in NHS hospitals — higher levels of
staff teamworking, training, development and appraisals were
associated with lower patient mortality. The objectives of this study
were to elicit teamwork and safety attitudes among staff in critical
care units and to investigate whether these attitudes were related
to case-mix-adjusted outcomes for patients.
Methods  The Safety Attitudes Questionnaire (SAQ) is a valid,
reliable questionnaire that elicits caregiver attitudes for six factors:
teamwork climate, safety climate, job satisfaction, working
conditions, stress recognition, and perceptions of management.
Staff received a sealed envelope containing a copy of the SAQ, a
cover letter, a pencil, and a FREEPOST (direct to ICNARC) return
envelope. Absolute confidentiality was maintained on
questionnaires with the sole identifiers being Site Code and job
category. Permission to link staff attitudes data to patient case mix
and outcome data was sought from the Director. The relationship
between patients’ mortality and staff attitudes was investigated in a
hierarchical logistic regression model after adjustment for case mix.
Results  A total of 106 units participated in the survey,
approximately 43% nationally. The mean number of staff was 69.8
(range 21–142). The staff response rate was 67.5%, ranging from
30.0% to 95.5% across the units. Of 4859 respondents, positive
attitudes were highest for safety climate (40.4%), teamwork
climate (35.0%), job satisfaction (31.9%) and working conditions
(22.3%), and lower for stress recognition and perceptions of
management, 12.1% and 9.7%, respectively. There was significant
variation for all six factors across units. Overall 14,064 (19.8%)
admissions died in the unit and 21,254 (29.9%) admissions died
before ultimate discharge from hospital. Ultimate hospital mortality
varied between 16.7% and 54.9% across units. Neither hospital
nor unit mortality were associated with the percentage of staff
positive within any domains of the SAQ either before or after
adjustment for case mix.
Discussion  Contrary to the results reported by West and
colleagues for NHS hospitals and by Wheelan and colleagues for
17 US intensive care units, despite a wide variation in staff
attitudes, negative attitudes were not associated with a poorer,
risk-adjusted patient outcome in critical care.
P342 The PIRO concept: prediction of bacteremia in patients admitted to the intensive care unit with infection
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Introduction Bacteremia in critically ill patients has a significant
attributable mortality. Routine use of blood cultures has been
questioned because of low yield and association with anemia.
Attempts to identify predictors of bacteremia in critically ill patients
have had variable success. The PIRO concept based on factors
related to predisposition (P), infection (I), response (R), and organ
dysfunction (O) has been introduced as a hypothesis-generating
model for research in sepsis.
Aim The aim of this study is to assess the association of PIRO-
related variables with the occurrence of bacteremia in patients
admitted to the intensive care unit (ICU) with infection.
Methods This retrospective, cohort study included 191 patients
admitted to three ICUs of a tertiary care medical center, with an
infection-related diagnosis between 1 July and 31 December
2002. Bacteremia was defined as the isolation of a bacterium in
one or more blood cultures. The P-related variables include
evidence of immunosuppression, dialysis-dependent renal failure,
nursing home residence, and performance status. The I-related
variables include site of infection and place of acquisition. The R-
related variables include heart rate, respiratory rate and
temperature. Sequential Organ failure Assessment (SOFA)
scores were calculated to quantify organ dysfunction. We used
Student’s t test, the Mann–Whitney U test, the chi-square test
and Fisher’s exact test for comparison between bacteremia and
nonbacteremia groups. To define which variables were
significantly and independently associated with bacteremia, we
performed logistic regression analysis including day 1 SOFA
score, temperature >38°C, heart rate, immunocompromised
status and site of infection (urinary 1, other 0). P < 0.05 was
considered significant.
Results The mean (SD) age of the patients was 64 (16) years and
92% were Caucasian. Bacteremia was documented in 44 (23%)
patients. In univariate analysis, only the SOFA score was
associated with the occurrence of bacteremia. The mean (SD)
SOFA score in the bacteremia group was 7.3 (4) vs 5.6 (3) in the
nonbacteremia group (P = 0.012). The day 1 SOFA score was
also found to be an independent predictor of bacteremia
(P = 0.0057) along with day 1 temperature >38°C (P = 0.016).
Conclusion The SOFA score, used as a measure of organ
dysfunction in the PIRO concept, may have a role in the prediction
of bacteremia in patients admitted to the intensive care unit with
infection.Critical Care    March 2004 Vol 8 Suppl 1 24th International Symposium on Intensive Care and Emergency Medicine
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Introduction Few studies have analyzed the prevalence of post-
traumatic stress disorder (PTSD) in survivors of medical intensive
care.
Patients and methods From June 1997 to December 1999 all
admissions (≥18 years) to our medical intensive care unit (ICU)
who were treated for at least 24 hours were eligible. On admission,
the pre-ICU functional status and subjective well-being were
assessed by interview [1]. Six months after admission survivors’
memory of the ICU stay was assessed (none, positive, negative). At
18-month follow-up a standardized interview at the patients home
was performed using the PTSD-10 Questions Inventory (PTSD-10)
[2], the 90-item Revised Symptom Checklist (SCL-90-R), the
Hamilton Anxiety Scale and Hamilton Depression Scale, the
57-item Giessen Subjective Complaints List and a 28-item quality
of life (QOL) scale.
Results A total of 444 patients were enrolled. Cumulative mortality
rates were 23% in the ICU, 33% in the hospital, 42% at 6-month
follow-up and 53% at 18-month follow-up. From the 209 survivors,
22% were lost to follow-up, 27% were unable to be interviewed
due to physical or cognitive reasons and 13% declined the
interview. The remaining 80 study patients had a mean age of
46 ± 12 (± SD) years; 69% were male, the mean ICU length of
stay was 12 ± 17 days, the mean APACHE II score after 24 hours
was 19 ± 9 and the mean SOFA total maximum score was
6.3 ± 4.7. According to PTSD-10 criteria 10 patients (12.5%) had
a diagnosis of PTSD. PTSD was more frequently diagnosed in
patients who had reported poor pre-ICU subjective well-being
compared with patients with good subjective well-being (8/41 vs
2/39 patients; 20% vs 5%; P = 0.05), in patients with multiple
organ dysfunction (MOD) compared with patients without MOD
(8/38 vs 2/42 patients; 21% vs 5%; P = 0.03), and in patients who
had negative or no memories of their ICU stay compared with
patients with positive memories (7/30 vs 3/50 patients; 23% vs
6%; P = 0.02). Patients with PTSD had significantly (P < 0.0001)
worse scores on the SCL-90-R global index of psychopathology
showed a significantly (P < 0.0001) higher degree of somatic and
psychic anxiety, major depression, bodily complaints and mental
exhaustion, and reported poorer self-perceived QOL.
Conclusion A small subgroup (12.5%) of our medical ICU
survivors developed PTSD. Subjective well-being before ICU
admission, MOD, and ICU memories were associated with PTSD
and related psychopathologic symptomatology. These criteria
could be used to identify survivors at risk for developing PTSD.
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Background Cost considerations may influence therapeutic
reasoning and decisions in the intensive care unit (ICU). To date
only very few data illuminating the association of costs and
consequences (i.e. outcomes) of critical care services are
available. In this study, the long-term outcome, health-related
quality of life (HRQL), and ICU and hospital costs of medical ICU
patients were assessed.
Methods Between October 1997 and February 1998 all
consecutive patients admitted to the medical ICU of a university
hospital were enrolled. The SAPS II, SOFA and TISS-28 scores,
and individual ICU and hospital costs were prospectively recorded.
Five years later, survival and HRQL were assessed using an
established methodology (Medical Outcome Short Form [SF-36]).
Effective costs per survivor (i.e. all costs divided by survivors
[ECPS]) for the index hospitalization, as well as quality-adjusted life
years (SF-36 fraction of an age-matched, apparently healthy
control × the years of survival [QALY]) were calculated.
Results Three-hundred and three patients mainly suffering from
cardiovascular and pulmonary diseases were enrolled. The mean
SAPS II score was 26 points, mean age was 62 years, 71% were
male, with a mean length of ICU stay of 3.7 days. Forty-four
patients (14.5%) died while in hospital. After 5 years 196 patients
(65%) were still alive, and 157 patients (80%) completed the
questionnaire. The majority of patients lived independently at home
(80%); only 11% were in need of care. Thirty-one patients (20%)
reported unpleasant memories with regard to the ICU stay. The
health status index of the sample was 79.4%, corresponding to
4 QUALY. The mean ECPS were €12.404 for 5 years and €2481
per life year saved, respectively. The mean costs per QUALY were
€3101. Increasing severity of illness (SAPS II quartiles) was
associated with higher ECPS and costs per QUALY (Table 1).
Conclusion A large proportion of patients survived >5 years and
reported a good HRQL. Considering the severity of illness and the
patients’ outcome, ECPS and costs per QALY were low compared
with other therapeutic approaches (e.g. beta-blocker
postmyocardial infarction, €20,000 per added life year).
Table 1
SAPS II Patients 5-year Costs per
points (n) ECPS (€) QALY (€)
0–19 53 8121 1785
20–23 44 9496 2208
24–30 36 14368 3158
>31 24 22966 5601Available online http://ccforum.com/supplements/8/S1
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Introduction Health-related quality of life (HR-QOL) is a relevant
measurement of intensive care unit (ICU) outcome. This study aims
to evaluate the HR-QOL in survivors of severe sepsis and septic
shock (sepsis group) compared with survivors without sepsis
(control group), using a specific questionnaire (QOL-SP),
developed by Fernandez.
Methods Six months after ICU discharge, survivors went to a
follow-up consultation and the QOL-SP was applied. The QOL-SP
comprises 15 items grouped in three subscales, which evaluate
Basic Physiologic Activities (BPA), Normal Daily Activities (NDA)
and Emotional State (ES), and enables the calculation of a global
index (QOL-SP Index). Patients from the sepsis group were
compared with those from the control group concerning
background variables (age, sex, gender, previous health state), ICU
variables (reason for admission, APACHE II score and length of
ICU stay) and QOL-SP variables. Patients younger than 18 years
old and those with an ICU stay ≤1 day were excluded. Patients
exhibiting nonsevere sepsis at or after ICU admission, and those
with severe sepsis/septic shock after ICU admission were also
excluded.
Results Between March 1997 and March 2001, a total of
1285 patients were admitted to the ICU, from which 697 were
included in the study. From these, 305(44%) were admitted for
severe sepsis/septic shock. Mortality in the sepsis group was 34%
and in the control group was 26%. One hundred and four patients
from the sepsis group and 133 patients from the control group
completed the QOL-SP questionnaire. There were no differences
in age and previous health state between both groups. Patients
from the sepsis group exhibit a significantly higher APACHE II
score and a significantly higher ICU stay. Sepsis survivors reported
significantly less problems in the BPA and NDA subscales;
furthermore, although not statistically significant, they exhibit a
better QOL-SP index than the control group (Table 1).
Conclusion At 6 months after ICU discharge, when evaluated with
a specific critical care questionnaire, survivors of severe
sepsis/septic shock exhibited a similar, if not a better, HR-QOL
than ICU survivors without sepsis.
Table 1
Sepsis/control group P
BPA (%) problems 18/32 0.015
NDA (%) problems 71/83 0.028
ES (%) problems 62/72 0.104
QOL-SP Index 4/5 0.058